Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AC011043.1		ENSG00000276256	"Uncharacterized LOC389831"		Unmapped	42939-49164	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 18.4;Distal tubular cells: 19.6;Proximal tubular cells: 27.9"					"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 140.0"															NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"																					6.2	12.2	10.6	7.4	10.3	0.8	16.5	11.9	13.5	10.3	9.0	16.7	25.7	15.3	19.2	11.3	16.6	13.3	11.9	11.1	11.4	60.9	43.0	7.2	8.9	11.2	12.0	20.5	40.2	21.5		20.8	11.0	39.0	19.9	12.7	10.0	32.1	6.9	11.1	15.0	18.6	11.4	10.5	20.4	7.6	10.8	18.9	8.7	22.9	6.8	17.2		12.2	140.0	70.7	76.1	75.6	39.2	40.8	23.0	13.9	9.0	11.2	16.3	80.4	24.2	11.3	45.4	9.6	79.7	50.9	12.6	42.1	18.1	70.7	49.1	24.7	22.5	47.5	8.5	13.6	21.6	14.0	18.1	14.0	36.3	39.1	14.3	17.2	53.7	18.3	48.8	7.8	19.1	65.9	6.4	65.2	7.0	0.0	31.7	5.2	11.8	19.6	28.5	73.8	2.2	26.1	77.6	13.3	25.6	13.6	8.1	32.2	13.9	1.4	31.5	0.7	2.0	0.5	18.7	4.6	20.7	0.0	0.3	0.0	1.2	0.0	2.0	1.1	0.5	1.7	2.0	0.2	0.3	1.3	0.0	7.2	0.1	1.3	2.9	0.8	10.6	10.3	11.9	13.5	11.1	11.4	11.2	12.0	11.0	11.4	10.8	12.2	1.8	12.8	11.8	0.0	0.9	1.9	2.2	4.7	7.4	2.2	2.5	3.4	0.0	15.7	4.6	18.4	0.0	2.7	1.3	3.7	19.6	14.8	1.4	1.7	2.7	4.2	8.5	7.2	0.0	5.9	5.2	2.9	5.6	2.1	3.8	3.7	4.2	1.8	0.6	0.0	0.0	5.0	4.1	0.3	0.7	2.0	0.9	1.0	0.0	0.0	1.8	9.2	5.2	0.0	0.0	8.6	8.3	3.4	2.9	1.3	6.2	27.9	8.6	1.0	6.6	3.0	2.1	0.1	0.4	4.4	1.7	4.1	1.2	2.3	5.3	1.8
AC020765.6		ENSG00000288656	"Novel protein"		16	28537040-28623555	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	4	"brain: 1.4"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																	NA	NA			"Cluster 48: NK-cells - Unknown function"																								0.1	0.0	0.2	0.1	0.4	0.0	0.1	1.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.3	0.0	0.0		0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	1.3	0.0	0.1	0.1	0.0	0.1	0.2	0.3	0.0	0.6	0.1	0.0	0.5	0.2	0.2	0.4	1.1	1.4	0.5	0.0	0.2	0.2	0.4	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC022150.4		ENSG00000269825	"Novel zinc finger protein"		19	52650447-52690533	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 15.0"									HPA042466	Uncertain		Approved	"Nucleoli rim"		NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 15: RT4 - Unknown function"		"Nucleoli rim"		"HPA042466: AB_10797497"	"unprognostic (2.33e-3)"	"unprognostic (9.06e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.55e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.73e-3)"	"unprognostic (3.17e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.89e-1)"	1.1	1.1	1.7	2.0	4.9	3.1	1.6	5.2	2.1	1.0	2.2	0.7	0.8	1.4	2.1	1.1	0.8	1.6	0.8	1.1	2.1	1.4	0.3	1.2	1.6	3.8	2.4	1.2	1.1	1.2		2.8	4.0	1.4	0.9	3.1	0.9	2.0	0.5	2.1	0.6	1.2	2.5	1.8	1.3	1.8	2.6	2.1	1.5	0.6	1.9	1.1		3.2	5.0	0.0	2.6	6.4	0.6	1.4	6.1	5.1	3.0	3.7	4.5	4.3	2.9	4.1	1.4	2.8	2.5	1.8	4.6	2.4	5.7	0.1	0.4	2.5	14.3	0.8	0.5	3.1	4.0	1.6	0.3	5.4	6.4	1.2	4.0	4.4	4.5	1.7	3.5	2.1	4.4	2.3	1.6	0.0	7.1	6.9	4.7	2.2	2.4	15.0	2.9	1.8	6.4	2.7	0.5	6.4	7.3	2.1	5.7	9.6	4.2	1.8	7.8	0.1	3.0	5.7	0.1	1.5	5.1	0.8	0.3	0.2	0.7	0.3	0.5	0.5	0.5	0.8	0.2	0.5	0.5	0.7	0.7	0.9	0.3	0.4	0.5	0.3	1.7	4.9	5.2	2.1	1.1	2.1	3.8	2.4	4.0	2.5	2.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC068775.1		ENSG00000255641	"Novel protein"		12	10412312-10436001	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 5.1;choroid plexus: 2.5;lymphoid tissue: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 134.8"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 134.8"	"Cell line enhanced"	"Detected in some"		"GAMG: 3.1;HeLa: 8.6;HSkMC: 1.5;SuSa: 3.4"									HPA062570	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"			"HPA062570: AB_2684795"					"unprognostic (6.09e-2)"													0.4	0.1	3.5	0.3	3.4	1.7	0.2	3.1	5.1	0.1	2.5	0.6	0.3	0.4	0.0	0.1	0.2	0.1	0.2	3.7	3.6	0.1	0.4	1.0	0.8	3.8	3.5	0.1	0.1	0.0	0.0	0.1	3.8	0.2	0.4	0.1	0.4	0.0	0.0	0.0	0.8	0.1	3.4	5.0	0.4	0.2	3.8	0.6	0.2	0.0	0.4	0.2	0.2	4.2	0.0	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.8	0.0	0.0	0.0	0.5	8.6	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.0	17.2	0.0	0.1	0.0	0.0	15.0	0.0	0.0	0.1	20.8	0.8	134.8	0.0	0.1	0.0	8.4	3.5	3.4	3.1	5.1	3.7	3.6	3.8	3.5	3.8	3.4	3.8	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
ACAD11	FLJ12592	ENSG00000240303	"Acyl-CoA dehydrogenase family member 11"	Q709F0	3	132558138-132660082	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.4;liver: 103.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 6.4;Erythroid cells: 5.7;Plasma cells: 7.6;Syncytiotrophoblasts: 9.7"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048317	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"			"HPA048317: AB_2680354"	"unprognostic (5.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.93e-1)"	16.2	7.6	8.6	2.8	11.3	7.8	6.1	9.3	13.3	8.5	23.3	7.7	17.0	8.0	6.7	4.0	8.5	4.0	15.4	8.8	9.0	64.4	103.6	5.8	3.3	10.2	9.9	9.9	8.2	8.8	9.8	9.8	10.0	6.6	3.4	11.7	5.7	6.0	4.3	6.3	15.8	6.4	9.6	4.3	4.8	8.2	10.3	4.6	6.4	2.0	3.2	5.5	6.5	11.5	5.8	5.2	10.5	13.6	23.2	17.9	10.5	13.6	21.0	8.0	10.5	19.3	2.1	3.9	7.6	7.7	9.0	4.3	8.0	11.9	12.7	6.7	5.6	4.3	5.5	18.1	23.0	4.7	4.1	12.2	8.9	11.0	27.2	18.6	7.9	5.0	2.3	8.2	11.2	7.8	3.0	3.2	6.2	2.8	5.2	3.3	8.4	6.4	18.0	3.8	4.1	6.7	10.5	5.0	28.5	10.9	10.5	3.4	6.5	6.3	3.9	3.6	4.8	6.7	2.3	4.0	8.4	1.6	5.2	0.0	0.2	0.0	0.6	0.4	0.5	0.6	0.6	0.3	0.2	0.6	1.4	0.7	0.0	0.9	0.3	0.9	0.3	0.2	8.6	11.3	9.3	13.3	8.8	9.0	10.2	9.9	10.0	9.6	10.3	11.5	1.4	6.4	3.2	0.0	2.1	0.1	0.2	0.7	2.8	0.9	0.6	0.4	0.0	0.0	0.8	0.0	0.0	4.2	0.8	0.4	0.0	0.8	0.6	1.5	2.0	1.0	4.8	5.7	0.0	1.1	0.9	1.6	0.0	0.8	1.3	1.5	0.4	3.9	0.7	0.0	0.0	0.5	0.0	0.8	0.2	0.2	0.6	0.8	0.0	0.0	2.3	0.6	4.1	0.0	0.0	0.4	0.2	0.7	7.6	0.2	4.4	1.6	1.0	2.9	0.0	0.9	1.1	0.1	0.3	0.9	0.3	9.7	2.2	1.1	0.7	0.1
ACVR2A	"ACTRII, ACVR2"	ENSG00000121989	"Activin A receptor type 2A"	P27037	2	147844517-147930826	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.5;Inhibitory neurons: 63.4;Oligodendrocyte precursor cells: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 26.3;RH-30: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046997	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA046997: AB_10970077"	"unprognostic (4.55e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.34e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.41e-3)"	"unprognostic (8.73e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.99e-2)"	7.3	4.0	6.2	4.6	7.4	3.3	7.0	10.8	6.4	5.4	1.0	6.3	7.7	5.2	6.6	7.2	4.5	7.7	3.7	7.5	7.5	5.6	7.4	4.6	3.1	2.6	4.5	4.5	4.4	4.3	3.9	7.7	3.9	6.8	6.5	8.3	7.5	5.2	17.5	19.5	9.3	7.0	3.8	4.0	6.8	6.4	8.6	2.3	6.7	6.3	3.9	7.4	7.4	4.6	1.8	2.1	13.2	5.0	7.3	4.7	5.4	4.1	5.0	6.9	12.0	5.8	8.1	0.1	3.6	6.7	2.5	6.2	12.0	6.1	8.8	1.4	7.3	0.9	3.6	10.2	26.3	1.0	0.9	8.1	7.3	4.5	8.9	5.2	5.3	1.6	2.0	3.5	4.7	4.8	0.4	0.8	14.9	5.5	3.6	0.2	23.3	1.3	5.6	11.5	13.0	7.3	3.5	4.2	5.4	5.6	2.5	1.4	4.1	6.4	7.5	6.1	2.9	1.0	0.3	2.4	3.9	0.5	5.2	0.2	1.7	0.2	0.6	2.0	0.2	0.1	2.4	1.1	1.3	0.3	1.5	0.3	0.0	4.8	2.0	1.7	0.2	0.7	6.2	7.4	10.8	6.4	7.5	7.5	2.6	4.5	3.9	3.8	8.6	4.6	13.7	6.4	7.0	26.8	1.5	29.7	6.9	9.5	13.1	15.4	6.8	12.4	7.9	17.2	10.7	7.3	14.6	4.9	6.0	16.5	1.9	6.3	5.3	6.4	12.2	11.9	9.0	0.0	62.5	6.3	2.5	17.4	6.6	5.7	0.0	2.2	11.7	12.1	5.4	11.8	63.4	12.9	8.2	7.3	18.9	2.1	9.9	5.7	10.6	33.7	7.2	3.3	6.2	84.9	34.1	7.6	10.0	11.3	5.2	7.7	23.7	5.8	10.2	9.4	32.9	8.3	10.9	18.2	14.1	14.4	29.8	5.3	5.9	2.9	11.7	11.8
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044578, HPA061919"	Approved					NA	NA		5300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	141.5	71.3	48.3	52.5	48.2	28.5	111.9	48.0	56.0	92.7	55.8	158.8	94.2	134.8	142.2	114.4	95.9	69.3	124.3	45.9	54.6	175.4	264.1	73.5	51.3	47.6	48.5	118.4	49.4	50.1	41.4	60.9	47.9	116.2	100.8	36.0	65.4	124.6	80.9	54.8	94.3	118.0	49.7	51.6	91.3	52.2	48.6	83.3	79.2	75.8	55.5	158.9	73.9	51.4	84.0	66.9	194.8	110.0	344.7	316.0	116.6	136.6	237.6	143.8	125.2	77.1	96.7	96.5	77.5	197.8	92.8	69.8	135.0	188.7	137.7	69.9	56.6	67.1	83.3	306.7	332.2	118.4	51.9	287.3	143.1	108.3	84.7	151.0	112.8	99.8	125.8	53.3	192.3	94.9	160.4	105.4	156.7	20.6	79.8	115.4	108.9	50.9	230.2	96.0	74.0	97.0	82.7	96.6	155.9	141.8	78.2	82.2	85.4	130.5	82.9	86.4	95.2	55.9	74.4	135.4	134.2	77.4	135.7	21.8	21.2	35.8	32.6	18.9	29.5	26.0	35.3	30.4	23.8	26.2	34.0	31.9	3.0	51.3	14.1	20.5	49.5	32.8	48.3	48.2	48.0	56.0	45.9	54.6	47.6	48.5	47.9	49.7	48.6	51.4	69.0	105.8	78.2	22.9	48.1	39.6	85.9	257.5	109.3	31.8	32.1	74.3	127.4	78.6	94.3	55.2	10.4	290.1	51.8	80.4	197.6	94.8	24.0	146.9	159.1	56.3	79.7	45.8	14.3	83.8	277.2	131.2	37.8	113.0	26.6	83.3	47.2	188.0	118.1	38.7	12.0	101.8	87.5	48.6	27.1	22.0	187.4	43.4	53.4	15.9	63.2	152.4	77.2	27.6	13.9	78.4	86.0	255.1	41.5	34.9	95.2	316.0	56.8	46.5	111.7	55.6	127.7	30.5	48.5	74.9	23.0	83.0	58.5	147.0	104.8	68.1
AGK	"FLJ10842, MULK"	ENSG00000006530	"Acylglycerol kinase"	Q53H12	7	141551278-141655244	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Cardiomyopathy, Cataract, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.4;Inhibitory neurons: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 97.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020959, HPA053471"	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria	Vesicles	"HPA020959: AB_1854206, HPA053471: AB_2682164"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.47e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.90e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.18e-1)"	10.1	14.7	9.4	8.5	10.9	5.6	11.9	8.3	12.8	11.5	10.2	11.8	5.9	11.7	14.5	12.2	12.2	7.8	30.4	11.1	10.8	15.7	14.1	11.6	12.1	8.0	8.8	11.3	10.1	21.5	13.7	10.0	9.0	12.8	13.1	12.7	13.7	11.4	8.6	9.6	12.0	15.4	8.2	16.6	12.2	6.6	10.0	14.0	12.7	10.0	14.7	10.8	11.5	9.0	23.7	25.6	26.7	21.8	21.2	29.4	16.2	23.5	29.3	44.5	50.9	24.7	18.3	26.3	24.0	26.8	40.5	18.7	41.6	32.8	51.0	33.8	32.7	26.1	10.7	18.7	34.1	15.6	12.5	29.9	26.9	36.3	33.1	19.8	34.1	32.3	36.3	36.9	25.3	24.6	47.3	9.1	25.6	19.9	32.4	29.2	4.2	80.1	33.1	20.8	23.3	29.6	24.6	29.7	27.1	26.1	16.3	20.2	19.5	18.9	14.1	23.8	38.1	29.5	31.9	14.4	30.7	9.1	50.4	0.4	7.1	1.2	22.1	13.9	15.3	10.8	17.3	26.0	16.2	6.5	12.8	23.5	1.2	97.3	8.2	6.3	18.9	15.7	9.4	10.9	8.3	12.8	11.1	10.8	8.0	8.8	9.0	8.2	10.0	9.0	8.4	0.0	6.0	22.5	11.4	3.1	5.6	7.9	5.2	11.8	5.5	5.1	18.1	2.8	6.6	12.9	8.4	15.7	15.8	3.0	9.8	6.6	9.9	7.4	9.0	7.5	0.0	11.8	43.4	6.9	8.2	7.7	10.7	6.6	8.2	9.9	4.2	4.1	7.0	15.2	43.0	3.9	12.2	5.1	4.9	12.0	6.8	5.6	7.2	26.2	12.4	11.2	27.8	38.7	37.9	6.1	2.1	10.5	22.1	2.9	2.4	8.2	7.6	17.4	0.0	6.2	8.0	6.2	4.9	11.3	2.7	9.2	15.0	14.2	5.6	3.8
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186613060-186621318	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4302	"liver: 5817.6"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 1242.5"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	78	"Hep G2: 2287.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	864000000000	110000000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	1.3	5817.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	1.0	2287.3	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	3.5	0.0	0.0	1.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.2	0.0	0.1	3.9	0.2	4.3	0.2	0.1	0.9	0.0	32.0	0.6	0.6	2.4	0.1	0.0	0.1	0.0	0.0	28.2	1242.5	1.3	0.0	0.1	0.0	0.0	32.4	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	2.0	0.0	0.0	0.1
ALG1L	ALG1L1	ENSG00000189366	"ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like"	Q6GMV1	3	125929275-125937039	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"epididymis: 10.8;urinary bladder: 9.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 33.6;Club cells: 15.2;Endometrial ciliated cells: 10.5;Ionocytes: 12.2;Respiratory ciliated cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.9;CAPAN-2: 14.3;HaCaT: 15.2;MCF7: 30.1;OE19: 19.1;T-47d: 19.7"									HPA036108	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA036108: AB_10673344"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.57e-2)"	"prognostic favorable (6.24e-4)"	0.5	1.1	2.5	1.1	2.7	0.3	1.4	2.0	3.0	1.6	1.4	1.4	0.4	1.4	10.8	1.6	2.2	0.8	0.7	2.4	2.6	1.7	1.4	1.0	0.4	2.5	2.4	2.3	1.3	0.6	1.8	1.5	2.5	1.8	0.8	0.6	1.9	0.9	6.7	5.8	0.5	0.5	2.1	0.3	1.5	1.2	2.4	1.1	1.6	2.6	2.7	9.4	1.5	2.5	1.1	0.8	0.4	0.0	0.0	0.2	1.8	0.1	0.0	0.2	0.4	15.9	14.3	4.4	6.8	0.0	0.3	15.2	0.4	0.0	0.8	0.6	3.6	0.8	2.4	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	4.1	1.2	1.4	0.0	30.1	1.0	0.3	6.4	19.1	3.8	0.1	0.1	7.4	0.0	0.9	2.4	0.9	0.5	0.2	0.7	3.2	19.7	0.4	0.3	0.2	2.2	0.2	0.1	10.9	1.7	5.9	0.2	0.0	1.0	2.5	0.0	0.1	2.0	0.1	1.1	1.6	1.0	2.2	0.0	0.9	1.2	0.7	0.4	3.2	0.0	1.3	2.7	0.9	2.5	2.7	2.0	3.0	2.4	2.6	2.5	2.4	2.5	2.1	2.4	2.5	0.2	0.0	0.5	0.3	0.7	3.3	1.7	33.6	0.6	0.3	2.1	2.4	0.0	0.0	15.2	1.8	0.0	3.5	0.5	0.3	1.9	0.4	1.7	10.5	0.8	0.3	1.8	0.0	1.2	0.4	2.0	1.1	0.0	0.4	1.3	1.4	0.0	0.1	0.3	0.0	1.7	0.2	12.2	0.0	1.2	1.8	1.8	0.1	1.8	0.0	0.2	1.5	2.1	1.0	0.6	0.6	1.4	3.0	0.4	0.5	0.0	1.0	46.0	0.0	0.0	2.7	2.6	1.4	1.6	0.3	5.1	1.4	0.5	2.4	0.4	8.2
ANO7	"IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G"	ENSG00000146205	"Anoctamin 7"	Q6IWH7	2	241188509-241225377	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.3;prostate: 69.6;stomach 1: 28.1"	"Group enriched"	"Detected in many"	5	"Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 53.4"	"Cancer enriched"	"Detected in many"	19	"prostate cancer: 32.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.2;Hep G2: 2.3;OE19: 2.5"	"Low region specificity"	"Detected in many"							HPA078464	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA078464: "	"unprognostic (1.93e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.94e-2)"	"unprognostic (4.82e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.53e-2)"	0.3	0.3	0.2	1.0	0.7	3.6	0.2	0.2	1.0	0.3	0.0	16.3	10.7	0.5	0.0	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.1	0.1	0.0	1.2	0.2	0.5	0.4	0.0	0.2	0.1	0.4	69.6	10.1	0.0	4.9	0.2	0.0	0.2	14.7	0.1	0.3	0.3	28.1	0.2	0.8	0.0	0.2	0.0	0.0	0.2	0.2	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.7	0.2	1.0	0.2	0.2	1.2	0.2	0.4	0.3	0.8	1.6	1.2	0.0	0.0	1.6	0.7	0.3	0.8	0.8	1.2	0.2	1.9	2.7	1.6	0.0	0.2	0.0	0.0	0.6	0.1	2.6	0.0	2.7	0.1	0.8	0.7	2.1	3.0	0.0	4.8	4.2	5.6	2.0	80.0	1.9	0.0	12.4	2.9	3.9	1.5	0.0	2.7	53.4	0.0	1.3	0.0	0.0	3.4	0.7	1.8	7.5	0.0	1.4	0.0	1.0	6.9	6.4	1.9	2.2	0.5	11.9	3.6	2.8	0.0	0.6	0.0	0.8	1.0	0.1	1.7	0.1	0.0	0.7	0.3	2.6	2.4	0.8
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000363-55009057	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: AB_2680448"	"unprognostic (2.90e-2)"	"prognostic favorable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.63e-4)"	7.2	8.9	6.1	8.8	6.3	10.0	7.2	6.0	6.6	7.6	6.5	8.9	8.9	7.4	8.5	15.5	7.3	6.3	9.0	5.9	6.4	10.8	11.0	7.2	11.3	6.4	6.3	9.6	7.4	7.1	7.0	9.0	6.3	7.8	10.5	2.3	7.0	6.6	7.5	12.2	9.1	7.0	6.3	11.2	7.9	4.1	6.6	10.9	6.3	7.3	13.5	10.2	9.4	6.7	36.9	32.4	12.5	18.3	17.9	11.9	21.3	14.8	19.8	28.0	27.2	17.8	30.0	24.1	22.7	14.0	33.0	26.9	29.1	28.2	21.0	19.7	22.1	29.4	31.6	18.3	11.5	18.3	26.6	11.8	22.6	39.6	14.2	13.2	22.6	25.3	15.4	15.9	21.2	35.7	24.9	23.8	25.0	17.4	38.6	21.8	20.8	26.4	15.2	18.1	11.6	12.7	28.0	33.4	14.7	28.5	26.4	14.1	13.1	16.6	23.9	33.7	19.6	16.4	22.9	19.9	17.7	30.9	20.1	16.2	11.5	13.1	10.2	14.4	8.6	8.2	9.6	10.2	13.7	8.5	8.5	8.4	4.1	42.0	13.4	7.4	11.6	10.1	6.1	6.3	6.0	6.6	5.9	6.4	6.4	6.3	6.3	6.3	6.6	6.7	6.1	3.2	11.8	1.6	12.7	12.9	12.5	20.1	6.8	3.6	7.2	7.1	5.9	15.7	14.9	11.0	0.0	52.7	7.1	17.9	15.6	31.5	0.3	6.0	5.7	11.5	6.1	31.5	0.8	15.1	35.3	7.6	10.2	9.7	8.8	13.1	10.4	11.4	24.2	6.7	0.7	10.1	10.2	10.9	11.1	1.1	5.9	12.0	0.0	1.9	21.7	5.2	16.5	1.0	1.9	20.5	19.1	8.6	9.8	10.5	16.6	21.6	11.8	2.1	19.7	4.4	6.9	1.4	10.6	13.8	12.6	47.6	11.6	12.4	13.7	13.2
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44946035-44949565	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Disease variant, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	83	"liver: 9641.4"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 1170.2"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	30	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	30	"NK-cells: 3.2"	"Group enriched"	"Detected in many"	4	"Hep G2: 713.0;THP-1: 1354.4"									HPA055877	Supported				"Secreted to blood"	NA	NA	43000000000	49000000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA055877: AB_2682953"	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"	1.2	5.4	49.5	1.7	55.2	1.1	5.3	55.1	116.2	4.5	44.7	4.3	41.4	1.2	4.8	2.4	4.3	3.7	0.8	50.7	69.2	16.3	9641.4	34.9	15.8	65.3	64.9	0.4	2.2	6.6	3.0	2.9	74.3	1.3	4.4	2.8	2.4	2.1	1.9	4.3	65.6	0.7	63.3	3.9	2.7	1.1	59.9	3.2	0.9	0.7	9.9	2.2	0.8	75.0	2.9	0.6	0.3	0.4	0.5	0.6	1.3	0.1	0.0	0.0	0.1	2.0	2.8	0.7	0.3	0.0	0.0	2.6	0.0	0.1	0.0	0.7	0.1	123.0	2.7	713.0	0.2	15.4	237.5	0.2	0.3	0.0	0.0	0.3	0.0	0.1	1.7	2.9	0.1	0.8	0.9	126.3	0.5	3.2	0.4	0.8	5.2	1.1	0.0	1.5	0.1	0.1	1.9	0.2	7.7	0.0	0.7	1354.4	0.0	0.3	0.6	0.8	0.8	2.3	0.9	2.2	0.2	3.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	49.5	55.2	55.1	116.2	50.7	69.2	65.3	64.9	74.3	63.3	59.9	75.0	0.1	0.0	2.3	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.1	11.5	0.0	3.7	0.0	0.1	0.1	0.0	3.9	0.0	0.0	0.0	0.1	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	13.6	1170.2	33.8	0.0	0.0	0.4	0.0	15.5	1.2	0.0	0.0	24.0	7.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	10.0	0.7	0.0	0.1	17.7	32.3	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.4	0.3	1.8	0.0	1.3	0.0
APOL1	APOL	ENSG00000100342	"Apolipoprotein L1"	O14791	22	36253071-36267530	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 220.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 106.1;Glandular and luminal cells: 216.2;Hepatocytes: 115.6;Pancreatic endocrine cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 243.9;HDLM-2: 166.1;HHSteC: 120.3;RPTEC TERT1: 91.1;RT4: 146.8"									"HPA018885, CAB056156"	Supported				"Secreted to blood"	NA	NA	1640000000	9200000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"CAB056156: AB_2665576, HPA018885: AB_1844953"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.07e-3)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (7.43e-6)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.05e-3)"	"prognostic favorable (2.01e-5)"	45.3	15.8	8.1	62.5	8.2	4.2	28.4	7.8	9.8	53.8	9.4	32.0	32.7	38.8	17.7	25.7	36.7	69.0	29.5	7.4	8.4	44.5	220.5	59.5	23.1	10.0	8.5	24.8	9.0	4.9	14.1	53.0	9.6	37.5	27.2	0.9	29.7	52.2	11.7	7.1	28.9	65.4	9.0	56.8	64.9	7.9	10.8	24.9	18.0	13.8	23.6	117.7	29.9	8.2	21.6	5.1	0.1	0.6	46.8	44.6	14.2	2.3	9.0	13.7	38.6	0.6	34.4	7.0	243.9	24.8	31.3	5.3	0.0	19.2	3.6	166.1	0.2	6.1	3.2	41.4	120.3	2.4	20.2	8.3	1.7	38.0	0.8	2.0	27.3	1.3	23.8	85.1	2.4	0.2	8.5	2.1	0.6	0.6	0.2	13.6	2.6	3.2	91.1	146.8	1.9	0.1	10.9	5.8	2.1	0.3	0.8	7.8	24.7	29.5	12.4	3.2	1.5	6.5	4.0	1.6	16.0	12.4	4.6	15.6	6.1	5.5	12.6	6.8	10.7	2.6	8.1	11.2	4.3	1.4	4.6	6.3	16.1	22.4	10.3	0.5	5.4	7.2	8.1	8.2	7.8	9.8	7.4	8.4	10.0	8.5	9.6	9.0	10.8	8.2	37.4	57.7	34.3	0.3	7.2	1.7	21.4	73.5	2.8	0.5	6.3	3.0	3.6	15.7	67.1	18.4	2.1	11.0	12.6	31.2	0.0	37.8	0.8	106.1	48.8	41.3	7.7	3.8	0.1	20.0	8.2	27.3	45.9	216.2	11.4	4.3	49.6	115.6	9.1	0.0	0.1	17.7	32.6	15.8	5.3	1.4	27.4	10.9	0.0	7.5	19.4	0.1	36.0	0.0	0.0	105.1	19.9	24.0	15.0	31.2	20.5	2.1	60.5	1.3	6.6	5.5	10.6	0.4	0.4	3.4	2.3	6.7	12.9	1.6	4.6	62.5
ARHGAP12	"FLJ10971, FLJ20737, FLJ21785"	ENSG00000165322	"Rho GTPase activating protein 12"	Q8IWW6	10	31805398-31928876	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000412	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA000412: AB_10964051"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (5.88e-3)"	"unprognostic (6.44e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.01e-2)"	"unprognostic (5.48e-3)"	8.6	12.5	9.3	8.5	13.0	4.2	16.4	18.5	7.6	13.2	15.8	15.7	15.4	9.3	10.8	9.3	7.8	15.2	11.8	8.0	15.7	14.6	16.3	12.3	7.2	22.1	17.8	14.9	21.3	19.5	6.6	10.8	20.5	11.6	14.7	17.8	16.6	8.0	7.9	8.1	15.8	8.0	17.9	17.8	29.4	6.6	15.0	5.9	16.1	9.6	8.0	10.8	6.9	27.0	23.3	30.8	18.8	16.6	28.0	31.3	12.4	14.4	19.3	11.0	16.1	16.5	56.6	6.8	8.6	23.6	18.9	13.1	9.1	16.6	19.3	3.0	8.8	1.3	5.5	31.5	17.7	1.2	1.3	19.9	14.0	16.7	12.0	18.2	11.7	6.3	14.0	2.1	25.1	16.5	4.4	2.5	6.6	31.0	4.7	6.0	22.1	5.7	19.7	22.2	10.2	9.8	7.4	7.1	37.0	16.9	4.8	4.7	17.3	12.6	18.8	29.2	11.0	2.0	2.7	7.5	18.9	9.4	16.4	0.0	1.2	0.0	3.0	2.7	2.4	2.5	2.5	3.3	0.7	2.2	3.1	3.2	1.7	4.2	2.5	1.0	3.1	1.6	9.3	13.0	18.5	7.6	8.0	15.7	22.1	17.8	20.5	17.9	15.0	27.0	19.0	48.1	45.3	54.5	17.8	24.6	14.9	17.1	37.5	14.5	34.2	19.3	33.5	34.3	29.4	22.0	29.2	9.1	20.0	32.9	11.7	28.5	1.3	21.2	24.2	14.9	33.0	3.8	39.1	29.6	5.4	34.0	69.8	28.6	3.8	24.5	13.6	19.4	19.2	58.9	103.2	38.1	8.2	18.7	12.6	3.3	18.0	13.4	21.4	156.4	6.5	20.7	22.6	94.0	81.5	34.3	28.3	22.2	12.9	22.1	26.9	21.3	27.1	25.1	13.1	49.5	17.8	12.6	24.5	16.5	20.6	9.7	17.3	37.4	24.1	22.9
ARHGAP32	"GC-GAP, GRIT, KIAA0712, MGC1892, RICS"	ENSG00000134909	"Rho GTPase activating protein 32"	A7KAX9	11	128965060-129279324	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 240.6;Excitatory neurons: 403.4;Inhibitory neurons: 239.7;Oligodendrocyte precursor cells: 170.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 26.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 36.6;RT4: 39.5;SK-BR-3: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038382, HPA038389, HPA061505"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544"	"unprognostic (1.17e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (1.47e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.64e-2)"	4.7	7.5	2.6	3.4	8.2	2.1	10.3	0.0	26.6	11.9	0.0	14.1	21.1	8.1	9.0	26.3	13.3	7.6	4.3	15.1	0.0	7.0	5.0	5.8	1.6	0.0	0.0	10.9	15.2	10.7	6.1	8.6	0.0	6.4	15.8	33.5	15.8	4.2	7.6	20.1	20.6	5.9	0.0	3.0	12.0	10.7	0.0	10.5	3.8	4.3	6.9	9.4	17.1	5.1	12.2	6.4	19.7	0.1	6.3	6.3	14.2	4.5	6.3	2.8	3.4	14.9	24.7	0.1	6.7	8.7	14.1	27.2	9.0	11.4	5.4	0.0	3.1	0.2	3.4	5.6	3.1	0.0	0.0	6.1	14.4	2.7	16.3	6.2	3.5	10.2	0.6	0.2	4.9	9.5	10.2	0.2	5.4	36.6	6.8	24.9	5.9	2.5	3.0	39.5	19.3	7.9	6.8	42.3	8.0	7.5	21.9	3.9	6.6	9.9	5.2	5.9	8.9	0.3	0.0	0.1	4.3	27.4	6.4	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.7	0.1	0.3	0.1	0.1	2.6	8.2	0.0	26.6	15.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.3	6.4	16.8	240.6	3.4	18.2	12.7	29.1	16.5	31.6	36.5	17.1	4.3	14.3	46.6	11.0	123.0	23.1	4.8	48.7	1.9	8.3	19.0	27.7	10.0	5.6	40.7	2.5	403.4	27.2	4.2	14.1	35.2	25.4	1.3	9.8	5.0	16.2	6.5	18.5	239.7	61.9	20.3	4.1	4.2	12.3	6.8	5.7	16.0	103.0	2.9	113.6	0.0	170.9	95.0	24.5	44.2	13.2	1.5	22.7	52.7	9.9	61.6	37.9	19.7	19.4	9.5	8.6	9.6	55.4	31.1	28.5	2.0	4.0	54.0	59.5
ARHGEF9	"KIAA0424, PEM-2"	ENSG00000131089	"Cdc42 guanine nucleotide exchange factor 9"	O43307	X	63634967-63809274	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 88.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 184.3;Cone photoreceptor cells: 233.5;Rod photoreceptor cells: 320.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035419, HPA055291"	Approved		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA035419: AB_10669859, HPA055291: AB_2682774"	"unprognostic (3.19e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.02e-5)"	"unprognostic (4.56e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.98e-2)"	7.7	15.6	32.6	6.4	39.3	4.1	10.6	5.1	51.0	8.4	5.2	13.6	15.8	9.3	7.1	11.2	7.7	8.0	35.9	46.2	36.6	13.2	5.6	6.3	6.3	13.1	14.3	16.2	5.2	15.0	15.7	5.8	14.3	13.8	14.3	88.1	6.3	14.6	5.9	9.1	13.4	17.2	10.0	6.9	8.9	2.8	26.7	9.5	8.2	8.9	7.3	14.3	6.5	27.2	6.3	9.7	20.2	10.3	7.6	11.1	1.2	12.3	11.8	12.8	9.8	0.6	6.8	14.1	8.7	8.0	10.8	0.2	8.4	14.5	15.1	18.5	6.6	13.7	4.5	0.6	4.5	6.7	4.2	12.2	6.9	5.9	18.5	11.9	7.1	14.8	1.5	20.8	14.0	10.0	12.6	3.3	16.4	6.2	12.1	22.9	48.2	13.5	7.8	6.0	0.1	5.1	5.6	9.8	6.7	8.4	7.5	8.9	3.4	7.1	6.4	34.6	5.1	7.8	6.5	10.2	8.7	10.7	5.1	0.8	1.4	1.3	4.5	2.0	3.2	2.2	2.7	3.1	2.2	2.9	3.3	2.9	1.1	8.4	1.4	1.8	2.6	1.9	32.6	39.3	5.1	51.0	46.2	36.6	13.1	14.3	14.3	10.0	26.7	27.2	9.2	9.6	11.4	59.4	20.3	5.7	6.5	8.7	12.5	184.3	26.0	17.4	45.9	7.2	10.0	11.0	233.5	5.0	19.4	18.2	13.7	6.3	2.0	6.5	9.8	10.8	20.9	3.8	105.9	8.8	1.4	11.8	24.5	6.0	14.5	20.0	11.7	10.7	10.5	82.4	90.5	16.0	12.2	5.7	6.3	6.2	15.5	8.2	14.2	33.7	3.8	29.9	34.0	89.0	50.5	7.9	14.5	15.4	12.4	4.3	19.1	17.3	9.3	320.8	0.0	12.7	22.0	1.9	3.4	11.2	6.0	4.4	21.8	39.6	21.8	6.1
ARL14EP	"ARF7EP, C11orf46, FLJ38968"	ENSG00000152219	"ADP ribosylation factor like GTPase 14 effector protein"	Q8N8R7	11	30323104-30338223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039634, HPA048127"	Approved		Supported	"Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA039634: AB_2676606, HPA048127: AB_2680277"	"prognostic favorable (2.50e-5)"	"unprognostic (8.93e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (2.50e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.76e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (7.49e-4)"	13.9	22.5	13.5	13.2	15.6	8.0	20.0	15.9	17.3	17.0	14.9	11.8	9.5	18.9	23.2	11.6	16.4	13.1	22.9	15.7	14.2	17.4	19.7	10.9	22.5	12.4	13.3	20.5	12.9	26.1	12.0	11.5	12.1	19.7	10.8	15.9	19.1	19.9	20.6	12.6	9.7	14.5	13.9	20.8	15.7	14.6	13.3	15.6	24.7	20.8	21.4	14.5	8.1	13.8	10.8	15.4	16.9	14.8	27.1	29.2	8.5	20.8	26.0	18.4	20.2	8.5	4.1	43.8	13.9	15.0	20.5	17.8	24.8	17.5	25.9	35.2	30.7	13.3	12.0	15.0	42.6	24.0	14.7	30.5	34.7	8.7	32.8	26.7	20.6	17.9	21.4	23.2	32.5	10.4	21.9	19.6	19.6	24.1	21.3	18.8	41.2	18.0	24.7	14.8	19.2	20.4	16.2	21.4	25.8	15.0	22.8	13.4	18.1	20.8	11.2	41.7	20.1	36.0	21.9	28.5	20.0	14.8	20.4	12.7	19.2	6.4	23.3	20.0	55.5	35.9	28.2	25.9	26.3	28.9	25.7	25.0	3.5	52.9	15.5	18.9	20.3	23.1	13.5	15.6	15.9	17.3	15.7	14.2	12.4	13.3	12.1	13.9	13.3	13.8	27.3	28.9	33.6	14.4	39.7	12.4	46.6	35.1	8.0	34.0	19.9	30.4	68.1	24.3	23.8	25.8	14.6	19.1	29.2	5.9	76.3	27.3	130.1	25.8	41.0	29.2	14.5	13.2	31.1	22.5	12.7	33.4	12.8	19.0	27.8	33.5	15.4	29.8	25.7	32.0	26.4	11.7	32.6	27.1	29.3	66.3	27.4	28.4	26.6	18.7	45.4	36.1	38.1	27.6	19.9	21.9	8.4	25.2	25.4	46.0	9.4	42.1	27.5	32.4	13.1	33.1	29.8	111.4	37.6	13.8	11.1	11.1	29.6	33.0	12.6	28.4
ARMC9	"ARM, FLJ12584, KIAA1868, KU-MEL-1"	ENSG00000135931	"Armadillo repeat containing 9"	Q7Z3E5	2	231198546-231376848	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 48.6;retina: 71.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 310.6;Excitatory neurons: 112.5;monocytes: 116.4;Rod photoreceptor cells: 202.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 15.5"	"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 275.2;SK-MEL-30: 222.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019041, HPA026671"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA019041: AB_1845035, HPA026671: AB_1845036"	"unprognostic (2.90e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.20e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.17e-3)"	"unprognostic (4.14e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (7.66e-5)"	2.3	15.0	4.0	5.4	5.3	1.9	3.3	1.1	15.5	5.6	48.6	14.7	1.7	19.5	5.6	4.2	8.7	7.7	2.3	5.9	1.9	5.2	0.8	7.1	1.6	0.4	2.4	9.4	3.7	10.8	11.1	5.7	0.1	5.5	5.2	71.5	3.2	6.6	1.0	2.6	6.5	23.5	0.0	1.1	8.9	9.4	0.2	3.0	7.6	1.1	2.1	6.8	2.7	1.7	21.2	10.8	20.3	15.1	14.5	23.7	8.3	23.3	275.2	28.6	35.8	3.1	10.3	2.7	11.0	68.3	46.6	12.2	24.8	22.7	25.0	1.7	15.2	1.5	14.0	11.6	41.3	5.0	5.1	63.8	8.8	38.3	13.7	73.3	21.7	12.2	4.7	0.6	46.0	29.9	6.3	6.9	44.4	7.7	12.0	7.8	18.2	0.3	30.6	6.9	15.6	32.2	9.3	25.2	222.7	17.8	9.7	5.4	22.6	17.6	10.9	10.0	10.4	24.8	6.2	1.3	33.9	1.0	17.7	1.1	0.2	0.3	0.2	0.1	0.1	0.6	0.2	0.3	0.2	0.3	0.3	0.3	0.5	2.6	0.2	0.3	0.2	0.2	4.0	5.3	1.1	15.5	5.9	1.9	0.4	2.4	0.1	0.0	0.2	1.7	1.3	3.2	36.1	25.8	1.4	1.8	5.6	6.8	1.2	24.0	5.1	5.7	3.3	2.8	7.5	3.7	310.6	4.8	0.1	4.0	1.9	7.3	69.5	25.1	22.3	4.9	7.8	1.3	112.5	17.3	3.0	7.2	3.6	4.1	3.8	6.6	2.5	1.0	10.6	1.7	62.7	6.0	0.0	0.3	2.4	23.8	14.0	6.6	19.6	17.8	116.4	16.7	1.0	25.6	14.1	11.5	1.8	21.4	1.1	1.9	0.7	5.1	31.3	202.4	6.6	5.3	6.4	36.7	15.7	0.6	0.9	2.2	1.3	6.3	10.0	2.1
ATP10A	"ATP10C, ATPVA, ATPVC, KIAA0566"	ENSG00000206190	"ATPase phospholipid transporting 10A (putative)"	O60312	15	25677271-25865184	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0"	"Cell type enriched"	"Detected in many"	6	"Microglial cells: 216.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 7.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 23.0;fHDF/TERT166: 22.9;HMC-1: 19.4;SK-MEL-30: 21.9;U-2197: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041496, HPA042509"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA041496: AB_2677513, HPA042509: AB_2678032"	"unprognostic (3.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.42e-2)"	6.5	8.7	13.7	2.7	9.3	2.5	5.3	6.0	8.9	2.0	0.7	3.2	0.8	1.5	0.1	1.9	2.3	3.7	2.0	5.9	5.8	5.8	0.6	7.1	1.8	9.9	9.7	1.1	1.4	3.5	2.1	1.7	9.5	2.2	0.8	0.1	7.9	0.6	0.6	2.5	3.0	2.8	5.9	1.5	3.2	4.3	15.0	1.1	2.5	0.7	1.1	2.5	1.4	4.9	0.0	5.7	1.3	0.0	2.2	2.8	0.0	23.0	9.3	6.1	9.9	0.0	0.0	0.0	1.6	22.9	0.0	0.0	9.3	1.2	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.0	19.4	0.9	0.0	0.6	0.0	2.5	0.0	1.2	0.0	0.0	3.3	0.0	1.2	0.0	1.5	0.0	1.5	4.4	4.6	2.8	9.9	0.0	0.0	0.1	0.0	0.0	21.9	0.0	7.4	1.2	0.0	8.9	0.2	12.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.3	0.5	0.1	0.0	0.7	0.6	0.0	1.2	0.0	1.0	0.1	0.3	13.7	9.3	6.0	8.9	5.9	5.8	9.9	9.7	9.5	5.9	15.0	4.9	0.3	32.1	8.6	2.0	0.8	1.0	0.0	2.7	0.6	0.2	2.6	1.8	1.7	1.5	5.3	0.0	0.0	0.0	11.1	0.1	0.0	0.5	23.2	2.8	2.8	4.2	0.0	0.0	4.5	0.0	0.1	5.0	3.1	7.9	15.2	0.0	0.4	0.1	2.5	0.0	2.1	0.2	0.0	2.5	5.2	21.8	4.1	4.5	17.8	216.4	2.3	0.0	14.4	1.5	2.7	0.8	0.0	17.7	1.7	0.7	0.0	0.1	4.2	0.1	0.0	4.7	9.1	0.4	1.2	0.0	0.4	0.0	8.6	0.1	0.0	0.0
B3GALNT1	"B3GALT3, beta3Gal-T3, galT3, GLOB, P1"	ENSG00000169255	"Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)"	O75752	3	161083883-161105411	"Blood group antigen proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 53.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 56.3;Cardiomyocytes: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 8.8;NK-cell: 22.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.8;NK-cells: 22.1"	"Cell line enhanced"	"Detected in many"		"RT4: 128.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041204			Approved	Vesicles		NA	NA		400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA041204: AB_10795585"	"unprognostic (3.85e-2)"	"unprognostic (5.11e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.26e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.19e-3)"	5.3	7.2	20.7	3.9	21.5	4.8	9.8	14.7	19.6	20.1	8.0	2.7	1.9	9.9	8.5	6.8	14.2	9.9	53.3	21.7	26.7	19.4	1.2	14.6	4.9	12.8	21.7	18.8	11.1	8.6	9.8	13.9	18.0	11.6	2.4	26.6	22.3	8.5	1.4	2.5	2.4	9.9	14.1	6.2	10.7	8.4	25.7	2.8	27.0	3.2	5.4	12.3	5.4	13.0	17.3	0.3	7.5	0.1	1.0	2.8	0.1	9.3	8.7	22.3	7.3	11.3	13.2	0.0	35.7	8.0	12.7	3.9	0.0	16.9	7.5	0.0	0.0	9.0	5.7	0.0	11.2	0.2	0.0	23.3	5.4	6.1	1.4	15.6	31.6	0.0	0.0	0.0	8.3	29.4	0.1	0.0	17.4	0.2	38.9	0.1	0.0	0.2	9.3	128.3	15.1	0.1	23.7	8.8	6.3	3.0	35.6	13.3	0.0	0.2	15.5	0.5	0.2	3.6	0.1	0.2	14.7	0.0	0.0	8.8	0.2	0.0	0.4	0.2	0.4	2.3	0.2	0.4	1.7	0.2	0.4	0.9	0.4	22.1	0.1	1.1	0.0	0.7	20.7	21.5	14.7	19.6	21.7	26.7	12.8	21.7	18.0	14.1	25.7	13.0	5.0	19.2	2.2	10.1	2.1	5.0	5.2	5.7	6.2	56.3	7.5	6.2	56.9	0.0	8.0	14.7	12.5	21.2	1.2	0.1	11.7	3.5	0.7	4.9	5.8	7.7	1.8	17.0	22.3	8.5	13.0	13.3	4.6	8.7	10.2	13.0	6.1	0.2	9.8	6.7	27.5	0.1	6.1	2.1	6.8	2.2	7.2	3.4	10.6	9.4	4.3	12.6	1.0	14.6	3.2	9.8	0.1	5.3	0.2	6.2	0.1	15.8	3.1	8.4	0.0	5.3	13.2	6.5	20.7	8.4	2.6	5.1	1.2	4.6	0.7	4.5
BAALC		ENSG00000164929	"BAALC binder of MAP3K1 and KLF4"	Q8WXS3	8	103140713-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 300.9;choroid plexus: 108.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 67.8;Astrocytes: 198.2;Excitatory neurons: 131.4;Inhibitory neurons: 62.3;Muller glia cells: 132.4;Oligodendrocyte precursor cells: 125.7"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"NK-cell: 3.7"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"AF22: 51.7;BJ hTERT+: 18.1;SCLC-21H: 27.9;SH-SY5Y: 20.5;U-87 MG: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: AB_2685971"	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	9.3	15.6	196.7	2.1	209.2	3.4	7.0	182.2	226.6	1.6	108.2	3.1	0.9	1.7	0.4	0.7	3.8	1.6	3.1	201.1	206.8	4.3	2.9	7.3	1.4	240.0	237.4	3.3	2.1	0.4	25.9	5.3	219.5	1.1	1.6	19.4	1.0	0.9	2.0	2.0	2.7	1.8	229.2	14.5	2.4	1.3	300.9	0.6	4.5	1.4	0.8	2.5	1.4	205.3	0.5	3.0	51.7	0.5	0.5	14.9	0.0	2.6	18.1	0.1	0.2	0.5	0.1	0.2	0.5	10.1	0.2	0.8	0.9	0.1	0.1	0.1	3.1	0.5	0.8	0.1	1.2	0.0	1.1	3.0	2.9	0.6	0.0	2.7	0.4	0.1	0.0	0.4	0.1	0.4	0.0	0.2	1.3	0.4	1.0	0.2	0.3	1.2	0.0	0.1	27.9	20.5	0.6	0.0	0.1	4.5	0.2	0.3	3.0	16.0	1.0	0.4	1.0	0.0	0.2	0.2	75.7	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	196.7	209.2	182.2	226.6	201.1	206.8	240.0	237.4	219.5	229.2	300.9	205.3	67.8	0.0	1.8	198.2	0.3	5.5	0.7	4.5	0.6	2.1	2.0	1.1	0.8	17.2	5.9	0.0	0.0	0.1	2.1	0.3	7.9	32.0	2.9	15.6	2.3	33.4	17.8	6.1	131.4	25.6	0.1	1.6	0.0	34.0	0.0	0.0	23.6	0.8	0.9	0.0	62.3	3.4	22.4	1.3	6.2	8.7	1.5	2.1	14.2	18.7	4.6	132.4	2.1	125.7	46.1	4.1	1.2	0.0	0.8	0.8	0.1	0.1	21.7	3.3	0.0	2.1	8.1	0.1	0.1	0.3	4.0	0.0	1.3	0.3	0.1	1.1
BBS4		ENSG00000140463	"Bardet-Biedl syndrome 4"	Q96RK4	15	72686179-72738475	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 120.9;Rod photoreceptor cells: 89.9;Spermatocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 62.3"	"Low region specificity"	"Detected in all"							HPA039418	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA039418: AB_10672962"	"unprognostic (3.47e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.76e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.05e-1)"	9.5	14.8	11.0	6.8	11.2	7.7	10.9	10.1	13.1	13.3	18.1	12.0	5.1	12.5	15.4	5.8	17.5	9.3	11.1	10.9	11.9	15.6	12.7	10.4	8.0	10.9	12.4	14.0	11.1	17.4	20.7	7.9	12.6	20.7	7.6	45.4	7.9	9.4	18.7	9.2	7.9	9.3	10.9	7.6	11.0	20.4	11.5	11.5	16.1	10.2	7.0	11.1	9.1	11.0	6.1	15.7	34.0	14.4	16.5	19.7	9.0	11.9	24.4	11.3	14.8	8.1	20.2	9.6	24.7	10.2	8.6	9.4	9.1	9.9	10.3	10.0	11.0	11.4	13.3	9.2	13.5	10.2	8.6	18.8	13.2	16.3	12.8	17.1	8.9	18.3	25.4	8.2	18.1	10.7	9.6	9.6	48.8	12.3	6.8	6.4	17.1	12.3	19.2	15.2	16.4	19.2	20.8	15.0	31.2	13.1	20.4	11.3	12.5	13.2	10.0	62.3	6.7	17.1	17.8	21.0	14.9	15.3	18.1	5.5	1.9	3.3	5.1	2.9	4.9	4.8	4.3	5.5	1.6	6.0	4.3	5.9	1.6	11.0	2.5	3.1	5.7	2.8	11.0	11.2	10.1	13.1	10.9	11.9	10.9	12.4	12.6	10.9	11.5	11.0	6.0	19.2	19.2	35.3	8.3	3.1	6.0	9.4	10.8	39.0	8.4	10.5	19.8	4.3	18.2	12.9	120.9	10.0	10.6	3.5	5.9	14.4	19.9	28.8	11.1	8.1	4.2	5.2	18.6	11.3	5.8	12.4	7.7	8.4	13.9	8.7	7.1	7.4	7.8	21.9	22.8	8.0	6.1	5.8	2.4	12.2	15.8	5.9	5.4	19.7	4.4	39.4	9.2	31.7	30.7	8.9	4.9	20.3	9.0	8.0	5.1	9.4	48.8	89.9	0.0	11.0	11.5	79.0	63.6	4.6	2.8	5.3	9.3	24.3	5.1	2.8
BIVM	FLJ20159	ENSG00000134897	"Basic, immunoglobulin-like variable motif containing"	Q86UB2	13	102799119-102841533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA050126	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"HPA050126: AB_2681027"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.89e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-2)"	7.4	7.1	8.2	3.6	8.6	3.6	8.8	10.9	10.6	8.6	7.6	7.1	6.3	9.2	11.5	5.5	7.7	6.9	19.4	8.3	7.8	16.3	18.8	6.7	4.5	7.5	7.9	9.2	10.4	9.1	8.9	7.7	7.7	7.8	8.2	9.0	6.1	7.6	17.8	7.2	6.3	8.9	6.8	7.4	8.6	2.3	8.5	10.4	8.0	18.9	4.3	7.4	6.5	9.1	16.8	4.6	19.9	18.7	24.2	37.4	4.1	19.3	23.9	14.5	16.5	6.1	7.7	0.1	8.2	22.1	10.3	11.5	17.9	16.3	17.5	17.1	16.3	14.7	14.2	8.8	19.5	16.8	22.2	28.2	18.8	7.9	20.5	25.4	20.2	22.7	14.4	0.0	25.7	3.7	19.3	16.1	4.3	24.1	12.9	0.0	9.0	6.4	50.0	7.2	23.8	21.1	8.5	9.2	12.3	7.2	13.3	22.7	12.9	13.0	4.3	9.4	11.8	12.5	5.6	0.1	21.2	0.0	25.9	5.5	0.4	1.1	2.2	0.2	5.2	0.5	1.4	2.9	1.6	0.5	0.7	1.4	0.3	7.6	0.0	0.4	1.0	1.0	8.2	8.6	10.9	10.6	8.3	7.8	7.5	7.9	7.7	6.8	8.5	9.1	9.3	9.6	12.8	2.9	2.6	3.7	3.8	7.0	11.4	19.0	7.7	6.1	30.7	21.5	11.2	18.4	14.6	7.1	3.8	5.6	29.4	6.5	0.5	5.1	11.8	11.0	21.8	9.2	13.9	5.5	7.8	11.8	6.1	4.9	6.3	15.2	17.2	34.0	7.0	23.5	16.8	15.3	6.1	5.0	3.4	0.4	13.7	3.3	3.6	4.7	2.4	8.1	5.2	9.0	6.3	4.1	9.3	11.3	4.5	4.9	9.7	30.8	8.9	12.4	19.7	10.4	9.8	2.0	12.6	11.4	4.8	2.5	8.1	10.3	15.2	3.4
C10orf88	"Em:AC073585.5, FLJ13490, PAAT"	ENSG00000119965	"Chromosome 10 open reading frame 88"	Q9H8K7	10	122930901-122954311	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 146.8;Late spermatids: 45.9;Spermatocytes: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039681, HPA040991"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA039681: AB_10796333, HPA040991: AB_10794432"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.59e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-2)"	2.9	4.4	4.2	4.4	4.2	1.5	4.0	4.3	6.4	3.6	3.7	3.1	3.5	3.9	4.3	3.1	2.9	2.9	3.3	4.3	4.7	3.4	3.3	2.9	5.8	4.4	4.4	4.6	2.3	4.2	2.1	4.4	4.5	3.6	3.6	6.6	2.7	2.9	4.3	3.5	3.3	3.2	4.1	3.9	3.0	10.7	4.5	5.1	4.2	4.2	4.8	3.8	1.5	4.6	6.1	6.3	7.9	7.7	5.9	8.4	6.0	9.8	11.9	10.4	12.2	5.1	5.8	6.0	4.1	7.6	9.2	6.6	8.5	4.9	15.3	10.3	7.0	6.6	5.7	5.9	8.8	7.0	10.0	6.6	9.6	9.9	13.5	14.1	10.9	7.9	6.3	6.8	17.7	3.5	7.8	7.8	4.7	5.2	5.4	7.6	9.2	1.8	6.1	3.8	4.4	9.0	5.1	4.9	11.2	8.8	4.1	4.8	8.2	7.6	4.6	7.4	12.2	6.9	6.7	7.8	8.1	9.6	6.3	1.4	1.7	3.3	2.7	0.8	3.2	3.0	3.6	3.6	2.4	3.1	3.5	3.4	0.2	3.9	1.0	2.1	5.3	2.7	4.2	4.2	4.3	6.4	4.3	4.7	4.4	4.4	4.5	4.1	4.5	4.6	4.7	3.2	4.8	9.4	5.8	6.0	2.3	6.9	6.8	9.8	3.4	3.0	4.6	5.7	6.8	0.0	6.2	5.6	7.2	2.8	11.7	5.3	146.8	4.0	7.0	4.6	4.8	6.9	10.9	3.0	5.3	6.0	3.6	6.0	2.5	4.9	2.2	2.4	4.9	6.7	11.9	3.2	6.1	3.3	2.0	45.9	4.1	4.1	3.6	6.5	3.1	6.1	5.2	13.0	16.7	4.5	1.3	5.7	2.4	2.2	2.5	5.5	5.6	9.2	6.6	5.0	5.7	52.2	14.8	5.3	4.1	3.6	5.9	3.2	3.2	1.7
C11orf95	MGC3032	ENSG00000188070	"Chromosome 11 open reading frame 95"	C9JLR9	11	63759892-63768775	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045002			Approved	"Intermediate filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Intermediate filaments"		"HPA045002: AB_2679179"	"unprognostic (4.23e-3)"	"unprognostic (7.24e-3)"	"unprognostic (6.47e-2)"	"unprognostic (9.01e-3)"	"unprognostic (7.54e-2)"	"unprognostic (3.89e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.85e-2)"	"unprognostic (6.60e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.31e-3)"	12.4	7.1	13.6	5.1	13.5	2.0	9.6	8.4	17.6	16.4	3.8	13.7	3.8	20.3	6.8	4.9	13.6	6.9	9.6	16.1	15.3	12.0	9.6	5.8	6.0	9.0	8.9	22.8	8.7	5.3	11.4	11.0	7.1	8.8	3.5	4.2	6.8	10.1	7.7	4.6	7.5	11.3	7.0	6.7	7.3	4.8	15.2	8.2	11.4	5.4	5.5	12.1	11.3	9.3	3.5	4.6	34.7	11.6	17.7	20.3	5.5	13.0	9.3	6.0	4.2	11.4	2.2	11.2	18.6	12.6	4.5	7.9	15.2	5.2	6.8	11.0	10.3	7.5	8.9	5.2	6.2	3.6	6.0	15.2	1.8	9.9	3.2	19.8	13.5	10.0	9.7	5.0	9.7	4.6	13.6	18.5	16.2	2.1	13.4	31.9	6.6	3.5	8.7	4.4	14.6	30.8	6.2	6.6	18.3	14.1	9.3	8.8	21.3	12.2	11.4	15.7	7.6	4.5	6.3	13.5	3.3	9.1	6.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	13.6	13.5	8.4	17.6	16.1	15.3	9.0	8.9	7.1	7.0	15.2	9.3	8.0	0.0	5.3	6.8	2.2	5.1	1.3	2.8	3.4	4.6	6.3	9.5	7.2	11.5	2.3	0.0	0.0	6.4	2.6	1.0	3.9	2.6	0.3	2.8	11.8	9.0	4.9	0.8	3.9	2.2	0.5	11.3	0.5	4.9	1.3	8.6	13.9	7.0	1.7	6.7	3.0	2.7	4.1	1.6	6.3	1.3	18.3	2.0	3.6	3.7	3.8	11.8	0.0	2.5	0.5	2.1	1.2	7.9	0.7	1.5	0.7	3.6	1.5	3.1	13.1	6.8	11.2	0.4	4.2	1.4	3.4	1.5	1.1	2.3	2.5	1.0
C1QTNF6	"CTRP6, ZACRP6"	ENSG00000133466	"C1q and TNF related 6"	Q9BXI9	22	37180166-37199385	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.7;placenta: 29.6"	"Cell type enriched"	"Detected in many"	11	"Extravillous trophoblasts: 398.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 114.2;RT4: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002042	Enhanced		Approved	Nucleoplasm	"Secreted to blood"	No	No	354000000		"Cluster 48: NK-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA002042: AB_1078342"	"unprognostic (9.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.25e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.61e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.52e-2)"	4.9	6.7	4.4	6.6	4.5	1.6	4.0	4.3	5.3	11.1	4.3	5.5	1.6	31.7	1.4	2.7	7.0	8.8	3.7	4.5	4.3	7.4	13.0	5.2	5.1	5.1	4.5	5.5	3.5	2.2	2.5	29.6	4.8	6.8	3.6	0.5	3.2	2.9	1.5	5.0	5.4	8.2	4.4	6.5	3.5	6.2	4.8	2.4	3.8	0.7	2.3	5.6	4.3	6.3	17.7	20.5	10.7	3.6	1.8	21.3	32.6	3.4	6.8	2.8	2.0	3.8	24.7	0.1	14.1	6.0	1.5	34.9	0.4	8.4	1.2	4.9	2.6	2.8	8.3	3.8	7.1	0.1	2.3	29.2	4.9	2.3	0.6	7.3	25.5	0.8	0.1	7.7	1.1	114.2	0.0	0.5	7.1	2.5	0.3	0.2	0.1	2.8	24.5	50.7	1.8	14.6	1.0	19.7	2.8	5.5	7.0	0.5	9.4	1.1	5.6	0.4	0.1	15.5	0.4	0.1	2.1	2.0	3.2	0.4	0.1	0.5	0.2	0.2	0.2	0.2	0.4	0.3	0.1	0.7	0.9	0.7	0.5	1.5	0.1	0.3	1.4	0.3	4.4	4.5	4.3	5.3	4.5	4.3	5.1	4.5	4.8	4.4	4.8	6.3	3.2	0.0	0.0	13.7	2.9	1.5	2.1	1.9	0.6	1.0	8.6	4.2	1.8	1.5	2.2	1.8	0.0	8.1	1.5	7.9	1.9	3.4	2.0	4.8	30.8	6.8	0.0	0.8	3.3	1.1	398.9	7.6	2.0	9.6	1.3	19.8	10.0	7.2	9.3	0.0	4.3	3.1	0.0	1.9	1.4	8.9	0.6	1.2	5.4	3.7	1.1	4.5	1.0	4.0	7.8	2.7	2.8	0.4	3.4	0.8	2.0	1.6	2.7	0.9	0.0	2.2	7.5	7.2	4.5	1.0	0.3	34.5	3.1	7.6	4.4	1.5
C5orf63	"FLJ44606, YDR286C"	ENSG00000164241	"Chromosome 5 open reading frame 63"	A6NC05	5	127042558-127073492	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	43	"brain: 760.0;choroid plexus: 360.8"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 49.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043240		Approved	Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Mitochondria		"HPA043240: AB_10962511"	"unprognostic (2.71e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-4)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	3.3	3.7	412.4	4.3	388.9	4.0	6.5	381.5	760.0	2.6	360.8	7.7	6.4	5.3	4.2	5.5	4.6	4.2	6.9	415.7	402.6	6.0	5.3	4.1	8.2	430.5	432.1	3.7	5.3	6.7	6.9	3.3	445.4	5.5	11.9	13.1	4.6	4.1	5.0	4.0	7.0	3.6	371.7	4.2	7.7	12.8	391.3	5.9	8.8	6.4	8.3	4.8	2.8	416.6	0.9	4.0	1.1	2.3	2.9	4.6	0.6	4.2	0.5	5.2	3.0	9.8	12.2	0.0	17.1	3.4	7.5	1.5	7.3	4.6	7.4	1.6	6.2	10.1	15.6	11.9	7.2	6.0	0.5	4.6	11.6	6.6	3.4	3.6	4.5	4.2	0.7	1.8	5.1	8.1	0.2	5.5	0.7	8.4	3.0	4.4	2.5	7.0	5.8	6.0	9.8	8.0	5.5	2.5	0.3	2.1	10.1	8.8	3.5	10.8	10.0	12.5	2.7	6.0	16.5	0.4	49.8	0.8	5.7	5.8	0.4	5.0	7.5	1.7	6.2	15.4	6.9	8.3	3.7	14.2	10.1	7.7	1.6	15.7	0.4	12.2	12.5	3.4	412.4	388.9	381.5	760.0	415.7	402.6	430.5	432.1	445.4	371.7	391.3	416.6	2.9	6.4	11.7	18.9	11.3	1.0	11.3	19.9	8.6	11.9	6.9	4.2	33.7	4.3	8.6	16.5	14.6	10.1	12.5	14.6	19.6	16.8	30.2	7.5	1.0	4.6	10.8	9.9	4.3	10.2	9.2	4.3	12.2	5.6	10.1	7.1	3.9	10.0	5.4	0.0	6.7	11.7	10.2	1.0	1.9	17.5	2.5	1.6	8.8	15.9	1.8	11.7	19.6	11.1	1.2	12.4	17.2	2.2	6.1	6.2	10.5	5.8	13.2	10.6	6.6	4.6	2.7	49.8	19.3	11.9	1.1	2.7	6.6	8.2	13.7	11.7
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 18.9;thyroid gland: 20.7"	"Group enriched"	"Detected in some"	4	"Melanocytes: 5.4;Spermatogonia: 5.1"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;endometrial cancer: 2.4;thyroid cancer: 0.9"	"Group enriched"	"Detected in many"	4	"hypothalamus: 6.8;medulla oblongata: 8.9;midbrain: 11.6;pons: 18.9;white matter: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.8;Karpas-707: 10.4;SH-SY5Y: 3.5;U-266/70: 16.0"	"Region enriched"	"Detected in some"	7	"pons and medulla: 9.6"	"Group enriched"	"Detected in many"	5	"amygdala: 30.4;basal ganglia: 74.3;hypothalamus: 50.1;midbrain: 33.9;pons: 41.7"	HPA059886		Supported			"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.3	0.0	0.1	0.3	0.2	0.0	0.2	0.5	0.6	0.2	0.1	1.4	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.3	6.8	1.0	0.8	0.1	0.1	8.9	11.6	0.1	1.5	0.3	2.2	0.1	18.9	0.1	0.2	0.1	0.3	0.0	0.8	0.1	0.4	0.1	2.3	0.1	0.1	0.3	1.0	0.0	20.7	0.1	0.1	0.0	0.1	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.2	5.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.9	0.0	0.4	0.1	0.0	10.4	0.0	0.0	0.0	0.6	2.9	0.1	0.1	0.4	0.0	0.2	0.0	0.0	1.1	3.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.0	0.6	0.4	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.6	0.3	6.8	8.9	11.6	18.9	2.3	1.0	4.7	0.0	0.0	0.0	0.3	0.2	1.3	0.1	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.4	0.2	0.9	0.5	0.2	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	5.4	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	5.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 113.7;Inhibitory neurons: 112.5;Oligodendrocyte precursor cells: 123.1;T-cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	17.3	5.8	5.6	6.7	4.6	11.9	11.0	17.4	5.9	6.8	5.8	6.3	6.2	6.3	4.3	3.5	8.8	8.4	12.2	5.2	7.3	4.3	4.4	9.9	14.5	4.4	5.3	10.0	3.6	2.3	3.8	6.5	5.7	4.7	5.1	9.2	6.7	2.3	7.8	6.8	8.2	3.0	2.0	8.5	8.3	6.4	6.5	4.3	9.1	5.1	6.9	10.0	6.5	4.0	2.4	3.2	10.7	5.4	11.8	12.1	6.8	7.6	4.0	2.3	3.7	4.1	2.6	5.2	5.4	4.2	3.6	3.9	1.5	1.4	2.8	3.8	4.0	2.8	16.1	2.7	17.7	2.0	2.0	11.9	4.3	6.2	16.7	8.5	7.9	5.2	3.0	15.5	5.0	2.8	2.9	1.3	3.6	2.9	4.4	6.1	3.1	0.9	5.9	10.2	8.2	8.9	9.5	1.1	11.9	7.3	2.4	4.3	4.8	32.0	2.6	4.5	2.0	8.8	0.7	8.3	8.6	1.7	2.1	0.7	1.4	2.8	8.9	0.9	7.9	2.1	4.6	5.1	1.3	4.8	3.9	7.0	1.0	10.2	2.0	3.1	5.7	1.7	5.6	4.6	17.4	5.9	5.2	7.3	4.4	5.3	5.7	2.0	6.5	4.0	26.0	16.0	6.1	57.8	43.1	10.8	6.9	35.6	25.6	42.6	12.0	9.7	43.7	2.8	13.7	12.9	27.1	10.1	113.7	12.8	5.9	8.4	34.1	20.9	47.0	34.0	12.6	10.8	48.9	7.8	83.2	55.2	43.8	26.4	8.8	21.3	33.2	8.1	13.9	3.3	112.5	18.8	6.1	13.5	17.1	14.4	7.5	14.6	16.0	74.9	9.0	7.5	59.8	123.1	100.3	15.5	8.6	10.9	53.1	8.9	17.6	3.9	20.2	28.9	6.6	23.6	28.9	11.1	13.3	10.3	7.0	45.4	111.5	5.5	9.9	7.0
CCDC117	FLJ33814	ENSG00000159873	"Coiled-coil domain containing 117"	Q8IWD4	22	28772674-28789301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 104.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000826	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Microtubules, Cytosol"	"HPA000826: AB_1078417"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.61e-3)"	"unprognostic (9.07e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-3)"	"unprognostic (8.25e-2)"	9.5	10.2	11.8	12.7	12.7	21.8	11.9	15.7	22.8	14.2	13.4	11.2	11.8	11.5	8.0	8.2	9.1	9.5	7.9	11.6	12.5	9.8	24.2	9.4	18.2	11.6	11.8	12.5	9.4	12.6	6.7	19.1	11.5	9.8	11.2	10.6	18.3	9.3	16.9	8.2	9.4	9.7	11.8	12.6	10.0	36.6	13.1	17.9	10.9	20.7	20.3	10.6	7.5	17.6	19.9	16.0	32.2	31.7	20.6	18.0	25.5	19.7	23.9	33.4	29.2	24.6	9.4	61.7	8.6	18.0	14.2	20.2	47.8	7.8	31.6	33.6	31.4	25.2	17.3	36.6	14.1	40.6	30.9	12.2	16.8	19.3	11.9	14.9	23.5	20.0	36.0	26.6	15.2	25.6	24.1	32.8	26.4	35.3	7.7	48.1	50.8	27.0	14.9	7.6	12.3	16.4	30.4	28.0	12.7	38.0	34.9	17.4	13.7	41.7	28.3	13.3	15.3	61.7	68.9	51.2	14.6	21.9	18.1	13.5	14.6	15.3	10.0	13.2	10.2	10.0	8.3	9.8	14.6	12.4	14.5	11.8	6.7	25.3	12.9	12.7	11.6	14.9	11.8	12.7	15.7	22.8	11.6	12.5	11.6	11.8	11.5	11.8	13.1	17.6	11.1	22.4	14.3	4.2	18.3	10.6	14.4	4.3	6.2	7.7	21.9	14.2	10.4	15.7	8.5	14.7	14.6	16.5	20.4	13.2	7.9	9.9	104.0	20.7	32.5	15.5	20.4	17.4	6.6	10.0	17.8	14.3	6.6	31.0	17.2	11.9	10.8	42.3	9.3	3.3	7.1	12.3	4.1	18.9	19.0	38.2	12.8	15.4	17.8	7.5	14.7	6.2	21.6	4.5	12.8	9.7	8.9	7.9	26.4	22.6	9.0	12.5	13.8	15.2	0.0	9.6	16.1	49.5	48.5	9.5	10.9	24.6	14.7	9.0	12.4	22.3
CCL25	"Ckb15, SCYA25, TECK"	ENSG00000131142	"C-C motif chemokine ligand 25"	O15444	19	8052318-8062660	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	1030	"intestine: 581.5;lymphoid tissue: 771.3"	"Cell type enhanced"	"Detected in some"		"Intestinal goblet cells: 149.1;Proximal enterocytes: 774.7;Undifferentiated cells: 399.3"	"Group enriched"	"Detected in many"	4	"liver cancer: 25.4;stomach cancer: 33.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 3.5"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;HEL: 2.1;NB-4: 2.6;REH: 6.1;RPMI-8226: 1.8;SH-SY5Y: 1.9"									HPA055883	Approved				"Secreted to blood"	NA	NA	183000000		"Cluster 48: NK-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA055883: AB_2682955"	"unprognostic (9.22e-3)"	"unprognostic (3.13e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-4)"	"unprognostic (6.43e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.2	0.5	0.0	0.1	1.3	512.4	0.3	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.0	1.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	581.5	0.0	0.1	0.5	0.5	0.6	0.3	771.3	0.2	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.6	0.1	0.0	0.3	6.1	0.0	1.8	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.2	1.6	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	149.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.6	0.0	1.5	0.0	774.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	399.3	0.0
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754430-116769229	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 249.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2"	"Group enriched"	"Detected in all"	10	"NK-cells: 1108.0;T-cells: 714.1"	"Group enriched"	"Detected in some"	25	"HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002430, HPA003883"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favorable (4.36e-4)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favorable (3.97e-5)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"	4.6	4.6	0.6	51.3	0.7	11.4	7.6	0.6	1.0	5.8	0.8	13.9	17.2	3.7	2.8	8.4	4.2	16.8	2.6	0.5	0.8	2.5	7.8	21.0	119.6	1.7	0.7	2.8	2.9	0.9	0.7	1.0	1.1	5.2	16.0	0.0	8.6	2.3	1.4	3.5	28.4	4.4	1.0	44.1	24.1	1.8	1.0	249.8	3.8	1.7	79.1	20.8	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.1	0.0	0.4	0.0	0.0	0.0	0.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.1	0.5	0.0	0.0	166.9	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.4	0.0	11.3	5.2	1.6	421.8	3.7	403.1	3.8	610.2	714.1	95.4	2.5	316.3	486.2	14.1	1108.0	2.8	21.0	655.2	565.1	0.6	0.7	0.6	1.0	0.5	0.8	1.7	0.7	1.1	1.0	1.0	1.1	5.0	3.2	17.5	0.0	12.3	5.0	0.4	0.0	2.2	0.0	4.0	4.7	2.1	0.0	2.5	3.7	0.0	0.1	158.3	0.2	0.0	0.5	23.5	1.1	1.0	2.9	3.0	24.0	0.0	0.0	0.0	2.5	10.7	0.9	5.1	0.0	8.2	1.5	0.6	0.0	0.0	0.0	0.0	10.9	16.6	7.8	0.6	19.1	1.8	1.0	15.5	0.0	178.2	0.0	0.0	0.0	0.0	0.4	42.3	0.1	0.0	1.7	0.0	0.0	0.0	2.9	4.1	0.3	0.2	0.4	3.7	0.0	476.8	0.0	0.5	0.2
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853232	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.3"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 18.3"	"Group enriched"	"Detected in all"	5	"B-cells: 9.9;dendritic cells: 5.8;NK-cells: 18.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 128.0;Karpas-707: 34.7;MOLT-4: 32.6;REH: 26.0;RPMI-8226: 20.9;U-266/70: 26.9;U-698: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	3.1	2.4	2.5	13.1	3.8	13.6	2.0	2.7	2.5	0.7	0.9	4.5	5.8	0.9	1.2	1.1	3.0	1.9	3.8	3.5	6.6	0.8	3.3	6.3	23.4	3.3	5.5	0.7	0.3	0.1	1.8	0.5	3.4	13.2	3.5	0.2	2.6	19.7	21.4	0.3	5.3	1.4	2.8	17.0	3.0	1.0	3.9	63.3	2.0	3.4	18.0	6.8	0.5	4.6	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	128.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	17.0	0.2	34.7	0.0	0.0	32.6	7.9	0.2	0.0	0.0	26.0	0.1	20.9	0.0	0.0	0.2	1.5	0.0	0.2	0.5	0.3	0.1	5.7	0.5	0.0	0.1	0.1	0.0	26.9	0.2	24.3	0.4	6.2	0.3	0.1	1.9	0.1	1.2	2.4	0.3	9.9	1.5	1.2	4.7	7.7	2.4	1.9	1.4	18.3	1.9	5.8	2.4	4.4	2.5	3.8	2.7	2.5	3.5	6.6	3.3	5.5	3.4	2.8	3.9	4.6	0.8	3.2	15.1	86.5	59.7	0.0	0.4	0.6	0.6	0.1	0.1	0.0	1.0	0.0	11.6	0.0	10.4	0.2	33.8	0.2	0.0	0.0	2.5	4.0	1.4	2.7	0.0	78.6	0.4	0.0	0.2	2.7	2.0	0.3	38.2	0.8	2.9	4.3	4.4	0.0	0.4	1.3	0.0	44.3	0.8	0.7	0.0	17.7	7.2	5.6	3.1	0.0	79.3	1.0	1.8	0.0	0.3	0.0	378.4	8.1	0.2	0.1	42.5	0.1	13.1	1.5	7.6	2.9	1.7	1.6	0.0	0.5	26.5	0.0	1.6	0.2
CD7	"GP40, LEU-9, Tp40, TP41"	ENSG00000173762	"CD7 molecule"	P09564	17	82314868-82317608	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.6;lymphoid tissue: 53.7"	"Group enriched"	"Detected in many"	9	"dendritic cells: 625.0;NK-cells: 1299.7;T-cells: 527.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 231.5"	"Group enriched"	"Detected in many"	22	"NK-cells: 231.5;T-cells: 71.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 52.0;JURKAT: 26.7;MOLT-4: 119.2"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.2"	"Not detected"	"Not detected"			"CAB002594, HPA039079"	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB002594: , HPA039079: AB_2676337"	"unprognostic (3.14e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.89e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (7.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (7.75e-11)"	"unprognostic (4.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.55e-3)"	8.2	1.3	0.7	32.9	0.8	28.6	2.6	0.8	1.3	2.5	0.9	7.3	12.4	3.0	0.4	3.9	3.9	3.2	1.8	0.6	1.1	7.1	7.7	17.1	36.8	1.4	0.8	0.8	1.2	0.1	1.4	3.3	1.0	4.4	1.9	0.0	3.1	1.0	0.8	1.7	21.1	1.1	1.2	53.7	8.1	0.6	1.1	48.8	3.5	0.1	14.8	3.9	3.9	1.2	0.0	0.0	0.0	0.0	0.1	0.4	12.9	0.0	0.2	0.1	0.2	0.6	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.7	52.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	26.7	0.1	0.0	0.1	0.0	119.2	0.0	0.0	0.0	0.2	0.1	0.1	2.3	0.2	0.0	0.4	0.3	1.8	1.1	0.0	0.3	0.0	0.0	0.0	0.3	0.3	1.0	0.0	1.2	0.2	0.0	0.2	0.0	0.0	0.5	0.4	0.5	66.6	0.2	57.6	0.4	29.8	49.0	0.3	0.2	69.4	71.5	2.3	231.5	0.6	6.9	28.7	30.9	0.7	0.8	0.8	1.3	0.6	1.1	1.4	0.8	1.0	1.2	1.1	1.2	5.3	0.0	0.0	0.0	12.1	7.5	0.6	0.1	1.8	0.0	4.2	3.7	0.5	4.3	0.3	0.0	0.0	0.7	625.0	9.4	0.0	1.3	0.1	2.8	2.0	4.5	0.0	47.7	0.0	0.5	10.3	12.4	43.8	5.3	8.2	0.0	16.8	3.3	3.6	1.7	0.0	1.5	0.0	18.5	8.8	0.0	0.0	19.2	12.4	0.0	11.6	0.0	1299.7	0.0	0.0	0.1	5.8	0.0	82.7	3.8	8.1	1.4	0.5	0.0	0.0	0.5	3.9	0.0	1.3	1.0	4.4	1.9	527.4	0.0	2.1	3.8
CDCP1	"CD318, SIMA135"	ENSG00000163814	"CUB domain containing protein 1"	Q9H5V8	3	45082277-45146422	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 121.2;Basal respiratory cells: 92.6;Pancreatic endocrine cells: 137.1;Urothelial cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.3;NK-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 94.9;HBEC3-KT: 109.0;hTEC/SVTERT24-B: 265.2;hTERT-HME1: 177.9;PC-3: 89.7;RPTEC TERT1: 81.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010978, HPA010979, CAB025637"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB025637: , HPA010978: AB_1846403, HPA010979: AB_1846401"	"unprognostic (9.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (9.98e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.34e-1)"	2.3	0.5	0.4	4.4	0.7	0.9	5.6	0.4	1.2	8.5	12.8	17.4	17.7	3.2	9.2	37.2	4.0	6.2	0.5	0.7	0.7	4.8	0.8	8.2	0.8	1.4	0.8	0.3	7.9	1.4	1.2	2.2	1.3	5.1	17.0	0.2	12.6	5.6	0.3	23.3	15.1	3.1	1.1	0.7	16.5	0.6	3.6	0.6	7.7	0.0	5.8	9.7	16.4	2.6	52.2	15.1	0.0	0.2	0.1	2.4	12.1	9.7	1.6	4.4	4.1	21.3	94.9	0.0	11.8	2.9	2.5	40.5	0.3	109.0	8.9	0.0	0.1	0.1	16.4	0.1	8.1	0.1	3.6	3.7	56.1	265.2	177.9	16.0	1.0	0.1	31.1	0.2	13.8	0.1	0.1	0.9	7.4	24.7	89.7	0.0	0.0	8.6	81.1	40.7	3.4	0.1	20.1	5.0	0.1	4.8	22.9	0.4	4.6	0.2	0.2	3.3	0.2	0.1	0.1	0.1	1.5	1.1	1.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.9	4.2	0.0	0.0	0.0	0.2	0.4	0.7	0.4	1.2	0.7	0.7	1.4	0.8	1.3	1.1	3.6	2.6	0.1	3.2	13.1	0.3	0.3	121.2	83.3	92.6	50.7	0.0	12.9	6.6	0.5	14.3	57.7	9.2	0.0	5.8	0.3	76.6	0.0	78.6	0.1	36.5	6.3	1.9	37.6	0.4	2.0	71.6	7.5	4.6	37.8	59.3	8.8	0.1	0.0	0.0	10.8	0.0	0.4	37.9	18.3	7.9	37.6	0.5	3.1	13.4	3.6	0.0	10.7	0.0	0.0	1.0	0.3	137.1	34.9	0.0	2.5	75.8	30.8	0.0	56.6	0.0	0.0	0.4	3.6	0.0	0.4	59.8	75.0	3.3	1.8	13.5	28.9	117.4
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790792	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	44.6	60.8	44.3	23.7	43.7	47.0	40.3	40.8	53.8	55.5	35.4	49.3	19.7	49.3	21.1	35.4	65.6	23.7	40.4	50.8	42.0	44.5	65.1	47.2	35.1	44.7	44.1	88.5	44.4	19.2	67.0	18.7	41.1	44.1	12.2	11.1	29.7	23.3	28.3	38.7	40.9	19.1	42.7	65.6	37.4	44.3	42.1	31.9	42.1	17.1	20.9	38.9	40.5	44.4	22.5	40.5	24.9	27.6	27.6	21.4	32.1	22.9	33.3	23.4	20.9	30.3	25.0	39.5	25.7	26.0	32.1	44.2	16.5	37.3	8.9	34.8	19.0	37.1	45.2	25.3	40.2	36.3	56.5	37.9	44.5	24.8	27.7	30.0	48.5	34.8	32.6	51.7	21.2	60.1	39.5	54.5	55.0	34.3	41.9	112.2	21.2	57.0	34.2	24.9	24.5	29.2	34.5	35.8	20.9	19.3	45.0	33.9	56.4	27.8	30.9	24.1	22.3	92.5	76.4	34.7	26.1	24.4	25.9	4.1	3.7	5.8	10.3	5.1	10.1	3.6	5.7	8.3	4.8	6.6	6.3	7.9	5.4	22.4	7.5	9.9	4.4	3.6	44.3	43.7	40.8	53.8	50.8	42.0	44.7	44.1	41.1	42.7	42.1	44.4	43.1	12.8	12.4	39.8	27.1	24.1	27.6	15.8	18.8	13.9	17.9	10.9	14.1	20.0	10.8	11.0	2.1	22.5	28.5	17.1	15.6	31.3	4.4	26.4	22.7	35.6	19.2	15.4	18.1	37.2	22.3	23.0	24.5	25.3	25.3	18.1	33.5	26.4	23.3	25.2	17.0	12.7	8.2	18.8	23.4	6.2	19.6	24.2	16.0	22.5	44.7	17.5	33.0	12.5	16.8	32.9	13.7	31.2	22.2	28.9	14.5	16.7	20.4	7.9	0.0	21.6	22.1	8.9	22.9	19.9	22.0	51.3	24.7	54.5	13.7	31.4
CEP78	"C9orf81, FLJ12643"	ENSG00000148019	"Centrosomal protein 78"	Q5JTW2	9	78236062-78279690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Cone-rod dystrophy, Deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;dendritic cells: 106.8;NK-cells: 249.3;Spermatocytes: 82.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 39.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 39.1;T-cells: 18.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048846	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA048846: AB_2680537"	"unprognostic (4.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.13e-4)"	"unprognostic (6.75e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (4.93e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.34e-1)"	2.2	2.9	4.3	4.6	5.0	12.3	4.3	5.9	4.4	4.1	3.8	3.5	2.8	5.6	3.2	3.5	3.4	2.4	1.6	4.2	4.7	3.6	3.5	3.4	6.2	4.6	4.5	4.3	2.5	4.3	2.7	3.9	4.6	3.1	3.9	9.2	3.3	3.4	1.6	3.5	2.9	4.7	5.1	5.0	3.0	15.1	4.3	11.5	3.7	1.7	7.7	3.2	3.0	6.2	31.7	14.5	33.3	20.5	5.4	9.4	22.3	25.6	10.1	15.1	19.1	2.7	8.4	28.9	12.7	9.2	21.4	36.9	49.6	13.7	22.5	24.3	16.6	15.4	17.1	11.4	4.9	26.0	14.6	5.2	2.9	17.1	11.1	7.5	23.4	29.4	12.2	22.4	19.8	20.3	32.6	12.8	35.2	32.7	14.0	32.2	38.4	8.4	9.0	14.0	30.4	21.1	33.7	10.6	8.4	22.7	12.6	6.9	12.5	13.3	22.6	27.5	24.7	13.1	17.8	18.4	11.8	17.6	23.0	0.7	0.8	0.7	18.3	3.4	8.9	5.0	7.9	16.0	2.3	3.4	3.9	12.8	0.5	39.1	5.5	4.2	13.1	8.3	4.3	5.0	5.9	4.4	4.2	4.7	4.6	4.5	4.6	5.1	4.3	6.2	10.3	25.6	9.2	26.1	13.7	5.1	8.1	6.9	8.0	27.1	7.6	10.5	8.9	4.3	7.2	1.8	110.5	14.0	106.8	3.9	5.9	8.4	14.1	18.7	16.9	9.0	7.7	25.7	28.6	6.7	19.5	10.3	10.2	10.4	5.1	20.6	7.1	9.0	9.6	3.3	20.5	8.0	4.1	6.1	6.1	9.9	14.9	10.0	1.8	9.4	9.7	14.7	249.3	27.2	24.6	4.7	4.1	15.1	43.7	3.7	1.0	5.1	22.1	49.4	0.0	14.8	11.3	82.1	34.2	10.0	4.8	4.0	34.0	12.3	13.2	4.0
CHMP4C	"MGC22825, Shax3, VPS32C"	ENSG00000164695	"Charged multivesicular body protein 4C"	Q96CF2	8	81732448-81759515	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 71.6;Pancreatic endocrine cells: 78.7;Proximal enterocytes: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 37.2;CAPAN-2: 41.5;hTCEpi: 51.4;hTERT-HME1: 41.6;OE19: 73.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023763, HPA023799"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Microtubules, Cytokinetic bridge"		"HPA023763: , HPA023799: AB_1846670"	"unprognostic (3.98e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (7.54e-2)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.99e-2)"	"prognostic favorable (1.96e-6)"	"unprognostic (3.29e-3)"	"unprognostic (4.95e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (6.45e-4)"	1.7	5.8	1.2	2.1	1.3	1.2	16.6	1.6	1.3	7.5	2.8	16.2	41.8	2.3	5.8	22.6	8.7	8.0	3.6	1.1	1.0	13.9	7.7	7.2	0.5	1.5	1.4	0.5	20.1	15.8	10.1	5.8	1.5	10.0	14.8	0.2	28.1	7.6	0.2	29.1	31.7	0.8	1.1	8.5	23.7	1.1	1.4	1.9	17.5	0.5	5.2	9.7	14.2	2.0	37.2	7.6	0.0	0.2	0.0	0.0	16.6	1.9	2.2	0.1	0.0	14.3	41.5	0.1	28.8	0.0	6.4	22.1	0.2	15.7	0.0	0.0	17.9	0.7	9.9	13.6	0.8	0.1	0.1	0.0	51.4	0.0	41.6	15.3	0.0	0.0	10.0	12.4	0.0	18.4	0.1	0.3	0.1	73.1	14.9	0.1	0.0	8.3	36.3	22.0	7.9	0.1	9.9	16.3	0.1	8.5	23.9	0.2	0.0	0.1	8.9	0.1	0.2	6.5	4.3	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.9	0.0	0.1	0.0	0.1	1.2	1.3	1.6	1.3	1.1	1.0	1.5	1.4	1.5	1.1	1.4	2.0	5.3	25.6	21.5	0.0	3.2	4.6	35.4	17.1	18.2	0.0	27.2	29.3	4.1	21.5	22.4	5.5	0.0	40.2	0.6	42.0	25.4	47.4	0.4	18.6	2.9	4.0	9.1	1.7	0.1	71.6	38.9	1.0	25.5	31.0	1.3	6.5	4.2	7.6	4.4	0.0	0.1	36.4	12.2	0.3	0.7	1.3	0.0	0.9	8.8	1.0	0.0	0.0	1.0	0.0	0.1	78.7	52.8	0.0	5.7	28.9	80.4	22.6	19.1	0.0	0.0	0.2	7.0	0.3	0.7	25.0	17.5	44.5	1.3	0.1	34.4	33.6
CHST12	"C4S-2, C4ST2"	ENSG00000136213	"Carbohydrate sulfotransferase 12"	Q9NRB3	7	2403588-2448484	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 158.7;Hepatic stellate cells: 152.8;NK-cells: 368.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 60.1;NB-4: 57.4;U-266/70: 88.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041680	Approved		Approved	"Golgi apparatus"		NA	NA		960000	"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA041680: AB_10959789"	"unprognostic (4.12e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (9.61e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	16.1	13.3	4.5	5.1	3.5	6.1	15.0	7.3	5.0	15.4	0.2	13.7	5.4	17.8	0.6	7.9	15.8	1.2	15.5	9.0	2.6	11.3	7.1	14.5	2.9	9.4	4.7	11.6	11.7	1.4	17.6	2.8	4.6	13.6	0.6	1.2	10.3	2.8	8.3	15.6	10.6	1.4	3.8	24.5	11.1	9.1	5.9	1.4	14.1	0.9	1.0	13.1	13.1	4.3	9.5	9.1	2.7	10.0	3.8	2.3	29.5	17.2	4.2	4.2	5.7	9.0	3.2	8.5	31.6	2.7	10.3	7.1	1.6	2.2	0.8	11.2	17.7	5.9	7.0	9.9	2.6	19.4	60.1	4.8	0.9	3.8	0.5	3.3	4.2	11.5	15.1	25.0	1.2	6.8	19.8	57.4	19.1	1.3	14.4	7.1	7.6	42.1	1.2	3.8	6.8	28.7	8.4	4.5	4.0	2.0	6.6	22.3	13.0	9.6	26.5	20.0	15.2	88.9	37.1	3.9	7.8	8.8	17.9	59.1	10.4	53.2	87.6	9.1	54.4	14.7	30.0	71.4	20.4	18.3	12.6	37.8	3.1	121.6	3.9	64.9	33.0	22.9	4.5	3.5	7.3	5.0	9.0	2.6	9.4	4.7	4.6	3.8	5.9	4.3	36.8	16.0	50.5	9.1	32.8	18.1	35.5	24.3	18.8	45.6	18.0	13.0	8.3	15.7	30.5	18.4	66.7	104.5	158.7	6.2	1.9	22.4	6.7	4.7	21.1	59.4	12.7	37.0	11.0	15.3	15.0	37.0	6.1	6.4	38.0	13.4	152.8	7.2	24.8	47.1	12.3	9.1	24.4	26.4	22.9	5.8	95.7	21.2	21.4	10.3	21.3	15.1	368.7	14.1	9.5	13.3	6.7	67.7	107.8	18.4	16.2	9.5	15.2	50.5	19.7	25.6	17.9	37.8	30.6	9.2	15.3	133.5	93.2	18.4	12.2	13.1
CIBAR2	"FAM92B, FLJ44299"	ENSG00000153789	"CBY1 interacting BAR domain containing 2"	Q6ZTR7	16	85098358-85112472	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"fallopian tube: 85.5"	"Cell type enriched"	"Detected in single"	8	"Plasma cells: 2.4"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 5.4;lung cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA041022	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"			"HPA041022: AB_10795500"	"unprognostic (1.77e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.81e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.10e-13)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	0.1	1.3	2.0	1.3	1.8	0.4	0.3	1.0	0.8	3.5	11.2	0.7	1.3	1.3	0.2	0.1	85.5	0.1	0.0	1.9	4.9	0.2	0.0	10.2	0.6	8.2	11.2	0.1	0.1	0.0	16.2	0.0	5.5	0.1	0.4	0.3	0.5	0.1	0.0	0.4	0.7	0.0	5.3	2.6	0.4	0.4	4.7	0.2	0.0	0.0	1.9	1.1	0.0	2.5	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.5	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.0	1.8	1.0	0.8	1.9	4.9	8.2	11.2	5.5	5.3	4.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CKMT2	SMTCK	ENSG00000131730	"Creatine kinase, mitochondrial 2"	P17540	5	81233320-81266398	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	49	"heart muscle: 1240.1;skeletal muscle: 1430.8;tongue: 2324.4"	"Cell type enriched"	"Detected in many"	20	"Cardiomyocytes: 814.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 3.5;T-47d: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051880	Enhanced					NA	NA		3000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA051880: AB_2681650"	"unprognostic (3.64e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.75e-3)"	18.2	33.6	12.3	0.8	15.0	0.1	4.6	17.3	12.3	8.1	24.4	3.2	1.1	6.4	11.4	20.2	6.9	8.1	1240.1	11.2	15.0	14.7	1.0	2.5	1.3	16.3	16.8	10.2	7.7	15.7	4.5	0.7	14.9	13.1	0.7	1.6	26.3	13.1	1430.8	4.7	2.8	8.8	12.0	1.8	17.9	3.6	16.1	0.8	4.9	2324.4	0.4	4.1	4.1	17.7	0.3	0.7	0.8	1.3	1.9	0.4	3.5	0.1	0.0	0.0	0.0	2.4	0.2	1.4	0.4	0.0	1.0	0.0	0.0	0.0	0.0	1.5	2.4	0.1	1.0	3.2	2.6	0.6	0.2	0.8	0.0	0.0	0.0	0.3	0.0	2.1	0.3	0.5	0.0	2.2	1.2	0.2	1.0	0.0	0.7	0.6	1.0	0.1	0.0	0.0	1.4	1.0	1.2	0.3	1.4	1.5	6.3	0.3	0.7	0.4	1.2	0.7	0.2	0.2	0.1	1.3	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	12.3	15.0	17.3	12.3	11.2	15.0	16.3	16.8	14.9	12.0	16.1	17.7	1.8	0.0	0.5	40.1	0.0	0.1	0.4	0.0	1.2	0.9	0.9	0.8	814.1	7.2	0.6	12.9	0.0	0.1	0.0	0.1	37.2	1.7	25.1	13.6	3.5	9.8	0.0	0.0	11.4	0.6	0.4	16.2	6.6	27.8	0.0	0.8	0.0	0.0	0.1	0.0	18.1	0.3	0.0	0.0	0.0	2.2	7.2	0.3	3.6	23.4	0.0	1.4	0.0	4.5	9.1	0.4	0.0	15.1	0.0	0.3	0.3	0.6	0.7	1.0	0.0	11.6	15.0	1.0	0.4	0.1	0.1	0.3	0.8	23.7	2.5	0.2
CLASP1	"KIAA0622, MAST1"	ENSG00000074054	"Cytoplasmic linker associated protein 1"	Q7Z460	2	121337776-121649476	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 197.9;Excitatory neurons: 248.4;Inhibitory neurons: 212.5;Oligodendrocyte precursor cells: 233.2;Oligodendrocytes: 283.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065219	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA065219: AB_2685436"	"unprognostic (6.21e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.06e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.94e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.50e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.14e-1)"	13.2	12.6	17.7	8.2	18.7	17.2	11.9	27.9	21.6	11.9	13.9	13.4	6.3	11.9	11.7	11.2	11.3	8.9	20.4	19.7	22.3	10.7	11.6	9.8	10.3	17.1	14.9	15.9	10.1	11.2	11.5	9.0	17.0	11.1	6.9	43.8	9.2	11.4	42.6	15.4	9.7	10.7	11.0	11.4	9.5	18.8	19.1	13.2	13.3	27.5	9.6	11.7	11.9	18.0	15.6	14.1	36.2	21.4	26.0	25.6	11.0	16.9	20.6	16.7	19.4	22.0	10.1	24.3	13.1	18.1	17.1	13.1	26.1	32.2	20.4	30.4	9.6	45.1	18.3	24.9	21.0	20.9	21.7	23.7	24.5	22.7	54.1	18.3	18.9	14.4	29.2	26.9	24.6	13.9	23.8	20.4	21.7	5.8	14.1	30.7	18.3	17.6	19.2	21.9	21.0	26.9	19.6	10.1	17.5	22.3	6.4	14.9	21.3	21.7	21.5	12.6	12.1	15.7	16.5	24.1	17.2	18.9	33.8	1.7	0.8	0.9	1.9	0.8	1.5	0.8	1.0	1.1	0.8	0.8	1.1	1.1	0.9	5.7	1.1	1.0	0.9	0.9	17.7	18.7	27.9	21.6	19.7	22.3	17.1	14.9	17.0	11.0	19.1	18.0	21.8	22.4	12.8	197.9	12.1	10.7	10.0	14.0	22.2	35.0	12.7	10.4	43.6	11.5	13.1	12.9	45.9	6.6	27.1	7.3	5.9	11.8	31.4	19.6	14.7	17.5	9.0	20.6	248.4	6.0	4.4	13.8	9.7	22.6	14.5	22.1	42.1	21.9	7.7	62.2	212.5	6.2	14.2	14.1	6.9	47.6	28.6	12.0	8.8	131.2	12.9	29.4	46.4	233.2	283.4	11.9	7.4	56.8	21.9	8.1	5.6	7.9	17.6	57.0	6.6	20.6	15.2	14.3	23.4	16.3	11.8	3.7	17.6	10.3	6.6	9.6
CLSTN3	"CDHR14, CSTN3, KIAA0726"	ENSG00000139182	"Calsyntenin 3"	Q9BQT9	12	7129698-7158945	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 161.2;Cone photoreceptor cells: 62.6;Excitatory neurons: 79.4;Inhibitory neurons: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		1700000	"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"				"prognostic favorable (5.08e-4)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.73e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (2.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (8.07e-4)"	12.9	14.5	23.1	13.6	20.8	12.4	13.3	18.6	42.7	13.4	0.0	8.3	6.8	11.0	2.7	6.8	11.7	10.1	7.0	21.1	33.9	21.2	29.2	12.7	14.3	13.5	7.7	25.4	10.4	11.2	30.3	3.7	24.8	9.6	3.9	20.2	11.0	4.4	2.5	10.5	14.2	7.3	0.7	20.7	7.5	4.3	22.3	10.2	12.4	1.6	9.0	9.9	9.6	14.0	6.7	11.2	4.3	10.3	4.7	5.2	30.1	3.9	9.4	7.1	12.1	18.3	10.1	12.1	2.9	6.0	9.1	8.4	6.7	8.0	3.5	10.9	7.5	19.2	19.9	18.6	5.9	2.7	34.6	15.2	5.9	8.5	7.4	30.6	9.1	11.2	19.0	6.6	1.3	2.4	8.3	2.8	12.6	0.6	0.7	5.3	0.1	3.5	10.7	13.8	5.6	9.2	8.4	9.5	1.7	10.4	5.4	7.0	4.6	3.9	13.6	8.6	2.4	8.7	2.2	1.6	7.6	3.2	2.8	1.5	0.0	0.0	3.3	0.0	1.9	0.1	1.5	2.9	0.1	0.1	0.5	1.2	0.2	6.9	0.0	0.0	2.0	1.0	23.1	20.8	18.6	42.7	21.1	33.9	13.5	7.7	24.8	0.7	22.3	14.0	6.0	0.0	3.9	5.2	2.8	4.1	2.3	4.9	7.4	161.2	15.7	7.5	2.3	4.3	3.3	14.7	62.6	5.4	14.1	2.9	0.0	9.2	1.2	3.3	18.0	15.3	29.3	1.3	79.4	7.5	9.3	12.0	7.7	6.3	5.7	8.6	5.7	26.6	1.2	26.9	60.2	4.0	16.2	2.0	7.3	1.9	12.8	3.6	5.4	4.7	1.1	9.5	13.4	10.6	3.1	7.2	3.2	6.4	12.7	1.9	1.3	23.3	3.0	40.3	6.6	5.1	6.8	0.7	1.1	2.7	5.7	3.3	16.6	6.8	3.6	1.8
CMC1	"C3orf68, MGC61571"	ENSG00000187118	"C-X9-C motif containing 1"	Q7Z7K0	3	28241584-28325142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 418.8;NK-cells: 694.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"NK-cell: 162.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043333	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA043333: AB_10797139"	"unprognostic (1.16e-1)"	"unprognostic (8.01e-3)"	"unprognostic (6.90e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.30e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (3.54e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.55e-1)"	"prognostic favorable (5.52e-4)"	15.9	18.7	9.4	4.8	9.4	4.9	11.8	9.6	14.3	10.6	9.7	14.7	7.6	10.1	5.3	11.9	11.4	4.0	34.6	9.1	9.8	24.2	24.8	11.5	4.3	9.4	9.4	10.5	11.8	5.0	16.9	6.5	9.6	11.4	4.0	3.2	9.3	4.5	24.8	9.1	9.9	3.4	9.3	12.3	14.7	4.2	9.6	4.1	9.6	13.7	2.9	12.2	11.4	9.5	15.2	24.7	6.8	7.1	18.5	18.5	17.4	20.0	6.1	8.5	8.5	7.3	21.0	13.5	24.8	3.3	14.2	7.1	8.7	18.7	5.1	30.4	21.9	14.5	22.1	16.2	19.1	9.3	10.9	9.9	13.8	8.6	10.8	19.2	10.7	34.0	14.2	19.3	6.9	13.7	13.6	25.1	7.9	15.2	27.0	12.7	7.9	11.0	10.9	6.7	6.7	12.5	14.7	9.1	44.9	9.4	18.8	27.4	12.9	9.1	11.2	13.8	13.1	8.9	22.0	19.7	24.1	20.5	19.2	24.2	21.9	17.1	40.2	28.9	57.7	18.4	25.4	69.6	29.9	17.1	18.8	41.9	6.7	162.2	32.9	30.4	27.2	29.4	9.4	9.4	9.6	14.3	9.1	9.8	9.4	9.4	9.6	9.3	9.6	9.5	51.5	38.5	33.0	26.4	28.3	21.2	38.0	68.6	23.9	16.2	40.0	53.5	202.8	30.0	42.3	31.3	10.4	68.4	418.8	68.2	221.1	61.3	226.4	67.2	38.5	42.1	28.2	128.6	51.5	58.6	42.4	39.4	24.5	42.5	36.7	25.9	50.3	88.7	64.5	3.3	61.2	71.7	67.1	61.7	26.2	31.1	49.4	36.4	30.2	41.2	53.8	37.4	694.1	53.8	63.3	66.1	71.3	39.1	32.7	42.9	56.2	134.4	56.0	25.4	39.5	31.2	71.6	26.3	49.3	28.6	32.8	31.5	222.5	58.2	67.9	42.2
CMC4	"MTCP1, MTCP1NB, p8, P8MTCP1"	ENSG00000182712	"C-X9-C motif containing 4"	P56277	X	155061622-155071136	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 113.5"	"Low region specificity"	"Detected in all"							HPA045866	Approved		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA045866: AB_10964642"										"unprognostic (4.54e-3)"				"unprognostic (7.31e-2)"				14.5	11.5	15.1	9.3	17.0	8.2	12.2	17.5	17.7	13.3	14.8	17.0	12.5	12.4	16.7	11.2	11.8	10.6	52.6	14.3	16.6	15.1	23.3	8.4	15.0	18.0	16.5	15.2	32.7	12.7	11.8	8.2	17.0	12.8	7.0	7.3	18.9	12.6	31.8	10.8	10.1	7.9	16.6	9.7	11.8	8.0	16.0	6.8	14.1	24.5	8.4	12.4	11.6	17.9	63.7	16.6	9.5	19.8	24.5	23.6	14.2	12.0	17.5	16.7	28.3	10.2	11.1	40.7	30.8	13.9	48.0	20.5	11.8	16.2	10.8	45.5	30.7	6.2	10.2	13.5	25.2	12.8	9.3	22.8	24.9	16.7	20.2	15.9	13.3	25.3	6.2	15.2	17.1	23.5	17.2	23.8	5.6	25.3	42.5	14.6	20.9	28.5	18.3	4.2	19.0	14.4	16.0	17.9	20.3	10.9	13.3	8.1	17.3	26.1	16.9	16.4	16.8	62.9	67.3	113.5	23.7	29.5	16.9	2.0	12.9	22.2	14.8	7.5	15.3	19.1	11.9	14.3	19.6	18.6	3.5	9.5	1.2	23.1	3.0	3.8	15.1	8.3	15.1	17.0	17.5	17.7	14.3	16.6	18.0	16.5	17.0	16.6	16.0	17.9	3.9	0.0	4.1	3.3	1.9	0.8	1.1	2.6	2.8	1.0	3.4	5.0	0.0	1.5	6.0	0.0	0.0	1.0	3.9	0.9	3.9	1.5	0.1	2.4	2.7	1.8	1.8	7.8	1.6	0.5	1.0	2.8	2.0	1.4	5.1	2.5	2.2	4.7	1.0	0.0	2.3	0.8	0.0	1.3	2.6	1.4	3.7	1.9	1.8	1.9	1.0	1.4	2.1	2.5	4.6	0.7	1.2	1.9	4.0	0.5	2.0	4.1	4.8	0.3	0.0	1.2	2.0	1.4	0.8	4.2	2.4	1.2	2.9	1.2	1.6	0.7
CNIH3	"CNIH-3, FLJ38993"	ENSG00000143786	"Cornichon family AMPA receptor auxiliary protein 3"	Q8TBE1	1	224434660-224740554	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 13.5;pancreas: 8.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 65.3;Distal tubular cells: 31.3;Excitatory neurons: 61.1;Inhibitory neurons: 47.5;Late spermatids: 38.0;Oligodendrocyte precursor cells: 68.3"	"Group enriched"	"Detected in many"	4	"glioma: 6.0;melanoma: 7.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.7;hTEC/SVTERT24-B: 47.0;hTERT-RPE1: 26.4;NTERA-2: 17.3;U-266/70: 25.1;U-87 MG: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.03e-1)"	"unprognostic (3.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.63e-1)"	0.9	0.3	6.9	0.2	7.2	0.0	0.9	1.8	11.0	1.1	1.8	0.5	0.3	0.7	0.4	0.2	0.9	0.6	0.3	11.9	13.5	0.7	0.3	0.4	0.4	6.7	6.7	1.9	8.0	0.1	1.0	0.1	2.7	0.5	0.2	1.2	0.6	0.5	0.4	0.4	0.2	0.4	3.2	0.2	1.0	2.2	5.0	0.2	0.5	0.4	0.4	0.8	0.9	5.4	0.5	0.3	0.6	0.6	0.5	0.9	0.2	3.5	18.7	0.5	1.0	0.1	4.3	0.1	1.8	8.2	1.4	0.0	0.0	0.0	3.1	0.1	1.0	0.0	0.0	0.0	0.3	1.7	1.4	0.6	0.0	47.0	0.5	26.4	0.0	0.2	0.0	0.1	2.8	0.1	0.1	6.0	17.3	0.2	2.2	0.1	0.9	0.0	3.0	1.7	0.6	0.4	0.0	0.0	12.1	1.8	0.1	0.4	0.1	0.1	4.2	0.1	0.5	25.1	1.1	0.0	55.3	0.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.9	7.2	1.8	11.0	11.9	13.5	6.7	6.7	2.7	3.2	5.0	5.4	2.7	0.0	2.0	65.3	1.8	2.8	2.1	3.6	2.8	2.8	5.3	7.7	2.4	1.5	2.9	1.8	0.0	2.3	1.0	1.4	31.3	0.9	16.0	3.0	3.3	2.9	1.2	4.0	61.1	3.0	0.6	3.9	0.5	1.9	2.5	6.9	3.3	2.6	6.2	0.0	47.5	2.7	0.0	0.6	2.5	38.0	2.8	1.9	0.0	19.7	1.1	15.1	2.1	68.3	25.3	0.6	0.8	1.2	0.8	1.9	0.4	17.3	28.8	0.7	0.0	5.0	2.5	2.3	8.6	3.2	2.3	5.1	2.5	5.3	1.5	2.7
COL13A1		ENSG00000197467	"Collagen type XIII alpha 1 chain"	Q5TAT6	10	69801880-69964275	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Osteogenesis"	"Developmental protein, Heparin-binding"	"Congenital myasthenic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 30.4"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 10.1;granulocytes: 20.3;Melanocytes: 5.4;Microglial cells: 6.5;NK-cells: 9.2;Smooth muscle cells: 5.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 63.6;BJ hTERT+: 61.6;hTERT-RPE1: 83.7;HUVEC TERT2: 102.2;PC-3: 93.1;TIME: 137.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA050392	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA050392: AB_2681110"	"unprognostic (2.79e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.67e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.36e-5)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.93e-2)"	1.2	1.9	1.5	2.6	1.7	0.3	2.0	9.5	3.3	5.7	1.9	4.6	2.9	1.8	30.4	1.9	2.8	2.4	3.4	1.4	1.5	2.0	0.8	10.9	0.9	1.6	1.6	0.9	2.1	0.8	3.7	1.7	1.8	13.6	3.4	0.0	0.7	8.0	0.9	5.2	3.8	2.9	1.6	8.0	6.2	0.7	1.7	0.3	1.5	1.4	0.8	3.8	1.8	1.5	1.5	0.6	22.1	0.0	0.1	4.3	0.1	63.6	61.6	10.9	5.5	0.0	1.4	0.2	10.5	30.1	1.0	2.3	0.0	0.2	18.9	0.0	1.6	0.0	0.0	0.0	2.9	0.0	0.1	9.8	0.1	27.5	9.0	83.7	102.2	0.0	0.0	0.1	10.4	0.4	0.0	0.2	5.3	0.0	93.1	0.1	0.0	10.3	0.4	0.0	2.4	0.0	0.0	0.2	3.4	0.9	0.0	0.2	137.4	0.3	17.1	5.7	45.7	13.4	0.0	0.1	37.2	0.1	51.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.5	1.7	9.5	3.3	1.4	1.5	1.6	1.6	1.8	1.6	1.7	1.5	0.9	0.0	0.6	0.3	0.0	3.4	0.3	0.3	0.6	0.2	0.1	2.0	2.1	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	1.3	0.0	0.0	0.2	3.4	0.0	0.0	1.4	0.0	0.0	10.1	0.0	0.1	20.3	1.8	1.1	0.0	0.1	0.0	0.3	0.0	0.0	0.3	2.3	0.0	0.0	0.3	5.4	6.5	0.0	0.1	9.2	0.0	0.3	0.1	0.0	0.4	0.3	0.5	0.9	0.0	0.1	0.0	0.0	1.1	5.6	0.5	0.5	0.2	3.0	0.1	0.6	0.5	0.1	0.1
CORT	MGC32686	ENSG00000241563	Cortistatin	O00230	1	10450031-10451998	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 12.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.3;Early spermatids: 4.9;Late spermatids: 5.1;Spermatocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted in brain"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.25e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-3)"	"unprognostic (7.08e-7)"	"unprognostic (2.01e-1)"	"unprognostic (9.01e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.14e-4)"	0.5	0.5	5.4	0.1	12.9	0.3	0.4	2.3	6.2	0.7	1.8	0.8	0.8	0.4	0.3	0.4	0.5	0.3	0.4	4.8	3.4	1.4	1.0	0.4	0.1	1.7	1.8	0.6	0.5	0.2	1.8	0.9	1.6	0.9	0.2	1.0	0.4	0.1	0.2	0.4	0.8	0.1	1.6	0.4	0.6	1.9	4.1	0.2	0.8	0.1	0.0	0.4	0.4	3.7	0.7	1.7	0.5	0.7	0.2	0.0	0.4	0.6	0.1	0.1	0.1	1.4	0.2	0.6	0.4	0.0	0.2	0.5	0.0	0.0	0.0	1.2	1.3	0.8	1.5	1.5	0.0	0.9	0.4	0.1	0.2	0.2	0.1	0.2	0.0	0.6	0.6	0.4	0.0	1.5	0.2	1.5	0.1	0.0	2.2	0.5	0.9	0.2	0.1	0.5	0.6	0.4	0.3	0.5	0.5	0.3	0.3	0.0	0.6	0.0	1.0	0.9	0.2	0.3	1.5	0.5	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.4	12.9	2.3	6.2	4.8	3.4	1.7	1.8	1.6	1.6	4.1	3.7	2.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	4.9	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	1.8	0.4	0.3	0.3	0.0	0.0	0.0	0.1	0.2
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428360	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	46	"heart muscle: 3905.3;skeletal muscle: 6742.0;tongue: 2096.1"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 4861.8"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	150	"NK-cell: 15.0"	"Lineage enriched"	"Detected in single"	150	"NK-cells: 15.0"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			1.9	0.9	1.8	0.1	1.3	0.0	2.9	2.3	2.3	0.4	0.2	1.4	1.1	1.0	0.0	74.8	0.9	0.0	3905.3	0.9	2.1	4.5	15.9	3.3	0.4	1.6	2.6	1.2	3.0	2.9	11.9	0.1	7.3	38.9	0.0	1.0	92.1	0.1	6742.0	3.5	1.2	0.0	0.8	0.5	1.3	1.3	2.6	0.5	2.0	2096.1	0.1	0.3	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	1.8	1.3	2.3	2.3	0.9	2.1	1.6	2.6	7.3	0.8	2.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.4	4861.8	2.8	0.0	3.7	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.1	48.8	0.0	0.0	0.0	0.4	0.0	96.2	0.0	0.1	0.0	0.2	0.4	75.7	2.9	3.3	0.0	0.1	0.0	1.6	0.0	0.8	0.3	1.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.1	1.3	24.9	0.0	4.2	19.7	258.0	53.7	0.2	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0
CPNE1	CPN1	ENSG00000214078	"Copine 1"	Q99829	20	35626031-35664956	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065876, HPA072634"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA065876: , HPA072634: AB_2686541"	"unprognostic (5.94e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.74e-10)"	"unprognostic (3.10e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	61.0	47.9	15.5	50.5	15.2	70.9	58.5	14.5	17.5	68.7	17.0	65.4	32.5	74.1	58.5	58.7	62.4	48.3	38.4	15.2	15.8	44.1	38.7	59.6	52.3	16.9	14.6	64.7	48.4	38.6	52.1	69.8	15.4	52.3	47.4	17.7	51.6	41.9	43.7	63.4	62.9	70.3	14.5	78.3	51.0	25.5	14.9	82.8	60.2	33.6	81.8	64.4	59.8	19.6	264.1	202.5	112.0	47.3	14.3	18.6	85.4	123.9	219.8	295.0	192.1	590.5	111.2	181.6	115.8	185.3	251.6	98.1	88.1	233.7	182.8	34.7	65.7	459.1	149.9	440.5	131.9	151.5	61.9	121.6	235.8	118.1	139.0	178.9	188.1	183.9	61.4	90.3	144.0	142.9	226.0	201.9	27.8	264.2	187.6	159.1	334.0	125.4	119.9	183.9	78.9	87.9	277.2	129.6	188.1	31.1	134.3	148.8	123.6	306.6	56.4	101.3	131.6	61.5	66.9	126.9	222.7	81.8	69.6	53.6	102.9	180.5	119.3	100.5	164.8	120.8	115.2	112.5	143.7	113.8	111.3	113.6	140.4	206.7	98.8	78.0	153.7	164.5	15.5	15.2	14.5	17.5	15.2	15.8	16.9	14.6	15.4	14.5	14.9	19.6	47.0	19.2	37.3	33.6	55.2	55.1	71.8	82.3	44.9	34.6	40.2	46.0	15.7	32.9	56.5	25.8	20.9	125.1	73.4	26.8	25.4	72.7	39.6	23.3	44.1	53.2	33.6	42.5	37.2	37.8	76.7	56.2	25.0	28.3	48.2	59.9	34.6	23.3	62.4	21.9	33.7	30.8	81.4	43.0	79.6	9.6	54.7	45.5	48.0	30.0	85.0	24.8	62.8	32.6	39.4	44.2	34.0	61.7	60.2	78.6	38.2	34.8	33.9	18.1	46.0	47.0	55.0	13.1	22.9	41.4	49.0	106.3	77.0	65.9	41.2	71.7
CPXM1	"CPX-1, CPX1, CPXM"	ENSG00000088882	"Carboxypeptidase X, M14 family member 1"	Q96SM3	20	2794074-2800627	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 86.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 162.7;Fibroblasts: 60.1;Theca cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebral cortex: 6.9"	"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 161.7;HSkMC: 85.7;NB-4: 148.1;REH: 150.8;SH-SY5Y: 108.2"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 8.7"						"Secreted in other tissues"	NA	NA		490000	"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"				"unprognostic (7.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (4.62e-10)"	"unprognostic (1.30e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.27e-2)"	59.0	4.8	0.9	9.7	1.2	19.0	31.2	0.7	6.9	72.4	2.5	4.1	1.4	76.8	8.4	4.2	27.1	86.0	4.5	0.9	0.9	6.5	0.3	5.4	6.5	0.9	0.7	41.9	3.1	3.8	5.3	51.5	1.1	7.1	1.5	0.0	4.8	2.3	1.2	12.7	3.3	38.8	1.1	0.9	2.2	3.6	1.4	9.6	24.5	0.0	2.8	55.5	29.4	1.0	0.0	0.0	161.7	0.0	0.0	4.9	0.2	0.4	0.7	2.0	0.6	0.0	0.0	0.0	0.5	0.3	0.1	0.0	12.1	0.0	0.5	0.7	8.5	22.1	0.0	0.0	2.2	0.1	3.2	85.7	0.0	7.7	0.0	0.0	0.0	31.1	9.3	0.0	0.1	0.1	0.6	148.1	34.5	0.0	0.0	150.8	0.0	4.2	0.0	0.0	0.2	108.2	0.0	0.2	0.0	25.8	0.0	1.9	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.9	1.2	0.7	6.9	0.9	0.9	0.9	0.7	1.1	1.1	1.4	1.0	3.9	0.0	0.5	0.0	0.3	2.7	5.8	0.7	4.0	0.0	1.1	3.8	0.7	0.0	0.8	3.7	0.0	2.9	1.7	0.5	0.0	3.0	2.3	5.8	162.7	3.1	0.0	7.6	0.0	0.0	3.3	60.1	0.0	4.2	2.5	17.7	0.7	0.0	6.5	0.0	0.0	0.0	0.0	0.0	2.6	2.8	17.4	0.9	1.8	0.0	0.7	0.0	0.0	0.5	0.0	0.3	0.0	0.7	0.5	2.5	0.0	0.1	3.1	0.0	0.0	0.4	10.2	0.0	1.5	0.1	2.0	3.3	1.4	28.2	0.6	0.8
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345664-87399794	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 136.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 71.7;RT4: 72.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favorable (4.02e-4)"	5.4	10.5	4.8	6.3	6.1	3.2	16.1	5.9	6.1	11.8	7.9	12.6	31.9	7.8	18.5	19.3	10.7	14.1	6.6	5.7	5.1	16.9	35.0	6.6	6.2	4.6	5.0	8.6	6.7	18.7	6.0	19.0	4.5	21.1	11.0	35.4	9.3	27.5	11.3	24.6	23.6	8.6	4.9	5.4	6.8	3.3	5.3	7.6	40.5	9.5	8.5	25.2	19.0	5.6	15.3	10.9	13.5	4.7	12.6	11.5	9.9	15.7	14.8	9.4	10.1	6.0	7.9	6.4	13.6	13.6	18.9	18.9	2.3	21.2	13.5	9.1	9.5	13.9	7.8	7.6	8.1	8.8	8.3	9.4	71.7	7.6	6.0	12.1	13.7	10.4	0.7	9.0	25.2	15.0	11.2	8.8	3.0	5.5	16.4	5.0	18.6	1.1	12.3	72.1	2.2	10.5	19.2	22.3	10.6	9.2	14.2	3.1	7.2	22.0	9.5	29.8	15.2	13.6	21.0	8.8	14.8	0.1	13.3	2.0	1.3	3.4	6.6	1.7	8.7	2.0	6.7	5.5	1.9	1.9	5.3	5.9	0.8	13.0	6.2	2.2	6.2	2.8	4.8	6.1	5.9	6.1	5.7	5.1	4.6	5.0	4.5	4.9	5.3	5.6	8.6	22.4	10.0	18.9	5.1	16.8	56.4	45.0	65.4	16.9	17.5	12.7	14.9	14.3	35.0	53.3	45.9	136.5	9.0	21.0	9.8	7.6	28.7	9.5	9.3	7.2	7.3	4.8	26.3	8.7	7.9	12.0	11.2	12.1	7.6	9.5	5.3	29.7	13.6	15.2	11.1	15.8	16.2	6.3	4.8	63.1	15.8	5.9	19.6	7.5	6.3	25.9	22.6	15.6	16.1	11.1	9.9	13.9	4.8	20.1	53.7	19.9	24.1	79.7	6.6	10.0	10.1	2.4	4.8	29.6	15.3	49.0	9.6	8.7	15.1	48.4
CRTAM	CD355	ENSG00000109943	"Cytotoxic and regulatory T cell molecule"	O95727	11	122838500-122872643	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Group enriched"	"Detected in some"	4	"dendritic cells: 63.8;Plasma cells: 16.0;T-cells: 54.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 54.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 54.0;T-cells: 33.3"	"Cell line enriched"	"Detected in single"	34	"SCLC-21H: 12.9"	"Region enriched"	"Detected in some"	44	"cerebellum: 102.6"	"Region enriched"	"Detected in all"	7	"cerebellum: 25.7"							NA	NA		6800000	"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (3.51e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.25e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.59e-2)"	0.3	0.3	0.3	2.3	0.5	1.8	0.5	38.2	1.4	0.3	0.3	0.5	0.6	0.8	0.5	0.3	0.3	1.5	0.2	0.2	0.4	0.1	1.0	1.8	8.8	1.1	1.4	0.3	0.1	0.1	0.1	0.2	4.2	0.3	0.6	0.0	0.7	0.2	0.1	0.3	1.2	0.2	0.5	3.6	0.8	0.2	0.7	4.9	0.2	0.0	3.5	0.8	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	4.6	0.6	13.0	5.6	12.9	0.1	1.5	27.0	3.6	0.2	4.3	33.3	1.2	54.0	10.5	0.2	0.1	6.0	0.3	0.5	38.2	1.4	0.2	0.4	1.1	1.4	4.2	0.5	0.7	1.6	1.1	0.0	1.1	0.3	0.8	1.5	0.4	0.1	0.0	0.0	0.4	0.9	0.3	0.0	0.0	0.0	0.0	0.1	63.8	0.1	0.0	0.0	1.2	0.4	0.4	0.3	0.0	0.4	0.5	0.0	0.2	1.6	2.0	0.6	1.3	0.0	0.4	0.2	5.9	0.0	0.7	0.0	0.0	8.8	8.1	1.2	0.0	10.3	3.6	0.0	9.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	16.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	0.6	0.3	0.5	0.0	0.9	0.1	54.1	0.0	0.0	0.5
CTSW		ENSG00000172543	"Cathepsin W"	P56202	11	65879809-65883741	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.3;lymphoid tissue: 42.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 717.8;NK-cells: 867.2;T-cells: 352.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	8	"gdT-cell: 1376.3;MAIT T-cell: 869.4;memory CD8 T-cell: 892.8;naive CD8 T-cell: 636.3;NK-cell: 2276.1"	"Group enriched"	"Detected in all"	39	"NK-cells: 2276.1;T-cells: 1376.3"	"Group enriched"	"Detected in some"	22	"HEL: 156.7;NB-4: 363.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB016345, HPA066903"	Enhanced				"Intracellular and membrane"	NA	NA		270000	"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB016345: AB_626813, HPA066903: "	"prognostic favorable (3.06e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.36e-6)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (3.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.01e-3)"	5.1	2.9	0.8	12.9	0.9	116.3	3.7	1.8	1.6	2.6	0.6	5.6	6.1	6.7	2.8	3.1	4.0	6.2	2.9	0.8	0.9	2.1	6.5	24.0	29.5	1.6	0.7	2.4	1.8	0.5	1.1	3.3	1.2	2.1	6.3	0.0	9.1	3.9	1.3	2.7	6.1	2.7	1.2	42.4	8.3	1.2	1.1	7.8	3.2	0.4	13.9	8.6	2.5	1.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	156.7	0.3	0.0	0.0	11.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.0	0.0	9.1	0.2	0.2	1.9	363.4	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	5.6	0.1	0.0	0.1	0.4	0.1	0.3	0.5	0.0	0.2	9.9	0.3	46.4	3.4	4.8	1376.3	4.0	869.4	5.1	145.3	892.8	37.6	3.7	86.0	636.3	25.7	2276.1	5.4	23.3	23.7	809.3	0.8	0.9	1.8	1.6	0.8	0.9	1.6	0.7	1.2	1.2	1.1	1.1	5.1	0.0	4.2	0.0	9.7	4.6	0.4	0.0	1.8	0.0	2.3	2.2	0.4	2.8	1.4	0.0	0.0	0.4	717.8	0.3	0.0	0.3	2.0	0.9	0.9	1.9	0.0	44.1	0.0	0.0	0.2	4.0	12.8	1.1	71.7	0.1	5.7	1.6	1.9	0.0	0.0	0.2	0.0	5.6	34.1	11.1	0.0	9.9	17.8	0.0	6.1	0.0	867.2	0.0	0.2	0.0	0.0	0.0	57.7	0.3	0.0	1.1	0.8	0.0	0.0	1.6	1.9	0.3	1.2	0.8	6.3	0.3	352.6	0.1	0.3	0.3
DCAF5	"BCRG2, BCRP2, D14S1461E, KIAA1824, WDR22"	ENSG00000139990	"DDB1 and CUL4 associated factor 5"	Q96JK2	14	69050881-69153150	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041575, HPA048098"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA041575: AB_2677558, HPA048098: AB_2680263"	"unprognostic (8.12e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-1)"	30.0	22.5	16.1	23.4	15.9	30.2	27.2	16.4	16.5	29.3	17.0	34.0	21.6	28.3	22.3	30.9	28.8	24.4	31.3	16.5	16.6	24.6	31.4	31.0	27.6	15.8	15.0	28.5	22.0	36.4	28.8	25.4	16.0	29.8	21.2	20.8	27.2	25.1	74.3	30.5	25.9	32.7	14.1	27.7	26.2	60.5	17.2	39.4	30.1	51.7	25.6	29.2	28.3	14.5	48.3	15.0	34.7	32.5	37.7	32.9	22.7	22.2	32.1	24.9	31.2	19.4	29.9	26.4	19.9	34.7	18.8	23.0	24.7	33.2	23.2	36.0	13.7	28.4	15.8	14.0	28.6	10.9	33.2	37.3	34.0	22.3	31.1	43.0	37.7	31.1	22.4	21.6	25.1	28.6	34.7	19.0	15.6	22.6	23.7	22.8	32.9	10.6	33.1	37.0	24.7	27.8	29.7	30.7	19.4	29.7	37.5	22.0	34.4	42.2	39.4	19.6	13.2	28.4	9.9	23.9	28.1	13.0	13.0	21.1	4.3	16.4	31.0	4.0	26.3	8.2	16.7	23.0	5.7	8.6	15.7	19.7	5.4	32.3	3.0	6.0	8.2	13.1	16.1	15.9	16.4	16.5	16.5	16.6	15.8	15.0	16.0	14.1	17.2	14.5	28.8	44.8	57.8	71.8	24.9	26.3	19.1	21.4	38.1	18.5	23.3	19.0	58.8	32.9	39.4	14.7	27.1	19.4	43.6	20.9	1.9	25.1	149.9	28.7	30.6	32.1	23.4	25.6	88.8	24.9	19.3	27.2	32.1	31.9	37.2	28.0	26.0	33.2	19.6	18.5	85.6	22.0	22.4	19.7	23.7	89.3	31.1	24.3	10.6	74.9	21.8	22.3	52.5	76.9	61.6	29.2	16.0	34.3	35.8	19.9	20.9	14.0	41.2	24.9	46.0	29.1	26.6	75.2	19.8	37.9	19.9	15.3	38.0	31.2	21.3	23.5
DDIT4	"Dig2, FLJ20500, REDD-1, REDD1, RTP801"	ENSG00000168209	"DNA damage inducible transcript 4"	Q9NX09	10	72273919-72276036	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 776.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 657.6;hTCEpi: 2252.5;hTERT-HME1: 877.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034507, HPA034508"	Approved		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA034507: AB_2674199, HPA034508: AB_10601206"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (7.65e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.66e-1)"	313.5	280.9	88.9	83.7	89.3	123.7	287.3	92.5	106.4	415.9	103.4	93.5	20.8	98.6	12.6	425.0	118.6	47.8	237.2	82.4	87.7	179.9	337.1	197.8	90.1	102.9	92.0	741.5	675.4	94.4	169.5	51.8	90.0	171.1	13.3	86.7	224.9	68.3	278.1	231.6	111.7	25.4	88.0	166.3	121.2	32.0	95.8	102.5	105.1	60.0	114.3	315.3	597.5	98.2	139.2	95.2	20.0	179.3	124.0	74.3	52.1	40.3	45.6	13.5	56.7	11.1	280.5	14.3	113.7	6.5	19.1	143.0	28.9	657.6	33.7	213.9	35.8	15.1	115.4	74.0	501.2	47.7	57.7	291.1	2252.5	59.2	877.9	127.1	60.1	33.9	135.3	347.2	51.5	58.7	28.5	62.1	4.2	67.6	22.2	15.2	22.4	265.7	115.9	30.9	33.2	46.2	98.3	152.0	583.9	43.0	20.9	104.4	118.7	4.6	35.4	8.7	22.3	234.3	135.1	42.3	252.9	99.9	29.8	68.8	7.6	51.1	236.4	14.5	249.6	97.4	163.8	141.3	40.3	122.4	274.5	213.7	17.1	408.1	13.0	197.4	136.9	215.0	88.9	89.3	92.5	106.4	82.4	87.7	102.9	92.0	90.0	88.0	95.8	98.2	366.5	12.8	27.1	136.1	290.6	228.5	383.5	534.1	290.8	87.8	129.8	112.5	16.1	77.2	226.6	60.7	79.2	9.9	680.2	109.2	60.7	310.7	3.1	46.4	101.8	177.9	75.1	129.0	2.1	165.3	141.1	203.8	116.2	69.2	415.0	30.8	249.1	83.8	89.7	30.3	3.8	105.6	173.0	102.4	485.9	7.0	88.3	280.5	396.6	5.6	38.9	682.8	249.3	7.1	5.5	131.5	177.7	128.2	776.1	143.5	41.6	19.3	100.6	143.3	72.3	124.2	338.3	2.1	5.7	519.6	251.5	19.0	537.4	126.0	70.6	359.6
DENND2D	"FLJ22457, RP5-1180E21.2"	ENSG00000162777	"DENN domain containing 2D"	Q9H6A0	1	111185969-111204535	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 93.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 71.2;NK-cells: 232.8;T-cells: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"gdT-cell: 236.8;MAIT T-cell: 204.4;memory CD4 T-cell: 172.0;memory CD8 T-cell: 243.8;naive CD4 T-cell: 265.5;naive CD8 T-cell: 256.8;NK-cell: 278.3;T-reg: 79.5"	"Group enriched"	"Detected in all"	6	"NK-cells: 278.3;T-cells: 265.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;MOLT-4: 154.0;SK-BR-3: 96.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043630, HPA048642"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA043630: AB_2678589, HPA048642: AB_2680474"	"unprognostic (1.72e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (2.60e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (5.09e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (8.66e-5)"	9.1	13.0	0.8	39.3	0.7	11.8	12.0	0.7	1.3	10.9	3.7	19.2	19.2	3.5	9.6	25.2	18.6	10.8	1.8	0.5	1.0	14.3	12.1	16.5	93.8	1.8	1.1	6.5	7.8	33.4	9.8	9.0	1.3	7.6	19.7	0.3	19.0	7.6	0.6	14.2	22.5	3.3	1.6	40.1	26.8	9.7	2.7	41.6	11.4	2.2	79.5	29.2	11.6	2.7	32.6	1.4	0.1	0.0	7.3	3.0	0.3	1.9	0.1	3.4	0.8	9.9	14.8	34.4	11.0	4.9	0.2	10.2	0.1	1.7	3.3	61.2	0.0	10.1	2.4	0.0	11.3	0.1	10.1	8.9	7.0	1.0	0.0	10.2	0.3	11.1	0.2	10.3	1.0	27.8	154.0	0.9	0.0	40.8	4.4	4.0	0.0	46.0	10.9	33.6	11.2	0.0	11.4	96.5	3.6	0.2	30.3	32.0	0.0	0.0	0.1	0.0	0.2	9.5	4.1	25.8	0.0	27.1	0.2	5.3	21.0	15.0	236.8	15.5	204.4	42.6	172.0	243.8	19.7	46.3	265.5	256.8	20.7	278.3	11.9	15.1	79.5	197.5	0.8	0.7	0.7	1.3	0.5	1.0	1.8	1.1	1.3	1.6	2.7	2.7	2.1	6.4	16.8	0.3	24.7	5.0	17.9	24.1	9.6	0.1	14.9	8.6	1.2	8.6	23.8	20.2	0.0	1.7	71.2	22.8	19.6	38.0	35.4	8.9	1.4	3.7	6.0	8.2	0.2	15.9	3.1	3.7	25.5	11.3	17.7	4.6	7.5	5.3	57.1	0.0	0.2	34.6	14.2	32.4	2.5	49.2	1.2	17.2	7.2	1.9	11.9	0.0	232.8	0.0	0.1	12.7	18.2	0.4	12.3	35.4	20.4	28.7	20.7	0.4	0.0	1.2	1.8	25.4	0.7	17.7	4.0	11.5	83.2	10.2	21.0	31.3
DLL1		ENSG00000198719	"Delta like canonical Notch ligand 1"	O00548	6	170282206-170306565	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 88.8;Basal keratinocytes: 66.9;Basal squamous epithelial cells: 82.0;Enteroendocrine cells: 51.9;Intestinal goblet cells: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 3.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.8;HBEC3-KT: 4.5;NB-4: 14.2;THP-1: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001255			Approved	"Plasma membrane"		NA	NA		690000	"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"		"HPA001255: "	"unprognostic (1.03e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.66e-1)"	20.9	8.6	2.8	2.1	6.9	0.7	19.2	3.3	4.5	21.1	0.2	15.4	3.9	10.1	0.3	21.9	11.5	0.8	15.9	2.2	2.9	12.5	6.4	13.1	1.9	6.0	5.1	4.2	16.9	0.3	6.2	1.2	4.8	28.7	0.9	0.4	17.7	1.1	5.3	26.2	19.3	0.8	2.0	53.9	10.9	1.6	4.0	0.2	12.4	0.7	0.4	9.6	22.9	11.0	0.7	0.1	3.3	2.0	0.1	0.1	1.5	0.3	0.2	0.2	0.3	1.0	0.1	0.0	0.3	0.1	0.6	6.8	1.4	4.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.6	0.0	0.4	0.1	0.7	0.0	0.0	0.0	0.1	0.8	0.0	14.2	0.2	0.1	0.0	1.1	2.8	0.0	0.0	0.4	1.6	0.2	0.1	0.0	0.0	1.1	0.4	14.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.3	0.4	0.0	0.0	0.1	2.8	6.9	3.3	4.5	2.2	2.9	6.0	5.1	4.8	2.0	4.0	11.0	88.8	0.0	0.5	26.1	2.7	66.9	14.9	31.2	82.0	1.4	5.4	14.7	11.8	0.0	7.2	1.8	22.9	3.1	3.0	3.0	0.0	0.3	0.4	5.1	10.1	28.5	51.9	0.4	6.9	1.8	5.9	19.2	1.5	5.3	5.7	0.2	21.4	0.2	1.3	0.0	6.4	80.3	16.2	4.8	6.6	1.9	0.3	2.7	7.2	4.7	0.2	1.1	0.0	28.6	26.7	0.7	2.5	1.2	0.3	4.8	2.5	0.1	9.0	0.6	13.1	12.3	8.2	0.5	2.0	8.5	12.8	3.7	4.7	0.1	3.6	1.1
DNAH14	"C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277"	ENSG00000185842	"Dynein axonemal heavy chain 14"	Q0VDD8	1	224896262-225399292	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.0;Excitatory neurons: 65.4;Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 48.8"	"Low region specificity"	"Detected in many"							"HPA027718, HPA028545, HPA031379"	Uncertain		Supported	Centrosome		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"HPA027718: AB_10601210, HPA028545: AB_2672665, HPA031379: AB_2673851"	"unprognostic (1.16e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.09e-3)"	"unprognostic (9.94e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.33e-9)"	"unprognostic (6.76e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	1.1	3.2	4.2	0.7	3.5	1.9	3.2	0.9	3.4	1.8	4.4	1.9	1.0	1.9	3.6	1.1	1.6	1.6	1.3	3.4	9.2	5.4	5.7	2.3	0.4	3.8	4.3	3.7	5.6	2.1	6.6	1.5	3.9	3.2	2.3	2.7	1.5	1.4	0.1	0.4	0.6	1.1	2.9	0.4	2.6	22.1	8.8	1.4	4.4	0.2	0.2	1.8	1.1	2.9	19.7	9.9	8.9	9.8	3.5	7.1	21.3	4.0	3.7	7.2	6.3	15.6	21.1	0.0	9.7	4.1	0.0	0.2	13.8	3.8	12.2	0.0	23.0	9.4	7.2	3.4	4.3	19.6	3.1	6.9	8.3	10.0	6.9	7.7	2.4	13.5	48.8	0.0	12.4	5.2	3.6	20.3	25.1	22.1	12.0	0.0	33.8	18.0	6.7	9.0	14.9	16.9	15.4	11.5	32.1	14.8	21.2	16.9	0.4	0.1	14.4	0.3	0.1	20.9	14.1	0.2	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.2	0.0	4.2	3.5	0.9	3.4	3.4	9.2	3.8	4.3	3.9	2.9	8.8	2.9	2.5	12.8	11.5	2.3	0.6	2.0	14.0	6.0	3.4	28.1	10.1	6.2	6.5	10.0	5.7	20.2	33.3	10.6	1.3	2.1	7.9	11.2	135.0	13.1	13.2	3.4	8.3	6.7	65.4	10.0	12.4	4.5	6.6	12.2	14.0	23.3	1.4	7.7	3.4	28.6	44.0	5.2	4.1	0.0	1.2	45.9	2.8	1.2	3.6	6.5	1.0	8.0	1.0	23.6	8.4	9.4	1.1	3.4	1.2	11.2	0.5	8.4	6.7	3.9	6.6	0.5	2.7	74.5	24.9	2.8	0.9	11.5	1.4	10.1	5.0	7.1
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 127.2;Horizontal cells: 95.9;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 59.6;REH: 59.5;SH-SY5Y: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	5.6	9.0	8.9	9.8	12.6	8.7	6.2	9.3	10.7	9.1	2.4	11.3	6.7	9.3	8.7	6.0	7.5	6.3	5.9	8.8	7.9	11.3	5.3	7.3	11.1	9.0	7.6	13.0	8.3	4.2	11.5	15.7	8.6	7.2	6.6	15.4	6.2	5.9	21.0	4.9	8.9	7.1	5.2	13.4	8.5	5.2	9.4	20.6	6.9	10.2	9.0	7.3	6.2	11.3	1.6	8.1	34.6	8.3	3.8	2.7	45.2	1.9	2.2	4.7	3.8	21.1	13.2	0.0	4.7	4.7	3.5	2.2	3.8	5.2	2.8	5.7	4.3	14.7	12.8	25.4	8.8	2.9	7.6	8.2	2.6	6.0	2.2	9.1	19.5	34.0	18.0	2.9	3.5	20.6	33.7	36.5	59.6	14.3	4.2	59.5	32.5	3.8	2.9	3.4	18.6	71.5	2.7	19.6	6.2	29.5	2.1	16.2	6.8	5.4	4.7	1.0	2.5	5.6	5.1	19.6	2.2	8.4	5.5	2.8	1.0	2.1	2.7	1.7	4.0	1.3	1.7	2.4	1.3	1.6	4.6	3.9	2.5	5.5	2.7	2.3	1.9	1.2	8.9	12.6	9.3	10.7	8.8	7.9	9.0	7.6	8.6	5.2	9.4	11.3	18.5	6.4	13.1	28.1	11.0	5.2	10.2	6.6	5.7	73.3	12.1	9.8	15.8	5.7	9.9	20.2	127.2	40.6	15.3	6.3	5.9	16.9	1.6	13.3	19.1	20.5	13.1	15.8	49.4	9.8	10.7	16.4	9.7	10.7	37.4	37.3	11.0	6.4	23.2	95.9	43.2	11.4	2.0	14.2	3.9	1.9	19.3	13.7	7.2	38.4	7.4	20.6	13.4	36.7	63.4	9.3	9.4	15.4	9.8	12.4	6.2	6.6	7.3	143.5	19.7	15.1	14.3	2.8	14.6	8.1	2.6	32.2	19.6	26.1	12.1	10.2
DPH6	"ATPBD4, MGC14798"	ENSG00000134146	"Diphthamine biosynthesis 6"	Q7L8W6	15	35217345-35546193	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 91.7;Oligodendrocytes: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042976, HPA055496"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042976: AB_10964890, HPA055496: AB_2682835"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.65e-6)"	"unprognostic (9.70e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	8.6	7.5	3.7	4.9	4.7	5.4	10.8	4.6	5.0	6.8	3.6	6.7	6.1	7.9	10.7	9.6	8.1	6.0	10.2	3.6	4.7	10.4	8.1	5.3	5.3	4.6	4.4	9.7	14.3	8.7	5.9	8.1	4.8	5.8	7.0	8.9	6.7	6.1	10.8	9.7	6.6	6.4	4.3	6.3	6.8	5.9	3.9	7.0	10.8	6.9	7.4	8.0	7.1	5.7	16.9	8.9	14.7	12.5	2.6	11.7	14.3	6.2	10.8	14.7	7.6	11.9	15.5	5.2	14.8	5.7	17.9	19.0	17.2	17.9	17.5	4.1	10.7	19.6	9.9	18.9	15.3	10.6	12.1	9.9	22.2	5.9	28.5	9.0	14.4	11.0	21.8	20.6	13.6	6.6	13.0	9.8	13.0	25.4	8.1	16.0	13.7	7.2	12.9	21.0	10.7	10.4	11.6	12.8	10.7	8.5	44.6	14.4	4.4	14.2	13.8	14.4	10.0	18.2	31.3	13.4	12.3	17.7	13.9	0.0	6.7	0.3	6.0	6.7	7.7	8.9	8.1	8.4	6.7	6.3	10.3	9.3	0.3	14.7	6.2	5.8	5.8	4.5	3.7	4.7	4.6	5.0	3.6	4.7	4.6	4.4	4.8	4.3	3.9	5.7	15.9	16.0	7.5	91.7	18.7	31.0	20.0	19.8	24.5	29.2	12.0	16.6	15.8	18.6	17.2	9.2	39.6	26.7	9.3	7.5	13.7	16.3	2.2	10.7	13.7	10.0	5.4	16.8	28.0	24.1	23.5	12.0	21.4	13.3	3.8	21.1	5.7	7.4	17.5	18.5	47.0	7.4	14.2	10.3	12.9	3.3	14.0	9.8	16.0	44.0	14.3	15.0	11.3	71.9	101.5	18.7	7.1	6.8	6.9	8.9	13.4	19.9	7.6	24.2	0.0	18.9	14.0	9.8	14.0	21.2	23.2	22.6	9.9	21.9	10.5	13.4
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522807-15663058	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 127.0"	"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favorable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.72e-4)"	"prognostic favorable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	16.2	9.3	40.8	17.6	60.1	16.7	14.8	35.1	46.6	13.2	32.5	26.0	11.8	13.5	18.3	11.3	11.6	12.6	21.5	42.8	45.7	18.0	8.6	14.7	29.3	40.2	41.9	11.0	11.9	21.0	11.5	14.9	40.8	13.8	16.4	127.0	13.7	14.8	26.8	13.6	17.4	17.8	38.0	22.1	17.1	12.0	44.3	21.4	13.2	16.0	30.9	19.8	12.5	37.8	30.6	12.9	10.9	23.7	15.5	17.8	16.6	15.3	20.0	36.0	32.4	17.6	13.7	42.9	40.5	21.8	29.6	10.4	21.8	16.3	32.6	27.3	28.9	30.2	15.4	25.7	27.3	30.6	24.8	16.9	24.7	18.5	26.8	16.6	32.2	29.0	29.3	10.2	22.1	35.9	31.9	48.7	7.7	25.4	18.6	37.7	21.2	33.4	33.7	31.7	22.1	9.5	12.1	28.4	36.4	25.1	20.6	19.4	15.2	20.5	13.4	21.2	28.6	27.7	57.3	30.9	9.5	27.1	39.5	11.1	10.1	14.4	19.5	12.4	13.1	24.8	16.5	17.2	11.0	31.3	15.5	12.6	11.6	49.3	9.0	30.8	12.1	11.5	40.8	60.1	35.1	46.6	42.8	45.7	40.2	41.9	40.8	38.0	44.3	37.8	23.2	12.8	11.3	35.3	42.6	29.1	16.5	12.5	11.4	47.2	14.3	13.1	29.3	15.7	11.4	14.7	58.4	41.4	29.6	18.6	37.2	37.5	50.5	16.3	9.8	31.7	13.8	5.5	36.3	35.8	17.9	16.9	14.3	14.5	54.6	54.1	20.0	6.0	54.8	25.2	38.6	17.5	8.2	18.5	32.4	26.6	10.2	22.1	37.4	39.4	29.8	55.2	64.9	26.7	36.3	26.5	12.1	15.4	20.2	12.9	27.2	81.6	13.0	173.4	6.6	12.3	20.8	22.3	18.3	8.6	22.0	16.7	29.1	11.0	19.2	12.0
ELOVL6	"FLJ23378, LCE, MGC5487"	ENSG00000170522	"ELOVL fatty acid elongase 6"	Q9H5J4	4	110045846-110199199	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 83.4;Hepatocytes: 102.0;Inhibitory neurons: 78.5;Oligodendrocytes: 77.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.4;MAIT T-cell: 2.6;memory CD4 T-cell: 1.0;memory CD8 T-cell: 1.3;naive CD8 T-cell: 1.0;NK-cell: 3.3"	"Group enriched"	"Detected in many"	21	"NK-cells: 3.3;T-cells: 2.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042355	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA042355: AB_10796577"	"unprognostic (3.92e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (6.74e-4)"	"unprognostic (8.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.32e-2)"	12.2	8.7	4.6	2.9	5.2	4.0	7.4	5.2	7.9	4.2	1.5	11.5	8.5	3.1	2.1	18.0	2.1	3.2	4.2	4.9	5.0	4.0	36.2	3.1	0.7	5.8	5.4	1.5	2.0	6.4	4.0	1.7	6.0	1.9	10.2	12.1	4.1	2.3	1.0	15.3	6.3	3.7	5.8	1.6	13.6	0.9	5.3	1.8	1.8	0.5	2.3	6.8	5.7	7.8	24.1	14.5	57.8	12.9	31.6	32.6	24.6	16.8	9.5	6.4	16.4	7.6	45.5	2.5	1.3	13.3	22.0	21.5	46.8	52.2	13.6	9.5	14.8	33.9	17.3	17.9	19.6	30.4	18.8	30.0	10.2	34.9	13.5	21.5	11.9	3.4	33.8	57.0	12.6	10.5	7.1	2.6	25.0	15.3	7.2	4.3	24.1	7.2	37.2	20.3	11.0	23.3	9.9	57.9	9.1	24.3	10.0	0.3	5.9	13.2	15.5	20.4	21.4	2.7	11.3	57.9	20.8	0.0	2.8	0.1	0.0	0.0	2.4	0.0	2.6	0.0	1.0	1.3	0.0	0.0	0.3	1.0	0.1	3.3	0.0	0.0	0.1	0.4	4.6	5.2	5.2	7.9	4.9	5.0	5.8	5.4	6.0	5.8	5.3	7.8	2.1	0.0	7.8	51.2	1.6	1.8	3.0	8.6	2.8	24.4	3.8	2.8	3.2	8.6	9.8	11.0	37.5	2.5	8.9	38.1	5.9	13.0	7.6	3.5	11.1	2.2	3.0	34.9	83.4	8.2	26.8	6.9	30.5	6.3	6.3	8.3	4.2	102.0	1.9	26.9	78.5	14.4	8.2	3.0	0.3	3.9	1.2	0.7	0.0	18.7	0.1	5.5	18.6	56.3	77.3	16.6	24.8	1.2	2.9	2.5	7.1	6.9	2.9	16.3	6.6	6.4	7.5	0.2	1.5	19.9	7.0	2.1	9.6	11.8	22.4	5.1
ELP6	"C3orf75, FLJ20211, TMEM103"	ENSG00000163832	"Elongator acetyltransferase complex subunit 6"	Q0PNE2	3	47495640-47513712	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046358, HPA064545"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA046358: AB_10961011, HPA064545: AB_2685282"	"unprognostic (2.00e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.42e-6)"	"unprognostic (1.54e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.29e-2)"	13.5	27.0	21.3	14.3	22.8	11.5	15.8	23.6	23.6	14.5	24.3	16.2	15.2	17.2	23.1	15.5	16.9	14.7	19.6	21.0	21.6	17.5	21.3	12.1	21.9	22.8	22.2	21.7	14.8	21.1	15.1	14.4	22.7	19.4	13.9	8.7	16.4	17.7	35.6	16.6	13.4	18.0	22.2	15.7	15.7	21.1	22.9	24.6	19.3	29.0	20.5	16.0	13.3	23.7	37.6	36.4	45.3	46.8	34.9	32.0	26.5	43.4	29.7	54.2	48.6	35.1	38.4	68.7	27.1	37.6	51.3	22.1	43.6	62.5	33.0	39.9	34.4	62.6	55.5	40.4	38.5	49.1	38.5	34.9	33.2	61.4	38.3	31.5	47.3	58.8	67.1	21.7	54.1	44.0	59.8	56.7	55.1	35.4	57.9	29.2	22.3	42.2	38.4	33.9	40.3	40.9	36.9	29.8	25.8	36.0	40.8	41.1	32.8	57.3	41.9	28.9	56.9	44.8	63.5	64.9	28.4	58.8	58.4	19.7	20.4	15.1	31.8	18.9	25.2	33.4	29.4	32.9	25.9	35.2	28.3	28.9	2.8	35.3	13.7	33.9	38.5	25.6	21.3	22.8	23.6	23.6	21.0	21.6	22.8	22.2	22.7	22.2	22.9	23.7	19.3	6.4	12.3	8.8	24.9	8.4	15.2	35.7	19.4	21.7	20.3	22.4	23.0	24.3	20.0	33.1	14.6	44.0	27.8	16.0	60.7	28.1	8.3	15.3	19.4	22.6	17.4	30.3	9.4	23.6	39.6	23.4	17.9	14.0	22.2	56.3	30.0	28.5	28.6	38.7	11.9	15.0	40.7	14.5	8.3	14.5	23.0	17.4	16.0	9.4	21.7	43.7	48.4	5.5	11.7	21.3	12.7	30.5	23.1	10.9	22.9	51.1	15.7	26.0	6.6	14.2	22.6	47.2	22.4	15.6	8.4	26.8	23.9	58.4	21.7	10.4
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 80.2;Fibroblasts: 56.9;Hepatocytes: 111.6;Peritubular cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.1;LHCN-M2: 21.1;U-138 MG: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		4400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	8.4	3.1	0.4	1.4	0.5	0.1	7.1	0.7	0.4	7.1	0.4	2.3	1.8	22.1	7.4	2.3	6.9	1.2	1.6	0.4	0.7	4.2	31.9	0.8	1.4	1.2	1.4	8.3	28.5	27.8	10.9	44.0	0.9	3.4	2.0	0.5	4.2	5.8	2.7	1.7	1.3	10.2	0.8	1.9	1.7	1.6	1.0	2.2	20.1	3.2	0.8	2.7	4.9	0.8	0.0	1.3	1.2	0.1	34.1	5.3	0.0	9.2	9.4	3.5	9.5	4.1	1.1	0.0	0.8	5.9	7.2	0.0	1.3	0.2	14.8	0.3	1.8	0.0	1.1	12.0	1.0	0.0	4.2	8.8	0.4	9.6	0.4	4.1	4.3	0.7	0.0	1.8	21.1	2.6	0.0	0.0	7.9	1.6	1.3	0.0	10.2	0.3	0.2	0.4	3.4	0.0	0.2	1.3	4.2	5.7	3.9	0.0	2.9	27.6	1.0	1.9	9.1	3.4	0.0	0.0	12.6	0.0	3.5	0.6	0.0	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.7	0.2	0.0	0.0	0.3	1.6	0.1	0.1	0.0	0.0	0.4	0.5	0.7	0.4	0.4	0.7	1.2	1.4	0.9	0.8	1.0	0.8	2.6	0.0	1.7	0.3	1.5	1.5	9.9	0.0	0.6	4.5	28.7	19.9	6.4	5.7	0.1	1.8	0.0	3.0	1.2	16.7	5.9	0.3	4.8	3.9	80.2	4.1	0.0	8.0	3.5	10.6	2.1	56.9	6.1	3.2	0.0	9.4	3.3	111.6	4.6	1.7	10.5	12.7	0.0	2.9	5.9	6.7	25.1	3.9	1.8	12.2	0.2	3.6	0.0	21.6	1.6	5.2	3.9	70.0	0.4	2.3	6.7	25.2	0.1	0.5	13.1	12.6	18.8	4.1	2.2	0.1	1.3	6.2	2.6	1.9	2.5	1.7
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.4;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 43.6;Erythroid cells: 16.8;NK-cells: 93.7;T-cells: 31.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 8.4"	"Group enriched"	"Detected in many"	7	"gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0"	"Group enriched"	"Detected in many"	107	"NK-cells: 33.0;T-cells: 26.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.4;JURKAT: 8.3;SCLC-21H: 3.9"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 77.5"	"Group enriched"	"Detected in some"	27	"cerebellum: 30.2;olfactory bulb: 12.7"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.0	0.6	0.2	3.2	0.1	1.8	0.6	8.4	0.4	0.4	0.4	0.7	0.4	0.8	0.8	0.3	0.4	1.6	0.3	0.2	0.3	0.4	2.4	2.2	15.0	0.2	0.3	0.5	0.3	0.1	0.2	0.4	0.6	0.5	0.8	1.6	0.9	0.1	0.1	0.2	1.4	0.4	0.3	12.8	1.3	0.4	0.2	1.5	0.5	0.1	5.4	1.3	0.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	1.3	0.0	7.4	1.1	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.8	0.0	0.9	0.3	0.0	8.3	0.2	0.0	0.0	2.0	2.0	0.0	0.2	0.2	0.9	1.3	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	16.5	0.0	26.2	0.0	3.0	19.5	0.0	0.0	0.2	11.9	0.2	33.0	0.1	0.1	0.0	2.9	0.2	0.1	8.4	0.4	0.2	0.3	0.2	0.3	0.6	0.3	0.2	0.4	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.8	1.5	0.0	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	16.8	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	2.2	1.6	0.2	0.0	0.0	0.0	0.0	3.1	0.7	0.0	0.3	1.3	1.8	1.0	1.1	0.1	93.7	0.0	0.0	0.0	0.0	0.4	9.8	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	2.0	0.0	0.1	0.0	31.5	0.0	0.0	0.0
EPS8L3	"FLJ21522, MGC16817"	ENSG00000198758	"EPS8 like 3"	Q8TE67	1	109750080-109764027	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"gallbladder: 35.7;intestine: 142.1;stomach 1: 50.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 254.4;Gastric mucus-secreting cells: 80.5;Intestinal goblet cells: 103.4;Late spermatids: 144.6;Paneth cells: 257.8;Proximal enterocytes: 285.3;Undifferentiated cells: 112.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 15.6;CAPAN-2: 14.4;Hep G2: 36.2;OE19: 67.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030998	Approved		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA030998: AB_2673691"	"unprognostic (1.73e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (5.55e-3)"		"unprognostic (3.71e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.87e-3)"	"unprognostic (3.89e-1)"		"prognostic favorable (1.82e-4)"	0.0	0.0	0.1	10.8	0.0	0.0	0.2	0.0	0.0	1.3	0.0	77.1	141.8	0.2	0.9	0.1	0.1	35.7	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	77.1	0.0	0.0	0.2	0.0	0.0	142.1	2.9	0.0	0.0	50.7	2.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.6	14.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	67.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	14.3	0.3	0.0	0.0	0.0	0.0	254.4	0.0	11.6	28.0	0.7	0.1	0.3	51.4	0.0	0.0	23.9	0.0	0.0	80.5	1.0	4.5	0.0	0.0	0.2	0.0	0.0	0.0	103.4	0.0	0.0	0.0	144.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.5	257.8	0.4	0.3	0.0	285.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.4	0.6	112.6	1.8
ERCC3	"BTF2, RAD25, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037153: AB_796181, HPA046077: AB_2679527"	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavorable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	24.4	25.9	15.0	14.5	16.0	19.8	24.4	15.1	16.5	32.2	19.6	28.9	9.6	27.0	11.6	22.7	28.9	14.2	23.4	16.6	14.9	22.8	22.2	22.1	21.6	15.7	14.8	29.5	23.8	26.3	33.8	13.6	16.0	27.4	13.8	4.4	23.2	16.8	35.3	27.7	24.3	21.5	15.1	32.6	23.7	29.8	15.6	26.6	25.0	25.6	22.4	27.2	26.4	15.2	45.9	30.8	37.8	40.6	40.6	27.8	46.4	41.3	52.9	65.1	62.5	48.1	32.9	34.5	33.2	37.8	41.7	40.2	57.7	43.3	56.1	54.4	51.4	43.6	35.8	51.0	30.5	38.1	45.4	28.9	39.8	75.7	32.4	41.5	42.4	44.3	43.0	22.1	41.7	45.1	54.8	42.2	55.0	29.2	47.3	44.5	42.7	28.8	36.4	42.2	45.2	49.2	35.3	52.6	55.0	42.4	28.7	43.0	34.1	39.2	45.2	35.8	49.7	39.2	81.5	54.0	34.3	18.0	42.8	8.0	11.5	8.8	18.2	12.0	18.4	13.7	13.1	15.7	16.9	12.7	17.7	12.2	3.5	25.0	9.9	13.6	20.5	15.5	15.0	16.0	15.1	16.5	16.6	14.9	15.7	14.8	16.0	15.1	15.6	15.2	12.2	22.4	14.6	24.8	17.7	7.6	9.5	20.6	21.1	0.0	13.0	11.6	13.0	5.7	25.4	7.3	0.0	18.6	18.9	6.1	1.9	13.7	9.0	22.9	13.9	12.2	6.1	3.8	22.3	14.9	12.2	16.6	18.8	13.1	10.1	17.1	15.4	8.6	14.6	0.0	23.5	10.0	14.2	12.5	7.6	5.1	16.4	10.7	8.8	10.3	12.3	0.0	14.4	18.1	22.4	15.5	7.3	12.8	16.4	7.4	6.3	8.5	45.2	0.0	13.1	17.6	13.3	41.1	31.0	11.3	9.5	14.6	15.7	12.3	10.6	8.5
ERMP1	"FLJ23309, FXNA, KIAA1815"	ENSG00000099219	"Endoplasmic reticulum metallopeptidase 1"	Q7Z2K6	9	5765076-5833117	"Enzymes, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 50.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 73.5;Granulosa cells: 53.4;Oligodendrocytes: 88.8;Urothelial cells: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.8;RT4: 154.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055582	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA055582: "	"unprognostic (1.93e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.59e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.81e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (5.83e-10)"	"unprognostic (1.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	3.9	7.9	4.2	3.7	10.4	2.0	6.3	10.9	3.7	10.8	14.4	11.3	4.4	5.6	2.6	14.9	6.4	11.3	10.0	2.9	6.1	24.9	4.6	6.3	3.5	10.1	10.3	4.5	3.9	50.1	1.5	7.8	8.8	6.0	11.4	2.2	19.1	4.1	7.6	9.3	6.5	3.8	6.5	3.1	13.3	4.7	8.9	4.6	26.6	9.9	6.4	17.1	4.8	13.1	45.1	43.1	1.8	5.2	22.6	20.7	22.6	5.1	11.1	2.3	1.9	10.4	27.2	10.7	19.2	8.4	25.9	32.2	9.6	29.4	3.3	55.6	7.6	56.2	20.0	20.4	4.8	16.0	21.3	10.5	12.9	2.1	13.3	28.6	30.1	4.6	6.9	9.9	2.8	20.7	0.6	6.2	6.6	28.0	8.4	1.7	5.3	14.1	76.8	154.6	9.9	3.3	7.1	52.2	8.1	24.5	33.7	20.5	18.0	1.5	5.0	3.4	16.1	8.9	13.6	5.5	6.7	13.0	4.1	0.2	0.1	0.3	0.4	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.0	0.1	0.1	0.1	4.2	10.4	10.9	3.7	2.9	6.1	10.1	10.3	8.8	6.5	8.9	13.1	3.4	6.4	1.1	24.8	2.2	2.9	18.3	13.3	2.8	4.0	11.1	5.8	13.7	12.8	22.8	73.5	10.4	6.8	5.2	32.1	0.0	4.6	22.3	11.4	10.9	6.3	11.4	6.3	21.0	3.0	7.1	4.6	13.7	13.8	8.9	53.4	2.9	6.1	5.7	3.3	32.8	8.9	10.2	1.6	2.2	41.8	3.1	4.5	1.8	24.4	2.1	3.0	8.2	22.1	88.8	3.5	22.5	4.9	4.1	7.0	9.2	3.3	16.6	2.9	6.6	5.8	4.3	8.8	4.6	17.5	4.5	4.1	5.9	39.8	15.7	66.9
ESM1		ENSG00000164283	"Endothelial cell specific molecule 1"	Q9NQ30	5	54977867-55022671	"Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 19.9;thyroid gland: 17.3"	"Cell type enriched"	"Detected in some"	8	"Endothelial cells: 142.4"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 65.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 302.2;TIME: 568.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB047364	Approved				"Secreted to blood"	NA	NA	1540000	340000	"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB047364: "	"unprognostic (4.70e-2)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.63e-3)"	"unprognostic (2.31e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.94e-1)"	1.3	4.2	0.4	0.7	0.7	0.6	0.5	0.2	1.1	2.0	0.8	0.2	0.7	3.6	0.4	0.2	0.2	1.3	3.6	0.3	1.3	19.9	2.6	11.3	1.2	0.5	0.5	0.7	2.3	6.0	2.2	0.4	0.3	3.5	0.0	0.1	6.3	3.7	0.2	0.1	0.8	0.7	0.8	0.9	0.3	0.6	1.6	0.2	17.3	0.2	0.6	1.3	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	79.8	9.5	4.1	1.0	0.0	0.0	0.1	7.4	5.7	2.3	0.0	0.0	1.0	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.7	0.4	8.5	302.2	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	568.0	4.7	13.7	39.2	21.3	0.1	0.0	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.5	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.1	0.4	0.7	0.2	1.1	0.3	1.3	0.5	0.5	0.3	0.8	1.6	0.4	6.3	0.0	0.6	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	16.1	0.0	0.1	0.1	142.4	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.0	0.7	0.0	2.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	1.5	1.7	0.1	0.3	0.0	0.1	0.1	0.6	1.1	0.0	0.7
ESYT2	"CHR2SYT, FAM62B, KIAA1228"	ENSG00000117868	"Extended synaptotagmin 2"	A0FGR8	7	158730995-158830253	"Plasma proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 185.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002132, HPA070823"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		24000	"Cluster 48: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA002132: AB_1078807, HPA070823: "	"unprognostic (2.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.13e-1)"	"unprognostic (7.54e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (2.81e-5)"	53.9	37.0	24.0	25.6	25.0	34.8	33.9	21.8	28.7	30.8	22.7	38.4	22.3	36.1	30.1	45.0	34.4	32.2	35.1	27.7	25.3	27.2	24.5	33.4	27.5	22.1	24.6	48.1	29.2	30.9	20.6	43.3	24.6	25.3	30.3	14.2	32.1	30.5	44.9	31.0	27.6	38.7	21.7	21.4	25.5	15.8	30.7	37.0	39.3	41.8	25.4	35.8	29.3	19.4	92.9	57.8	19.5	19.8	62.2	72.6	55.3	47.5	48.9	36.7	40.6	29.7	106.1	27.5	52.2	86.2	66.6	46.0	27.8	50.2	35.1	31.5	28.3	26.2	44.0	32.2	64.1	95.0	55.8	53.4	51.8	41.8	55.2	73.1	44.8	81.9	56.4	97.8	61.9	71.7	96.0	66.7	29.2	53.9	56.7	82.4	37.0	38.8	58.6	38.4	46.8	30.2	151.6	109.7	66.7	43.4	37.7	96.3	69.3	40.3	18.8	178.7	60.5	68.6	17.3	27.5	102.4	93.8	121.5	1.7	1.4	1.2	6.1	1.8	3.4	1.1	5.1	4.3	2.8	0.6	4.6	5.5	0.9	5.4	1.2	1.8	4.2	2.3	24.0	25.0	21.8	28.7	27.7	25.3	22.1	24.6	24.6	21.7	30.7	19.4	65.7	38.5	32.4	55.5	18.1	46.1	12.9	22.6	19.4	15.0	32.6	21.6	30.8	21.5	33.7	47.8	16.7	31.6	54.0	41.0	3.9	15.3	18.0	60.6	17.8	48.5	21.1	17.7	137.1	20.0	26.1	44.2	15.8	47.0	12.6	36.8	23.2	20.9	20.2	13.5	119.3	31.2	24.4	20.2	83.6	5.3	35.1	27.7	51.6	185.5	21.9	12.1	43.3	67.3	61.4	29.9	14.1	54.5	36.2	23.2	28.0	8.7	61.8	10.8	32.9	42.6	60.4	10.6	10.2	22.0	51.7	40.8	43.4	19.5	26.0	25.8
EXOC1L		ENSG00000250821	"Exocyst complex component 1 like"	A0A1B0GW35	4	55819790-55837489	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"Theca cells: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	20	"NK-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 1.9"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.5"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.8"	"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"																					0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0
EXPH5	SLAC2-B	ENSG00000110723	"Exophilin 5"	Q8NEV8	11	108505435-108593768	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;skin 1: 25.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Basal keratinocytes: 107.7;Glandular and luminal cells: 89.5;Respiratory ciliated cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	15	"cerebellum: 67.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 7.9;hTERT-HME1: 11.2;RT4: 20.5;SK-BR-3: 9.7"	"Group enriched"	"Detected in many"	4	"cerebellum: 20.9;cerebral cortex: 6.7"	"Region enriched"	"Detected in many"	8	"cerebellum: 30.9"							NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.34e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.42e-6)"	"unprognostic (2.91e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (4.57e-3)"	"prognostic favorable (5.12e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.51e-1)"	0.4	0.1	1.3	0.5	2.5	0.2	2.9	67.7	2.3	2.2	12.8	3.9	0.7	0.7	2.7	7.4	1.7	0.3	0.2	2.1	1.9	2.4	7.7	3.9	0.1	1.5	3.6	0.3	1.0	4.7	0.5	2.8	4.6	1.5	4.4	0.3	4.4	0.3	0.1	25.8	0.8	0.4	1.1	0.2	3.2	0.7	1.7	0.8	1.0	0.2	1.4	0.7	3.8	3.4	3.9	0.4	0.2	0.1	0.0	0.1	3.2	0.2	0.1	0.0	0.6	1.0	5.9	0.0	0.2	0.2	0.9	7.9	5.7	2.1	0.2	0.1	1.7	1.6	0.8	0.0	0.5	0.8	0.1	0.1	3.3	0.0	11.2	0.5	0.0	1.3	3.0	0.0	3.1	0.6	1.0	0.0	0.2	6.4	2.4	0.0	0.1	0.0	0.6	20.5	1.4	0.8	1.0	9.7	0.2	1.1	6.4	0.1	0.1	0.0	2.3	0.0	1.1	0.1	0.0	0.0	0.1	0.4	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.5	0.5	0.8	0.9	0.1	0.2	0.0	0.1	1.3	2.5	67.7	2.3	2.1	1.9	1.5	3.6	4.6	1.1	1.7	3.4	0.6	147.4	60.0	18.6	0.9	107.7	12.9	16.6	58.6	0.6	14.1	8.6	5.7	4.3	65.3	20.2	14.6	44.5	2.4	47.9	3.9	5.4	10.3	74.8	7.8	2.5	4.9	3.2	9.0	4.9	4.9	5.6	20.9	89.5	1.3	0.9	0.7	24.2	3.8	0.0	4.9	38.6	14.2	0.6	15.2	2.3	0.6	1.8	5.4	16.9	1.3	0.5	1.0	3.0	0.6	3.6	17.5	0.0	1.5	30.4	1.9	3.7	98.5	1.4	0.0	0.3	2.1	1.1	0.5	46.9	72.2	54.6	2.8	0.4	29.1	19.3
FAM71E1		ENSG00000142530	"Family with sequence similarity 71 member E1"	Q6IPT2	19	50466785-50476848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 76.6"	"Group enriched"	"Detected in many"	50	"Early spermatids: 2052.1;Late spermatids: 3617.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048111			Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center"		"HPA048111: "	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.65e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.35e-7)"	"unprognostic (7.26e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-2)"	0.4	1.0	3.6	0.2	4.1	0.0	0.9	6.4	6.6	0.9	2.6	0.9	1.1	0.6	0.7	1.6	1.4	0.6	1.5	3.5	4.8	3.5	2.7	1.0	0.0	5.4	3.9	2.5	2.4	1.2	4.0	0.4	4.5	2.0	0.2	1.2	2.5	0.7	3.7	1.6	0.9	0.0	3.7	0.3	1.5	76.6	3.9	0.4	2.2	1.7	0.2	0.6	0.8	3.1	1.9	1.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.3	0.0	0.1	0.4	2.9	0.0	0.7	0.0	0.2	13.8	0.0	0.7	0.0	2.1	0.1	1.7	0.6	1.4	0.1	0.3	0.2	0.0	1.0	0.5	0.8	0.0	2.4	0.5	0.0	0.0	3.6	2.1	1.5	0.2	0.8	0.8	2.5	3.2	0.7	1.0	3.4	0.4	0.8	2.6	0.8	0.0	0.0	0.8	0.1	0.2	0.7	1.6	0.1	0.0	0.0	0.1	0.4	0.4	0.9	0.8	0.1	1.2	0.5	0.8	0.4	0.1	1.1	0.8	1.0	0.4	1.5	0.2	0.9	0.1	0.2	3.6	4.1	6.4	6.6	3.5	4.8	5.4	3.9	4.5	3.7	3.9	3.1	1.5	0.0	0.5	0.3	1.1	0.6	3.5	3.9	2.8	5.0	8.2	12.4	2.1	0.0	2.3	3.7	0.0	7.0	0.0	0.9	11.7	3.9	2052.1	3.8	1.9	2.0	3.0	0.4	1.7	5.4	3.6	2.2	4.6	2.0	0.0	7.4	2.2	2.4	2.0	5.0	2.5	5.3	2.0	0.0	0.4	3617.6	17.1	1.7	0.0	0.0	1.6	11.6	0.0	0.5	1.1	2.4	2.1	15.1	0.4	4.4	2.3	16.3	3.9	9.9	19.7	1.2	1.5	56.2	30.2	5.2	2.4	14.0	0.4	5.6	3.2	4.1
FAM72C	RP5-998N21.9	ENSG00000263513	"Family with sequence similarity 72 member C"	H0Y354	1	143955364-143971965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.9;lymphoid tissue: 5.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 7.8;Extravillous trophoblasts: 4.5;Sertoli cells: 6.6;Spermatocytes: 9.4;Spermatogonia: 3.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 64.9"									"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.98e-3)"	"unprognostic (9.46e-5)"	"unprognostic (1.23e-3)"	"unprognostic (4.36e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.47e-2)"	0.4	0.2	0.1	1.5	0.1	2.9	0.3	0.2	0.2	0.2	0.0	0.4	0.6	0.2	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	4.5	0.1	0.1	0.1	0.2	0.0	0.0	0.5	0.1	0.1	0.6	0.0	0.2	0.0	0.0	1.2	0.4	0.3	0.1	1.2	0.3	1.6	0.1	5.4	0.1	0.1	4.5	0.4	0.4	0.2	18.7	10.6	12.5	5.7	0.6	1.7	12.1	8.9	2.8	12.0	9.0	1.6	21.7	44.4	11.6	1.0	11.0	17.4	17.2	5.5	13.0	15.3	10.0	19.1	9.4	3.3	0.4	39.5	16.6	0.3	0.1	9.1	24.3	2.5	5.1	34.7	34.0	20.5	0.8	1.4	23.2	30.4	10.2	20.8	6.6	29.7	9.0	31.5	2.1	2.3	6.3	11.5	8.7	5.0	4.9	13.0	12.5	33.4	3.7	9.4	15.4	12.5	20.3	41.9	64.9	26.0	5.1	24.1	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.8	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.6	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	2.3	0.3	0.2	1.3	0.0	7.8	0.2	0.2	4.5	0.3	0.0	0.1	0.0	0.5	1.8	0.1	1.7	0.0	0.3	0.6	0.0	2.2	1.4	0.5	0.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	6.6	0.3	0.7	9.4	3.5	1.3	0.3	0.3	0.7	0.3	0.5	0.0
FBXL8	Fbl8	ENSG00000135722	"F-box and leucine rich repeat protein 8"	Q96CD0	16	67159932-67164570	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035587, HPA035588"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA035587: AB_2674690, HPA035588: AB_10670023"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (3.79e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.94e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.68e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.17e-3)"	12.2	24.0	3.1	5.4	4.2	3.4	18.4	5.3	5.7	17.7	1.7	16.6	9.8	17.0	2.5	15.6	20.3	2.3	10.9	3.7	1.7	14.6	16.7	14.6	4.3	5.2	3.2	16.2	53.5	4.9	24.9	5.7	4.3	35.5	6.4	2.2	35.8	2.6	11.2	30.1	12.2	2.5	2.2	13.5	22.6	4.3	3.9	2.0	20.9	1.2	2.7	12.7	14.9	8.6	5.9	7.2	1.1	9.7	5.2	9.2	25.0	4.9	4.0	4.0	4.0	6.8	16.0	4.6	7.4	4.6	4.0	19.9	2.9	4.8	1.1	11.9	11.7	4.7	17.2	7.5	3.7	2.7	18.1	6.9	5.2	4.2	3.4	11.6	2.6	12.6	9.3	10.1	2.8	16.8	3.9	10.4	0.6	5.4	17.6	12.7	3.3	22.4	6.1	8.1	10.2	9.5	12.4	6.4	3.3	2.9	31.7	6.2	6.3	10.0	11.5	23.4	4.4	43.4	10.4	6.0	11.0	8.7	6.1	5.1	4.7	4.9	3.8	2.2	3.4	1.6	10.7	5.0	2.4	1.7	2.3	2.4	6.4	5.8	2.0	4.3	4.0	3.1	3.1	4.2	5.3	5.7	3.7	1.7	5.2	3.2	4.3	2.2	3.9	8.6	3.4	0.0	3.1	0.0	2.8	3.2	4.4	3.4	17.1	1.7	5.0	4.3	0.9	7.2	5.1	5.5	8.4	2.8	6.0	7.6	1.9	6.9	0.1	3.3	3.4	3.2	6.7	0.4	0.2	8.0	3.1	4.6	18.8	3.7	0.0	4.7	1.8	4.4	2.8	5.0	0.1	10.4	2.0	1.9	2.9	0.5	9.3	2.9	10.6	0.0	7.7	1.9	8.2	0.0	1.1	9.3	5.2	5.7	4.6	5.4	10.6	6.2	4.1	4.7	6.6	2.4	4.2	0.1	1.0	7.2	4.4	1.5	4.2	8.4	9.0	5.6
FBXW8	"FBW6, FBW8, FBX29, FBXO29"	ENSG00000174989	"F-box and WD repeat domain containing 8"	Q8N3Y1	12	116910950-117031148	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5;Excitatory neurons: 40.6;Inhibitory neurons: 38.9;Late spermatids: 84.1;Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038850, HPA038851"	Supported		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA038850: AB_2676238, HPA038851: AB_10673479"	"unprognostic (2.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.55e-1)"	5.3	4.9	2.5	4.7	9.5	3.5	5.9	1.5	3.0	5.8	10.1	4.9	3.6	6.5	3.9	5.3	6.3	4.1	4.7	4.1	3.0	4.0	4.0	4.5	5.6	2.9	2.3	8.6	7.1	8.5	8.2	7.6	1.9	4.8	4.9	4.4	6.6	5.2	5.3	5.8	4.3	5.8	1.3	4.1	5.9	4.9	3.7	5.5	9.4	3.4	6.6	5.2	5.0	2.6	8.6	15.5	13.4	10.8	12.1	16.9	8.8	16.0	16.6	11.8	11.4	4.9	5.9	13.0	5.9	21.1	6.3	9.1	10.1	6.3	9.5	20.6	7.3	6.3	7.1	5.0	20.7	8.1	4.7	17.6	5.4	11.0	24.7	16.7	13.2	11.7	8.2	6.0	10.7	22.3	6.4	5.5	15.7	3.9	9.4	10.0	6.1	11.2	9.5	14.6	12.0	33.4	11.5	4.1	7.9	11.3	15.2	7.1	16.7	10.4	4.3	10.8	5.0	19.0	12.6	12.2	14.2	4.9	17.2	0.2	0.8	2.0	1.4	0.8	1.3	2.4	0.8	0.9	1.1	1.9	0.5	0.8	0.0	3.9	1.0	1.1	1.2	0.7	2.5	9.5	1.5	3.0	4.1	3.0	2.9	2.3	1.9	1.3	3.7	2.6	3.2	0.0	6.4	21.9	5.4	1.9	3.0	1.4	5.2	9.1	3.5	4.2	3.1	4.3	5.6	1.8	25.0	9.4	5.5	1.4	1.9	4.2	53.5	4.1	6.6	3.6	9.1	3.8	40.6	4.5	6.5	5.4	8.6	3.6	2.5	11.1	0.7	3.0	4.3	1.7	38.9	4.2	0.0	3.5	0.8	84.1	9.3	2.6	0.0	33.7	2.3	3.1	5.2	38.2	28.3	2.4	3.3	5.3	7.7	5.4	1.0	2.2	4.7	15.2	0.0	7.2	4.2	4.6	6.7	3.5	1.4	6.7	4.5	11.6	3.7	3.2
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 11467.1;tongue: 9770.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1145.1;Early spermatids: 373.8;Late spermatids: 1206.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 88.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 36.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 36.1;T-cells: 18.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 303.7;fHDF/TERT166: 258.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavorable (2.11e-4)"	938.4	65.8	120.8	75.5	117.2	11.7	441.8	95.9	126.3	315.5	85.8	672.0	83.2	464.6	107.7	538.1	281.6	127.6	1462.3	130.8	144.9	45.2	43.1	285.6	41.7	103.9	125.4	102.8	39.4	196.5	92.9	106.6	115.9	408.8	161.4	76.2	161.3	541.1	11467.1	101.3	235.5	486.5	114.8	43.0	368.4	60.2	130.1	25.1	310.1	9770.8	32.1	469.6	253.1	102.9	0.4	44.3	60.7	57.8	127.2	52.3	1.5	183.7	303.7	34.8	81.3	0.3	12.7	0.7	55.8	258.8	95.0	0.5	119.2	148.0	28.2	0.4	136.7	0.7	34.4	0.0	121.6	0.3	26.8	96.6	24.4	41.2	128.7	14.1	36.6	34.5	0.1	26.0	81.9	2.5	26.1	1.6	19.1	0.2	52.2	69.8	2.6	38.2	1.1	0.1	43.5	63.8	6.6	0.2	12.4	24.1	0.3	2.4	102.5	150.2	71.0	5.9	44.7	6.8	16.0	1.1	11.9	1.4	18.2	0.1	0.7	0.0	5.2	0.1	13.8	5.8	18.2	7.2	3.1	3.6	12.0	4.0	1.2	36.1	0.0	19.4	2.2	11.1	120.8	117.2	95.9	126.3	130.8	144.9	103.9	125.4	115.9	114.8	130.1	102.9	203.0	48.1	11.7	32.0	8.1	56.5	26.9	15.1	14.2	36.2	1.4	8.3	1145.1	0.0	4.9	11.0	8.4	0.6	8.6	0.5	1.9	3.0	373.8	4.3	32.3	61.1	13.8	17.9	70.2	0.2	1.1	236.0	2.0	2.0	15.8	41.0	113.6	6.1	4.3	99.3	55.6	0.8	0.0	5.1	47.0	1206.9	123.9	35.6	32.0	16.9	7.4	209.6	2.1	35.2	8.2	0.6	7.6	152.4	15.5	20.1	0.6	11.6	4.8	19.4	105.2	248.1	235.7	7.4	88.6	2.7	44.8	2.7	15.5	9.6	2.0	2.6
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease variant, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 3645.4"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 1595.6;Distal tubular cells: 2952.4;Ductal cells: 892.8;Proximal tubular cells: 3423.7"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"memory CD8 T-cell: 14.8;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.3;NK-cell: 9.6;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;NK-cells: 9.6;T-cells: 14.8"	"Group enriched"	"Detected in some"	25	"MOLT-4: 2255.4;RPTEC TERT1: 4711.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"spinal cord: 27.7"	"HPA064218, HPA068838"	Supported		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	2.0	0.9	0.7	1.4	0.6	3.3	1.2	1.4	1.7	1.0	0.0	2.1	1.4	1.5	1.2	0.8	1.8	353.1	1.2	0.8	0.0	3645.4	23.8	4.4	8.9	0.0	0.1	2.4	612.6	0.2	1.6	0.8	0.0	1.7	0.8	1.1	835.6	0.7	0.3	1.0	1.6	2.2	0.0	3.1	2.8	0.6	0.0	74.8	1.0	0.6	4.5	1.8	0.9	0.4	0.0	118.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	3.5	0.0	0.2	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.2	83.6	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.9	140.3	0.0	0.0	0.2	0.3	2255.4	0.0	1.2	0.0	0.0	0.6	0.0	4.6	4711.9	0.0	1.9	0.0	0.0	2.9	0.2	0.2	0.8	0.3	0.8	0.0	1.3	0.5	0.0	1.0	0.3	0.2	0.1	0.2	0.0	0.0	1.2	0.0	1.0	0.0	1.0	0.2	1.8	14.8	0.2	0.3	5.1	4.3	0.0	9.6	0.0	3.8	1.7	2.1	0.7	0.6	1.4	1.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.0	0.0	0.6	0.0	33.6	1.1	0.1	0.8	0.6	0.2	0.1	0.5	1.2	1595.6	0.1	435.9	0.0	0.1	0.7	0.0	2952.4	892.8	21.8	1.6	4.1	2.2	15.1	2.7	0.0	10.0	0.1	3.5	0.5	41.3	0.0	0.6	4.2	3.9	3.6	0.0	0.0	0.3	16.2	4.5	4.1	25.9	9.3	24.8	0.0	0.0	8.8	0.5	1.0	0.0	0.0	23.2	0.0	7.5	0.4	0.2	0.0	3423.7	0.1	3.3	6.6	1.6	3.8	0.3	0.3	0.2	0.9	0.3	27.7	1.2	0.1	0.0
FYTTD1	"DKFZp761B1514, UIF"	ENSG00000122068	"Forty-two-three domain containing 1"	Q96QD9	3	197737179-197787596	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054474, HPA074880"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"HPA054474: , HPA074880: "	"unprognostic (3.61e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.33e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.74e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.15e-1)"	29.7	20.9	12.1	27.1	12.6	39.2	26.6	16.1	14.6	24.8	9.1	19.9	16.7	30.4	19.6	43.9	19.1	24.4	41.3	12.1	14.9	25.7	28.9	23.6	32.4	12.4	13.9	27.5	36.4	28.7	12.6	33.5	13.0	25.1	21.6	33.8	18.2	28.8	92.6	27.1	19.3	34.9	12.8	26.3	18.2	41.1	13.3	34.1	29.6	67.0	37.7	33.6	16.9	14.9	104.5	22.6	43.7	41.7	50.1	55.3	13.4	50.0	50.8	75.4	61.4	35.3	34.8	66.4	177.1	59.3	40.0	36.7	55.5	51.0	79.8	14.5	24.9	99.8	32.9	16.1	48.9	75.1	46.5	40.0	64.6	40.8	58.3	52.1	60.4	36.8	45.9	139.0	67.6	86.9	82.2	18.1	9.6	45.1	41.2	74.9	53.6	47.4	54.8	67.3	82.4	35.7	76.8	60.0	56.4	31.8	141.2	39.1	54.0	38.5	38.1	49.0	53.6	83.5	137.2	79.3	40.8	106.4	40.6	59.2	26.9	26.5	32.4	31.8	40.7	20.0	30.7	35.9	29.9	18.9	33.4	32.2	8.5	64.6	31.0	16.9	30.2	45.7	12.1	12.6	16.1	14.6	12.1	14.9	12.4	13.9	13.0	12.8	13.3	14.9	60.6	35.3	27.2	14.7	78.5	82.3	46.6	24.3	42.7	35.1	47.0	34.4	109.7	25.8	30.1	47.8	31.3	24.4	63.9	19.0	90.1	35.5	21.7	27.3	58.9	55.2	56.4	25.2	23.7	36.1	27.5	53.7	30.1	42.6	66.6	29.4	36.4	50.7	38.0	45.4	19.6	23.7	28.5	48.6	67.8	18.3	32.0	54.8	51.6	22.5	108.6	41.8	82.4	19.6	23.0	34.3	16.5	37.2	65.4	74.5	17.1	51.1	44.6	45.2	39.5	45.8	63.1	96.3	90.7	54.0	91.1	50.1	60.7	51.9	20.0	63.6
FZD6	Hfz6	ENSG00000164930	"Frizzled class receptor 6"	O60353	8	103298433-103332866	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 127.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017991	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA017991: AB_1849138"	"unprognostic (8.22e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.20e-6)"	"unprognostic (3.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.54e-2)"	11.7	10.6	3.0	4.2	2.8	1.0	15.1	3.1	4.3	14.2	5.7	7.0	5.7	13.0	9.5	18.7	23.5	10.6	9.1	2.9	3.0	14.5	4.0	18.6	5.1	3.8	3.1	5.4	11.2	25.3	9.8	15.1	3.8	12.6	7.0	4.6	11.7	10.3	2.0	24.0	4.6	9.3	3.0	4.0	7.4	3.6	3.3	10.0	22.3	5.6	9.9	21.6	10.2	3.2	59.8	11.0	29.6	0.0	7.9	20.6	17.1	31.0	34.1	27.2	17.6	6.2	47.8	0.0	51.4	29.7	9.1	90.3	16.8	65.7	51.0	13.5	18.0	31.4	12.2	8.5	93.4	0.0	0.0	23.0	127.6	29.4	91.5	67.1	58.2	7.0	3.2	27.0	31.5	25.5	29.8	2.7	6.7	4.7	20.6	2.3	12.3	0.0	59.1	39.5	10.0	7.9	44.8	22.8	59.9	15.8	0.0	11.6	4.1	6.1	32.0	24.9	32.7	6.4	3.7	13.3	18.0	0.0	40.4	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.8	0.4	0.3	0.5	0.9	0.4	0.0	4.0	0.0	0.1	0.4	0.2	3.0	2.8	3.1	4.3	2.9	3.0	3.8	3.1	3.8	3.0	3.3	3.2	38.3	25.6	22.5	10.1	2.8	46.9	15.9	51.1	42.7	4.1	16.1	12.7	4.8	8.6	35.4	12.9	2.1	22.7	2.1	4.9	0.0	11.7	9.6	51.0	5.8	42.0	5.3	6.7	19.9	8.2	7.1	7.0	14.8	73.6	0.0	11.2	13.9	3.7	2.4	6.7	7.3	7.4	26.4	1.0	5.1	2.9	1.2	1.3	14.2	16.9	0.7	11.8	1.0	8.5	3.6	9.5	3.2	1.5	8.6	13.4	2.8	7.1	53.8	4.8	0.0	1.6	7.7	7.0	0.8	41.9	44.6	14.6	3.0	1.7	5.6	23.2
GALNT11	GalNAc-T11	ENSG00000178234	"Polypeptide N-acetylgalactosaminyltransferase 11"	Q8NCW6	7	152025674-152122340	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Notch signaling pathway"	"Glycosyltransferase, Transferase"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 408.0;kidney: 229.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 131.1;Inhibitory neurons: 130.7;Proximal tubular cells: 196.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 30.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039330	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039330: AB_10795249"	"unprognostic (6.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.24e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.51e-2)"	32.4	25.4	27.9	15.2	30.7	12.7	29.0	24.1	29.3	23.7	408.0	21.9	14.5	23.8	24.6	26.3	22.4	26.1	26.4	39.1	25.1	229.5	19.9	27.5	16.1	20.8	23.9	28.1	84.1	58.0	24.4	45.8	21.6	32.3	17.6	40.6	22.8	25.6	28.4	23.8	15.0	24.2	16.9	20.5	22.0	11.8	30.3	23.8	34.4	26.0	17.8	24.2	24.0	27.0	28.9	25.4	36.8	41.2	83.1	81.3	37.7	22.6	25.6	18.6	17.4	20.7	29.7	0.1	57.8	36.8	51.8	13.3	17.6	31.9	22.8	23.5	26.3	5.8	23.4	18.2	27.3	26.2	29.3	72.1	40.3	15.5	13.0	32.3	34.1	19.9	29.5	0.2	47.0	24.9	22.7	23.6	30.4	45.1	20.2	0.1	16.1	0.9	61.1	43.8	32.6	43.3	37.5	18.0	31.0	39.0	26.8	22.3	31.1	24.8	8.8	31.6	25.1	8.4	11.4	0.5	51.6	25.1	86.6	10.2	12.7	13.5	28.1	15.2	27.8	9.5	15.4	25.8	13.0	5.7	13.1	19.9	6.6	26.2	21.3	4.0	12.7	14.4	27.9	30.7	24.1	29.3	39.1	25.1	20.8	23.9	21.6	16.9	30.3	27.0	28.7	12.8	25.2	44.4	12.9	10.5	24.6	20.5	13.1	123.9	23.5	20.7	30.7	15.7	16.1	35.0	27.1	84.0	49.1	8.7	60.7	17.8	4.8	31.5	38.8	22.8	22.8	7.8	131.1	18.7	13.5	33.8	11.7	57.1	14.5	26.0	22.1	15.8	25.3	75.7	130.7	10.0	8.2	19.7	12.5	3.5	19.9	21.7	17.8	46.9	18.0	37.8	43.3	54.3	42.0	13.0	8.3	36.1	20.3	26.3	9.6	196.7	21.2	39.4	0.0	36.3	25.0	38.7	27.5	24.7	11.8	36.3	29.1	24.3	9.3	19.1
GALNT12	GalNAc-T12	ENSG00000119514	"Polypeptide N-acetylgalactosaminyltransferase 12"	Q8IXK2	9	98807670-98850081	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 74.7;intestine: 55.8;stomach 1: 54.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 101.2;Intestinal goblet cells: 142.4;Undifferentiated cells: 42.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 128.4;U-2197: 160.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA048292, HPA071076"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA048292: AB_2680343, HPA071076: "	"unprognostic (7.85e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-3)"	"unprognostic (6.87e-2)"	5.0	2.0	1.2	7.7	1.3	2.2	3.4	6.5	1.8	8.7	4.3	55.3	34.2	3.7	74.7	19.6	7.5	10.5	1.2	1.1	1.4	4.8	0.4	11.7	3.2	2.6	1.4	0.4	13.6	6.3	3.4	2.6	2.7	4.6	55.8	0.6	25.5	4.3	1.3	3.4	27.1	14.0	1.1	2.2	54.8	4.6	1.5	3.3	14.7	0.6	6.1	11.9	4.6	1.6	5.4	4.1	3.4	13.5	10.0	7.8	0.0	1.4	2.1	2.0	4.6	0.8	21.6	0.0	5.0	0.9	12.2	38.0	2.9	1.3	1.6	26.2	1.7	2.4	0.2	0.0	0.5	1.6	0.5	3.8	0.9	6.4	0.0	2.7	2.3	19.3	30.2	0.0	0.6	13.9	2.6	4.7	16.7	128.4	5.6	6.5	0.3	0.1	2.3	7.7	12.4	1.1	0.5	30.6	3.0	7.7	4.5	4.5	4.3	0.0	0.3	160.9	0.0	2.1	4.8	2.3	37.1	0.0	0.9	0.0	0.0	0.5	0.3	0.0	0.6	0.0	0.4	0.2	0.0	0.1	0.6	0.3	0.0	0.6	0.0	0.1	0.0	0.1	1.2	1.3	6.5	1.8	1.1	1.4	2.6	1.4	2.7	1.1	1.5	1.6	1.3	3.2	25.7	2.0	2.3	2.4	1.3	8.3	1.2	2.4	0.4	0.1	1.0	18.6	16.9	11.0	16.7	1.0	2.6	101.2	0.0	11.2	1.8	4.8	1.6	1.6	19.9	1.3	7.4	25.4	1.7	12.5	32.1	8.7	2.5	2.4	0.0	0.0	2.3	0.0	5.7	142.4	2.0	0.3	3.9	1.4	2.1	3.9	0.0	3.7	0.2	0.8	3.1	3.5	7.0	32.0	36.5	7.5	1.7	7.4	21.9	2.7	16.9	0.2	0.0	0.7	1.5	5.9	10.5	9.9	1.3	1.1	4.5	5.1	42.5	11.1
GCDH	ACAD5	ENSG00000105607	"Glutaryl-CoA dehydrogenase"	Q92947	19	12891160-12914207	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 115.5;Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043252, HPA048492"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA043252: AB_2678390, HPA048492: AB_2680418"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.79e-3)"	"unprognostic (8.07e-3)"	"unprognostic (8.20e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (7.28e-5)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.46e-2)"	"prognostic favorable (6.79e-8)"	"unprognostic (7.09e-3)"	"unprognostic (3.42e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.59e-1)"	16.8	17.8	20.2	11.2	22.4	13.0	15.6	22.1	23.3	10.2	21.8	13.2	11.8	12.6	8.6	14.0	15.2	8.4	29.3	19.2	19.4	24.5	89.1	9.3	16.8	20.7	20.9	16.8	15.5	11.5	10.6	5.4	21.0	13.6	8.5	5.5	20.0	11.5	30.5	10.1	13.0	8.2	19.9	12.8	18.6	4.5	20.9	17.8	11.9	27.1	11.9	14.9	9.9	22.7	22.9	14.1	15.0	27.5	21.4	9.8	13.8	17.2	11.1	21.6	15.7	26.9	10.8	33.0	31.9	10.5	10.8	15.6	20.8	16.4	10.6	28.6	22.8	21.0	24.6	33.1	24.8	43.7	18.8	13.8	19.9	15.3	16.1	8.8	18.1	44.4	51.8	11.4	10.7	28.9	51.7	41.7	16.7	22.0	36.1	48.2	15.3	68.9	12.6	12.1	32.3	18.9	22.8	22.6	16.7	9.6	17.8	29.3	13.3	18.0	12.9	29.9	18.2	59.5	32.2	34.6	11.0	50.7	15.4	13.9	13.9	8.5	18.8	12.1	18.8	18.1	23.2	21.0	24.0	19.5	30.9	23.8	3.1	38.8	9.8	14.7	21.4	20.0	20.2	22.4	22.1	23.3	19.2	19.4	20.7	20.9	21.0	19.9	20.9	22.7	6.0	3.2	5.3	25.5	21.2	7.9	14.5	13.3	11.4	14.2	17.3	10.8	10.0	22.8	8.6	11.0	25.0	16.2	17.2	11.6	52.8	14.0	2.6	7.7	10.0	7.3	15.6	60.4	7.1	11.2	21.5	10.2	12.8	10.9	7.0	19.5	13.6	115.5	21.5	8.4	7.4	13.8	16.2	14.4	5.0	1.8	13.1	9.9	17.8	5.6	20.7	18.6	18.6	14.6	15.1	10.2	9.7	12.8	25.4	11.3	17.4	147.8	7.2	12.3	0.0	13.7	9.8	8.3	7.4	13.4	5.3	16.3	20.9	33.0	20.6	12.1
GCHFR	"GFRP, HsT16933"	ENSG00000137880	"GTP cyclohydrolase I feedback regulator"	P30047	15	40764068-40767708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 350.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 787.2;Hofbauer cells: 522.9;Proximal enterocytes: 620.8;Proximal tubular cells: 500.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 120.3;RPTEC TERT1: 146.6;SCLC-21H: 124.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 10.3;midbrain: 11.8;pons and medulla: 9.4"					HPA046258	Enhanced		Supported	Nucleoplasm		NA	NA		170000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA046258: AB_10967205"	"unprognostic (2.50e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.72e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.62e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.03e-3)"	"unprognostic (9.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.55e-1)"	37.4	20.1	13.6	8.9	13.3	19.5	34.5	17.4	20.1	16.1	18.5	18.7	38.8	6.5	2.2	57.2	15.8	10.0	10.9	13.1	14.5	73.5	350.1	46.4	24.7	18.2	67.3	19.2	15.3	9.8	12.2	6.6	33.7	19.4	6.9	4.2	22.3	3.2	4.5	31.1	60.7	1.7	13.5	13.0	16.4	3.3	15.9	23.0	12.8	7.4	19.5	12.2	17.6	12.2	0.3	7.7	6.2	33.3	9.5	3.4	16.7	2.2	7.8	3.7	7.4	90.7	49.7	46.0	31.1	1.9	2.4	6.1	16.4	3.1	0.8	36.2	26.2	45.5	65.3	120.3	7.7	29.9	15.2	7.8	3.8	1.6	0.6	2.9	14.4	3.7	23.2	13.2	1.1	17.2	7.9	60.4	16.0	8.2	56.5	64.7	0.5	28.8	146.6	24.2	124.6	1.9	20.1	87.7	10.4	8.1	25.3	30.0	0.0	0.6	1.2	2.2	0.3	0.9	6.0	28.9	4.9	66.3	4.0	18.0	73.3	102.4	76.8	23.6	129.0	48.2	67.1	71.1	48.7	31.2	68.3	44.7	11.7	132.6	22.4	90.4	144.4	109.0	13.6	13.3	17.4	20.1	13.1	14.5	18.2	67.3	33.7	13.5	15.9	12.2	24.3	3.2	54.0	0.3	24.9	14.5	21.6	72.2	8.6	2.5	81.4	48.0	0.1	84.4	87.0	64.4	12.5	161.9	25.9	75.7	76.3	52.5	0.6	46.2	4.9	13.7	60.6	24.4	1.6	32.7	37.0	10.1	16.3	35.7	44.4	12.2	31.4	787.2	522.9	0.0	1.7	74.4	111.9	56.1	18.5	0.5	17.7	71.9	67.6	0.0	29.0	26.1	102.0	0.0	0.4	18.7	161.8	8.6	12.8	25.6	620.8	500.2	58.3	22.4	0.0	4.7	12.4	2.9	12.5	79.7	14.9	36.5	49.2	1.7	125.3	40.8
GIMAP6	"FLJ22690, IAN6"	ENSG00000133561	"GTPase, IMAP family member 6"	Q6P9H5	7	150625375-150632648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 95.3;Endothelial cells: 83.5;Hepatic stellate cells: 92.1;Kupffer cells: 75.2;monocytes: 37.4;NK-cells: 91.6;T-cells: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"monocytes: 75.1;NK-cells: 217.3;T-cells: 127.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 18.4;HUVEC TERT2: 124.9;MOLT-4: 43.3;TIME: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026715, HPA050740"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA026715: AB_1849675, HPA050740: AB_2797239"	"unprognostic (8.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.91e-4)"	"prognostic favorable (1.56e-4)"	"unprognostic (2.88e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.75e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	42.0	9.4	9.7	33.9	9.7	2.5	21.8	9.7	10.6	14.9	8.0	12.0	13.6	19.3	7.3	8.4	16.9	14.7	29.1	8.0	9.5	12.4	12.7	38.8	50.2	11.4	10.5	5.7	5.2	8.0	3.3	32.3	11.3	6.4	12.2	0.6	7.8	10.0	24.7	6.4	18.7	25.8	10.9	64.0	11.6	3.2	11.6	29.3	14.2	34.7	33.9	16.5	6.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	6.3	0.0	0.0	0.0	0.4	18.4	0.1	0.0	0.0	0.0	0.0	124.9	0.5	0.0	4.6	0.0	0.0	43.3	5.4	0.0	0.0	0.0	4.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.8	35.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	13.0	0.0	11.6	58.1	2.1	112.9	75.1	127.2	0.4	104.3	120.2	22.1	0.3	108.3	103.0	8.0	217.3	60.2	0.7	105.7	163.5	9.7	9.7	9.7	10.6	8.0	9.5	11.4	10.5	11.3	10.9	11.6	10.1	95.3	0.0	1.1	0.0	3.1	3.8	0.1	0.0	0.6	0.0	1.1	1.0	7.4	0.0	0.0	0.0	0.0	0.2	24.5	0.1	0.0	0.0	0.4	0.1	0.2	83.5	0.0	19.4	0.0	0.2	0.3	3.4	0.0	0.2	2.5	0.3	92.1	1.7	30.6	0.0	0.0	0.1	0.0	75.2	6.5	2.2	1.2	20.0	1.8	13.1	37.4	0.1	91.6	0.0	0.1	0.1	0.0	0.0	2.9	0.1	0.0	0.2	0.7	0.4	0.0	2.6	2.2	0.3	0.1	0.4	3.1	0.4	41.2	1.2	0.0	0.3
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	79768028-80226181	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 220.0;Oligodendrocytes: 410.7;Suprabasal keratinocytes: 214.2;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 12.8"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 12.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome		NA	NA		1600000	"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: AB_2677870"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	47.5	26.2	8.9	2.6	18.8	0.4	34.9	14.9	17.7	18.5	4.4	25.4	4.7	14.8	0.7	19.7	10.9	3.2	9.4	10.8	13.3	36.6	15.2	15.2	2.0	18.8	15.0	17.1	4.5	1.3	10.9	13.6	18.4	8.8	2.6	1.5	10.4	3.0	6.2	47.9	9.9	4.1	15.5	5.9	17.7	13.0	14.2	1.3	14.2	2.9	1.5	24.7	19.9	36.6	2.2	18.6	10.5	0.0	14.5	7.9	9.1	14.3	7.2	5.5	8.7	0.0	3.4	0.0	4.5	9.3	5.1	2.6	7.0	9.5	5.4	0.0	11.9	10.4	12.9	1.2	14.8	1.8	0.0	12.0	19.9	4.1	9.5	4.4	3.5	0.0	0.0	0.1	7.7	0.6	0.0	0.1	6.1	0.2	11.0	8.6	5.2	7.8	15.7	7.0	12.5	9.2	13.5	0.0	10.3	5.4	2.0	0.3	13.0	21.8	15.6	5.1	4.4	0.0	0.0	0.2	6.1	1.2	10.2	1.3	0.4	0.4	0.1	0.4	0.0	0.0	0.1	0.1	1.9	0.1	1.1	0.5	0.3	12.8	1.0	0.2	0.1	0.4	8.9	18.8	14.9	17.7	10.8	13.3	18.8	15.0	18.4	15.5	14.2	36.6	121.1	19.2	13.8	11.4	0.9	220.0	20.6	81.6	35.3	3.9	7.0	7.7	6.7	21.5	42.3	29.5	0.0	83.6	1.3	11.1	88.0	7.2	1.7	23.2	58.5	31.5	19.9	4.2	71.4	3.8	84.6	35.9	4.6	40.3	30.3	43.9	17.5	20.0	10.0	26.9	77.4	7.8	36.7	1.0	28.6	7.0	33.5	3.9	103.2	4.7	2.9	49.1	0.0	53.3	410.7	9.4	6.3	74.4	1.2	17.4	0.9	18.4	36.8	5.0	111.7	10.6	70.8	9.7	45.7	31.9	214.2	183.5	2.9	2.9	10.7	19.2
GNLY	"D2S69E, LAG-2, LAG2, NKG5, TLA519"	ENSG00000115523	Granulysin	P22749	2	85685175-85698852	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 288.7;endometrium 1: 71.9;lymphoid tissue: 86.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5070.6;NK-cells: 8318.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"NK-cell: 17623.2"	"Group enriched"	"Detected in all"	63	"NK-cells: 17623.2;T-cells: 7874.6"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"CAB025186, HPA058021"	Enhanced				"Secreted to blood"	NA	NA	2920000	17000	"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025186: , HPA058021: AB_2683581"	"unprognostic (5.80e-2)"	"unprognostic (5.64e-3)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.48e-5)"	"unprognostic (4.34e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.79e-2)"	"prognostic favorable (6.60e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.46e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (8.07e-4)"	6.9	2.7	8.1	11.6	7.8	288.7	5.2	8.1	18.7	4.3	7.1	5.7	4.0	71.9	3.9	2.6	6.1	6.5	4.3	7.8	9.8	2.9	10.4	36.8	21.9	12.7	11.6	1.5	1.2	0.8	1.8	17.0	10.6	2.0	6.1	0.5	2.0	5.3	9.2	1.5	10.3	4.3	8.8	86.3	5.0	0.9	9.8	3.5	3.6	3.5	17.6	6.4	2.5	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.1	0.0	177.1	26.2	17.7	7874.6	26.3	2145.8	34.2	837.4	3344.7	22.4	23.0	231.3	2928.7	202.5	17623.2	32.3	58.2	40.3	8118.6	8.1	7.8	8.1	18.7	7.8	9.8	12.7	11.6	10.6	8.8	9.8	9.8	26.8	12.8	78.9	0.0	23.3	7.0	0.2	0.0	0.0	0.1	7.2	3.7	3.0	10.0	6.2	0.0	2.1	2.3	5070.6	1.3	1.9	1.9	0.0	7.5	12.0	13.0	1.8	47.2	0.2	0.0	3.4	29.3	0.5	10.6	52.4	0.1	23.2	5.3	6.0	0.0	0.1	3.3	0.0	22.4	7.2	0.2	0.3	28.4	80.0	9.4	48.6	0.1	8318.3	0.0	0.1	0.0	1.2	0.0	247.4	0.1	2.4	9.5	3.6	0.2	0.0	7.0	5.4	0.2	0.6	0.6	7.7	1.1	1230.0	1.0	1.6	0.6
GOLPH3L	GPP34R	ENSG00000143457	"Golgi phosphoprotein 3 like"	Q9H4A5	1	150646230-150697154	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 313.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072016			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA072016: "	"unprognostic (1.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.24e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-2)"	10.9	14.3	8.8	11.8	9.3	6.0	20.8	9.3	11.4	21.8	13.5	31.1	17.9	14.7	33.3	30.3	25.3	14.1	10.3	8.7	11.4	18.6	9.6	13.6	12.6	9.3	13.3	21.4	22.8	19.0	11.0	13.0	11.7	15.8	36.4	12.8	23.3	17.6	14.7	18.9	20.1	15.2	9.0	11.0	22.7	14.4	10.9	15.8	25.7	13.5	18.5	21.5	13.5	8.5	25.2	23.0	12.2	7.6	31.8	22.5	21.8	22.6	33.0	23.7	32.9	10.3	45.1	29.3	31.5	14.7	16.1	21.6	20.8	18.5	28.6	21.1	21.5	33.8	13.2	15.2	26.7	27.8	28.2	16.1	31.8	24.2	54.4	26.1	37.5	21.1	27.6	19.6	14.1	25.4	24.2	13.1	25.7	46.1	21.6	16.8	14.5	36.5	30.6	17.5	19.3	18.8	11.6	33.2	18.0	31.4	25.6	32.5	29.3	7.3	13.3	10.2	18.5	23.8	22.9	313.5	22.3	28.3	10.9	7.5	1.6	2.8	9.5	1.6	13.0	10.5	9.9	9.7	8.7	9.8	12.7	9.4	1.4	18.0	3.6	12.6	11.6	5.4	8.8	9.3	9.3	11.4	8.7	11.4	9.3	13.3	11.7	9.0	10.9	8.5	11.7	9.6	10.3	12.1	9.8	12.9	11.3	16.7	9.6	9.0	26.3	14.4	10.4	24.3	22.6	12.9	6.2	22.1	9.7	50.0	25.4	21.6	22.2	27.5	10.3	14.1	21.0	10.9	12.7	36.6	17.9	12.9	17.9	15.6	11.4	48.6	16.1	10.9	12.4	0.0	13.6	46.6	14.2	9.1	7.4	12.7	16.4	7.5	16.0	24.4	13.1	14.9	6.2	11.6	13.5	21.2	34.6	19.9	15.0	27.7	31.6	26.9	51.2	13.3	0.0	10.0	9.5	14.6	4.3	15.7	17.8	30.8	10.4	22.0	36.0	39.6
GPC6		ENSG00000183098	"Glypican 6"	Q9Y625	13	93226807-94408020	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 163.2;Excitatory neurons: 333.6;Inhibitory neurons: 496.1;Oligodendrocyte precursor cells: 691.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.5;HSkMC: 70.8;hTERT-RPE1: 64.3;SuSa: 39.5;U-87 MG: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA017671	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		420000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA017671: AB_1849833"	"unprognostic (5.24e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.21e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.35e-3)"	9.1	2.2	0.8	8.9	1.9	0.1	2.2	1.7	1.5	3.6	1.1	6.3	2.3	2.4	2.4	5.2	4.1	17.0	6.2	1.3	3.1	7.7	17.7	3.5	0.4	1.7	2.4	7.3	1.6	1.8	2.9	1.3	2.3	6.2	6.5	5.6	3.1	15.1	0.6	1.1	4.3	7.8	2.0	2.2	5.4	2.0	1.9	1.7	1.7	1.9	0.9	11.6	2.4	2.1	0.0	4.7	10.2	4.5	62.5	19.5	0.0	7.2	0.0	4.9	6.4	0.0	0.0	0.2	0.0	16.0	0.0	0.0	5.7	1.2	9.1	0.0	4.1	0.0	0.1	20.2	37.8	0.1	0.1	70.8	0.5	11.7	8.1	64.3	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.1	6.4	0.0	3.4	0.0	1.6	0.1	5.5	0.0	4.1	16.8	0.0	1.9	0.0	39.5	14.0	0.0	0.0	26.9	22.6	25.4	12.3	15.9	0.1	0.0	52.8	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	1.9	1.7	1.5	1.3	3.1	1.7	2.4	2.3	2.0	1.9	2.1	0.6	0.0	0.5	163.2	0.0	0.6	0.5	0.5	0.6	50.3	0.6	1.9	1.7	4.3	0.7	7.3	10.4	0.2	0.0	0.1	0.0	0.3	6.7	1.6	25.9	1.1	0.0	0.0	333.6	0.0	0.1	31.2	0.0	3.1	0.0	36.0	5.7	41.2	0.5	0.0	496.1	0.1	2.0	1.3	1.0	5.0	4.7	0.5	1.8	31.9	0.0	2.7	0.0	691.6	13.2	0.1	0.0	1.9	0.1	1.6	0.0	14.5	0.0	115.0	0.0	34.4	20.9	4.2	2.7	0.5	0.4	0.1	0.7	11.9	0.1	0.2
GPD1L	KIAA0089	ENSG00000152642	"Glycerol-3-phosphate dehydrogenase 1 like"	Q8N335	3	32105689-32168709	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.4;tongue: 253.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 154.1;Distal enterocytes: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 136.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.23e-1)"	"unprognostic (3.12e-2)"	"prognostic favorable (7.05e-4)"	"unprognostic (2.63e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (5.71e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.33e-15)"	"unprognostic (1.50e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-3)"	"unprognostic (5.51e-3)"	39.0	44.7	18.2	8.3	20.1	6.9	30.6	17.2	21.2	22.8	27.1	40.1	26.5	11.6	9.8	40.9	19.1	9.2	124.8	21.2	20.5	34.2	2.8	31.3	9.0	19.2	18.6	16.6	21.6	32.8	5.9	20.8	19.3	59.9	36.7	9.8	22.0	41.2	158.4	10.3	29.0	16.6	20.5	12.8	29.7	6.1	18.3	6.8	40.3	253.1	10.2	31.0	12.9	21.9	11.1	10.0	3.5	15.3	49.3	11.9	136.1	8.8	3.1	9.2	7.1	10.7	5.2	19.4	13.2	6.2	11.3	12.6	23.4	9.3	11.6	8.3	21.4	11.3	13.2	16.8	12.4	29.4	39.3	35.5	12.1	8.9	12.5	9.4	16.3	15.7	8.0	6.1	7.3	15.1	12.6	11.0	2.1	27.6	44.8	23.1	15.7	40.0	14.6	66.8	15.1	15.0	6.7	61.1	25.0	4.8	38.7	14.1	8.6	10.5	4.9	16.3	23.6	4.3	2.0	19.3	24.0	22.3	6.0	0.5	2.8	5.7	3.3	3.2	8.0	1.5	4.1	4.0	5.6	1.2	2.5	3.7	1.4	7.4	2.1	4.4	8.8	2.8	18.2	20.1	17.2	21.2	21.2	20.5	19.2	18.6	19.3	20.5	18.3	21.9	10.2	28.9	41.8	1.3	4.1	4.6	5.3	3.5	8.6	4.1	20.3	10.7	154.1	2.8	18.6	9.2	2.1	36.4	10.8	75.2	39.2	2.0	8.0	5.3	4.4	10.5	7.8	6.9	23.1	3.7	6.1	10.5	17.3	9.2	39.3	9.8	13.2	0.7	10.0	1.7	23.7	21.3	26.4	6.3	5.7	20.7	5.9	4.4	8.8	24.4	2.3	32.9	7.2	3.0	11.1	4.3	21.6	12.8	8.7	13.8	33.9	18.4	15.0	3.9	0.0	8.0	8.7	0.8	2.1	32.3	7.0	27.1	10.4	3.3	26.9	8.5
GPRASP2	"FLJ37327, GASP2"	ENSG00000158301	"G protein-coupled receptor associated sorting protein 2"	Q96D09	X	102712176-102717733	"Disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.6;Cardiomyocytes: 16.4;Horizontal cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017438	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA017438: AB_1849504"	"unprognostic (8.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.14e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.71e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (4.60e-6)"	"unprognostic (1.19e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (6.63e-5)"	5.1	15.0	19.1	2.1	18.9	0.4	7.8	10.6	22.3	13.6	6.7	7.5	1.7	17.7	9.0	4.2	10.7	5.1	14.5	18.6	31.4	10.2	6.8	5.0	1.8	13.8	15.0	30.1	9.3	14.9	20.0	3.7	15.8	12.5	3.1	12.7	9.2	11.8	7.5	5.8	3.2	10.3	12.8	4.2	4.0	4.7	24.8	4.5	15.2	6.5	1.7	6.4	6.5	13.4	0.6	6.8	17.8	13.8	5.5	6.5	1.3	10.3	9.3	8.7	16.9	2.3	3.1	0.0	3.5	10.8	4.3	2.4	21.5	5.6	11.0	0.0	8.3	0.9	2.0	0.5	4.0	1.7	1.2	6.9	5.8	9.7	0.4	10.1	6.2	1.7	2.7	0.7	10.6	3.2	4.9	0.7	8.9	2.2	9.3	6.4	2.9	0.0	5.4	2.5	3.9	12.2	10.4	2.0	1.5	5.4	5.7	3.6	5.6	6.1	12.9	12.5	9.9	0.3	0.4	0.0	8.2	1.1	3.5	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.4	0.2	0.1	1.4	0.6	0.0	0.8	0.0	0.5	0.5	0.4	19.1	18.9	10.6	22.3	18.6	31.4	13.8	15.0	15.8	12.8	24.8	13.4	4.3	0.0	1.5	0.0	0.5	2.3	5.1	2.1	4.0	19.6	3.5	4.1	16.4	7.2	3.6	5.5	2.1	6.2	0.3	0.6	9.8	1.6	0.5	0.7	4.1	4.3	3.0	0.0	0.0	0.9	0.5	6.6	0.0	0.6	0.0	13.2	8.2	7.3	0.9	16.8	0.0	1.4	2.0	0.6	0.8	1.1	12.2	0.6	0.0	0.0	0.5	12.2	0.0	0.0	0.0	1.1	1.8	12.4	0.0	3.2	0.3	10.8	0.8	6.8	6.6	8.9	4.9	13.4	9.1	2.4	3.0	2.2	0.7	8.0	1.1	1.5
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 497.7;intestine: 453.8;liver: 634.0;stomach 1: 374.6;urinary bladder: 350.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 386.1;Distal enterocytes: 436.6;Gastric mucus-secreting cells: 912.3;Hepatocytes: 753.4;Intestinal goblet cells: 438.6;Paneth cells: 463.0;Undifferentiated cells: 776.8;Urothelial cells: 1062.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 493.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 4748.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.2"	"Low region specificity"	"Detected in some"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	1.9	0.2	0.1	53.8	0.3	0.3	5.3	0.5	0.3	23.5	0.1	333.5	96.7	0.7	1.7	187.7	4.9	497.7	0.3	0.2	0.5	30.6	634.0	2.6	0.1	0.4	0.2	0.2	24.5	0.0	1.2	0.2	0.4	43.3	453.8	0.0	71.8	24.9	0.3	25.4	175.7	9.7	0.1	0.6	374.6	2.5	0.3	3.3	0.5	0.0	1.2	350.5	108.2	0.7	0.0	1152.6	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	36.9	9.6	0.0	6.0	0.0	1.9	303.7	0.6	4.8	0.0	0.2	0.1	0.1	1.1	1048.6	0.0	0.1	0.4	0.0	9.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	5.6	0.6	0.3	1.3	4748.8	0.2	0.5	0.2	0.2	0.1	727.5	324.2	0.2	0.1	13.4	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.2	0.5	0.4	0.2	0.4	0.1	0.3	0.7	0.1	0.0	0.0	0.3	6.9	9.9	169.4	104.5	42.1	0.2	0.6	4.1	0.4	386.1	17.1	23.9	0.0	0.1	0.0	436.6	11.7	272.8	13.8	3.8	0.5	3.5	115.2	50.8	0.2	260.6	0.1	2.1	912.3	2.8	13.4	0.1	17.5	753.4	0.0	0.0	0.2	438.6	36.7	26.1	0.8	66.6	0.9	3.5	0.0	1.9	3.2	0.0	0.0	0.0	0.4	163.7	463.0	0.0	2.4	100.7	68.1	31.4	9.0	0.7	0.0	0.0	3.6	0.4	0.0	315.5	9.7	0.0	5.9	0.1	776.8	1062.0
GRAMD4	"DIP, KIAA0767"	ENSG00000075240	"GRAM domain containing 4"	Q6IC98	22	46576012-46679790	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.1;Distal enterocytes: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (8.67e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.19e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.04e-4)"	"unprognostic (1.08e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.38e-2)"	"unprognostic (8.69e-2)"	15.1	52.1	15.1	17.4	15.9	22.6	11.9	9.3	20.2	11.5	11.9	40.6	34.6	7.5	9.9	24.2	16.1	20.5	45.0	15.6	11.9	18.6	168.2	19.6	17.6	11.6	11.6	10.8	17.6	10.0	24.1	10.5	12.0	14.1	26.6	9.1	17.8	7.1	23.8	45.3	36.0	9.1	11.2	16.0	28.0	7.4	11.8	23.5	20.3	11.9	26.6	9.4	13.2	13.8	12.6	14.2	16.3	20.9	21.4	12.5	16.8	9.5	5.9	3.8	4.8	5.1	19.6	45.9	15.9	10.7	11.1	26.2	10.0	5.2	5.8	12.2	11.3	15.4	10.9	12.2	17.4	96.9	60.0	8.4	12.2	3.0	6.8	13.4	5.3	34.6	29.4	30.3	5.4	22.0	56.4	51.0	8.9	28.2	6.6	25.3	2.5	30.2	7.4	14.6	11.6	32.3	10.2	20.3	37.1	18.7	19.8	33.8	8.3	4.9	9.7	6.6	6.3	6.2	21.5	24.3	10.9	37.4	43.1	1.2	1.4	1.0	0.6	0.9	0.3	1.0	0.5	0.4	2.0	0.3	0.4	0.2	0.5	3.9	0.4	2.4	1.9	0.8	15.1	15.9	9.3	20.2	15.6	11.9	11.6	11.6	12.0	11.2	11.8	13.8	17.7	16.0	18.4	45.1	5.9	8.2	3.6	7.6	6.8	5.0	7.1	10.8	19.3	8.6	4.1	3.7	0.0	3.7	9.5	56.1	0.0	4.7	0.3	13.4	7.2	7.5	20.8	3.8	21.6	6.7	2.2	4.7	8.2	10.6	7.0	5.4	2.5	23.0	14.0	3.3	18.2	20.7	6.1	10.1	14.7	1.1	4.7	12.0	7.2	11.2	10.9	12.2	3.1	13.6	5.9	7.9	18.9	5.7	8.6	5.0	34.5	3.0	5.1	1.7	0.0	3.4	5.3	1.2	3.8	8.2	10.4	3.4	7.0	5.9	22.8	3.7
HBM	"HBAP2, HBK"	ENSG00000206177	"Hemoglobin subunit mu"	Q6B0K9	16	153892-166764	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"bone marrow: 459.9"	"Cell type enriched"	"Detected in some"	504	"Erythroid cells: 8988.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"									NA	NA		980000	"Cluster 48: NK-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 6: Erythroid cells - Oxygen transport"								"unprognostic (1.30e-1)"										"unprognostic (7.59e-2)"			1.2	0.1	0.2	0.0	0.4	459.9	0.3	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	1.4	0.3	0.0	1.9	3.1	3.9	0.0	0.1	0.0	0.2	0.1	0.0	1.2	6.3	0.1	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	17.5	0.1	0.2	0.0	0.2	0.7	0.9	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	6.9	0.2	0.4	0.0	0.4	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8988.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	3.5	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.6	0.0	3.3	17.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	2.1	0.0	0.1	0.0	1.9	0.0	0.0	0.0
HDAC11		ENSG00000163517	"Histone deacetylase 11"	Q96DB2	3	13479724-13506424	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 122.7"	"Group enriched"	"Detected in many"	6	"Early spermatids: 357.7;Late spermatids: 692.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 47.7;T-47d: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (5.22e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.78e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.94e-1)"	"prognostic favorable (7.88e-10)"	"unprognostic (3.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.39e-3)"	7.7	10.1	92.5	3.9	115.5	0.8	9.4	89.2	98.4	16.9	62.8	18.0	12.2	11.8	6.5	17.6	13.3	9.1	31.4	82.5	90.5	25.1	6.6	9.1	2.8	95.2	100.1	16.7	38.1	23.2	22.8	4.6	87.4	15.9	6.9	6.2	17.4	12.2	51.5	18.7	13.4	7.3	83.9	5.3	12.8	84.2	100.5	4.9	16.5	15.5	4.1	14.7	14.4	122.7	12.0	8.0	8.0	6.6	11.9	10.4	6.5	7.5	5.4	7.8	5.1	4.0	10.4	1.0	9.3	11.6	12.3	8.9	4.7	14.6	5.0	5.1	4.4	2.4	3.7	11.3	12.6	0.2	4.1	9.0	26.6	8.7	6.8	14.2	5.8	7.6	5.0	2.1	7.7	12.2	1.5	1.7	2.1	8.1	20.9	1.7	11.8	3.4	16.6	9.0	1.3	6.2	12.1	47.7	21.8	6.6	42.6	2.8	5.3	6.7	13.0	13.0	4.7	1.5	4.5	0.2	2.1	1.8	4.1	0.1	2.6	5.8	3.3	1.6	2.3	1.1	3.1	2.6	1.8	0.4	3.0	2.1	1.0	9.6	0.6	1.7	2.6	1.9	92.5	115.5	89.2	98.4	82.5	90.5	95.2	100.1	87.4	83.9	100.5	122.7	5.2	9.6	5.0	11.4	0.9	11.5	7.7	11.0	8.6	8.5	10.6	8.0	84.6	8.6	8.9	11.0	0.0	18.9	2.8	23.1	19.6	14.6	357.7	8.6	5.2	6.3	8.9	0.8	6.9	11.4	3.1	9.7	9.7	7.8	1.3	5.0	7.1	2.8	6.0	10.1	7.1	14.4	18.3	3.5	3.8	692.3	16.1	3.6	8.8	1.0	4.6	21.8	2.1	12.5	46.9	11.1	13.6	15.4	0.7	5.1	36.1	24.9	12.0	5.6	0.0	5.6	9.5	15.3	7.3	10.1	10.5	5.7	3.3	3.1	20.0	6.8
HOPX	"HOP, LAGY, NECC1, OB1, SMAP31"	ENSG00000171476	"HOP homeobox"	Q9BPY8	4	56647988-56681899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 716.7;skin 1: 1439.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 750.0;Alveolar cells type 2: 569.2;Basal keratinocytes: 414.6;dendritic cells: 345.3;NK-cells: 1150.4;Suprabasal keratinocytes: 377.2;Syncytiotrophoblasts: 321.8"	"Cancer enhanced"	"Detected in many"		"glioma: 43.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 518.2;NK-cell: 781.6"	"Group enriched"	"Detected in all"	15	"NK-cells: 781.6;T-cells: 518.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.2;HUVEC TERT2: 66.9;RT4: 50.5;TIME: 76.2;U-266/70: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018632, HPA030180"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"	Cytosol	"CAB018632: AB_2120833, HPA030180: AB_10603770"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.33e-2)"	9.5	33.7	212.8	27.7	235.6	12.1	112.2	215.4	322.0	250.1	239.2	30.5	17.2	19.1	541.4	716.7	10.5	35.1	48.8	237.4	212.0	24.0	2.9	372.8	18.4	237.6	211.6	9.4	5.3	13.3	11.7	59.6	218.5	26.9	7.0	22.1	172.0	64.7	19.2	1439.9	11.3	115.6	238.8	11.9	33.9	45.3	215.0	15.8	224.5	31.8	190.4	34.1	368.6	234.2	0.0	0.0	0.0	0.0	5.0	15.7	5.9	0.0	0.0	1.4	1.0	0.0	0.0	12.6	0.7	0.3	2.3	2.2	1.4	0.0	1.9	31.2	0.2	0.1	0.0	0.0	2.0	0.0	0.1	2.6	11.9	3.6	0.0	3.4	66.9	0.0	0.0	0.5	3.2	0.5	0.1	1.0	0.1	3.6	0.0	0.0	0.0	0.3	0.0	50.5	1.0	0.6	0.0	0.0	0.0	4.6	0.0	0.0	76.2	0.0	0.2	0.5	0.1	26.0	0.1	0.1	3.2	0.0	0.0	5.7	1.1	2.0	518.2	3.5	282.0	43.4	123.6	227.6	2.6	36.5	20.9	150.8	11.2	781.6	4.5	3.6	9.1	365.6	212.8	235.6	215.4	322.0	237.4	212.0	237.6	211.6	218.5	238.8	215.0	234.2	14.5	750.0	569.2	38.2	23.3	414.6	42.2	8.7	59.7	3.5	3.4	3.0	14.8	2.8	125.6	1.8	0.0	2.3	345.3	0.8	1.9	0.4	33.3	2.8	4.0	28.7	8.4	30.5	62.2	0.2	5.5	16.7	5.6	5.2	10.1	99.5	5.3	1.2	4.0	0.0	7.9	11.1	4.1	11.4	30.9	45.9	3.1	7.9	35.6	14.0	41.4	166.4	1150.4	7.1	6.7	1.7	0.0	3.0	9.6	31.3	1.2	0.6	12.5	5.6	32.9	3.7	104.8	3.3	15.3	31.6	377.2	321.8	219.9	0.1	1.4	28.8
HOXA10	"HOX1, HOX1H"	ENSG00000253293	"Homeobox A10"	P31260	7	27170592-27180261	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 76.8;skeletal muscle: 76.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 174.0;Enteroendocrine cells: 68.1;Paneth cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 10.7;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.7;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 179.0;THP-1: 96.7;U-937: 100.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	190	"spinal cord: 18.9"	"CAB019384, HPA071918"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Nuclear bodies"	"CAB019384: , HPA071918: "	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-2)"	13.4	6.8	0.0	6.1	0.0	4.3	6.8	0.0	0.0	40.8	0.0	32.6	0.1	76.8	9.1	0.2	8.3	0.1	0.0	0.0	0.0	13.7	0.1	0.1	2.3	0.0	0.0	0.8	0.0	0.0	0.0	13.4	0.0	26.3	13.2	0.0	0.0	15.4	76.4	6.0	7.9	44.9	0.1	0.2	0.1	0.3	0.0	5.2	0.1	0.0	0.2	20.4	17.2	0.1	20.6	4.3	0.0	59.9	29.3	28.0	0.2	40.1	27.2	18.0	16.8	6.1	17.8	0.0	10.9	31.6	0.0	22.6	15.5	0.0	13.2	9.5	179.0	21.6	15.0	0.5	0.8	9.6	31.4	17.8	0.9	1.5	0.0	0.0	27.5	6.3	0.9	0.0	13.3	0.0	0.0	63.1	0.0	16.6	18.8	1.9	4.0	0.1	34.7	9.6	46.7	0.1	13.8	0.0	0.1	6.4	0.1	96.7	0.0	0.0	16.1	21.1	0.2	0.4	0.1	0.0	0.0	100.4	0.5	10.7	0.1	0.3	2.2	0.0	0.0	0.1	0.0	0.2	1.2	0.3	0.0	0.0	0.0	13.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.5	0.0	0.0	0.0	0.2	3.7	10.0	0.0	0.6	0.0	4.4	4.6	1.6	0.0	0.0	7.3	0.0	0.5	4.5	28.8	19.6	0.0	0.0	3.1	174.0	5.4	68.1	15.5	0.0	0.0	0.4	13.3	0.0	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	25.0	0.0	2.5	4.7	0.0	0.0	2.0	5.4	0.0	0.5	0.0	7.2	0.0	0.0	0.0	32.1	0.4	1.3	18.1	18.8	27.1	0.0	0.0	0.0	13.3	15.7	2.3	4.6	0.5	4.1	0.5	3.1	0.0	25.5	10.1
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 29.1;Distal tubular cells: 131.0;Early spermatids: 29.4;Proximal tubular cells: 53.4;Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"medulla oblongata: 4.6;pons: 2.1;spinal cord: 8.2;white matter: 5.1"	"Immune cell enriched"	"Detected in single"	6	"NK-cell: 4.7"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 36.9;RPTEC TERT1: 45.4;SCLC-21H: 36.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.3"	"Region enriched"	"Detected in some"	6	"spinal cord: 21.4"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear membrane"	"HPA074048: AB_2686655"	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	8.2	17.8	0.0	5.9	0.0	0.3	9.4	0.0	0.1	4.2	0.0	13.8	0.2	5.8	17.8	2.8	15.5	0.1	0.0	0.0	0.0	20.1	0.0	2.7	2.1	4.6	0.1	0.8	0.2	0.2	0.0	0.3	2.1	4.9	8.9	0.0	0.0	6.7	16.5	12.0	8.6	3.8	8.2	1.7	3.9	2.4	0.1	2.9	0.5	0.1	0.4	7.3	5.2	5.1	13.6	4.6	0.0	14.1	0.0	0.0	0.8	4.7	8.0	9.6	11.0	7.0	5.1	9.2	12.8	3.7	0.3	9.1	36.9	0.0	5.8	0.0	23.2	0.6	4.8	0.2	0.9	0.8	0.5	7.5	0.4	1.1	12.9	0.0	18.5	15.7	0.0	0.0	3.7	2.4	0.0	2.2	0.5	9.6	1.4	4.8	8.5	0.0	45.4	9.1	36.3	0.1	25.6	0.0	0.1	2.5	0.4	3.7	1.6	0.0	8.6	26.0	4.6	0.0	0.2	0.2	0.0	17.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	4.7	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.1	2.1	8.2	0.1	5.1	11.0	0.0	0.0	0.0	0.6	9.1	7.2	0.1	12.0	0.0	18.7	29.1	0.4	0.0	0.1	12.9	0.0	1.1	1.3	10.3	131.0	0.0	29.4	0.2	2.1	5.9	16.2	5.5	0.0	0.0	3.9	5.8	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	12.5	0.0	0.0	1.9	7.2	0.6	0.6	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.8	0.0	1.7	5.2	2.3	53.4	0.1	0.0	0.0	10.8	16.1	27.4	4.1	8.6	12.4	0.3	1.0	1.2	16.1	5.3
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162438-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.4;skin 1: 25.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Endometrial stromal cells: 31.1;Enteroendocrine cells: 39.4;Proximal tubular cells: 75.1;Suprabasal keratinocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 6.7;myeloid DC: 5.6;NK-cell: 11.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.6;granulocytes: 6.7;NK-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 124.4;PC-3: 43.9;RPTEC TERT1: 42.0;SCLC-21H: 113.4;U-937: 42.3"	"Not detected"	"Not detected"							"HPA061982, HPA076200"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA061982: AB_2684651, HPA076200: "	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	4.7	5.9	0.0	2.8	0.0	2.5	6.9	0.0	0.2	12.7	0.0	22.0	0.0	17.0	5.6	1.0	19.6	0.0	0.0	0.0	0.0	28.4	0.0	0.4	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.1	14.1	3.9	0.0	0.0	4.5	16.1	25.7	14.8	1.9	0.2	0.9	0.2	0.0	0.0	1.9	0.1	0.0	0.0	16.8	13.8	0.2	37.7	0.0	0.0	18.4	6.0	4.4	0.0	14.6	11.7	1.2	1.2	2.4	1.4	0.3	1.4	7.9	0.0	34.7	23.5	0.0	1.2	0.0	124.4	0.3	1.1	0.0	0.6	0.0	0.5	6.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	43.9	8.1	0.0	0.0	42.0	0.7	113.4	0.0	15.6	0.0	0.3	0.6	0.0	31.3	1.4	0.0	11.4	14.0	0.2	0.0	0.0	0.0	0.0	42.3	0.0	6.7	0.8	0.0	1.3	0.2	0.2	0.1	0.0	0.1	5.6	0.9	0.2	0.0	0.8	11.5	0.3	1.8	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	6.2	0.0	0.0	0.0	2.0	25.1	14.9	0.0	3.4	0.0	12.2	14.7	0.5	0.0	0.0	18.4	0.0	0.2	2.9	10.5	54.8	0.0	0.0	1.0	31.1	4.3	39.4	16.6	0.0	0.0	0.3	4.8	0.0	0.6	0.0	0.0	0.7	0.0	0.3	0.0	0.0	21.7	0.0	3.4	4.2	0.0	0.0	1.9	5.4	0.0	0.8	0.0	2.1	0.0	0.0	0.0	20.2	0.0	0.9	19.4	13.3	75.1	0.0	0.0	0.0	3.0	4.6	0.0	1.0	2.6	27.6	0.3	2.2	0.3	21.4	14.2
ID2	"bHLHb26, GIG8"	ENSG00000115738	"Inhibitor of DNA binding 2"	Q02363	2	8678845-8684461	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1209.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 2393.2;monocytes: 1987.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1038.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 731.4;HEK 293: 459.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027612			Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nuclear bodies"	Centrosome	"HPA027612: AB_10599729"	"unprognostic (2.53e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (4.39e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.92e-3)"	160.8	175.9	86.6	73.9	88.5	390.3	82.6	83.8	118.2	97.4	68.5	149.9	99.1	69.7	21.0	35.3	108.3	150.8	177.4	89.6	86.8	128.2	562.5	108.1	92.6	80.2	82.9	213.1	60.1	1209.7	65.7	70.3	85.2	125.1	124.7	69.7	114.3	142.4	18.9	69.6	99.4	85.3	81.4	107.4	66.7	13.8	90.1	73.8	223.5	41.2	47.4	110.2	76.2	95.8	2.0	132.4	56.0	68.6	86.8	13.9	208.5	156.6	18.3	68.4	29.1	266.0	7.3	4.1	175.1	262.5	16.9	115.9	36.0	1.0	20.7	731.4	459.5	101.3	81.7	333.9	24.8	76.5	266.3	23.4	3.1	30.5	1.9	19.2	1.4	6.7	6.2	113.9	109.1	45.3	7.8	9.0	102.4	338.5	102.9	9.7	38.4	75.6	71.3	60.5	103.5	146.6	8.4	117.8	12.1	142.0	19.3	44.9	27.5	83.9	14.5	126.5	9.4	8.9	7.9	88.7	106.6	230.2	46.5	110.3	76.0	1038.0	356.7	221.7	214.2	3.6	108.1	251.9	223.8	1.6	133.7	262.1	96.6	880.8	248.9	10.3	9.2	200.1	86.6	88.5	83.8	118.2	89.6	86.8	80.2	82.9	85.2	81.4	90.1	95.8	429.9	141.1	237.9	316.7	41.4	131.3	143.0	494.8	138.9	9.8	231.2	218.4	179.5	316.0	211.2	101.2	16.7	260.3	604.5	337.7	555.7	471.0	12.0	601.1	344.6	281.1	425.9	59.8	23.5	160.3	142.4	276.0	189.1	647.2	973.6	17.1	487.6	554.7	700.3	6.7	13.8	548.0	494.4	415.8	2393.2	21.7	124.2	528.4	282.8	15.9	1987.9	519.9	1070.1	26.7	3.2	69.6	301.9	32.7	86.0	130.1	231.3	264.1	66.7	27.4	19.7	166.6	185.6	2.1	39.9	97.6	104.6	666.0	690.0	16.7	323.1	51.3
IFITM1	"9-27, CD225, DSPA2a, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	310041-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8"	"Group enriched"	"Detected in all"	7	"granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9"									"HPA004810, CAB017615"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	477.7	102.3	291.8	282.0	303.4	367.1	401.7	293.8	402.1	563.3	321.5	249.0	128.4	314.6	1152.4	147.4	537.4	247.9	368.4	292.6	305.4	317.5	191.4	246.5	417.2	324.8	295.6	607.5	78.8	154.0	145.1	278.5	322.5	190.6	172.0	14.9	199.8	324.3	134.2	164.6	252.4	367.4	308.6	679.7	141.6	56.3	317.5	296.5	263.4	259.3	295.9	307.4	364.7	304.3	125.7	5.5	1011.4	74.5	79.1	279.8	7.4	250.1	1038.8	2266.3	4016.8	3.7	782.2	3.0	157.9	257.1	23.5	269.0	36.5	26.2	52.0	255.3	51.8	125.9	77.5	11.8	668.2	182.8	1138.9	496.3	0.2	26.6	2.6	27.0	4.2	41.1	450.0	880.7	1.7	23.9	85.1	318.2	264.5	0.5	33.5	27.1	3.1	24.5	654.9	0.0	1.0	2.2	122.7	11.9	196.9	138.5	42.1	17.0	8.8	3.8	4.7	1.5	1.1	61.6	44.8	6.8	3.4	253.8	3.1	544.4	62.1	1494.7	2906.3	312.7	2003.4	364.9	3120.6	3000.3	114.2	323.6	2939.3	2996.4	2741.6	4679.9	539.0	33.7	1944.8	4673.8	291.8	303.4	293.8	402.1	292.6	305.4	324.8	295.6	322.5	308.6	317.5	304.3	240.7	35.3	119.4	2.6	88.2	27.9	17.1	70.2	673.8	0.0	13.0	12.6	8.4	2.8	115.3	33.1	0.0	3.3	258.6	13.7	5.9	1.7	1.4	14.6	96.5	364.4	1.2	27.8	0.0	1.4	30.7	236.0	33.6	20.8	18.9	5.6	164.6	24.6	11.8	0.0	0.0	17.3	10.2	10.1	26.8	3.8	300.8	45.4	78.2	42.2	2.1	0.0	126.7	0.0	0.2	0.7	15.0	124.5	141.2	2.3	15.0	1.0	26.0	0.0	276.1	16.4	213.4	0.6	1.5	50.4	14.3	4.0	595.8	2.1	29.2	5.7
IFNL1	"IL-29, IL29"	ENSG00000182393	"Interferon lambda 1"	Q8IU54	19	39296407-39298673	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"dendritic cells: 3.0;Langerhans cells: 6.4;NK-cells: 14.4;T-cells: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"gdT-cell: 2.7;MAIT T-cell: 2.8;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.7;myeloid DC: 2.3;naive CD8 T-cell: 1.4;NK-cell: 4.6"	"Group enriched"	"Detected in many"	33	"dendritic cells: 2.3;NK-cells: 4.6;T-cells: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	97000		"Cluster 48: NK-cells - Unknown function"			"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.08e-2)"	"unprognostic (8.74e-2)"		"unprognostic (2.46e-4)"		"unprognostic (5.76e-2)"		"unprognostic (6.91e-3)"	"unprognostic (5.73e-3)"	"unprognostic (3.94e-2)"	"unprognostic (4.80e-2)"		"unprognostic (2.96e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	2.8	0.0	1.3	2.7	2.3	0.0	0.1	1.4	0.0	4.6	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.5	0.0	0.0	0.4	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.6	0.0	0.0	0.0
IGFBP2	IBP2	ENSG00000115457	"Insulin like growth factor binding protein 2"	P18065	2	216632828-216664436	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 956.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1379.1;Granulosa cells: 1649.7;Hepatocytes: 658.6;Theca cells: 2199.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2139.8;HMC-1: 5110.0;NB-4: 1106.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077723			Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	303000000	810000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"		"HPA077723: AB_2686853"	"unprognostic (2.58e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (5.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.22e-1)"	219.5	58.8	15.9	28.3	14.8	21.4	90.5	15.6	30.2	86.9	123.3	85.5	76.8	232.5	59.9	145.6	157.0	26.9	169.2	15.6	16.3	187.3	607.7	71.0	8.8	15.3	21.7	281.7	956.0	12.4	66.9	81.0	19.3	217.3	35.0	2.4	76.4	196.2	23.3	30.8	44.6	49.7	13.2	398.9	492.2	58.0	16.0	33.6	57.8	21.9	14.5	132.6	97.4	13.2	0.1	52.3	402.1	396.3	2139.8	652.9	8.5	125.2	61.9	6.1	0.6	1.2	1.5	0.1	171.7	0.8	15.2	11.5	145.4	156.9	0.6	0.8	84.9	91.3	0.2	26.3	53.3	38.6	5110.0	219.3	15.8	2.5	7.1	12.5	0.2	184.7	3.9	11.7	2.8	103.1	162.8	1106.5	437.4	98.2	4.8	139.2	9.1	2.0	2.0	117.1	84.1	443.4	0.3	3.4	2.6	362.2	332.4	67.3	0.5	1.6	2.4	1.6	6.2	6.2	0.9	9.7	6.0	177.4	478.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	15.9	14.8	15.6	30.2	15.6	16.3	15.3	21.7	19.3	13.2	16.0	13.2	354.3	3.2	0.6	2.0	3.3	13.8	534.0	238.2	19.4	0.2	79.0	498.0	12.5	11.5	40.1	264.8	2.1	1.8	5.4	86.4	29.4	3.0	1.0	153.2	1379.1	149.2	321.0	31.1	4.5	128.4	7.7	296.7	411.8	176.0	4.5	1649.7	92.1	658.6	5.3	0.0	0.8	191.6	54.9	24.1	5.0	4.9	5.6	21.8	3.6	13.1	1.3	3.6	3.1	1.0	1.0	60.7	51.3	79.4	0.4	255.7	4.2	1.2	195.9	1.7	105.2	17.9	435.7	6.0	35.8	103.3	5.5	2.2	16.0	2199.1	133.8	304.0
IGFBP4	"BP-4, HT29-IGFBP, IBP4, IGFBP-4"	ENSG00000141753	"Insulin like growth factor binding protein 4"	P22692	17	40443450-40457725	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 672.7;Endometrial stromal cells: 542.2;Endothelial cells: 502.3;Fibroblasts: 585.4;Hepatic stellate cells: 566.5;Hepatocytes: 501.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 19.5;NK-cell: 37.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 37.0;T-cells: 19.5"	"Cell line enhanced"	"Detected in many"		"A549: 1334.8;ASC diff: 961.5;ASC TERT1: 933.8;BJ: 1066.4;BJ hTERT+: 1088.2;HSkMC: 2001.2;U-2197: 882.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066240	Supported				"Secreted to blood"	NA	NA	227000000	410000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA066240: AB_2685643"	"unprognostic (1.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (5.49e-4)"	"unprognostic (4.55e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.81e-2)"	884.7	248.1	26.0	307.7	26.9	2.4	754.6	25.3	46.5	1020.7	65.0	618.0	82.8	795.8	141.9	246.7	791.1	391.4	502.9	25.6	28.2	464.4	1475.9	390.1	60.0	29.5	34.1	1270.4	164.4	44.6	203.7	231.8	28.9	470.0	133.5	13.1	264.4	279.0	107.3	241.7	289.5	645.1	28.3	295.5	369.6	67.7	35.3	38.9	501.4	97.4	44.2	552.1	576.2	25.8	0.2	1334.8	66.8	0.5	961.5	933.8	2.2	1066.4	1088.2	199.7	154.4	59.7	17.3	0.3	563.7	511.0	27.2	11.9	22.6	6.8	90.2	4.8	1.3	4.3	91.3	89.9	601.2	2.9	0.5	2001.2	4.6	267.7	37.7	23.8	350.6	0.1	21.7	0.2	290.5	41.2	0.8	252.5	37.2	58.9	178.2	67.2	1.3	2.1	8.4	42.1	18.3	53.0	482.3	2.0	17.0	63.5	486.6	24.7	534.7	276.0	14.4	882.1	1.1	0.9	0.6	1.7	163.8	9.9	72.4	0.0	0.0	0.0	2.7	0.0	19.5	0.8	5.0	6.7	0.0	5.2	0.3	0.6	0.0	37.0	0.0	0.2	0.0	1.4	26.0	26.9	25.3	46.5	25.6	28.2	29.5	34.1	28.9	28.3	35.3	25.8	672.7	9.6	37.4	1.3	17.6	56.3	97.1	36.7	79.1	3.2	118.9	163.2	16.9	90.1	16.2	7.3	0.0	6.1	10.6	93.3	17.6	4.1	6.7	69.8	542.2	502.3	8.4	37.9	3.8	2.4	7.2	585.4	13.7	59.1	2.5	230.9	566.5	501.2	273.6	1.7	3.4	74.7	4.1	42.8	94.0	16.5	246.4	21.3	72.9	18.7	3.4	3.8	1.0	1.0	0.3	39.1	72.1	118.5	7.4	63.8	71.6	204.7	18.5	1.1	190.7	13.8	299.9	1.9	8.2	26.8	47.7	7.5	20.3	25.9	109.0	73.6
IL12RB2		ENSG00000081985	"Interleukin 12 receptor subunit beta 2"	Q99665	1	67307364-67398724	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5;placenta: 7.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.4;Excitatory neurons: 22.5;Inhibitory neurons: 16.6;T-cells: 12.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.8;head and neck cancer: 2.5;melanoma: 5.6;renal cancer: 1.7"	"Region enhanced"	"Detected in many"		"hippocampal formation: 4.5"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 21.3"	"Group enriched"	"Detected in many"	35	"NK-cells: 21.3;T-cells: 6.0"	"Group enriched"	"Detected in some"	9	"HMC-1: 4.6;SCLC-21H: 6.8;SK-MEL-30: 18.4;THP-1: 13.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.4"	"Low region specificity"	"Detected in all"			HPA024168	Uncertain		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"HPA024168: AB_1851629"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.90e-1)"	1.9	0.3	1.2	1.2	1.6	0.8	0.4	0.0	2.3	0.6	0.0	0.4	0.3	0.2	0.3	0.8	0.1	0.5	0.2	4.5	0.0	0.3	0.8	0.4	1.8	0.0	0.7	0.2	2.6	0.8	0.0	7.0	0.0	0.1	0.4	0.1	1.3	0.7	3.5	1.4	0.4	0.4	0.0	1.4	0.3	1.0	0.3	1.0	0.1	0.7	0.9	0.7	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.1	18.4	0.0	0.0	13.4	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	6.0	0.0	3.2	0.0	1.6	1.0	0.0	0.0	0.0	0.1	0.3	21.3	0.0	0.0	3.9	1.2	1.2	1.6	0.0	2.3	4.5	0.0	0.0	0.7	0.0	0.0	0.3	0.7	0.2	0.0	2.3	1.0	0.6	0.5	0.2	0.1	0.6	0.0	0.1	0.3	0.7	0.0	0.7	0.0	0.0	0.0	8.4	0.0	0.0	0.0	1.5	0.3	0.3	0.1	0.0	0.8	22.5	0.0	0.0	0.9	2.6	0.7	0.0	1.5	0.0	0.0	3.8	0.0	16.6	0.0	0.0	0.8	0.9	0.9	0.0	0.5	1.8	2.8	0.0	0.0	4.1	1.0	1.6	0.2	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.0	0.6	0.0	12.8	0.0	0.0	0.1
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398777	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 24.2;lymphoid tissue: 18.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.7;granulocytes: 111.2;Langerhans cells: 25.4;NK-cells: 42.2;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4;HHSteC: 35.4;U-937: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007615	Approved		Approved	Mitochondria		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"	8.2	2.3	1.3	5.6	1.4	2.4	5.4	1.2	1.9	4.5	1.6	4.0	4.1	3.1	1.6	2.2	3.7	2.9	4.5	1.0	2.4	4.4	6.6	24.2	4.1	1.5	1.3	1.1	1.3	3.2	1.7	6.9	1.8	3.3	1.0	0.2	2.2	5.7	0.9	2.6	8.8	0.7	1.3	18.5	4.3	0.5	2.0	2.0	2.1	1.1	2.2	4.0	2.8	1.3	1.8	0.6	0.0	0.0	1.3	0.8	2.3	0.0	1.1	0.1	0.5	0.0	0.8	0.0	0.1	0.0	3.4	0.9	0.0	2.4	0.0	27.4	1.2	2.1	0.5	0.1	35.4	8.8	10.1	7.8	1.9	3.1	5.4	0.0	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.4	1.1	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.2	0.1	0.3	0.1	0.0	0.0	0.8	0.9	0.5	3.2	0.6	0.0	0.0	0.0	0.1	52.0	3.6	10.0	0.0	4.8	6.2	0.1	16.3	0.1	3.6	4.7	3.6	0.2	0.6	1.4	6.7	45.6	0.0	10.4	4.1	1.9	1.3	1.4	1.2	1.9	1.0	2.4	1.5	1.3	1.8	1.3	2.0	1.3	10.2	0.0	8.5	0.3	2.7	0.8	1.1	1.1	0.6	0.0	0.3	0.3	3.9	0.0	2.3	1.8	0.0	0.0	44.7	0.3	1.9	0.9	0.1	1.0	4.1	7.4	0.0	3.6	0.2	0.6	1.0	3.1	5.1	1.1	111.2	0.0	10.0	7.6	0.1	0.0	1.0	0.1	0.0	2.4	25.4	0.1	0.3	16.5	3.6	12.2	1.0	0.2	42.2	1.5	0.0	1.1	0.4	0.0	10.3	1.0	0.1	0.9	3.8	0.2	6.6	0.9	1.4	0.4	1.3	0.3	1.0	0.0	25.4	0.1	0.4	0.9
IL18RAP	"AcPL, CD218b"	ENSG00000115607	"Interleukin 18 receptor accessory protein"	O95256	2	102418689-102452565	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 104.6;lymphoid tissue: 46.7"	"Group enriched"	"Detected in some"	6	"dendritic cells: 42.2;NK-cells: 66.9;T-cells: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 118.1"	"Group enriched"	"Detected in many"	107	"granulocytes: 67.6;NK-cells: 118.1;T-cells: 65.2"	"Cell line enriched"	"Detected in some"	11	"U-937: 54.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025270	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025270: "	"unprognostic (1.73e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.07e-3)"	"unprognostic (4.64e-6)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.86e-5)"	"unprognostic (5.09e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.73e-2)"	6.8	0.6	0.4	12.0	0.4	104.6	1.5	0.3	1.1	0.7	0.7	2.0	2.3	0.5	0.3	1.1	5.5	3.0	1.6	0.3	0.4	1.5	3.5	16.2	2.6	0.4	0.4	0.4	0.6	0.1	0.6	1.4	0.7	1.1	1.7	0.0	0.8	0.6	0.5	0.4	6.3	1.0	0.5	46.7	2.6	0.1	0.6	0.8	1.1	1.1	2.8	2.5	1.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.1	2.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.3	0.2	0.1	19.3	46.2	0.1	65.2	0.0	5.9	12.6	0.5	0.0	0.2	1.5	67.6	118.1	0.0	0.7	0.4	6.4	0.4	0.4	0.3	1.1	0.3	0.4	0.4	0.4	0.7	0.5	0.6	0.4	0.4	3.2	1.1	0.0	0.8	0.3	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.1	1.3	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.8	5.3	0.0	0.0	1.9	0.0	1.9	0.6	0.0	66.9	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	22.5	0.0	0.0	0.0
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37125843-37175054	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 50.2;placenta: 36.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 130.1;Extravillous trophoblasts: 85.5;NK-cells: 388.3;T-cells: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 50.8;NK-cell: 186.4"	"Group enriched"	"Detected in many"	22	"NK-cells: 186.4;T-cells: 50.8"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 525.8"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Low region specificity"	"Detected in some"			HPA062657	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA062657: AB_2684822"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (6.76e-4)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.44e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (4.63e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.46e-2)"	3.2	1.3	2.0	22.4	1.6	36.8	1.9	0.8	2.3	2.2	1.5	5.1	5.5	7.6	2.9	3.5	2.9	6.8	1.9	2.2	1.0	1.0	8.5	12.4	35.7	2.4	2.2	1.6	0.8	0.4	0.6	36.3	1.9	2.3	5.2	0.0	4.3	3.2	0.7	8.9	8.3	2.5	1.7	50.2	6.4	1.5	3.3	14.9	1.8	0.7	24.0	8.0	1.0	1.8	0.4	0.0	1.0	0.0	0.0	0.0	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	525.8	0.6	1.0	0.0	0.1	0.0	0.0	24.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.0	0.7	0.1	4.2	3.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	0.6	2.3	0.0	0.9	0.0	0.0	13.2	0.0	0.6	36.2	66.0	0.1	0.4	0.4	0.5	5.4	0.1	0.5	50.8	0.6	27.4	0.4	11.4	28.6	0.1	1.9	3.6	15.0	1.2	186.4	0.5	0.3	24.4	37.3	2.0	1.6	0.8	2.3	2.2	1.0	2.4	2.2	1.9	1.7	3.3	1.8	1.5	3.2	6.8	0.0	3.6	3.2	0.7	0.1	5.7	0.0	1.0	0.8	1.7	0.0	0.6	1.8	0.0	0.6	130.1	0.2	0.0	0.3	2.2	0.5	1.2	1.0	0.0	16.8	0.1	0.2	85.5	1.4	5.6	1.2	10.1	0.1	7.1	1.8	2.3	0.0	0.1	0.1	0.0	5.3	1.7	1.6	0.3	3.7	5.4	0.0	2.0	0.0	388.3	0.0	0.1	0.0	0.0	0.0	18.6	0.2	0.1	0.2	0.7	0.0	0.0	0.2	0.9	0.0	0.3	0.5	1.6	1.2	103.6	0.0	0.3	0.1
IL37	"FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7"	ENSG00000125571	"Interleukin 37"	Q9NZH6	2	112912971-112918882	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 136.8"	"Cell type enriched"	"Detected in some"	26	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in some"	6	"lung cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.7;PC-3: 5.9;RT4: 3.2"									"HPA054371, HPA057950"	Uncertain		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	76700		"Cluster 48: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"		"HPA054371: AB_2682465, HPA057950: AB_2683561"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.71e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"		"unprognostic (1.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.26e-3)"			"unprognostic (3.95e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-2)"	0.1	0.0	0.0	0.2	0.0	0.2	16.7	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.1	0.4	136.8	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.1	0.2	2.7	0.2	0.2	0.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.4	0.8	0.1	0.0	1.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.2	0.2	5.9	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	73.2	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.8	0.0	0.1	0.0	0.0	0.0
INSC		ENSG00000188487	"INSC spindle orientation adaptor protein"	Q1MX18	11	15112424-15247208	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"parathyroid gland: 25.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Early spermatids: 4.6;Exocrine glandular cells: 3.1;Oligodendrocyte precursor cells: 8.0;Pancreatic endocrine cells: 10.9;Proximal tubular cells: 8.9"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.7;hTERT-HME1: 6.0;Karpas-707: 3.3;LHCN-M2: 3.6;TIME: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039769	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039769: AB_10697556"	"unprognostic (1.64e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.88e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.00e-2)"	0.2	0.8	0.2	1.0	0.1	0.6	0.2	0.1	0.2	1.1	0.1	4.7	2.1	0.1	0.1	0.5	0.3	0.6	1.2	0.1	0.2	0.3	0.2	0.9	0.0	0.3	0.2	0.1	0.9	25.3	0.2	0.0	0.2	1.0	1.8	0.0	0.5	1.0	0.0	0.1	3.0	0.5	0.2	0.1	2.4	0.7	0.1	0.2	0.3	0.1	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.0	0.3	11.7	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.4	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.6	6.0	0.0	0.0	0.0	0.0	3.3	3.6	0.0	0.0	0.2	0.0	0.1	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	1.0	0.0	0.0	1.5	0.2	0.0	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.9	0.1	4.6	0.2	0.0	0.1	1.8	0.0	0.5	3.1	0.0	0.9	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.0	0.0	10.9	0.0	0.0	0.1	0.2	0.0	8.9	0.0	0.0	0.0	0.0	1.1	1.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.6
IRAK2		ENSG00000134070	"Interleukin 1 receptor associated kinase 2"	O43187	3	10164919-10243745	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 43.7;Oligodendrocytes: 34.3;Prostatic glandular cells: 23.4;Urothelial cells: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.2;BJ hTERT+: 35.2;CAPAN-2: 35.6;GAMG: 62.6;RT4: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013483, HPA050520"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"CAB013483: , HPA050520: AB_2681154"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.60e-5)"	6.4	3.6	4.0	6.0	3.9	23.3	4.6	3.9	8.0	2.9	1.7	2.1	2.0	2.0	0.7	7.2	1.8	4.4	1.9	3.2	5.1	3.4	10.8	10.4	3.8	5.1	4.1	1.0	1.9	1.0	1.2	2.2	5.6	3.3	1.7	1.5	3.6	1.8	17.0	5.2	5.4	1.4	3.4	4.5	3.4	1.3	4.2	3.9	3.1	4.3	11.5	16.1	4.5	8.0	2.7	7.6	0.3	1.0	8.1	6.7	33.2	2.9	35.2	4.7	4.5	3.6	35.6	0.1	0.9	4.3	62.6	0.8	0.8	9.0	6.3	2.3	2.5	0.8	1.7	9.9	3.9	0.0	1.1	4.1	1.5	17.3	22.4	12.4	9.7	0.3	1.8	10.7	5.7	0.1	0.0	1.8	0.3	4.2	7.5	1.7	0.0	0.6	10.3	49.2	0.5	0.3	3.3	0.1	0.3	0.8	0.8	1.7	10.1	10.7	0.9	6.5	7.0	3.6	11.3	2.1	22.9	4.7	1.9	0.2	1.0	0.1	5.8	0.7	6.0	4.2	1.7	3.3	1.0	3.2	1.2	3.0	2.1	7.4	0.2	0.0	0.7	2.2	4.0	3.9	3.9	8.0	3.2	5.1	5.1	4.1	5.6	3.4	4.2	8.0	3.9	0.0	4.1	1.6	8.3	8.0	20.8	9.9	5.2	0.9	1.6	1.3	2.0	0.0	6.1	0.0	0.0	0.2	3.8	1.3	0.0	9.8	4.1	4.3	2.4	12.3	0.0	0.0	6.3	4.2	0.7	4.3	7.7	16.7	0.0	0.1	0.7	4.8	3.4	0.0	7.0	0.7	4.1	2.9	43.7	1.5	0.9	20.9	5.4	13.1	1.9	2.1	7.2	7.1	34.3	15.7	0.3	0.0	7.4	23.4	2.6	1.1	1.3	0.0	0.0	4.2	2.0	0.7	0.9	4.7	7.4	1.0	3.9	0.2	0.5	30.4
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438167	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 223.6;testis: 223.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1141.3;Sertoli cells: 315.5;Syncytiotrophoblasts: 1034.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.5;NK-cells: 14.4;T-cells: 8.9"	"Cell line enriched"	"Detected in many"	4	"BEWO: 492.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	36.0	32.6	15.2	2.8	13.8	5.8	30.5	12.5	19.5	47.3	223.6	14.2	3.6	44.2	4.4	15.2	78.9	3.7	36.1	19.4	24.5	114.4	13.1	22.2	4.4	16.8	18.8	96.0	40.1	12.8	50.7	46.3	14.2	41.4	0.7	0.9	17.7	26.7	13.2	16.2	16.1	2.8	12.7	35.1	11.3	223.8	25.4	3.0	23.7	3.1	1.8	23.5	31.9	11.3	13.9	42.4	98.6	31.0	0.8	0.2	492.7	6.6	1.0	0.6	0.3	24.5	26.1	0.2	33.5	3.2	0.2	36.6	3.0	0.1	0.0	39.8	116.4	52.0	3.1	80.3	10.2	0.6	1.1	9.4	0.4	2.8	0.4	0.4	6.3	1.1	106.0	2.1	0.0	84.1	4.0	3.4	51.7	14.2	33.7	71.2	0.2	24.6	9.5	0.3	30.4	74.3	1.7	9.9	53.1	20.2	68.2	7.1	18.7	0.5	1.1	0.7	1.6	13.9	7.3	3.2	3.0	1.9	17.7	1.0	0.1	0.0	8.1	0.2	6.2	4.5	8.1	6.9	0.8	2.4	6.2	8.9	0.8	14.4	0.1	2.2	6.2	5.0	15.2	13.8	12.5	19.5	19.4	24.5	16.8	18.8	14.2	12.7	25.4	11.3	38.8	3.2	1.1	2.6	9.0	12.0	82.1	74.9	72.8	0.8	26.1	47.0	4.7	20.0	24.0	47.8	2.1	1141.3	8.4	4.1	52.8	39.4	101.3	33.4	10.9	30.5	64.8	21.5	1.0	8.2	114.0	30.2	7.1	14.8	14.0	36.9	25.7	1.1	84.9	0.0	4.3	4.0	28.5	9.0	7.8	230.1	37.3	4.1	23.2	11.2	5.4	8.6	13.4	0.0	0.3	3.4	1.8	50.4	1.8	21.6	0.7	6.1	23.6	0.7	315.5	5.6	163.6	53.7	21.0	10.6	5.7	1034.6	14.9	14.5	6.2	36.8
ITGAD	"ADB2, CD11d"	ENSG00000156886	"Integrin subunit alpha D"	Q13349	16	31393335-31426505	"CD markers, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 20.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.1;Kupffer cells: 4.2;Late spermatids: 1.0;Macrophages: 1.6;T-cells: 2.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA026786	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA026786: AB_10603773"	"unprognostic (2.79e-2)"	"unprognostic (2.39e-4)"	"unprognostic (2.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.44e-4)"	"unprognostic (6.99e-3)"	"unprognostic (6.89e-3)"	"unprognostic (5.02e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.51e-2)"	0.2	0.0	0.0	0.8	0.0	3.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	1.3	0.3	4.5	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	20.5	0.1	0.2	0.1	1.2	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.4	0.0	0.8	0.0	0.2	0.0	0.0	4.2	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0
JAK1	"JAK1A, JAK1B, JTK3"	ENSG00000162434	"Janus kinase 1"	P23458	1	64833229-65067754	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 700.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 336.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013088	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB013088: "	"prognostic favorable (9.63e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.66e-2)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.51e-1)"	99.6	38.2	44.8	73.9	42.6	51.4	60.7	46.7	45.4	58.2	61.7	50.5	33.9	56.7	60.8	38.7	40.7	64.2	49.5	46.0	53.9	55.4	86.6	62.1	110.1	56.0	47.0	77.1	46.7	55.0	35.6	57.0	49.1	42.2	54.5	41.7	34.2	55.2	83.4	79.2	50.8	64.2	44.0	88.3	49.5	46.8	59.8	103.8	45.0	118.6	101.7	81.2	39.3	45.5	50.4	66.2	27.7	3.0	336.8	177.2	35.1	76.3	116.1	64.6	75.7	21.4	27.7	76.5	59.1	142.8	118.7	27.8	19.4	63.6	93.8	102.7	29.5	104.0	32.1	56.2	126.6	40.2	68.4	159.9	92.6	97.2	103.0	78.4	208.7	37.0	37.9	78.9	80.1	31.2	22.3	39.6	18.6	65.3	37.4	30.5	77.8	28.5	213.8	84.9	19.8	57.9	107.4	51.6	52.9	56.6	104.3	28.6	180.8	74.7	34.1	174.2	42.0	47.7	23.6	60.4	70.5	57.9	34.1	162.4	52.1	146.8	94.0	66.3	105.7	89.1	90.2	100.7	69.4	73.1	97.0	80.6	177.9	305.4	76.2	55.0	117.1	130.8	44.8	42.6	46.7	45.4	46.0	53.9	56.0	47.0	49.1	44.0	59.8	45.5	211.2	51.3	94.9	62.3	219.8	116.6	150.7	91.3	78.0	37.0	66.2	71.6	112.8	87.2	84.2	112.2	22.9	9.0	345.0	89.2	43.0	171.3	125.2	90.1	167.0	183.0	66.4	52.8	59.6	213.8	105.2	131.9	91.3	151.2	57.0	48.7	174.2	91.4	58.5	21.9	85.3	62.0	69.2	160.2	148.9	101.7	96.0	177.9	49.8	80.6	234.8	53.5	700.3	61.3	42.7	217.5	58.6	84.7	175.2	183.8	53.7	79.0	61.9	38.6	164.3	70.6	191.8	40.8	53.1	71.2	166.1	12.2	256.0	95.7	47.6	200.1
JHY	"C11orf63, FLJ23554"	ENSG00000109944	"Junctional cadherin complex regulator"	Q6NUN7	11	122882683-122963862	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Endometrial ciliated cells: 41.5;Glandular and luminal cells: 8.7;Proximal tubular cells: 12.0;Respiratory ciliated cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039612, HPA040344, HPA077658, HPA077748"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (9.97e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.77e-4)"	"unprognostic (6.46e-3)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (7.79e-2)"	6.0	1.8	1.7	2.2	2.7	1.1	3.6	3.4	2.4	3.1	17.3	3.5	1.5	2.1	2.7	1.8	7.4	2.6	2.2	1.8	3.8	7.8	0.4	4.5	2.2	4.1	5.4	3.2	2.8	5.6	4.8	1.3	3.8	3.5	1.7	1.6	1.4	2.5	0.2	1.9	1.9	2.0	3.8	2.5	2.0	35.7	3.2	3.2	5.1	0.8	2.0	2.6	1.8	3.6	2.8	3.9	2.2	0.1	0.6	0.4	0.7	5.9	6.8	2.5	1.1	0.3	10.3	0.1	1.5	9.1	13.6	2.4	2.7	1.4	1.1	9.5	2.8	0.1	1.8	0.1	0.9	1.7	4.7	2.8	7.4	0.4	0.6	6.3	3.8	4.1	0.0	0.1	2.0	1.8	0.1	0.6	0.3	8.2	3.5	1.0	0.0	1.3	7.0	3.2	5.8	4.2	7.1	3.9	2.6	2.8	4.7	0.6	1.2	7.9	1.0	0.2	4.8	0.1	0.0	0.1	2.1	2.1	5.3	0.5	0.3	0.1	1.3	0.1	1.8	1.1	1.3	1.7	2.4	0.6	0.9	1.0	0.4	2.4	0.1	0.6	0.3	0.5	1.7	2.7	3.4	2.4	1.8	3.8	4.1	5.4	3.8	3.8	3.2	3.6	4.4	12.8	4.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.3	3.2	0.0	0.0	7.4	5.5	0.0	0.2	2.2	0.0	3.9	5.5	0.0	41.5	3.1	1.1	0.0	0.0	0.0	1.4	0.9	2.2	0.0	8.7	0.0	2.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.7	0.0	0.0	12.0	19.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	1.8	1.3	0.0	0.0
KANK3	"ANKRD47, FLJ46061"	ENSG00000186994	"KN motif and ankyrin repeat domains 3"	Q6NY19	19	8322584-8343262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 196.2;Endothelial cells: 83.8;Hepatic stellate cells: 55.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 7.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"NK-cells: 1.2;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.1;TIME: 14.8;U-266/70: 5.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"olfactory bulb: 16.2"	HPA051153	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA051153: AB_2681365"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-4)"	"unprognostic (1.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.77e-1)"	"prognostic favorable (1.69e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.24e-1)"	25.6	7.6	12.0	2.3	9.7	0.6	26.1	9.6	12.2	8.2	5.8	6.2	2.9	10.2	0.7	5.1	11.2	2.5	32.9	8.7	8.9	22.2	4.2	33.4	2.8	12.5	11.5	3.6	3.9	1.5	6.9	14.6	11.5	7.6	0.5	0.3	4.1	1.8	13.7	6.7	7.3	2.4	9.7	35.5	6.2	2.4	13.2	0.7	15.5	6.0	0.8	7.9	6.8	8.9	0.1	0.6	0.2	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.0	2.3	0.0	0.0	0.1	0.5	2.6	0.0	0.7	1.4	0.3	0.3	0.4	0.1	0.2	1.3	0.0	0.8	0.0	0.0	0.0	8.1	0.6	0.0	0.3	0.0	0.4	0.0	0.4	0.5	0.5	0.2	1.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.5	0.0	14.8	0.0	1.3	0.3	0.1	5.9	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	1.0	0.0	0.5	0.1	0.5	0.1	0.0	0.1	0.2	0.4	0.2	1.2	0.0	0.0	0.4	0.2	12.0	9.7	9.6	12.2	8.7	8.9	12.5	11.5	11.5	9.7	13.2	8.9	196.2	6.4	3.2	2.0	0.3	2.5	0.4	0.6	0.6	0.3	1.5	2.5	2.2	0.0	0.8	0.0	4.2	0.4	3.8	0.1	5.9	0.1	6.6	0.5	0.7	83.8	0.0	2.7	0.6	1.8	0.3	6.4	1.5	0.8	0.0	0.2	55.3	1.0	0.5	0.0	0.9	0.0	0.0	1.3	2.1	8.1	0.6	0.9	5.4	18.7	0.0	0.4	12.3	0.5	1.6	0.6	0.1	0.4	0.4	1.0	0.0	0.4	0.7	0.7	19.7	8.3	12.9	6.5	3.6	1.1	1.3	0.3	2.8	4.0	0.1	0.8
KATNAL1	MGC2599	ENSG00000102781	"Katanin catalytic subunit A1 like 1"	Q9BW62	13	30202630-30307551	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 144.3;Excitatory neurons: 80.6;Oligodendrocytes: 78.5;Spermatocytes: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 63.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046205			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA046205: AB_10965325"	"unprognostic (3.34e-1)"	"unprognostic (6.44e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.83e-3)"	8.7	3.8	7.0	5.0	8.8	6.5	4.7	7.5	8.9	9.7	0.0	8.7	1.4	9.3	2.7	5.8	4.8	3.8	17.9	8.0	8.1	4.0	3.9	4.9	6.5	7.2	6.4	4.2	1.9	2.2	2.9	3.0	7.0	4.5	4.1	7.9	2.2	5.9	5.1	2.6	2.8	15.0	7.5	3.3	2.8	20.8	8.4	9.2	3.0	6.6	7.1	5.0	5.2	11.8	11.7	9.6	16.5	8.8	12.3	26.0	0.4	47.5	15.2	24.9	19.4	1.9	11.6	18.8	5.5	63.7	31.3	3.2	11.8	12.2	37.5	16.3	4.4	13.4	11.2	4.4	6.5	6.7	8.7	10.1	6.0	28.0	6.8	23.3	26.4	10.2	7.3	8.1	30.8	2.4	15.2	6.1	7.1	0.2	6.1	16.8	19.4	1.9	8.8	0.8	6.8	14.3	12.6	2.6	9.0	13.6	4.1	4.1	24.2	21.8	32.7	12.1	19.3	4.2	8.2	25.8	8.7	6.5	32.1	1.5	0.7	2.9	4.4	0.4	2.1	1.9	3.4	4.4	1.9	4.5	0.8	1.8	0.2	7.7	0.9	5.5	5.8	1.2	7.0	8.8	7.5	8.9	8.0	8.1	7.2	6.4	7.0	7.5	8.4	11.8	12.9	9.6	1.8	30.3	7.2	5.9	3.9	4.7	6.2	10.2	4.0	5.6	41.4	2.8	2.3	5.5	27.1	0.4	6.6	0.3	3.9	6.5	144.3	10.3	26.5	9.3	10.2	16.4	80.6	1.5	0.8	12.3	1.5	3.6	10.1	10.3	7.9	10.6	2.9	21.9	34.5	1.0	0.0	2.8	8.9	50.7	9.0	5.9	17.8	21.5	21.9	9.6	13.4	29.1	78.5	5.7	0.0	5.3	6.4	1.9	0.3	8.4	14.7	18.7	6.6	11.9	13.7	59.0	24.6	5.2	5.7	0.3	9.8	19.2	0.7	1.7
KIR2DL4	"103AS, 15.212, CD158D"	ENSG00000189013	"Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4"	Q99706	19	54803535-54814517	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"lymphoid tissue: 4.5"	"Group enriched"	"Detected in some"	6	"dendritic cells: 23.6;NK-cells: 6.2;T-cells: 20.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	28	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 2.8"	"Not detected"	"Not detected"																"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.98e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-4)"	"unprognostic (2.23e-1)"	"unprognostic (5.95e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.92e-5)"	"unprognostic (5.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.53e-8)"	"unprognostic (6.47e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.10e-4)"	"unprognostic (3.59e-3)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.8	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.2	2.5	0.0	0.7	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.1	0.0
KLHL23	"FLJ37812, MGC22679, MGC2610"	ENSG00000213160	"Kelch like family member 23"	Q8NBE8	2	169694488-169776989	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 132.5;Cone photoreceptor cells: 89.6;Sertoli cells: 170.9;Smooth muscle cells: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047593			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Actin filaments"		"HPA047593: "	"unprognostic (4.77e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.87e-3)"	6.9	2.1	8.1	6.1	9.6	1.7	6.2	13.2	9.9	9.6	0.2	20.8	11.1	25.6	4.0	12.0	8.9	6.7	8.0	9.8	7.2	6.6	5.9	5.9	3.1	3.7	5.8	17.9	7.2	6.4	3.3	12.8	4.6	13.6	13.9	13.6	8.0	12.5	12.0	1.6	11.8	25.0	4.0	2.8	5.1	10.9	7.6	11.1	8.1	16.3	2.9	8.7	3.9	6.3	17.0	8.6	64.5	18.3	3.6	1.3	43.7	8.0	6.1	14.4	15.8	18.0	14.4	10.6	6.7	0.8	20.9	2.6	67.7	5.8	21.9	37.7	33.2	31.3	16.9	29.9	5.4	44.2	4.7	2.5	4.7	6.0	10.2	9.3	11.2	38.3	43.5	1.4	4.8	8.2	65.0	17.9	52.7	9.0	6.7	20.7	55.1	1.1	13.1	49.9	83.4	57.1	12.7	1.2	7.8	20.3	10.6	14.2	4.2	5.8	18.6	5.7	13.6	4.9	4.9	47.3	4.5	13.0	9.0	0.0	0.0	0.0	0.7	0.0	0.9	0.3	0.6	0.5	0.1	0.3	1.0	1.0	0.0	3.4	0.0	0.9	0.8	0.3	8.1	9.6	13.2	9.9	9.8	7.2	3.7	5.8	4.6	4.0	7.6	6.3	13.7	3.2	8.7	0.0	1.1	1.5	6.9	2.8	7.4	132.5	15.0	17.1	52.9	14.3	6.7	0.0	89.6	5.6	3.8	14.6	3.9	15.6	4.6	2.4	12.8	12.6	31.8	9.7	0.0	30.5	9.6	11.2	4.1	5.5	0.0	27.5	7.5	11.8	0.9	40.4	0.0	21.2	28.5	0.8	1.9	3.7	2.5	1.3	0.0	0.0	0.2	14.6	5.2	0.0	0.0	16.1	13.6	8.6	0.4	17.2	9.7	16.9	4.9	34.8	170.9	11.4	102.6	3.4	20.9	4.7	1.0	1.2	5.5	13.8	20.9	4.1
KLRC1	"CD159a, NKG2, NKG2-A, NKG2-B"	ENSG00000134545	"Killer cell lectin like receptor C1"	P26715	12	10442264-10454685	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.7"	"Group enriched"	"Detected in some"	8	"dendritic cells: 104.2;NK-cells: 254.3;T-cells: 100.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 229.2;NK-cell: 367.6"	"Group enriched"	"Detected in many"	46	"NK-cells: 367.6;T-cells: 229.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 5.6;Karpas-707: 1.9"									HPA058052			Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (8.17e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.58e-7)"	"unprognostic (3.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-3)"	0.7	0.5	0.8	2.2	0.8	5.3	2.0	0.6	1.4	0.7	0.4	1.8	1.4	3.1	1.5	1.4	0.9	2.0	0.7	1.0	1.6	0.3	1.8	3.3	3.1	1.4	1.4	0.7	0.8	0.3	0.3	2.2	1.0	0.7	2.0	1.2	1.2	0.4	0.4	1.0	2.6	0.9	1.2	6.7	4.3	0.9	1.8	1.1	0.7	0.0	2.5	1.0	0.6	2.0	0.2	0.8	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.4	0.8	0.0	0.6	0.1	0.0	0.2	1.6	0.1	0.3	1.4	0.5	0.4	0.2	1.0	5.6	0.0	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.0	0.4	0.3	0.6	1.9	0.4	0.0	0.1	1.4	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.4	0.0	0.1	1.7	0.1	0.0	1.3	0.2	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.4	0.0	1.9	0.3	0.2	229.2	0.3	29.1	0.6	0.1	40.1	0.3	0.2	0.3	33.2	6.4	367.6	0.6	0.4	0.1	28.6	0.8	0.8	0.6	1.4	1.0	1.6	1.4	1.4	1.0	1.2	1.8	2.0	1.2	0.0	0.6	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.9	1.3	0.5	1.5	0.0	0.0	0.0	0.1	104.2	0.8	0.0	0.1	1.3	0.3	0.4	0.4	1.8	11.2	0.2	0.0	0.0	0.6	3.1	0.4	0.0	0.0	3.9	0.9	0.1	1.7	0.1	2.8	0.0	4.0	0.4	0.4	0.6	2.0	5.4	0.0	1.4	0.0	254.3	1.0	0.0	0.0	1.2	1.2	17.6	0.1	0.6	0.6	0.0	2.0	0.0	0.1	0.8	1.1	0.6	0.5	0.1	0.1	100.2	0.0	0.5	0.4
KLRC2	"CD159c, NKG2-C"	ENSG00000205809	"Killer cell lectin like receptor C2"	P26717	12	10426854-10442300	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.4;lymphoid tissue: 5.8"	"Group enriched"	"Detected in some"	6	"dendritic cells: 111.5;Oligodendrocyte precursor cells: 32.6;T-cells: 49.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 24.6;NK-cell: 84.5"	"Group enriched"	"Detected in many"	103	"NK-cells: 84.5;T-cells: 24.6"	"Cell line enhanced"	"Detected in some"		"GAMG: 19.1;HEL: 5.8;HeLa: 17.5;HSkMC: 4.1"									HPA058052			Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (9.05e-4)"	"unprognostic (2.54e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-3)"	"unprognostic (1.55e-9)"	"unprognostic (8.10e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.31e-3)"	0.4	0.1	3.9	0.4	3.8	2.2	0.8	3.6	9.4	0.3	2.8	1.3	0.7	0.9	0.0	0.5	0.5	1.1	0.1	3.7	4.1	0.1	0.8	1.0	1.1	4.2	4.2	1.0	0.2	0.0	0.1	0.4	4.1	0.3	0.8	0.3	0.3	0.2	0.0	0.1	1.1	0.0	4.2	5.8	2.3	0.4	3.9	0.3	0.3	0.0	1.3	0.4	0.3	4.7	0.0	0.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	19.1	0.0	0.0	2.2	0.0	0.0	0.0	5.8	17.5	0.3	0.0	0.6	0.0	4.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.1	1.2	0.1	0.4	0.0	0.0	0.0	0.0	0.6	2.8	0.1	0.1	0.0	0.0	0.0	24.6	0.0	0.6	0.0	0.0	11.0	0.0	0.0	0.1	9.2	0.5	84.5	0.1	0.0	0.0	4.6	3.9	3.8	3.6	9.4	3.7	4.1	4.2	4.2	4.1	4.2	3.9	4.7	0.5	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	0.3	1.2	0.0	0.6	0.0	0.0	0.0	111.5	0.2	0.0	0.2	0.0	0.1	0.1	0.1	9.6	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.2	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	9.2	32.6	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	49.9	1.7	0.3	0.2
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412315-10420595	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;brain: 2.1;lymphoid tissue: 4.0"	"Group enriched"	"Detected in some"	4	"dendritic cells: 19.2;Oligodendrocyte precursor cells: 36.2;T-cells: 15.9"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 63.1"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 63.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.4;GAMG: 2.8;HEL: 1.3;HeLa: 7.0;HSkMC: 1.2;SuSa: 1.3;U-698: 1.9"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA039910: , HPA062570: AB_2684795"	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"		0.2	0.1	1.3	0.3	1.4	1.9	0.1	0.7	2.1	0.1	0.2	0.5	0.8	0.5	0.1	0.2	0.2	0.6	0.0	1.3	1.7	0.1	0.5	0.6	1.7	1.7	1.1	0.1	0.1	0.0	0.0	0.1	1.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	1.3	0.1	1.3	4.0	0.6	0.2	1.3	0.4	0.1	0.0	0.8	0.1	0.1	2.1	0.0	0.0	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.6	0.0	0.0	0.0	1.3	7.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	7.0	0.0	0.0	0.1	8.7	0.6	63.1	0.0	0.0	0.0	3.6	1.3	1.4	0.7	2.1	1.3	1.7	1.7	1.1	1.2	1.3	1.3	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.7	0.1	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	1.0	36.2	2.3	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.1
KLRD1	CD94	ENSG00000134539	"Killer cell lectin like receptor D1"	Q13241	12	10226058-10329608	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 740.2;NK-cells: 1316.2;T-cells: 324.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 512.6;memory CD8 T-cell: 217.7;naive CD8 T-cell: 218.7;NK-cell: 737.5"	"Group enriched"	"Detected in many"	68	"NK-cells: 737.5;T-cells: 512.6"	"Low cell line specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069688	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA069688: AB_2686170"	"unprognostic (3.75e-2)"	"unprognostic (2.15e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.53e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.37e-2)"	1.6	1.4	1.5	2.8	1.1	8.4	1.8	2.1	2.1	1.2	0.0	1.6	1.8	1.2	1.5	1.3	1.1	1.6	1.1	1.6	0.7	0.8	4.1	4.7	6.8	0.4	0.2	1.1	2.2	0.5	4.6	1.3	0.4	0.6	0.9	1.3	1.3	0.6	1.2	0.9	3.4	0.7	0.1	17.0	2.1	1.2	1.0	0.5	1.2	0.2	4.0	2.1	0.8	3.0	0.2	0.1	0.2	0.4	0.4	0.2	0.2	0.7	0.0	0.0	0.2	0.4	0.3	0.3	0.2	0.3	0.2	0.3	0.0	0.2	0.0	0.5	0.5	0.4	0.7	0.1	0.5	0.3	0.2	0.1	0.5	0.1	0.3	0.3	0.1	0.3	0.3	1.2	0.0	0.5	0.3	0.3	0.3	0.2	0.4	0.1	0.4	0.3	0.2	0.3	0.6	0.2	0.2	0.6	0.1	0.9	0.2	0.6	0.3	0.5	0.9	0.4	0.1	0.5	0.5	0.3	0.7	0.2	0.4	1.7	0.8	1.1	512.6	2.0	58.1	0.8	3.5	217.7	1.6	0.8	1.3	218.7	9.2	737.5	1.5	2.1	1.3	163.0	1.5	1.1	2.1	2.1	1.6	0.7	0.4	0.2	0.4	0.1	1.0	3.0	7.4	0.0	10.5	1.3	5.8	0.5	1.2	0.2	0.6	0.7	1.7	1.0	2.7	7.2	1.9	0.0	6.2	1.8	740.2	0.4	0.0	0.6	9.0	1.1	1.2	7.7	0.0	24.0	3.1	0.0	1.0	4.5	10.7	1.8	2.5	0.4	15.0	4.3	0.7	1.7	2.0	0.2	0.0	18.3	1.2	12.6	0.3	7.0	5.4	4.7	5.1	0.3	1316.2	1.5	1.8	0.0	0.0	0.7	91.0	1.3	0.2	1.1	1.5	1.0	0.0	2.2	1.7	1.9	3.5	0.3	0.6	0.8	324.9	0.0	0.3	1.4
KLRF1	"CLEC5C, NKp80"	ENSG00000150045	"Killer cell lectin like receptor F1"	Q9NZS2	12	9827481-9845007	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.8;lymphoid tissue: 18.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 302.0;NK-cells: 963.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in many"	7	"NK-cell: 664.4"	"Lineage enriched"	"Detected in all"	7	"NK-cells: 664.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.5;HAP1: 1.5;U-937: 4.4"									HPA054038			Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA054038: "	"unprognostic (2.96e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.95e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.43e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.89e-3)"	1.5	0.1	0.6	1.4	0.6	12.8	0.8	0.6	1.4	0.7	0.6	0.7	0.3	0.9	3.8	0.6	1.5	1.4	0.6	0.6	0.6	1.2	4.5	4.4	3.4	0.8	0.6	0.1	1.3	0.3	0.5	1.0	0.6	0.5	1.0	0.1	1.4	1.1	1.2	0.5	0.8	0.8	0.6	18.0	1.2	0.6	0.6	0.4	0.8	0.4	3.5	0.9	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.4	0.6	0.4	0.8	0.9	71.5	1.5	94.4	3.4	3.6	35.2	1.5	1.5	1.4	35.4	5.8	664.4	1.1	2.3	1.2	83.0	0.6	0.6	0.6	1.4	0.6	0.6	0.8	0.6	0.6	0.6	0.6	0.6	3.2	0.0	2.2	0.0	2.3	1.5	1.1	0.2	0.6	0.0	1.3	0.1	0.3	5.7	1.3	0.0	0.0	0.9	302.0	0.1	9.8	0.5	0.5	0.5	0.5	2.2	0.0	24.0	0.1	0.2	0.7	1.2	0.0	1.0	1.3	0.1	8.9	1.8	1.4	0.0	0.2	0.1	0.0	9.1	6.6	1.1	0.0	2.1	12.4	2.8	3.9	0.4	963.0	0.0	0.3	0.4	0.0	0.0	12.7	0.9	0.0	0.8	0.2	0.0	0.0	0.1	0.2	0.2	2.0	0.2	1.1	0.5	80.6	0.0	0.3	3.1
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.1;lymphoid tissue: 42.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.2;NK-cells: 6.2;Plasma cells: 4.5;T-cells: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	40	"gdT-cell: 287.4;MAIT T-cell: 111.5;memory CD8 T-cell: 261.2;naive CD8 T-cell: 258.8;NK-cell: 335.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 335.8;T-cells: 287.4"	"Cell line enriched"	"Detected in some"	9	"U-698: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"		NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB021896: , HPA068877: AB_2686052"	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"	5.5	2.1	1.7	12.6	1.9	22.1	4.1	1.7	2.8	2.2	1.2	3.9	4.7	2.5	2.3	2.2	2.8	7.3	1.8	1.7	2.0	2.0	5.5	12.1	37.0	2.0	1.7	2.4	1.1	0.5	1.1	1.4	1.8	2.5	4.5	0.4	4.4	0.9	0.8	1.3	12.2	1.8	1.7	42.9	7.2	2.5	1.7	9.9	3.6	1.5	19.0	4.5	3.2	2.4	0.3	0.0	0.7	2.8	0.2	7.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.2	0.2	0.0	0.7	1.4	0.0	0.3	0.0	0.4	0.2	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.8	0.3	0.1	0.1	0.0	2.0	0.2	0.3	0.1	0.1	0.8	0.0	0.0	0.0	0.0	64.2	0.2	0.0	0.3	0.4	0.5	0.2	287.4	0.6	111.5	6.2	1.7	261.2	0.6	6.1	2.3	258.8	4.8	335.8	1.3	1.9	0.7	127.9	1.7	1.9	1.7	2.8	1.7	2.0	2.0	1.7	1.8	1.7	1.7	2.4	0.0	0.0	1.3	0.0	2.4	0.0	0.1	0.2	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.5	1.8	0.0	0.5	0.0	6.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	22.2	1.0	0.0	0.0
L3HYPDH	"C14orf149, FLJ25436"	ENSG00000126790	"Trans-L-3-hydroxyproline dehydratase"	Q96EM0	14	59460363-59484408	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056694	Approved		Uncertain	Vesicles		NA	NA		49000	"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA056694: AB_2683210"	"unprognostic (3.39e-2)"	"unprognostic (5.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.14e-1)"	18.1	14.0	4.8	12.5	5.2	4.8	16.3	9.9	6.6	15.9	10.0	10.6	11.0	16.0	8.5	9.2	15.4	11.5	14.8	5.0	5.8	17.4	17.3	11.2	17.5	7.9	5.8	18.0	12.6	12.2	14.8	10.4	7.4	13.5	10.2	5.2	13.0	11.9	8.9	9.7	13.8	11.9	5.6	13.0	10.5	17.1	4.8	4.3	16.6	5.6	13.7	13.4	14.5	8.3	12.0	31.8	6.8	16.2	14.4	37.6	9.5	31.7	25.1	17.9	17.4	6.4	21.1	4.1	13.0	17.7	31.8	31.8	11.1	17.0	17.7	7.0	14.4	11.0	30.1	23.7	16.2	10.0	7.6	27.3	11.4	18.0	27.6	27.8	22.3	11.3	14.8	18.4	18.8	14.3	3.8	16.4	10.9	4.7	28.5	5.5	11.1	16.6	28.7	6.8	6.9	9.9	29.8	12.2	11.9	5.6	12.8	6.4	31.3	20.9	25.6	16.4	37.5	4.7	2.3	4.0	35.9	8.3	41.7	0.0	3.5	0.5	3.2	5.1	2.4	1.5	1.7	2.0	5.7	1.4	2.5	0.9	0.0	5.6	2.4	3.2	0.8	1.8	4.8	5.2	9.9	6.6	5.0	5.8	7.9	5.8	7.4	5.6	4.8	8.3	11.2	3.2	6.1	11.1	10.9	5.2	5.4	4.2	6.2	2.9	5.6	8.6	8.7	5.7	4.3	3.7	2.1	13.7	3.5	1.0	7.9	7.7	12.2	6.8	17.5	8.1	3.0	5.5	26.7	2.5	11.4	16.0	4.6	2.3	14.0	6.5	11.0	16.8	8.3	1.7	18.9	4.3	4.1	4.6	2.9	7.4	19.3	4.9	3.6	10.3	3.5	4.6	4.1	10.6	17.1	4.4	1.0	12.0	5.5	6.6	3.4	47.0	17.3	2.7	13.1	17.4	11.6	14.1	5.7	7.5	3.4	4.9	6.0	11.9	3.5	2.0
L3MBTL1	"dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3"	ENSG00000185513	"L3MBTL histone methyl-lysine binding protein 1"	Q9Y468	20	43489442-43550954	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.4;Oligodendrocyte precursor cells: 31.2;Oligodendrocytes: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SuSa: 5.1"									HPA059648			Supported	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA059648: "	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.65e-4)"	"unprognostic (6.02e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-4)"	2.7	4.8	8.6	0.8	8.5	0.8	3.9	6.4	10.2	6.4	6.1	6.1	1.1	5.0	2.0	4.2	6.9	0.6	3.9	8.0	9.4	5.9	2.0	3.0	0.8	8.0	8.8	7.5	3.3	1.1	16.7	0.6	8.7	6.4	0.7	3.4	4.6	1.7	5.1	3.9	4.8	0.8	6.1	5.5	3.9	10.1	10.8	0.8	6.9	1.1	0.5	4.8	6.4	7.6	0.1	0.1	1.6	0.9	0.1	0.0	2.6	0.2	0.3	0.5	0.4	0.2	1.7	0.9	0.4	0.9	0.5	1.1	0.0	0.4	0.3	0.0	1.1	0.3	1.4	2.1	0.3	0.0	0.3	0.3	0.6	0.1	0.0	2.9	0.3	0.9	0.6	0.2	0.1	0.3	0.4	1.2	1.0	0.7	1.4	0.6	0.2	0.5	1.2	0.4	0.4	1.3	0.5	0.5	0.1	5.1	0.6	1.7	0.6	0.2	1.1	0.0	0.4	1.0	0.4	0.3	1.5	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.2	8.6	8.5	6.4	10.2	8.0	9.4	8.0	8.8	8.7	6.1	10.8	7.6	1.2	3.2	3.2	16.0	3.3	0.9	2.0	1.9	8.0	17.2	2.7	2.8	1.9	1.5	4.2	5.5	14.6	2.1	5.2	0.9	1.9	1.3	2.0	2.4	2.6	2.2	1.2	1.7	12.4	0.2	3.3	1.9	2.0	1.8	5.1	8.3	1.8	0.6	1.4	6.7	24.4	2.1	4.1	1.6	1.8	2.8	5.0	2.0	3.6	4.7	1.0	4.7	4.1	31.2	25.4	0.8	1.9	6.0	1.7	2.5	3.1	0.7	6.6	10.8	0.0	4.2	2.8	13.9	12.3	1.5	1.1	1.9	2.3	4.6	1.8	1.4
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388561-45554726	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 35.4;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	3.3	4.7	9.5	3.4	10.3	2.4	3.9	10.1	11.7	3.7	9.2	6.9	3.9	4.6	4.3	4.2	4.5	3.0	5.5	9.3	10.5	7.5	8.1	2.9	4.3	9.5	10.2	3.8	2.4	12.3	3.7	4.2	9.5	4.3	6.9	4.2	3.6	4.2	6.2	3.6	2.9	4.4	9.2	3.2	3.6	2.2	11.5	6.9	4.5	6.4	4.8	5.0	3.7	8.5	6.3	11.2	10.7	9.3	11.8	13.0	11.1	11.6	15.7	24.7	16.2	20.3	8.8	13.8	8.9	18.0	18.2	5.8	49.0	30.4	16.0	9.5	12.7	12.9	13.6	18.4	12.1	20.9	4.4	19.0	16.8	26.0	12.5	13.1	14.9	19.5	25.1	5.5	19.0	9.7	21.1	11.6	28.4	15.0	21.9	8.9	9.8	16.9	23.6	18.8	7.6	9.7	17.3	7.9	11.8	13.5	14.6	14.7	9.1	12.1	8.3	8.5	12.3	5.3	12.3	15.4	14.0	16.9	9.5	0.0	0.6	0.6	1.2	0.9	1.5	1.0	0.7	1.1	1.2	0.5	0.8	1.0	0.3	1.9	0.8	1.0	0.6	0.7	9.5	10.3	10.1	11.7	9.3	10.5	9.5	10.2	9.5	9.2	11.5	8.5	3.9	0.0	2.0	28.7	4.8	1.1	1.5	1.8	3.4	5.5	3.2	2.8	9.0	1.5	1.8	5.5	4.2	5.0	3.5	4.4	5.9	2.9	0.6	7.6	5.7	4.2	4.8	5.2	35.4	2.7	5.2	3.2	6.6	4.9	1.3	9.8	2.2	7.7	5.4	1.7	37.8	4.5	0.0	2.9	1.3	1.2	1.2	2.6	1.8	19.7	2.3	4.0	2.1	22.6	25.2	3.2	7.0	2.2	5.0	1.9	2.6	2.4	2.9	4.7	0.0	3.1	2.9	0.7	2.4	4.8	1.3	2.9	3.2	8.3	6.8	1.7
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1 regulator of NFKB signaling"	O95751	X	141111605-141177129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 123.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 43.0;Proximal tubular cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 24.7;MCF7: 31.9;PC-3: 34.3;U-251 MG: 21.9"	"Region enriched"	"Detected in many"	5	"cerebellum: 19.2"					"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA051768: AB_2681599, HPA061842: AB_2684624"	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	32.3	34.0	4.7	0.9	5.5	0.1	28.0	2.9	8.5	45.8	0.2	18.8	0.9	53.9	1.8	21.4	48.5	1.6	15.1	6.2	5.8	33.2	4.8	19.6	0.8	5.3	5.0	46.8	19.3	10.5	123.3	0.0	5.0	34.3	0.3	3.4	55.1	5.9	5.5	31.5	12.5	2.0	1.2	14.2	18.4	10.8	5.0	0.9	53.7	0.4	0.7	33.1	30.6	6.0	0.0	24.7	3.0	8.4	5.0	6.2	0.0	5.0	5.8	6.3	8.8	0.0	8.0	0.0	4.2	7.7	6.1	10.4	3.4	7.1	4.5	0.0	6.6	0.0	11.7	0.0	2.0	0.0	1.9	10.9	3.6	5.5	2.9	5.1	5.7	0.0	0.1	0.0	5.7	31.9	0.0	0.0	3.3	0.0	34.3	0.0	2.7	0.0	7.7	4.7	0.0	3.2	0.0	4.0	0.0	1.6	5.1	0.0	11.9	0.0	6.8	0.0	21.9	0.0	0.0	0.0	3.5	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.8	0.9	2.5	0.8	0.2	2.1	2.2	1.4	0.0	6.4	0.0	1.4	2.6	1.0	4.7	5.5	2.9	8.5	6.2	5.8	5.3	5.0	5.0	1.2	5.0	6.0	8.6	0.0	5.3	4.2	4.9	6.0	16.8	4.6	16.5	29.3	23.8	20.2	2.2	30.0	8.2	23.9	8.4	2.8	5.7	0.1	43.0	13.8	0.7	7.8	13.5	12.8	5.4	0.8	9.4	14.0	1.8	16.1	3.6	6.0	2.5	8.8	12.8	0.1	0.9	20.2	9.9	0.4	8.2	0.3	1.8	1.1	22.1	1.0	3.6	7.5	0.3	21.2	5.2	7.1	15.0	13.7	0.2	38.7	0.9	11.9	0.0	43.8	4.6	13.0	13.1	15.3	26.2	0.9	7.6	16.7	6.8	1.5	5.2	13.5	0.3	15.0
LGALS9B		ENSG00000170298	"Galectin 9B"	Q3B8N2	17	20449395-20467539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 15.4;intestine: 11.1;stomach 1: 30.9"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 17.7;Gastric mucus-secreting cells: 109.1;Intestinal goblet cells: 32.6;NK-cells: 28.8;Paneth cells: 42.3"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	17	"NK-cell: 12.7"	"Lineage enriched"	"Detected in single"	17	"NK-cells: 12.7"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 8.5;U-937: 2.8"									"HPA046876, HPA047218"	Approved		Uncertain	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.05e-1)"	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	1.6	0.0	8.2	3.3	0.0	0.0	15.4	0.0	7.4	0.0	0.1	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	11.1	0.0	2.2	0.0	0.0	0.6	3.4	0.3	0.0	0.6	30.9	0.1	0.0	0.0	0.0	0.0	1.7	0.0	4.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.3	0.1	12.7	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	2.3	0.3	1.1	0.6	0.0	0.0	0.0	0.1	1.5	2.2	0.0	0.0	0.0	9.9	17.7	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	109.1	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.6	2.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	28.8	0.0	0.0	0.6	42.3	0.0	1.2	0.2	7.7	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	2.1	0.0	6.6	0.3
LGALS9C		ENSG00000171916	"Galectin 9C"	Q6DKI2	17	18476737-18494945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.3;intestine: 9.3;stomach 1: 11.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 48.1;Gastric mucus-secreting cells: 194.2;Intestinal goblet cells: 37.9;Paneth cells: 58.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"neutrophil: 1.9;NK-cell: 5.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;NK-cells: 5.5"	"Not detected"	"Not detected"											"HPA046876, HPA047218"	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.47e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.17e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.84e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	9.3	1.1	0.0	0.0	10.3	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.7	0.0	1.6	0.0	0.0	0.2	4.3	0.0	0.0	1.4	11.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.4	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	1.9	5.5	0.6	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.6	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.1	3.4	48.1	0.0	0.2	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0	0.0	0.0	194.2	0.1	0.0	0.0	0.4	0.1	0.7	0.0	0.0	37.9	4.1	2.2	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.0	9.2	0.0	0.0	0.4	58.4	0.0	0.2	0.0	13.5	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.1	4.5	0.1	0.0	1.8	0.0	10.8	0.2
LRRC37B		ENSG00000185158	"Leucine rich repeat containing 37B"	Q96QE4	17	32007872-32053504	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 101.9;Excitatory neurons: 45.4;Spermatocytes: 66.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.5;NK-cells: 3.8;T-cells: 2.6"	"Low cell line specificity"	"Detected in all"											HPA015135	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA015135: AB_1853309"	"unprognostic (5.46e-3)"	"unprognostic (2.56e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.60e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.72e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.72e-3)"	"unprognostic (6.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-3)"	4.7	3.7	7.5	3.7	6.6	25.1	5.2	13.7	10.3	6.9	0.9	4.9	3.4	6.2	4.7	4.2	6.8	3.6	2.6	8.0	4.2	3.6	2.1	5.6	4.6	4.8	3.4	9.1	3.2	5.7	8.3	3.5	5.2	4.7	4.6	6.9	4.7	2.8	3.5	10.5	5.0	5.2	2.2	6.2	5.0	17.9	5.1	10.9	4.1	1.4	4.5	4.6	5.9	7.1	2.7	5.0	15.6	8.9	3.9	4.7	4.8	2.4	9.0	6.9	8.7	6.8	2.6	7.1	5.0	5.5	8.5	3.6	9.3	1.9	5.4	2.2	7.6	3.4	8.1	2.6	5.8	13.3	5.8	5.1	5.9	6.3	15.9	6.6	5.9	12.1	8.2	6.8	2.6	2.5	23.4	20.5	4.8	2.5	3.3	16.2	3.7	5.9	3.9	6.6	2.9	5.0	6.1	3.8	8.8	5.2	10.4	20.9	5.0	4.8	3.2	10.8	6.1	6.8	10.4	7.5	3.4	13.2	3.4	0.0	0.2	1.5	0.5	0.2	1.0	0.1	1.0	1.4	0.4	0.4	1.4	0.4	0.5	3.8	0.1	0.6	2.6	0.3	7.5	6.6	13.7	10.3	8.0	4.2	4.8	3.4	5.2	2.2	5.1	7.1	7.4	6.4	9.1	39.2	5.1	4.1	6.9	3.8	2.8	10.0	7.3	5.6	4.7	7.2	7.1	1.8	0.0	2.3	10.0	2.9	9.8	8.9	101.9	7.9	6.3	6.0	1.8	7.4	45.4	10.5	2.3	6.0	1.5	4.7	3.8	7.0	8.2	2.9	9.7	3.3	33.4	5.7	4.1	8.7	6.9	22.9	6.8	7.9	8.8	14.0	9.3	14.5	20.6	39.7	28.3	9.2	1.8	7.2	3.8	9.1	6.8	8.3	7.8	9.7	0.0	8.9	7.8	66.7	13.0	1.6	5.1	2.2	9.0	4.6	4.8	7.7
MAB21L4	"C2orf54, FLJ22671"	ENSG00000172478	"Mab-21 like 4"	Q08AI8	2	240886048-240896889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 262.6;vagina: 80.4"	"Cell type enriched"	"Detected in single"	7	"Cytotrophoblasts: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 45.9;HaCaT: 34.3;SK-BR-3: 117.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052722			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA052722: "	"unprognostic (5.86e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.77e-4)"		"unprognostic (1.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.05e-1)"	0.2	0.1	0.3	1.0	0.5	0.0	1.8	0.5	1.3	36.0	0.0	2.9	11.5	0.2	0.1	262.6	0.9	0.5	0.1	0.8	0.0	13.3	13.0	10.0	0.3	0.3	0.0	0.1	1.2	0.0	0.2	0.8	0.5	1.5	2.5	0.3	29.2	0.2	0.3	60.8	4.9	0.1	0.0	0.2	5.8	0.2	0.2	1.1	0.1	0.0	23.5	2.0	80.4	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	45.9	2.7	0.3	0.3	0.0	0.0	34.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	5.7	0.1	0.1	0.2	7.3	0.0	0.1	0.0	11.4	0.3	5.9	2.3	0.0	0.0	117.0	0.0	0.2	0.9	0.7	0.0	0.0	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.3	0.8	0.0	0.3	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MARS2	"mtMetRS, SPAX3"	ENSG00000247626	"Methionyl-tRNA synthetase 2, mitochondrial"	Q96GW9	2	197705369-197708395	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 17.1;Suprabasal keratinocytes: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035589, HPA035590"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 28: Keratinocytes - Keratinization"			"HPA035589: AB_10601870, HPA035590: AB_2674693"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (3.50e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-3)"	"prognostic favorable (6.14e-5)"	"unprognostic (1.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.74e-2)"	3.0	4.7	1.8	4.7	2.9	3.6	4.1	3.0	3.0	1.8	1.4	5.4	4.7	1.9	1.4	4.9	2.3	2.2	4.1	2.1	2.5	4.0	5.7	2.0	6.5	2.7	2.7	1.6	5.3	4.1	0.9	2.5	3.2	2.0	5.0	1.7	3.1	1.7	4.8	3.2	3.7	2.5	2.5	4.5	3.3	1.9	2.7	3.2	3.1	6.0	6.6	4.2	2.2	4.1	6.9	8.2	7.7	13.0	7.2	3.5	14.5	5.2	4.1	9.8	7.3	21.1	6.3	43.4	7.6	3.0	5.2	12.8	27.2	11.2	10.3	11.8	15.9	26.7	9.7	18.7	6.8	39.7	12.3	3.7	14.0	6.6	11.3	2.6	6.5	12.6	31.7	15.1	5.6	11.7	20.3	18.7	13.3	16.1	20.6	20.7	8.1	30.7	11.8	12.2	13.6	6.5	6.5	17.5	11.9	10.0	7.5	13.8	5.2	8.0	6.3	6.1	15.4	10.0	8.0	35.7	6.0	23.8	7.5	0.0	2.5	0.7	4.3	4.0	5.0	2.7	3.5	3.9	4.0	3.0	5.6	6.3	0.1	8.6	1.9	2.8	6.6	3.6	1.8	2.9	3.0	3.0	2.1	2.5	2.7	2.7	3.2	2.5	2.7	4.1	0.7	0.0	1.1	0.7	5.3	17.1	6.2	2.6	9.1	1.7	3.3	1.4	1.9	0.0	1.8	3.7	0.0	1.8	2.1	3.7	5.9	2.1	2.8	0.6	1.7	2.2	0.0	7.2	1.7	1.8	1.3	1.6	3.1	0.9	4.5	1.5	1.1	7.7	2.6	0.0	1.7	1.6	0.0	2.2	4.2	0.8	1.5	0.8	5.4	2.8	1.7	1.6	0.0	1.5	2.0	1.2	2.4	0.4	2.1	3.1	1.1	4.4	1.3	2.3	0.0	2.5	3.1	3.5	2.7	7.3	18.9	0.8	3.9	4.1	5.4	4.8
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.5;brain: 41.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 177.0;Hofbauer cells: 57.4;NK-cells: 422.2;T-cells: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 76.8"	"Group enriched"	"Detected in many"	57	"NK-cells: 76.8;T-cells: 46.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 108.3;HMC-1: 30.9;K-562: 48.9;MCF7: 34.4;NB-4: 74.8;SCLC-21H: 30.9;THP-1: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favorable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"	4.7	1.3	18.3	6.6	21.3	20.5	2.5	2.9	41.9	1.1	1.6	2.1	6.6	0.9	0.1	2.1	4.0	4.4	1.4	25.9	8.7	2.4	3.2	9.9	9.4	10.4	11.0	0.7	1.2	0.7	2.7	1.0	8.8	1.3	1.1	2.2	3.2	0.7	0.8	1.9	6.2	0.8	4.7	16.5	4.0	3.1	14.1	3.8	1.6	0.2	4.0	1.6	1.1	23.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.2	1.7	0.0	1.0	10.6	13.8	0.4	0.0	0.0	18.1	12.0	1.5	2.9	0.0	108.3	30.9	0.1	0.0	0.2	0.1	0.0	0.0	1.2	48.9	0.1	0.0	34.4	0.3	74.8	8.4	9.0	0.3	0.0	0.1	0.0	0.0	0.0	30.9	0.1	0.1	0.1	0.1	0.9	0.0	27.4	3.3	0.0	0.6	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	46.2	0.0	31.3	0.0	5.7	29.3	0.8	0.9	2.7	16.4	1.0	76.8	0.2	0.3	0.4	7.6	18.3	21.3	2.9	41.9	25.9	8.7	10.4	11.0	8.8	4.7	14.1	23.6	1.4	0.0	1.1	0.3	11.1	0.4	0.1	0.0	0.0	1.4	4.9	7.2	1.3	0.0	0.0	0.0	12.5	0.3	177.0	0.3	0.0	0.0	2.0	0.2	0.5	1.9	7.1	28.6	17.7	0.0	0.5	0.8	11.7	0.5	44.5	0.1	8.6	1.1	57.4	0.0	8.3	0.3	0.0	6.0	14.6	5.1	0.0	11.5	1.8	4.7	3.0	1.3	422.2	2.0	1.6	0.0	1.1	0.0	17.1	0.1	0.3	0.2	0.7	2.0	0.0	0.5	1.2	0.4	4.5	1.3	1.1	0.3	99.7	0.0	1.1	0.0
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Muscle protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	38	"heart muscle: 13154.5;skeletal muscle: 40709.4;tongue: 29085.2"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 5182.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.3"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 175.6"	"Low region specificity"	"Detected in many"							"CAB000060, HPA003123"	Enhanced					NA	NA	13500000	140000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	8.1	4.6	1.2	1.5	1.2	0.3	43.4	1.2	2.2	2.9	0.9	14.6	1.8	2.3	0.3	736.1	18.7	4.1	13154.5	1.0	1.9	2.8	5.8	14.9	5.3	1.4	1.4	5.3	26.9	16.1	10.6	3.1	1.2	214.2	12.9	0.2	367.1	0.5	40709.4	23.0	11.1	1.4	1.2	2.1	3.8	4.5	1.5	0.8	8.5	29085.2	1.8	1.3	4.5	1.0	1.9	7.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	4.6	0.7	0.1	0.3	1.0	0.8	0.2	0.0	0.0	5.4	0.3	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.5	0.5	0.0	19.2	0.1	0.6	0.0	1.9	2.3	0.9	0.5	8.0	0.0	6.4	1.5	0.2	19.0	175.6	0.0	0.3	39.4	0.1	0.4	0.5	1.2	2.2	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.2	1.2	1.2	2.2	1.0	1.9	1.4	1.4	1.2	1.2	1.5	1.0	0.3	0.0	0.0	0.3	0.1	0.3	4.3	12.5	0.0	0.0	30.7	23.9	5182.1	0.0	30.8	0.0	0.0	0.1	0.5	3.8	0.0	4.7	20.1	20.2	0.1	40.7	11.5	0.0	0.0	0.2	0.0	145.2	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.0	0.1	114.6	14.2	0.0	0.4	70.0	0.0	2.1	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.7	0.0	21.8	2.6	0.1	19.9	0.0	0.0	420.9	42.0	0.3	0.7	0.6	0.1	0.3	2.8	0.1	2.9	15.1
MCTS2P	"MCTS2, psiMCT-1"	ENSG00000101898	"MCTS family member 2, pseudogene"		20	31547412-31548081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA001045			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"		Cytosol	"Plasma membrane"	"HPA001045: "	"unprognostic (1.71e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.17e-3)"	"unprognostic (6.04e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-2)"	"unprognostic (3.90e-4)"	"unprognostic (6.59e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	0.9	0.6	0.2	1.6	0.3	1.5	2.2	0.7	1.3	1.0	0.3	1.6	1.0	1.0	0.5	1.3	1.4	0.6	0.6	0.3	0.4	1.0	0.7	0.8	1.8	0.2	0.5	2.5	0.7	1.7		1.5	0.4	1.2	1.1	1.4	0.8	0.9	0.6	0.6	0.5	1.4	0.1	0.8	1.3	1.3	0.4	2.3	1.6	0.7	2.7	2.1		0.4	8.8	0.0	7.6	7.2	2.2	5.4	0.0	3.2	5.1	10.3	4.3	0.2	4.1	13.3	0.1	4.4	3.8	11.1	0.1	15.0	12.4	0.2	10.1	20.2	2.4	2.3	3.1	17.4	10.7	3.8	7.2	4.1	7.4	3.3	4.2	8.0	9.7	4.6	3.8	3.2	16.0	2.8	0.2	23.1	7.9	8.4	25.4	4.7	3.4	1.0	10.9	10.4	3.4	9.1	3.0	5.6	4.9	7.2	5.5	5.2	11.4	4.0	8.2	3.4	4.7	10.0	6.2	11.9	6.5	0.0	0.3	0.1	0.3	0.2	0.7	0.4	0.4	0.5	0.8	0.5	0.7	0.6	0.0	0.8	0.1	0.4	0.1	0.3	0.2	0.3	0.7	1.3	0.3	0.4	0.2	0.5	0.4	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717447	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Focal adhesion sites"	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	11.3	7.0	2.7	8.6	3.2	13.0	10.9	4.1	5.2	12.4	3.3	11.0	4.9	13.7	8.5	6.2	12.3	4.6	9.5	2.4	4.1	8.2	9.7	9.5	10.2	4.5	3.3	16.8	10.8	8.6	12.8	7.4	3.5	10.1	6.9	14.1	9.1	8.2	11.0	9.4	10.9	8.9	2.0	11.3	8.4	28.2	3.4	14.5	16.4	5.8	11.3	10.7	9.3	3.6	36.7	11.1	47.4	34.8	6.3	10.0	23.0	14.8	10.0	25.2	21.3	22.7	8.5	37.7	17.5	17.0	23.5	20.2	63.0	28.6	34.9	29.9	65.6	43.4	28.7	12.5	4.1	27.1	16.9	7.9	9.2	48.6	27.3	9.0	11.5	25.7	61.0	36.7	19.1	14.7	14.6	20.0	20.6	8.4	7.8	33.2	24.7	37.4	11.0	10.7	39.9	23.2	11.5	26.2	13.5	29.1	21.8	16.8	13.8	24.8	26.4	19.2	26.3	19.3	21.6	34.5	7.8	63.9	34.3	0.1	0.1	0.1	0.6	0.1	0.3	0.4	0.4	0.5	0.1	0.7	0.5	0.5	0.0	3.2	0.1	0.7	0.0	0.3	2.7	3.2	4.1	5.2	2.4	4.1	4.5	3.3	3.5	2.0	3.4	3.6	9.7	16.0	13.0	10.1	13.4	4.5	5.5	5.6	15.9	11.5	6.8	8.6	7.6	7.2	5.7	5.5	8.4	7.9	11.0	2.5	3.9	5.3	4.7	8.0	8.7	9.7	6.7	14.5	8.3	6.2	11.4	11.2	4.1	13.7	17.1	12.8	6.1	12.0	6.7	5.0	8.1	3.3	12.2	6.0	5.7	3.9	7.8	7.3	1.8	11.2	5.9	10.6	14.4	12.5	9.9	5.2	1.1	6.0	16.9	2.9	1.2	3.0	8.0	17.1	13.1	16.2	8.3	74.5	18.0	8.7	3.7	1.9	12.1	7.7	6.0	1.9
MED23	"CRSP130, CRSP3, DRIP130, MRT18, Sur2"	ENSG00000112282	"Mediator complex subunit 23"	Q9ULK4	6	131573966-131628242	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 72.0;Inhibitory neurons: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070341			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA070341: AB_2686257"	"unprognostic (1.11e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.53e-2)"	7.7	10.5	3.4	11.5	3.7	22.0	14.3	9.8	5.0	12.0	3.7	10.6	11.4	13.3	10.6	8.5	11.0	8.9	6.5	3.5	3.6	10.3	7.9	9.9	14.8	2.4	2.8	14.2	10.7	18.3	6.0	11.0	3.1	11.7	12.4	11.5	12.7	11.6	7.4	11.5	10.6	10.4	2.7	12.8	11.6	10.5	3.5	18.0	14.4	10.1	15.3	10.1	7.8	6.4	7.2	7.8	18.2	23.0	22.1	16.8	16.7	17.6	19.8	16.0	23.0	8.2	9.8	15.9	12.5	18.2	15.4	12.6	9.9	11.4	24.7	18.1	13.8	16.6	14.9	14.0	16.0	27.8	27.1	14.9	13.3	17.7	17.8	18.6	20.1	16.9	21.7	16.2	17.0	11.0	21.3	17.4	8.7	12.3	7.8	18.9	11.4	9.6	12.2	10.4	13.6	12.3	12.6	17.4	11.6	20.9	4.8	19.3	20.4	11.8	13.3	19.0	16.2	17.0	12.3	22.6	14.5	12.6	16.1	4.9	4.5	7.6	5.5	4.6	8.3	4.7	5.5	6.2	5.6	4.2	5.5	5.1	3.6	12.9	3.3	2.9	6.6	3.9	3.4	3.7	9.8	5.0	3.5	3.6	2.4	2.8	3.1	2.7	3.5	6.4	16.3	19.2	9.6	24.8	21.5	9.2	6.3	11.9	13.6	23.7	15.5	10.9	6.5	8.6	15.7	23.9	16.7	8.7	23.7	15.5	3.9	7.6	2.1	14.8	14.7	13.9	14.4	12.0	72.0	7.7	6.8	12.5	14.3	16.6	14.0	18.3	14.3	12.4	8.1	11.8	67.1	17.4	6.1	17.6	9.5	3.2	14.3	12.8	5.4	36.5	16.9	7.7	21.6	42.3	60.8	9.1	14.9	10.1	19.4	10.7	14.7	8.5	13.4	24.4	13.1	13.8	10.2	13.5	5.3	12.0	8.7	7.8	20.7	14.6	14.3	12.8
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: AB_2681671"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	9.6	5.8	8.2	9.3	14.8	6.2	10.2	15.7	10.3	18.4	8.0	38.6	6.4	28.4	3.1	46.6	13.6	6.4	10.7	8.7	9.8	8.7	7.0	11.7	5.9	19.7	16.8	4.8	18.5	10.6	4.4	17.3	17.4	17.0	4.6	0.8	17.8	24.0	10.8	36.6	12.5	19.7	14.1	7.2	44.0	10.8	15.3	5.4	10.0	5.2	7.1	25.4	26.0	22.2	25.4	13.7	13.0	15.4	10.4	11.9	59.9	32.3	17.5	34.8	25.3	17.3	13.1	10.8	10.5	22.2	22.7	65.0	9.1	69.9	17.2	21.2	31.3	5.7	11.6	16.7	24.0	11.6	11.8	11.3	101.2	42.5	70.1	10.4	22.1	4.9	8.9	8.1	22.7	10.6	2.9	6.7	5.0	12.9	12.1	16.6	27.4	6.1	8.1	53.0	9.6	8.5	19.3	19.7	20.2	15.4	10.8	10.9	34.3	61.1	47.3	37.8	27.5	9.4	3.7	7.2	55.2	5.8	29.0	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.3	0.5	0.3	0.5	0.3	0.2	0.5	0.5	0.1	0.6	0.1	0.4	8.2	14.8	15.7	10.3	8.7	9.8	19.7	16.8	17.4	14.1	15.3	22.2	10.9	0.0	7.8	1.3	4.8	7.5	10.1	12.8	23.9	0.7	7.3	7.9	11.9	7.2	9.5	5.5	0.0	31.0	7.8	7.7	1.9	10.5	18.1	11.3	5.4	12.2	3.5	1.3	0.7	10.2	26.3	4.3	27.5	6.8	1.3	5.8	6.4	5.9	8.7	5.0	4.4	3.9	6.1	4.4	3.4	28.8	1.8	4.3	1.8	1.0	7.2	0.7	7.2	2.5	17.8	15.4	2.2	4.1	6.4	13.6	4.4	2.7	6.0	0.7	0.0	3.5	9.4	5.5	2.2	27.2	9.1	39.4	5.2	1.5	3.7	15.2
MLC1	"KIAA0027, LVM, MLC, VL"	ENSG00000100427	"Modulator of VRAC current 1"	Q15049	22	50059391-50085426	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 262.7;choroid plexus: 145.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 115.6"	"Cancer enriched"	"Detected in some"	69	"glioma: 122.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 20.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 228.2;NB-4: 219.8;THP-1: 401.5;U-266/70: 131.6;U-266/84: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003040	Enhanced		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA003040: AB_1079387"	"unprognostic (2.68e-2)"	"unprognostic (5.46e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.54e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-3)"	"unprognostic (8.39e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.92e-1)"	0.3	0.1	239.3	0.7	235.7	36.4	0.1	212.7	261.8	3.0	145.6	0.1	0.4	0.3	1.0	0.1	1.8	1.0	0.6	225.8	234.5	0.1	0.4	1.6	0.3	262.7	243.1	0.3	0.1	0.0	1.1	2.3	221.8	4.8	0.0	4.1	0.1	1.4	0.1	1.0	0.1	0.2	231.9	2.2	0.2	3.8	231.5	0.5	0.1	0.0	0.5	0.4	11.9	217.2	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	68.1	0.0	0.0	0.1	228.2	68.4	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.8	219.8	0.3	0.0	0.1	24.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	401.5	0.0	0.0	0.2	0.1	0.3	131.6	120.2	0.4	0.3	35.7	2.2	0.0	1.1	0.0	3.9	6.8	0.1	0.1	0.3	1.6	0.9	0.0	0.1	1.8	0.1	20.2	9.2	0.2	0.1	4.0	239.3	235.7	212.7	261.8	225.8	234.5	262.7	243.1	221.8	231.9	231.5	217.2	0.0	0.0	0.5	115.6	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.1	17.2	0.0	0.0	0.0	1.1	0.1	0.4	0.1	0.0	7.8	0.4	0.0	0.1	2.4	0.0	0.1	1.3	4.4	0.4	0.0	3.5	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.6	1.8	7.5	0.6	16.3	18.6	0.5	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.3	2.7	0.1	0.0	0.0
MMRN1	"ECM, EMILIN4, GPIa*, MMRN"	ENSG00000138722	"Multimerin 1"	Q13201	4	89879532-89954629	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 158.0;Hepatic stellate cells: 146.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"NK-cell: 6.3;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.2;NK-cells: 6.3"	"Cell line enriched"	"Detected in some"	13	"HUVEC TERT2: 1242.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035769	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		200000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA035769: AB_10696511"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.23e-2)"	22.6	3.8	0.8	10.9	0.8	1.8	27.3	0.8	1.1	28.5	1.4	9.9	5.4	15.0	2.8	14.5	23.1	21.1	3.6	0.6	0.9	1.1	8.7	16.1	14.0	1.4	1.4	4.9	3.4	0.5	0.7	40.1	1.2	3.8	14.9	0.5	2.7	4.6	1.1	8.2	13.5	16.8	1.1	0.6	5.2	12.7	1.5	3.7	23.1	6.6	7.6	19.6	9.8	1.1	0.0	0.0	94.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1242.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	6.3	0.0	2.2	0.2	1.2	0.8	0.8	0.8	1.1	0.6	0.9	1.4	1.4	1.2	1.1	1.5	1.1	15.4	0.0	12.0	0.3	2.3	4.2	0.1	0.0	0.0	0.0	0.7	0.1	2.2	0.0	0.6	0.0	0.0	0.0	3.9	0.0	1.9	0.0	17.7	0.3	0.7	158.0	0.0	25.9	0.2	0.0	0.0	1.9	0.0	0.4	2.5	0.1	146.3	2.4	0.6	0.0	0.1	0.0	0.0	5.7	5.9	7.7	0.3	9.1	1.8	21.5	0.7	0.8	2.1	0.0	0.4	0.0	0.0	0.0	5.0	0.4	0.0	0.0	1.5	0.4	0.0	0.3	0.9	15.4	0.0	0.8	4.5	0.0	1.6	0.0	0.0	0.1
MRPS6	"C21orf101, MRP-S6, RPMS6"	ENSG00000243927	"Mitochondrial ribosomal protein S6"	P82932	21	34073224-34143034	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 281.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 747.4;Prostatic glandular cells: 568.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007861, HPA008163, HPA049676"	Supported		Supported	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA007861: AB_2667920, HPA008163: AB_2667998, HPA049676: AB_2680846"	"unprognostic (2.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.16e-3)"	"unprognostic (4.01e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.06e-5)"	67.6	72.5	53.9	33.8	56.1	15.6	46.1	53.0	118.1	42.7	85.9	81.6	22.7	37.1	50.7	31.3	37.9	24.8	57.3	55.4	60.8	281.0	50.6	37.8	46.7	54.7	56.5	41.7	22.2	24.2	39.4	51.8	55.6	33.1	36.5	25.6	26.2	41.6	96.1	53.5	39.0	36.7	58.9	28.6	51.3	44.8	63.3	38.3	97.5	76.8	49.8	50.6	33.7	57.8	70.8	56.6	211.0	77.2	74.1	72.9	71.4	79.5	185.4	68.7	70.0	181.8	134.9	105.6	51.7	104.0	92.8	28.7	124.6	106.0	73.4	193.5	65.4	89.6	34.3	47.8	35.4	45.2	31.7	35.0	107.8	127.2	116.5	104.2	47.4	45.2	116.5	28.0	140.7	66.0	73.4	104.1	136.9	135.4	122.1	99.6	37.4	101.5	307.4	60.4	187.5	50.0	84.5	46.2	103.6	112.6	87.3	58.7	24.3	62.8	36.6	115.4	46.3	132.5	125.8	96.3	204.2	118.4	62.8	67.0	53.8	60.4	90.3	53.7	66.6	74.9	67.0	81.4	56.1	48.4	83.8	87.3	46.8	115.7	57.5	101.4	74.0	79.6	53.9	56.1	53.0	118.1	55.4	60.8	54.7	56.5	55.6	58.9	63.3	57.8	45.1	22.4	40.9	32.3	83.9	266.8	229.8	226.6	126.9	40.5	78.9	125.9	59.8	28.6	75.8	252.0	10.4	195.2	103.0	56.3	747.4	41.1	83.1	85.2	88.6	58.0	91.5	45.4	25.7	36.7	237.0	111.7	32.6	58.6	137.7	184.5	25.7	95.7	126.5	8.4	57.9	211.0	75.3	36.4	207.6	73.1	28.0	104.8	101.4	32.8	164.0	37.9	108.1	45.2	6.2	52.8	138.5	102.7	102.0	568.4	61.0	159.2	66.0	26.5	118.3	26.9	104.8	90.4	136.5	71.0	331.0	182.4	124.2	49.8	99.9	335.6
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47403067-47663146	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 46.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes		28000	"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	8.1	7.5	8.3	12.8	10.5	15.7	15.7	14.6	10.6	9.7	12.2	11.9	7.8	11.7	14.0	9.5	12.4	5.8	10.1	9.6	9.0	8.2	6.7	8.1	23.7	8.6	8.0	8.7	6.5	14.8	6.2	11.6	9.5	8.6	15.0	34.9	8.5	7.7	7.1	11.1	9.3	8.8	8.5	10.8	8.1	16.2	7.9	32.6	15.8	7.2	25.0	7.9	6.4	8.9	114.3	35.3	103.3	57.9	7.3	21.2	64.3	62.9	33.3	80.9	76.9	72.3	50.1	141.2	84.6	23.8	56.6	49.8	78.6	37.4	122.3	68.1	55.8	99.3	42.3	65.6	7.7	97.7	34.9	12.3	11.2	68.1	19.0	19.1	45.2	3.9	165.1	34.0	63.1	44.2	119.6	75.4	195.7	69.3	45.1	151.1	182.2	84.4	35.8	57.3	85.9	91.6	58.4	49.2	48.0	83.6	46.9	38.8	18.7	55.5	70.9	57.1	74.6	20.8	63.4	180.1	33.1	72.5	35.4	3.0	1.3	4.9	8.0	4.4	9.3	6.7	7.7	10.3	2.5	7.9	12.6	13.1	1.0	14.2	3.9	3.4	11.8	6.5	8.3	10.5	14.6	10.6	9.6	9.0	8.6	8.0	9.5	8.5	7.9	8.9	14.7	9.6	11.5	18.6	13.0	8.3	7.9	14.4	8.6	17.4	7.5	7.1	15.6	5.7	12.6	9.2	45.9	19.9	14.2	6.6	3.9	11.5	17.8	21.0	11.3	13.4	3.5	54.1	59.9	8.4	20.7	12.2	7.1	18.8	12.0	28.2	5.0	1.6	11.4	11.8	58.0	12.1	14.2	4.1	4.6	22.8	5.3	5.1	8.8	16.9	5.5	22.6	17.5	35.7	54.7	7.3	5.0	6.4	12.4	2.8	5.4	4.5	23.3	41.1	0.0	9.8	9.0	56.5	50.8	9.3	6.5	5.1	12.8	24.3	13.5	3.8
MYO19	"FLJ22865, MYOHD1"	ENSG00000278259	"Myosin XIX"	Q96H55	17	36495636-36543435	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021415, HPA059715"	Approved		Enhanced	Mitochondria,Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria	Cytosol	"HPA021415: AB_2266815, HPA059715: AB_2684111"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (8.33e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.17e-2)"	7.8	5.5	2.3	7.1	2.6	13.1	8.0	2.3	3.0	11.3	3.5	11.7	13.0	7.3	5.2	22.1	7.5	4.9	5.6	2.3	2.4	13.5	11.1	7.8	5.7	3.0	2.4	6.8	13.2	17.0	9.5	6.4	3.2	7.9	14.6	2.1	15.4	3.9	8.5	24.2	13.0	7.2	2.2	8.4	14.4	9.6	2.9	6.4	9.4	4.5	10.0	7.3	14.5	3.1	41.6	47.3	21.7	25.1	10.1	12.5	32.5	34.0	27.0	53.2	57.9	42.6	46.4	21.9	15.6	23.3	20.0	66.5	48.0	38.3	36.8	18.9	24.0	30.6	58.8	29.4	8.4	36.5	40.0	6.9	20.2	41.6	40.8	13.5	22.2	29.7	46.5	24.2	28.2	28.9	25.3	29.4	23.9	44.1	20.4	32.8	30.7	28.4	27.7	32.3	37.9	18.5	44.9	31.7	15.4	30.3	55.2	17.6	15.9	32.8	41.1	47.5	65.3	19.8	41.4	21.3	22.8	24.7	44.5	0.5	0.6	0.4	1.1	0.4	0.9	0.6	0.7	1.1	1.2	0.5	0.6	1.2	0.0	1.4	0.2	0.6	0.6	0.4	2.3	2.6	2.3	3.0	2.3	2.4	3.0	2.4	3.2	2.2	2.9	3.1	13.1	9.6	12.0	23.8	12.3	29.6	12.3	14.4	23.9	18.4	11.0	12.3	4.4	17.2	8.6	5.5	35.5	12.0	9.6	24.4	1.9	10.7	81.4	10.6	12.7	10.6	10.8	24.6	25.8	13.3	21.6	9.6	23.9	16.7	2.5	20.4	6.8	9.5	10.9	3.3	36.4	23.5	14.2	7.9	10.1	20.8	12.5	7.8	3.6	10.3	11.0	3.9	15.5	22.6	24.4	16.4	13.9	9.8	19.4	26.4	23.0	4.4	6.4	24.8	0.0	13.3	9.0	19.7	19.4	29.1	23.4	7.3	13.0	9.9	32.5	16.3
MZF1	"MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6"	ENSG00000099326	"Myeloid zinc finger 1"	P28698	19	58561931-58573575	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 46.0;HeLa: 41.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001757	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA001757: AB_1080718"	"unprognostic (8.25e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.16e-3)"	"unprognostic (7.15e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.62e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.83e-8)"	"unprognostic (1.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (4.09e-5)"	7.5	13.5	5.4	6.5	5.5	5.8	8.5	6.5	8.5	14.7	12.7	11.3	11.6	12.0	7.0	9.6	17.5	4.4	7.5	5.5	5.1	13.5	11.4	10.0	5.9	8.1	6.6	15.8	11.4	6.7	16.9	3.6	6.3	15.4	4.0	9.2	10.1	6.0	10.8	10.3	10.4	4.3	5.4	8.2	12.8	6.6	6.2	4.5	19.0	2.4	2.9	10.7	10.6	7.2	8.0	19.9	8.1	5.0	4.5	4.0	10.1	7.2	3.5	1.2	2.4	4.3	9.4	5.7	3.5	1.9	5.9	9.0	2.0	4.7	0.6	10.3	46.0	6.0	41.5	2.6	2.7	4.5	10.0	2.7	12.3	1.8	5.3	7.7	4.1	6.4	5.0	7.0	1.8	8.8	2.7	2.6	3.1	4.6	8.1	7.4	2.0	10.5	4.1	16.9	7.9	11.0	3.7	6.7	4.6	1.6	7.1	6.1	5.1	13.0	4.1	2.3	3.7	12.6	15.3	4.9	10.5	5.0	3.4	0.0	0.9	0.4	2.1	0.6	3.2	2.1	3.6	2.6	1.6	2.7	5.9	3.8	1.7	5.3	0.7	0.4	2.4	2.4	5.4	5.5	6.5	8.5	5.5	5.1	8.1	6.6	6.3	5.4	6.2	7.2	7.9	12.8	17.0	28.4	15.0	8.0	11.4	11.9	22.2	39.4	22.0	22.4	5.9	10.0	8.0	11.0	33.3	6.0	11.1	20.3	3.9	8.3	22.1	39.1	9.8	7.2	16.8	10.7	23.4	5.4	3.6	8.8	43.3	16.7	4.5	15.8	9.7	10.7	4.9	30.3	20.1	14.5	16.2	5.3	3.3	28.7	10.5	7.6	10.6	7.5	4.2	19.4	15.5	10.6	21.3	6.5	13.4	13.2	9.0	9.6	14.7	10.6	29.8	47.8	19.7	16.6	7.7	10.2	3.8	11.2	8.2	6.4	12.5	16.3	11.9	7.8
NCALD		ENSG00000104490	"Neurocalcin delta"	P61601	8	101686542-102124907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 100.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 251.6;Inhibitory neurons: 460.2;Oligodendrocyte precursor cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 87.3"	"Group enriched"	"Detected in many"	13	"NK-cells: 87.3;T-cells: 42.2"	"Cell line enhanced"	"Detected in many"		"AF22: 136.4;HDLM-2: 159.9;U-266/70: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043245	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA043245: AB_2678385"	"unprognostic (3.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.30e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.00e-2)"	21.4	7.3	30.3	9.4	43.4	1.8	44.0	0.0	62.5	13.5	0.0	22.3	6.0	7.6	4.4	12.6	39.6	12.6	12.1	52.4	11.3	14.9	15.1	19.7	13.6	3.6	13.3	37.5	10.0	1.9	13.7	10.0	15.3	12.3	8.8	15.9	100.6	14.9	15.4	18.0	10.2	11.0	1.2	8.3	11.2	7.3	29.4	5.5	5.2	11.6	11.1	11.1	4.0	21.6	6.9	9.8	136.4	0.5	1.1	22.3	0.0	2.3	0.3	0.1	0.0	0.1	0.1	9.0	3.0	10.4	0.6	0.0	1.0	0.0	0.0	159.9	1.0	0.7	0.0	0.0	0.0	6.1	0.9	4.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	19.3	0.8	0.2	1.2	2.4	1.5	0.0	0.0	3.7	0.0	0.4	22.0	0.3	0.6	13.4	0.0	3.1	5.7	22.5	0.9	4.8	0.2	1.6	0.3	0.2	0.4	39.3	5.6	0.1	0.3	0.1	2.2	0.4	0.3	0.3	42.2	0.2	37.1	0.9	16.0	24.8	5.0	0.6	3.9	20.6	1.3	87.3	0.3	0.4	17.5	13.6	30.3	43.4	0.0	62.5	52.4	11.3	3.6	13.3	15.3	1.2	29.4	21.6	17.3	0.0	2.6	11.8	0.5	4.2	0.5	1.0	0.0	14.6	88.6	74.4	7.5	14.3	3.2	0.0	25.0	3.2	28.9	1.7	7.9	9.6	12.8	32.2	5.0	11.3	21.0	4.0	251.6	1.2	13.0	39.8	4.1	23.8	2.5	20.5	14.6	15.0	1.9	13.5	460.2	4.3	61.1	2.6	6.9	6.6	2.8	2.8	103.2	75.9	0.8	46.6	64.9	281.0	26.5	3.5	0.5	1.5	7.1	1.3	0.0	19.5	26.0	4.7	26.3	91.0	24.5	1.5	1.8	3.0	3.1	3.0	17.4	19.4	0.4	1.1
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 290.1;heart muscle: 145.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 530.8;Excitatory neurons: 461.4;Inhibitory neurons: 441.2;Oligodendrocyte precursor cells: 939.0;Oligodendrocytes: 1013.5"	"Cancer enriched"	"Detected in many"	8	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"NK-cell: 53.7"	"Lineage enriched"	"Detected in many"	15	"NK-cells: 53.7"	"Cell line enhanced"	"Detected in many"		"HEL: 61.3;RH-30: 132.5;SCLC-21H: 107.4;SH-SY5Y: 52.7;U-138 MG: 72.8;WM-115: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA	1200000	2300000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Cytosol	"CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705"	"unprognostic (7.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (9.11e-6)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.82e-5)"	4.6	65.7	124.0	3.9	169.1	1.5	2.7	118.1	140.3	35.1	0.0	47.8	4.6	62.7	3.5	7.0	40.4	4.8	145.5	135.6	179.1	3.2	2.9	1.8	1.3	140.4	134.2	43.8	2.6	0.0	22.2	0.5	147.4	14.9	6.6	117.7	3.6	17.7	31.2	2.1	18.3	46.9	129.7	4.7	23.0	5.0	137.0	0.4	30.2	29.5	1.0	34.8	24.3	290.1	0.1	0.0	20.8	0.3	0.2	0.5	0.3	1.0	0.0	0.7	1.2	0.3	0.3	3.1	18.2	20.1	0.8	0.3	0.1	0.0	0.0	0.4	12.1	61.3	0.1	0.0	2.1	0.0	9.5	12.4	0.1	0.1	18.6	0.1	0.0	0.1	0.0	1.0	20.8	0.0	0.2	5.2	1.8	0.0	0.4	0.1	132.5	10.0	0.0	0.0	107.4	52.7	0.1	0.5	0.1	2.0	0.2	0.8	0.2	72.8	33.4	0.3	31.8	0.1	0.5	0.1	8.3	28.4	79.0	0.0	0.2	0.0	3.6	0.0	1.2	0.0	0.1	0.5	0.1	0.0	0.0	1.4	0.7	53.7	0.0	0.0	0.2	1.9	124.0	169.1	118.1	140.3	135.6	179.1	140.4	134.2	147.4	129.7	137.0	290.1	13.7	0.0	0.0	530.8	0.4	1.7	0.5	0.0	0.0	123.5	5.7	0.6	131.7	0.0	0.0	0.0	37.5	0.6	27.7	0.1	1.9	18.3	6.7	0.3	2.4	2.8	5.4	0.0	461.4	0.0	0.2	12.8	5.1	0.5	1.3	11.7	7.1	0.7	0.4	175.0	441.2	0.0	8.2	4.7	3.8	5.9	15.2	1.8	0.0	35.6	1.2	216.6	59.8	939.0	1013.5	1.3	0.0	10.1	5.6	0.4	0.0	0.2	0.7	98.0	0.0	107.5	4.8	1.0	2.8	0.4	1.7	0.1	13.4	5.6	0.0	0.2
NCR1	"CD335, LY94, NK-p46, NKP46"	ENSG00000189430	"Natural cytotoxicity triggering receptor 1"	O76036	19	54906148-54916140	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.5"	"Group enriched"	"Detected in some"	7	"dendritic cells: 30.2;NK-cells: 110.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Region enriched"	"Detected in single"	7	"cerebral cortex: 1.0"	"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049311			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"HPA049311: AB_2680707"	"unprognostic (3.92e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.87e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.32e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.05e-3)"	0.2	0.0	0.1	0.2	0.0	0.7	0.1	0.1	1.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	6.6	0.4	0.0	0.0	0.1	1.1	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.3	0.0	0.0	0.6	0.3	0.0	0.0	1.8	0.0	1.9	0.1	0.0	110.2	0.5	0.4	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.1
NEIL1	"FLJ22402, FPG1, hFPG1, NEI1"	ENSG00000140398	"Nei like DNA glycosylase 1"	Q96FI4	15	75346955-75357115	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 105.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.2;memory B-cell: 4.8;naive B-cell: 6.4;NK-cell: 15.8"	"Group enriched"	"Detected in many"	11	"B-cells: 6.4;NK-cells: 15.8;T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.5;HeLa: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054084	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA054084: AB_2682372"	"unprognostic (9.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.50e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.27e-3)"	8.0	14.6	2.0	3.1	3.1	4.3	11.6	6.2	5.0	14.7	2.0	9.3	5.8	10.0	1.7	7.3	12.9	3.9	5.8	2.2	1.7	8.8	12.8	8.3	6.1	1.4	0.4	13.3	10.9	3.3	11.0	2.5	0.7	12.4	1.1	2.6	16.6	4.1	9.0	8.9	8.3	1.9	0.0	8.8	10.5	3.7	1.1	2.7	10.7	0.6	3.0	8.2	10.9	2.2	2.2	3.6	2.3	1.4	0.7	0.8	4.5	1.3	0.0	0.5	0.1	0.6	4.0	11.5	2.1	0.2	1.1	6.1	1.4	0.4	0.0	5.7	9.1	2.0	11.8	1.7	0.9	2.1	2.6	0.3	1.7	0.6	0.0	5.6	1.4	1.1	1.4	3.3	0.3	2.9	0.4	6.3	2.1	0.4	0.8	2.1	1.5	0.5	2.1	2.4	1.4	2.8	2.2	1.0	3.2	1.2	4.2	3.5	6.3	1.3	2.3	1.8	1.2	5.2	5.5	9.7	1.1	9.4	1.2	0.0	0.6	0.0	5.2	0.3	1.3	4.8	0.9	1.2	0.2	6.4	1.4	1.4	0.8	15.8	0.2	0.3	0.3	1.4	2.0	3.1	6.2	5.0	2.2	1.7	1.4	0.4	0.7	0.0	1.1	2.2	15.9	22.4	19.2	19.9	33.7	6.4	15.4	10.1	23.3	20.0	22.1	15.9	2.9	10.0	21.9	14.7	10.4	10.8	19.1	13.6	1.9	9.0	20.4	31.8	7.3	16.9	21.6	8.0	33.5	8.3	3.6	7.7	22.4	15.4	11.4	105.6	24.3	11.5	3.4	10.1	29.9	20.0	10.2	5.7	7.0	2.6	19.0	3.3	8.8	8.4	1.7	14.6	55.6	5.5	4.5	7.3	16.0	13.5	9.1	9.2	21.4	8.9	41.9	6.5	6.6	6.6	6.4	1.6	1.5	11.0	5.8	4.8	10.0	2.0	14.5	8.7
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309874-177362936	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.6;lymphoid tissue: 23.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 14.7;Granulosa cells: 4.8;Plasma cells: 6.1;Squamous epithelial cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 72.1;HL-60: 79.1;Karpas-707: 99.1;MOLT-4: 80.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.3"	HPA065761			Enhanced	Nucleoplasm		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA065761: AB_2685555"	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.1	0.0	0.0	1.7	0.0	6.6	0.3	0.0	0.1	0.2	0.0	1.1	1.1	0.1	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	2.3	1.3	0.5	0.0	0.4	0.6	1.5	0.1	23.6	0.0	0.0	3.5	0.4	0.4	0.0	19.3	15.8	16.4	8.2	1.8	3.3	8.0	23.4	8.6	25.3	14.9	5.8	16.5	21.2	3.4	6.2	25.1	8.8	17.4	9.3	36.6	72.1	11.4	14.7	11.9	15.2	0.5	79.1	9.7	0.3	0.5	26.2	5.6	5.2	9.9	53.9	15.3	99.1	16.7	8.4	80.7	30.2	7.5	5.7	11.5	16.2	11.2	6.8	6.8	2.6	12.8	8.9	11.7	13.4	6.3	7.2	10.9	20.4	4.7	15.2	11.8	7.8	24.0	6.8	4.8	33.5	10.1	27.8	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.1	0.4	1.2	0.0	0.2	0.1	0.4	0.0	1.3	0.0	0.0	2.6	1.6	0.5	0.0	0.0	0.1	0.1	0.6	0.3	0.0	14.7	0.1	0.2	3.3	0.9	0.0	0.5	0.0	4.8	0.4	0.0	1.5	0.0	0.1	1.0	0.0	1.3	0.4	0.2	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	6.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.5	2.7	2.4	4.5	1.3	0.3	1.0	0.5	1.2	0.2
NFILZ	LINC01862	ENSG00000268480	"NFIL3 like basic leucine zipper"	A0A5F9ZHS7	19	8630635-8677708	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	20	"NK-cell: 17.5"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 17.5"	"Group enriched"	"Detected in some"	81	"HMC-1: 9.4;NB-4: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 3: HMC-1 - Innate immune response"																						0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.1	0.0	0.0	0.1	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	17.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NLRP2	"CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2"	ENSG00000022556	"NLR family pyrin domain containing 2"	Q9NX02	19	54953130-55001142	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 45.2;Extravillous trophoblasts: 216.1;Syncytiotrophoblasts: 97.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 78.1"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 42.2;BEWO: 177.9;OE19: 79.7;SuSa: 80.3;T-47d: 46.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021183			Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Vesicles, Cytosol"		"HPA021183: AB_2670615"	"unprognostic (1.66e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.60e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.57e-2)"	0.4	0.3	0.9	2.7	0.6	1.0	1.0	0.0	0.8	2.6	0.1	1.7	1.8	1.1	1.8	7.9	1.9	0.9	0.4	0.7	0.1	1.9	0.4	1.6	2.1	0.1	0.2	0.3	1.6	0.4	1.2	7.1	0.1	1.5	1.9	3.1	2.4	1.1	0.6	3.0	1.7	0.8	0.0	2.1	2.5	7.2	0.3	3.4	4.4	0.0	1.9	7.1	4.3	0.2	20.4	42.2	15.8	0.4	0.2	0.1	177.9	0.1	0.0	0.6	0.2	35.9	0.7	14.7	0.1	0.1	0.1	8.1	0.0	24.4	0.3	1.7	0.2	9.8	0.5	0.1	0.4	0.1	0.4	0.2	0.3	0.0	0.1	0.1	0.9	0.0	32.7	0.2	0.0	0.3	0.1	1.3	5.0	79.7	0.0	8.8	0.0	24.0	26.4	0.7	5.3	0.7	0.0	8.1	0.0	80.3	46.7	0.2	0.0	0.3	0.7	0.4	0.3	5.2	16.6	0.7	0.4	1.0	0.0	0.1	0.2	0.0	1.8	0.3	1.3	0.6	0.4	0.7	0.2	0.6	0.3	0.8	0.2	3.0	0.1	1.0	1.3	0.4	0.9	0.6	0.0	0.8	0.7	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.0	9.6	7.3	0.3	1.5	0.5	1.9	8.1	0.0	2.7	1.9	1.5	0.8	4.3	10.1	1.8	4.2	45.2	3.5	2.9	0.0	5.3	23.1	8.6	1.3	0.7	2.4	0.8	3.0	1.9	216.1	1.1	2.0	13.1	4.5	0.7	0.0	0.0	11.6	0.0	1.9	3.0	6.1	0.3	0.5	7.2	0.9	1.1	0.0	0.0	3.0	0.7	8.2	0.5	0.5	6.7	1.0	0.0	1.5	2.5	0.8	0.4	8.4	2.7	0.0	0.3	0.8	16.8	11.7	0.0	1.3	97.3	2.4	0.3	3.0	4.7
NMD3	CGI-07	ENSG00000169251	"NMD3 ribosome export adaptor"	Q96D46	3	161104696-161253532	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035019			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA035019: AB_10600922"	"unprognostic (1.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.97e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-3)"	26.9	21.5	13.1	18.1	13.8	64.7	32.3	19.3	14.1	27.0	12.8	18.6	17.6	26.3	15.3	24.4	20.2	22.6	40.0	11.2	14.2	29.2	77.7	19.7	22.3	10.8	13.4	26.4	34.9	21.9	12.7	25.6	11.8	27.7	21.2	17.0	32.8	20.0	60.3	17.2	15.4	28.3	12.1	21.1	42.5	16.0	13.0	18.7	25.2	34.5	24.7	39.3	16.5	13.9	68.7	39.2	37.8	38.6	46.3	63.1	51.9	76.3	57.9	55.9	64.8	66.5	54.9	86.4	94.8	53.8	39.3	43.8	60.9	56.1	86.4	90.2	37.4	89.0	31.4	41.7	50.7	108.0	51.7	53.2	40.9	39.7	129.1	59.4	61.4	29.9	66.3	46.3	66.8	155.7	49.6	41.3	47.4	82.1	61.7	59.8	54.5	87.9	53.1	153.2	59.8	37.3	43.5	105.2	63.9	40.9	78.3	49.0	54.2	44.1	31.5	51.3	93.4	75.6	54.5	87.1	55.5	69.5	61.5	30.5	16.6	8.9	16.5	17.6	25.9	17.3	19.2	20.4	19.8	15.6	25.3	20.1	3.6	35.4	11.4	11.0	26.8	20.7	13.1	13.8	19.3	14.1	11.2	14.2	10.8	13.4	11.8	12.1	13.0	13.9	30.6	19.2	14.6	22.9	25.3	64.9	52.9	23.8	34.7	24.7	26.8	16.5	43.9	21.5	25.1	11.0	14.6	33.3	25.2	14.0	35.2	25.6	19.3	13.8	29.6	30.1	13.8	32.2	16.6	38.9	48.8	34.0	31.1	19.3	25.4	20.3	22.1	41.6	23.4	30.3	15.3	19.4	26.4	33.1	47.0	7.0	25.4	21.6	24.9	12.2	26.1	12.8	21.6	19.6	18.2	33.0	13.9	27.4	20.9	46.7	19.7	39.9	18.5	20.8	26.3	29.1	87.5	39.2	27.4	33.4	74.3	56.6	25.8	24.4	21.2	72.7
NQO1	"DHQU, DIA4, DTD, NMOR1, QR1"	ENSG00000181019	"NAD(P)H quinone dehydrogenase 1"	P15559	16	69706996-69726668	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 522.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 539.8;Respiratory ciliated cells: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 2434.0;OE19: 4177.0;SiHa: 2756.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007308, CAB012421"	Enhanced		Supported	Cytosol		NA	NA		490000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"CAB012421: , HPA007308: AB_1079501"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-3)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.27e-1)"	100.9	95.1	88.9	20.7	97.2	0.8	264.8	88.1	165.6	24.3	113.4	85.6	106.8	16.1	27.2	162.2	29.3	183.1	24.3	86.7	95.0	93.9	5.6	36.5	4.8	83.5	86.2	8.9	9.2	19.5	15.3	12.0	85.9	20.7	74.0	21.4	47.7	25.1	34.2	11.7	56.1	35.0	83.0	22.8	522.7	6.4	93.6	4.3	112.7	27.0	16.5	79.0	34.2	86.8	224.2	2434.0	203.4	901.3	473.1	682.7	77.5	363.1	632.7	363.9	547.0	302.0	1395.7	7.1	433.1	1850.6	634.3	232.1	79.1	410.3	185.2	91.3	3.3	10.9	564.4	2169.9	631.7	53.8	170.6	166.2	246.8	642.8	74.4	537.9	903.9	18.5	95.3	16.3	1914.1	725.9	11.6	98.7	107.0	4177.0	237.1	18.9	44.0	101.6	708.3	781.5	73.0	17.2	2756.6	384.8	1690.4	226.6	631.3	173.1	626.5	368.8	155.8	140.0	297.1	12.7	53.1	11.2	470.2	29.1	1864.0	1.1	3.9	0.3	6.3	0.4	3.1	5.7	7.3	8.3	3.8	2.4	2.2	5.3	0.9	18.7	0.4	1.3	15.6	5.1	88.9	97.2	88.1	165.6	86.7	95.0	83.5	86.2	85.9	83.0	93.6	86.8	88.5	25.6	14.6	8.8	2.9	5.2	26.4	185.5	32.5	10.0	31.1	30.5	4.8	138.7	90.9	42.3	4.2	1.7	3.5	165.7	146.8	25.6	0.4	117.2	11.7	81.0	20.4	1.3	1.9	147.5	4.3	32.9	539.8	65.7	19.7	10.1	28.5	2.6	15.2	3.3	1.6	81.7	107.8	3.5	7.6	1.2	25.1	10.9	17.8	4.7	128.5	10.6	7.2	0.0	5.0	75.1	59.4	12.0	2.3	22.6	62.9	44.3	471.3	15.1	6.6	21.1	72.1	0.3	1.3	128.3	4.5	1.9	5.6	17.3	51.5	40.6
NSMCE1	NSE1	ENSG00000169189	"NSE1 homolog, SMC5-SMC6 complex component"	Q8WV22	16	27224994-27268772	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"granulocytes: 275.5;Late spermatids: 420.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041567, HPA043091"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA041567: AB_10964260, HPA043091: AB_10962722"	"unprognostic (6.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	43.8	68.3	58.8	32.2	61.7	35.1	52.5	65.2	71.7	43.3	66.0	53.1	25.3	42.3	55.0	45.5	62.2	35.8	47.6	57.4	63.3	58.3	55.9	42.4	54.5	65.5	61.4	45.0	59.3	86.1	37.3	37.3	64.6	57.4	36.8	24.9	46.2	51.7	45.2	40.7	37.0	45.2	64.0	33.5	51.3	79.8	61.3	56.4	53.0	44.9	54.7	51.4	39.1	67.0	56.5	80.6	53.8	58.6	85.8	114.2	43.1	58.9	60.4	44.5	46.1	62.7	134.1	110.0	137.7	91.1	45.7	59.5	101.9	178.6	57.3	136.3	70.6	51.0	68.6	122.1	149.1	59.9	37.4	112.6	122.3	111.7	211.5	127.8	60.3	104.3	69.6	33.8	82.9	96.7	80.0	67.5	46.8	94.0	54.7	69.1	65.8	174.7	129.9	36.3	56.4	51.0	40.2	55.9	104.3	65.1	92.3	71.9	37.8	53.3	33.2	61.1	57.8	101.0	78.1	85.9	114.0	59.4	23.3	125.3	91.2	86.2	78.9	81.6	86.3	84.2	111.1	95.7	128.4	133.1	126.7	99.7	29.6	213.8	81.5	124.6	113.0	120.3	58.8	61.7	65.2	71.7	57.4	63.3	65.5	61.4	64.6	64.0	61.3	67.0	34.8	35.3	36.4	8.5	38.1	28.3	57.6	110.7	33.0	14.9	60.7	83.8	49.6	62.9	58.5	44.1	2.1	126.2	41.2	45.6	129.1	79.2	209.9	40.3	32.9	33.9	58.7	24.0	5.4	73.0	63.3	44.5	17.3	29.6	275.5	37.4	52.8	64.0	83.2	13.5	6.7	65.8	44.7	53.3	45.6	420.8	24.2	39.5	46.2	12.2	98.1	64.7	43.3	12.5	14.8	40.1	45.7	39.9	28.1	49.0	83.9	173.8	94.6	18.8	26.3	58.1	50.1	119.0	39.4	43.5	32.7	64.3	55.3	39.9	46.7	48.3
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148444	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA035929: AB_10671236, HPA058122: AB_2683613"	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	17.5	13.1	6.4	15.8	7.1	35.0	23.4	11.9	9.3	22.4	6.2	19.2	16.5	23.5	18.8	18.1	20.0	15.8	12.2	6.6	7.7	15.2	22.2	16.1	22.1	6.4	6.4	24.3	16.6	15.7	7.5	24.4	6.6	18.5	20.6	12.4	14.7	18.4	12.7	19.3	16.0	20.4	7.1	16.6	16.3	21.8	6.3	28.7	20.6	14.2	24.5	21.7	15.0	9.2	42.6	14.2	52.3	37.1	44.2	40.8	45.0	42.1	61.1	62.1	63.1	36.9	58.4	64.4	34.5	42.3	33.4	27.5	57.0	47.6	76.5	42.5	31.1	38.5	19.1	36.7	41.1	75.8	44.1	37.4	33.6	48.8	50.7	27.1	52.8	41.4	67.1	38.9	44.4	35.9	81.0	39.9	81.3	51.2	14.2	61.6	81.0	25.0	37.3	39.1	31.7	26.6	38.6	45.2	35.4	39.5	18.7	47.2	35.5	48.2	43.0	58.8	52.8	25.1	10.0	60.8	35.1	44.5	44.0	10.1	8.8	9.3	13.3	10.7	18.4	9.7	14.0	13.1	12.9	10.9	14.7	14.1	4.1	26.6	12.6	9.5	14.9	8.5	6.4	7.1	11.9	9.3	6.6	7.7	6.4	6.4	6.6	7.1	6.3	9.2	26.1	22.4	16.7	25.5	31.3	35.2	42.8	29.4	32.5	13.8	18.8	19.3	11.8	14.3	17.8	11.0	20.9	41.3	30.5	13.5	29.4	25.1	12.5	24.9	31.6	23.7	14.4	35.7	42.8	27.7	47.5	26.8	17.3	34.4	24.1	23.0	19.2	13.6	21.7	8.4	42.0	20.8	16.2	16.4	24.2	7.4	27.4	20.2	17.8	18.7	28.6	12.8	35.0	34.2	54.2	19.2	17.1	25.9	30.5	34.1	14.4	20.4	19.2	22.2	32.9	24.8	26.5	46.8	39.9	30.2	29.1	39.1	31.8	21.6	24.4	36.1
OR4D1	"OR4D3, TPCR16"	ENSG00000141194	"Olfactory receptor family 4 subfamily D member 1"	Q15615	17	58148449-58159555	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"dendritic cells: 2.4;T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"			"Cluster 7: Non-specific - Mitochondria"																					0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.9	0.0	0.9	0.0	0.8	0.8	0.0	0.0	1.2	1.4	0.1	1.8	0.0	0.0	0.2	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.3	0.3	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0
PAQR6	"FLJ22672, PRdelta"	ENSG00000160781	"Progestin and adipoQ receptor family member 6"	Q6TCH4	1	156243320-156248117	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	37	"brain: 674.6;choroid plexus: 196.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 44.1;Muller glia cells: 70.9;Oligodendrocytes: 65.1"	"Cancer enriched"	"Detected in all"	6	"glioma: 34.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 5.7"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"RT4: 14.8;T-47d: 17.8;U-266/70: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (1.64e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (7.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.50e-3)"	"unprognostic (4.75e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (1.99e-4)"	"prognostic unfavorable (1.58e-8)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.86e-4)"	1.9	1.8	275.4	0.8	321.1	6.1	2.7	319.1	674.6	3.2	196.2	7.9	1.3	0.9	0.4	4.8	3.4	1.3	2.3	240.1	271.1	6.3	7.2	2.6	0.4	413.7	327.9	1.8	1.9	0.4	11.8	0.7	397.2	7.0	0.8	6.7	3.1	1.0	1.5	11.2	3.7	0.5	369.6	4.7	3.3	4.2	320.9	0.6	3.7	0.3	0.7	1.9	4.2	380.4	1.7	1.5	3.8	3.1	0.8	0.5	9.9	0.3	0.6	0.2	0.2	1.3	6.7	3.7	2.0	0.7	0.4	7.5	0.0	1.6	0.5	2.2	2.6	2.4	2.6	1.5	0.5	1.2	7.5	1.6	4.3	2.8	3.0	3.7	0.2	8.6	2.4	9.4	0.5	7.4	0.5	1.1	5.3	1.1	1.3	1.8	0.9	2.4	3.0	14.8	3.3	6.8	0.5	1.3	5.0	6.9	17.8	1.7	0.6	1.2	6.2	2.0	0.8	27.4	7.7	2.4	0.5	10.5	1.2	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.6	0.0	0.1	275.4	321.1	319.1	674.6	240.1	271.1	413.7	327.9	397.2	369.6	320.9	380.4	0.6	0.0	0.5	44.1	1.7	1.3	0.5	1.8	0.0	3.9	1.8	2.0	3.5	1.5	1.3	0.0	0.0	0.1	1.0	0.9	0.0	0.7	0.4	1.3	0.6	0.7	4.2	3.2	1.5	3.4	0.2	1.3	4.6	1.7	1.3	1.1	0.7	0.9	0.6	6.7	1.4	0.5	2.0	1.3	0.4	0.8	0.3	0.9	0.0	3.7	0.6	70.9	0.0	6.0	65.1	1.8	0.0	2.2	3.5	0.7	0.8	0.4	2.3	11.2	0.0	0.6	0.5	1.3	0.5	0.6	1.4	0.3	2.3	0.5	1.1	0.5
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809624-27838082	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 22.8;testis: 70.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 364.9;Spermatocytes: 436.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 282.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.7;white matter: 13.9"	"Not detected"	"Not detected"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	1.1	0.6	0.1	6.6	0.1	9.1	2.3	0.0	0.1	1.1	0.0	8.9	8.4	1.2	0.0	6.6	0.6	0.7	0.2	0.1	0.1	0.4	1.1	0.7	12.8	0.1	0.3	0.2	0.4	0.2	0.0	5.1	0.2	0.4	10.1	0.0	0.9	0.0	0.2	4.8	8.1	2.7	0.1	1.5	3.6	70.3	0.3	22.8	0.5	0.1	12.4	1.6	2.1	0.1	282.8	94.2	94.4	57.9	8.3	15.7	36.9	129.5	63.0	133.2	112.3	33.7	51.2	156.4	43.3	51.7	150.2	76.4	87.6	44.7	145.7	35.8	48.0	35.0	64.6	49.2	0.6	25.7	54.1	4.4	36.0	62.6	32.8	24.3	68.5	75.9	54.3	100.6	160.4	34.5	87.7	29.1	15.6	80.1	80.0	54.4	126.9	41.2	51.2	44.9	36.1	53.2	48.2	56.0	75.0	26.2	58.0	37.3	40.6	85.6	207.3	111.5	141.5	15.4	39.4	70.1	54.0	43.4	188.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	4.2	8.9	2.8	10.8	0.0	0.0	2.9	2.4	0.5	2.8	2.6	0.0	0.0	29.8	1.3	5.5	0.0	0.6	364.9	2.5	2.2	2.4	0.0	61.7	0.1	0.0	49.3	6.7	6.6	3.5	0.0	13.5	5.7	1.7	5.0	0.0	0.1	9.4	6.1	1.9	1.6	76.8	8.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	3.0	14.0	2.0	1.5	0.3	0.1	0.0	6.6	0.1	5.8	436.4	38.1	9.4	2.4	6.7	1.9	2.4	18.7	3.8
PCDHGB4	"CDH20, FIB2, PCDH-GAMMA-B4"	ENSG00000253953	"Protocadherin gamma subfamily B, 4"	Q9UN71	5	141387698-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.1;Horizontal cells: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.3;SuSa: 15.5;TIME: 22.7"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.33e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.27e-2)"	1.3	1.1	1.3	0.4	1.5	0.0	0.9	4.4	1.4	1.5	1.8	1.1	0.2	1.6	1.5	0.7	1.3	0.5	1.5	2.0	3.2	1.4	1.6	1.1	0.1	2.0	2.0	2.4	1.0	1.9	1.2	3.0	1.5	1.2	0.4	1.4	1.6	1.4	1.0	1.7	0.5	1.0	1.4	0.4	0.4	0.5	2.5	0.7	1.7	0.8	0.2	1.0	1.1	1.5	0.0	1.1	11.1	0.1	6.9	8.5	1.3	10.8	43.3	4.4	3.0	0.0	0.0	0.4	8.3	0.3	0.2	3.3	0.0	0.0	4.6	0.0	0.0	0.0	0.2	2.4	2.8	0.0	0.0	8.4	0.1	4.1	0.0	0.1	6.7	0.0	0.4	0.1	0.0	0.0	1.1	0.2	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	15.5	5.6	4.2	22.7	6.0	1.8	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	1.5	4.4	1.4	2.0	3.2	2.0	2.0	1.5	1.4	2.5	1.5	0.2	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 2050.3"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 4448.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basophil: 127.0;NK-cell: 220.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 127.0;NK-cells: 220.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.2;NB-4: 5.8;NTERA-2: 8.9;REH: 11.9;SuSa: 6.2"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.7"	"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles		"HPA045118: AB_2732517"	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	1.5	0.3	0.0	4.7	0.1	7.8	0.9	0.2	0.5	1.0	0.2	1.6	0.6	0.2	0.1	0.8	0.7	2.5	0.4	0.1	0.7	2.1	4.2	3.0	20.6	0.1	0.2	0.0	0.0	0.1	0.1	12.0	0.2	0.2	1.0	2050.3	0.5	0.4	1.2	0.3	1.6	0.9	0.1	19.9	1.7	0.8	0.3	8.3	0.4	0.3	7.1	3.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	5.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.8	0.2	0.1	0.2	0.4	0.3	0.0	5.8	8.9	0.0	0.0	11.9	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.1	0.1	6.2	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.1	0.6	0.9	0.4	3.1	0.1	127.0	18.1	30.5	4.1	26.2	1.3	2.7	0.8	2.3	28.9	5.1	2.1	7.4	2.4	220.2	15.5	2.9	0.1	13.5	0.0	0.1	0.2	0.5	0.1	0.7	0.1	0.2	0.2	0.1	0.3	0.2	0.3	0.0	0.6	0.3	1.1	0.9	0.0	0.0	0.6	422.5	0.3	0.4	0.2	0.0	0.0	5.5	517.1	0.2	4.3	0.1	1.9	0.4	0.8	1.5	0.3	27.2	0.0	1.7	0.2	0.2	0.4	0.2	0.0	0.5	23.6	0.1	2.9	0.2	22.6	262.5	0.1	0.2	0.0	4.8	8.0	2.3	0.0	4.4	3.6	0.0	13.3	709.0	11.3	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.1	1.0	0.0	4448.6	0.0	0.1	0.1	1.1	0.2	0.3	1.4	0.3	1.7	2.1	0.0	0.1
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA019950: AB_1855156, HPA062059: AB_2684671"	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"	6.0	2.6	3.6	1.8	4.6	1.5	3.6	6.9	5.2	2.0	7.7	3.8	5.4	2.6	3.4	3.7	3.4	2.0	1.8	3.6	4.3	9.2	8.6	3.4	2.6	6.2	4.6	7.4	4.5	6.1	3.0	4.0	6.8	3.8	4.1	5.0	3.6	2.6	2.5	2.1	3.2	2.1	3.5	2.0	3.0	3.8	5.7	2.5	9.3	4.1	3.0	2.1	2.2	4.3	9.8	11.7	7.1	14.1	18.7	9.6	8.9	5.0	19.2	11.3	17.0	23.9	6.7	13.5	6.9	6.9	10.8	12.1	20.8	11.3	10.9	3.2	10.5	6.8	5.9	15.9	10.1	8.8	11.5	7.4	8.3	16.1	16.6	12.3	4.9	14.9	13.3	9.5	10.3	6.3	17.1	6.2	8.4	6.5	14.7	16.7	9.9	21.4	6.0	10.3	14.3	8.0	15.9	6.5	6.0	5.5	8.7	4.3	4.6	7.0	9.2	4.2	7.5	16.6	16.9	13.4	9.5	6.9	7.0	1.1	0.2	1.2	3.8	0.1	3.1	1.0	1.8	3.2	0.8	2.1	2.6	3.0	0.7	4.2	0.1	0.5	0.6	1.3	3.6	4.6	6.9	5.2	3.6	4.3	6.2	4.6	6.8	3.5	5.7	4.3	2.5	9.6	22.9	8.1	3.1	5.2	6.4	1.3	6.2	9.6	5.8	4.2	5.1	8.6	3.1	9.2	14.6	12.8	3.3	13.3	7.9	3.4	0.2	3.5	3.2	3.3	3.6	0.8	8.8	2.9	2.2	4.1	3.1	4.3	6.3	14.4	7.1	20.5	2.4	5.0	7.6	4.2	2.0	1.3	0.4	2.4	3.1	1.2	3.6	3.7	0.4	8.1	7.2	4.5	4.3	3.4	6.6	4.5	4.5	8.9	7.4	9.9	1.2	6.7	0.0	5.9	2.7	12.6	5.7	8.0	2.4	3.6	3.4	4.0	5.5	6.5
PDZD7	"bA108L7.8, DFNB57, FLJ23209, PDZK7"	ENSG00000186862	"PDZ domain containing 7"	Q9H5P4	10	101007679-101032295	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 21.5;intestine: 20.0;pituitary gland: 6.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 15.9;Cone photoreceptor cells: 22.9;Excitatory neurons: 32.3;Inhibitory neurons: 16.5;Proximal enterocytes: 56.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 7.5;SCLC-21H: 11.7;THP-1: 18.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074542			Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA074542: "	"unprognostic (1.46e-1)"	"unprognostic (2.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.54e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.80e-1)"	1.5	1.3	5.8	1.0	8.0	1.3	0.5	10.2	15.4	0.7	0.7	0.4	12.8	1.4	0.9	0.3	0.4	1.9	0.6	5.7	4.5	1.5	0.1	1.0	0.9	21.5	7.7	0.6	0.9	1.1	6.0	1.0	21.0	0.7	0.2	2.3	1.1	0.5	0.9	2.4	20.0	1.0	2.7	1.6	1.0	1.2	8.8	0.7	1.2	0.2	0.1	0.4	0.8	9.9	7.5	0.9	0.5	0.7	0.9	0.1	2.3	1.2	0.6	0.0	0.3	1.5	1.7	3.7	3.5	0.3	1.0	2.2	0.2	0.7	0.0	1.0	2.5	0.2	3.8	2.3	0.6	0.5	3.1	0.3	0.1	0.2	0.1	4.2	0.2	3.3	0.6	0.7	0.1	1.8	0.5	1.2	0.6	1.5	2.4	1.6	1.0	0.4	1.8	0.6	11.7	5.4	0.8	0.3	1.2	1.0	2.4	18.2	0.5	1.1	2.4	1.4	1.0	1.5	0.1	0.2	6.4	1.2	0.6	0.6	0.4	0.5	0.3	0.4	0.3	0.3	0.2	0.4	0.1	0.3	0.4	0.2	1.6	0.8	0.3	0.1	0.1	0.3	5.8	8.0	10.2	15.4	5.7	4.5	21.5	7.7	21.0	2.7	8.8	9.9	0.8	0.0	0.0	1.3	0.1	0.5	0.5	0.2	0.0	15.9	0.5	0.9	1.4	2.8	0.2	1.8	22.9	0.2	0.1	0.2	1.9	0.7	1.7	2.1	0.3	0.7	0.0	0.0	32.3	0.4	5.2	0.8	1.1	0.3	0.0	1.6	0.7	0.0	2.1	1.7	16.5	1.5	0.0	1.3	2.7	2.6	0.3	1.0	0.0	5.6	0.3	0.9	1.0	0.5	6.9	1.3	1.2	1.2	0.3	0.4	56.7	1.6	1.3	8.3	0.0	1.4	1.7	2.9	3.7	0.2	0.4	1.9	0.8	0.1	1.0	0.2
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 595.8"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 280.0;Proximal tubular cells: 1113.8"	"Group enriched"	"Detected in many"	4	"liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 14.7"	"Immune cell enriched"	"Detected in single"	5	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 4.2"	"Group enriched"	"Detected in many"	4	"RPTEC TERT1: 250.0;T-47d: 653.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favorable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.6	3.5	0.7	0.5	0.9	0.6	19.6	14.7	2.0	2.4	1.9	4.7	74.8	0.7	15.8	0.2	1.0	22.0	0.4	1.0	0.5	595.8	128.1	0.3	0.7	1.4	0.8	0.3	16.6	0.0	0.6	0.5	1.8	0.3	8.2	3.0	0.4	0.8	0.3	2.6	124.9	0.8	0.4	0.7	2.8	0.6	0.8	0.3	0.3	0.1	0.2	0.2	0.3	1.5	7.6	1.2	0.8	0.8	0.3	0.4	3.0	1.2	0.3	0.2	1.0	106.6	1.0	0.7	1.3	5.9	0.5	3.4	0.2	0.6	0.6	10.3	2.0	0.9	2.8	45.7	0.0	1.1	0.9	0.3	0.7	0.4	0.2	0.8	0.0	0.4	0.8	1.6	0.8	6.0	0.7	1.4	1.2	1.5	3.6	0.4	7.3	1.6	250.0	0.3	0.6	6.7	1.7	1.8	0.2	6.4	653.8	0.9	0.5	1.3	1.3	0.9	1.1	8.8	1.2	0.6	1.0	0.6	0.5	0.1	0.1	0.0	0.7	0.1	0.2	0.6	0.2	0.8	0.0	0.4	0.2	0.3	0.1	4.2	0.0	0.5	0.0	0.3	0.7	0.9	14.7	2.0	1.0	0.5	1.4	0.8	1.8	0.4	0.8	1.5	0.2	0.0	0.0	2.0	4.1	0.1	0.0	0.1	0.0	0.4	20.2	3.3	0.5	72.9	0.0	57.0	0.0	0.0	0.9	27.4	138.9	1.2	8.6	1.1	0.5	0.4	6.6	0.0	2.8	2.0	0.1	0.5	0.5	4.9	0.0	0.2	1.1	47.9	0.2	0.0	1.9	7.8	0.0	0.9	0.3	9.0	0.0	4.9	0.0	1.9	0.0	0.3	2.1	3.0	0.7	1.5	7.4	0.0	0.0	0.1	280.0	1113.8	0.1	0.5	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.1	4.1	4.3	6.5	0.1
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1"	ENSG00000258724	"PIN2 (TERF1) interacting telomerase inhibitor 1"		8	10725399-10839847	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"cervix: 2.9;vagina: 5.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.9"									HPA009065	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"									"unprognostic (2.57e-1)"					"unprognostic (6.34e-2)"				0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	2.9	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	3.2	6.7	12.4	10.4	26.6	20.7	12.0	14.2	5.6	0.0	0.0	0.0	8.6	8.2	3.7	12.5	0.0	4.0	6.9	11.7	0.0	37.0	0.0	0.0	7.3	8.4	6.9	25.0	0.0	0.0	5.3	7.7	0.0	14.0	0.0	12.5	7.0	0.0	3.3	22.4	5.0	8.2	5.4	10.3	32.7	9.3	3.9	7.2	13.1	3.3	9.0	7.2	17.6	15.3	0.0	5.3	6.4	14.0	20.2	6.5	13.3	7.0	22.1	0.0	12.5	5.5	21.5	22.7	12.0	28.6	0.0	8.3	0.0	9.6	8.9
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 294.4;skin 1: 223.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 345.0;Extravillous trophoblasts: 176.8;Paneth cells: 248.9;Proximal enterocytes: 195.6;Undifferentiated cells: 142.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 151.3;CAPAN-2: 102.6;HaCaT: 199.1;hTCEpi: 126.9;MCF7: 94.9;SK-BR-3: 148.0"	"Region enriched"	"Detected in single"	37	"cerebellum: 8.9"	"Low region specificity"	"Detected in all"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	1.1	0.1	0.3	3.7	0.2	0.0	9.1	0.2	0.6	50.2	0.1	34.3	31.1	1.4	4.7	294.4	7.5	4.9	0.8	0.3	0.3	4.2	0.8	9.7	0.1	0.6	0.2	0.3	27.4	9.1	15.8	10.9	0.6	19.8	10.2	0.0	52.8	5.0	1.0	223.0	28.6	0.5	0.2	0.2	29.1	0.7	0.3	2.5	12.8	0.1	8.8	9.2	104.3	0.3	151.3	28.8	0.0	0.6	0.1	0.2	60.3	1.2	1.0	3.1	1.6	59.2	102.6	0.1	6.0	1.1	6.4	199.1	0.0	75.1	0.5	0.1	36.9	0.1	18.0	41.7	0.6	0.0	0.3	0.5	126.9	0.5	30.8	0.5	0.5	0.0	45.3	0.9	0.4	94.9	0.5	0.2	0.3	75.6	49.1	0.8	0.3	0.6	1.6	29.9	41.1	0.7	42.7	148.0	0.2	1.8	53.8	0.4	5.4	1.0	5.2	2.7	0.8	0.2	0.4	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.6	0.3	0.3	0.6	0.2	0.6	0.2	0.3	0.3	0.2	16.0	13.0	0.0	1.1	72.1	52.0	56.1	54.7	0.2	27.7	26.5	1.1	11.5	36.8	12.9	0.0	133.8	0.4	345.0	0.0	83.8	0.0	16.1	1.8	1.8	21.7	0.0	0.2	62.9	176.8	2.3	91.3	27.4	13.4	0.4	0.0	0.3	13.2	0.0	0.0	95.1	36.7	0.3	6.5	0.4	0.9	0.9	1.8	0.0	2.0	0.6	0.0	0.0	0.0	140.2	248.9	0.0	0.2	63.5	195.6	0.9	17.9	0.2	0.0	0.0	2.8	0.2	1.7	114.1	88.7	109.7	1.6	0.0	142.9	60.4
PLA2G1B	"PLA2, PLA2A, PPLA2"	ENSG00000170890	"Phospholipase A2 group IB"	P04054	12	120322115-120327779	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1519	"pancreas: 117705.6"	"Cell type enriched"	"Detected in many"	17	"Exocrine glandular cells: 20351.4"	"Cancer enriched"	"Detected in many"	185	"pancreatic cancer: 763.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047822, HPA060803"	Enhanced				"Secreted to digestive system"	NA	NA		3900000	"Cluster 48: NK-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA047822: AB_2680169, HPA060803: AB_2684369"	"unprognostic (1.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.60e-1)"	"unprognostic (8.61e-4)"	10.0	6.5	0.2	1.7	0.1	2.9	5.8	0.2	0.6	5.8	0.0	2.3	15.8	2.3	0.0	3.3	1.8	0.9	21.5	0.2	0.2	2.7	7.2	32.1	4.0	0.1	0.1	77.5	117705.6	0.0	4.4	6.0	0.2	4.4	0.3	0.7	21.3	0.0	1.9	3.4	7.7	0.1	0.1	3.0	8.7	4.3	0.1	0.3	1.5	0.0	0.0	1.3	1.9	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	1.9	0.2	0.2	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.6	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	12.8	91.5	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.8	1.3	0.4	0.0	0.8	0.0	0.0	0.0	0.2	0.2	1.9	24.3	10.6	0.4	0.1	1.1	1.2	0.0	0.1	20351.4	0.0	0.3	0.0	0.0	0.0	8.6	0.0	1.9	0.0	0.0	0.1	1.2	0.0	0.0	0.0	41.0	3.1	1.5	0.0	1.0	43.9	0.0	2.1	0.0	0.0	1142.1	1.7	3.4	0.1	0.2	4.1	7.6	1.0	0.0	0.0	0.0	3.4	0.5	0.2	0.0	0.1	0.0	0.3	12.5	1.2	0.1
PLA2G6	"iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9"	ENSG00000184381	"Phospholipase A2 group VI"	O60733	22	38111495-38214778	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Lipid metabolism, Phospholipid metabolism"	"Calmodulin-binding, Hydrolase"	"Disease variant, Dystonia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.5;Spermatocytes: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 39.1;HMC-1: 25.6;U-266/70: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001171	Approved		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centriolar satellite, Cytosol"		"HPA001171: AB_1079145"	"unprognostic (5.26e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.74e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.67e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.37e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.55e-4)"	20.0	22.2	14.1	4.6	16.6	12.2	19.5	15.2	20.3	24.9	12.3	11.4	9.2	17.8	10.6	10.3	26.2	13.2	9.5	14.3	13.7	24.0	13.3	10.4	8.5	17.2	15.0	24.3	16.1	6.7	17.7	4.1	19.5	24.9	2.8	8.3	15.9	9.2	10.7	17.2	12.5	3.4	15.3	17.1	13.2	42.1	15.4	11.7	51.8	4.4	4.6	13.2	14.4	25.5	0.8	1.3	2.6	6.3	8.0	5.5	9.8	0.9	1.0	0.5	1.2	3.2	2.4	5.9	6.7	1.3	0.9	3.5	2.2	2.5	0.3	9.2	11.1	39.1	3.4	3.5	3.1	2.6	25.6	13.3	3.7	2.3	4.6	6.6	0.8	11.7	8.0	13.3	0.7	3.1	8.5	3.0	3.4	2.7	1.3	6.5	1.2	6.1	2.8	5.9	7.1	1.9	1.9	3.1	6.7	3.9	4.1	2.4	0.6	2.1	4.5	0.9	0.6	20.6	2.7	4.0	4.0	3.2	2.0	1.4	0.1	0.0	1.0	0.0	0.7	0.5	1.0	1.5	0.4	0.3	0.4	1.2	0.6	3.7	0.2	1.3	1.6	0.7	14.1	16.6	15.2	20.3	14.3	13.7	17.2	15.0	19.5	15.3	15.4	25.5	5.6	3.2	2.7	19.9	4.6	3.1	3.5	4.0	4.6	9.9	7.4	6.5	2.0	4.3	5.0	12.9	4.2	3.3	11.1	11.3	0.0	2.1	28.5	9.5	4.4	3.1	11.4	7.4	6.4	1.0	2.7	3.3	11.2	8.7	0.0	10.6	3.6	3.5	1.7	15.2	5.9	8.6	2.0	1.0	0.8	18.3	5.9	2.1	1.8	4.7	2.3	4.9	8.2	4.5	25.2	1.1	12.6	3.8	4.7	2.9	21.9	1.9	7.6	7.5	6.6	2.6	3.4	44.5	7.7	4.1	3.4	4.9	6.6	6.8	8.4	2.1
PLCH2	"KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1"	ENSG00000149527	"Phospholipase C eta 2"	O75038	1	2425980-2505532	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 44.8;skin 1: 59.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 102.5;Cone photoreceptor cells: 75.0;Oligodendrocytes: 37.4;Rod photoreceptor cells: 169.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HBEC3-KT: 130.9;hTCEpi: 58.9;hTERT-HME1: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072705	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA072705: AB_2732211"	"unprognostic (2.06e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.95e-2)"	"unprognostic (6.61e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.64e-2)"	"unprognostic (5.80e-2)"	0.6	1.4	1.0	3.9	1.7	2.2	6.2	7.9	4.8	6.3	0.0	1.1	2.2	0.3	1.7	19.3	3.2	2.9	0.2	2.4	1.0	0.8	2.1	1.8	5.3	3.3	3.1	0.1	5.1	0.0	7.9	0.4	3.6	14.6	0.8	44.8	16.4	5.8	0.2	59.6	3.3	0.1	1.2	5.5	2.0	0.6	6.9	4.4	1.7	0.0	6.5	9.1	18.3	7.2	0.3	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.2	0.2	0.0	17.1	0.0	130.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	58.9	0.0	32.8	0.0	0.0	0.0	0.0	3.1	0.3	0.6	0.0	0.0	0.1	1.9	1.4	0.1	0.1	0.0	0.2	6.1	14.7	2.9	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.6	0.2	1.0	1.7	7.9	4.8	2.4	1.0	3.3	3.1	3.6	1.2	6.9	7.2	0.2	0.0	1.7	2.9	6.1	15.4	14.5	22.8	10.8	102.5	1.7	5.5	3.3	2.8	10.8	0.0	75.0	0.0	7.3	0.7	1.9	0.1	0.1	0.7	0.2	0.7	1.2	0.0	9.3	0.0	0.0	0.4	1.5	1.4	0.0	0.1	0.0	4.9	0.1	26.9	19.8	1.9	2.0	0.3	1.1	0.2	0.0	0.5	3.6	1.9	0.4	14.9	7.2	2.5	37.4	0.5	0.6	0.0	1.9	4.9	3.8	33.5	5.8	169.0	0.0	0.0	1.0	0.2	0.3	13.0	14.6	0.0	7.0	0.1	0.5	9.2
PLCL2	"KIAA1092, PLCE2"	ENSG00000154822	"Phospholipase C like 2"	Q9UPR0	3	16802651-17090604	"Metabolic proteins, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 212.5;Extravillous trophoblasts: 73.0;Inhibitory neurons: 163.7;Microglial cells: 124.6;Oligodendrocyte precursor cells: 121.7;Oligodendrocytes: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 21.1;Daudi: 24.7;HAP1: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047616, HPA061728"	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA047616: AB_2680105, HPA061728: "	"unprognostic (2.95e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.83e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (2.98e-10)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.97e-2)"	7.8	11.8	2.8	5.8	5.0	10.0	5.9	13.7	4.0	4.2	1.1	5.6	6.6	6.6	2.5	1.3	4.3	4.1	21.1	3.3	1.6	7.4	5.6	4.8	10.2	3.6	1.7	12.5	6.7	0.8	6.0	3.8	4.1	3.1	5.7	2.1	2.8	1.4	27.1	1.9	8.3	4.2	0.8	12.9	5.4	3.9	1.7	5.9	3.7	7.7	7.7	2.6	3.1	2.9	0.0	1.9	2.5	0.0	9.3	21.1	2.0	1.8	5.0	0.8	2.0	0.0	1.8	24.7	0.0	1.6	1.0	0.0	24.8	0.9	1.8	11.8	5.2	0.0	2.6	0.0	0.3	3.8	2.7	3.4	0.2	6.9	0.0	1.5	4.3	8.1	5.8	9.4	0.0	0.0	4.3	0.4	5.0	0.0	2.6	9.4	0.0	13.5	0.0	0.4	8.0	3.6	1.0	3.0	0.7	1.7	0.0	4.0	4.4	1.2	1.7	1.1	4.2	8.9	0.0	15.7	1.3	5.2	0.9	0.9	0.8	1.9	2.1	0.9	2.6	1.4	2.0	2.9	1.0	1.3	1.9	2.1	1.8	6.5	1.2	0.5	1.5	1.1	2.8	5.0	13.7	4.0	3.3	1.6	3.6	1.7	4.1	0.8	1.7	2.9	8.6	0.0	2.2	8.1	17.5	1.0	0.9	1.1	1.2	11.5	0.6	0.4	38.6	11.5	1.1	3.7	4.2	2.5	34.1	12.5	7.9	2.6	1.1	7.5	4.1	6.6	3.6	7.0	212.5	9.2	73.0	7.8	17.3	2.1	2.5	5.6	5.7	6.4	7.8	16.8	163.7	9.8	0.0	8.7	4.6	1.5	19.6	13.8	0.0	124.6	12.3	1.2	39.1	121.7	72.2	2.9	22.6	19.2	18.2	0.5	9.5	10.9	1.3	1.8	6.6	9.6	5.0	2.5	5.4	0.3	0.6	49.8	24.2	6.5	5.4	0.6
PLEKHA1	TAPP1	ENSG00000107679	"Pleckstrin homology domain containing A1"	Q9HB21	10	122374696-122442602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 10.3;NK-cells: 21.3;T-cells: 27.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 203.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002043, HPA064795"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA002043: AB_1079632, HPA064795: AB_2685354"	"unprognostic (1.79e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.42e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.23e-2)"	18.0	10.4	21.2	13.9	25.5	4.4	19.6	10.7	42.0	18.6	5.0	21.4	25.9	25.9	20.5	39.4	12.7	24.0	29.2	25.9	14.8	39.1	38.7	36.6	14.9	12.4	14.9	19.2	27.3	27.6	21.8	37.3	13.3	17.9	20.1	19.8	25.2	18.8	31.8	66.5	25.1	23.6	13.2	13.7	21.2	40.7	13.7	15.6	27.3	57.4	18.0	24.9	21.7	36.9	25.9	23.5	23.3	16.1	33.1	37.5	28.0	28.2	49.1	16.8	18.0	20.0	31.8	16.1	13.3	25.6	17.0	55.4	22.3	86.1	15.4	11.4	21.8	0.0	22.6	23.6	21.8	2.9	7.3	20.5	69.7	13.9	58.3	27.5	56.8	33.2	24.3	0.1	15.6	9.9	14.8	2.5	18.1	39.3	15.5	4.0	33.1	3.2	203.2	28.3	31.6	15.5	36.4	26.8	28.9	32.7	14.9	0.3	54.6	14.1	11.5	15.4	14.3	0.1	0.0	5.4	21.6	0.1	8.8	0.3	2.7	2.3	27.1	2.4	17.5	5.1	16.3	21.9	3.2	10.3	25.4	21.9	0.8	21.3	2.9	1.6	11.9	11.6	21.2	25.5	10.7	42.0	25.9	14.8	12.4	14.9	13.3	13.2	13.7	36.9	48.6	144.2	42.0	19.9	28.0	72.8	54.7	51.6	97.9	46.5	25.6	19.2	55.9	55.8	46.0	57.0	75.0	58.4	47.6	39.1	41.1	63.1	202.0	50.2	30.6	70.8	22.3	6.9	133.8	85.3	53.9	34.3	28.1	83.7	5.1	20.8	32.5	45.1	37.2	26.9	92.9	19.6	22.4	23.7	23.6	336.5	44.1	20.4	24.9	35.6	28.5	20.2	147.2	35.2	161.9	71.4	26.9	36.1	7.4	91.4	64.4	118.1	29.1	49.5	26.3	32.2	28.9	119.4	86.1	71.6	84.8	39.7	39.7	14.7	27.5	83.5
POC5	"C5orf37, FLJ35779, hPOC5, MGC120442, MGC120443, MGC120444"	ENSG00000152359	"POC5 centriolar protein"	Q8NA72	5	75674124-75717448	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 102.7;Late spermatids: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037509, HPA037510, HPA061521"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA037509: AB_2797227, HPA037510: AB_10672349, HPA061521: AB_2797263"	"unprognostic (1.33e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.60e-7)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.62e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.09e-4)"	5.8	6.1	5.3	6.1	7.6	10.2	9.5	6.9	8.1	7.6	4.3	5.1	4.6	7.6	8.3	3.8	8.9	4.4	3.8	5.2	5.8	5.2	4.5	6.0	11.4	6.8	6.5	11.2	5.1	5.7	3.3	5.9	6.9	6.9	6.3	29.2	4.3	5.2	3.8	6.0	5.9	7.3	5.9	9.7	5.5	20.1	6.1	14.3	5.7	3.5	11.0	5.6	5.5	10.5	16.1	12.4	20.5	20.4	8.7	7.0	15.0	14.9	8.9	25.9	19.4	18.3	14.3	21.5	27.9	8.4	34.8	14.8	18.3	14.8	19.3	23.3	12.7	14.1	9.3	10.2	11.7	16.2	26.3	7.8	14.3	19.6	32.4	8.7	10.5	21.6	13.8	38.1	12.2	19.1	26.3	20.5	8.9	3.6	10.9	16.5	17.0	25.8	11.9	7.8	16.1	17.7	14.0	7.6	15.7	10.3	14.5	18.5	4.5	8.7	19.2	15.3	30.5	23.4	53.1	31.6	13.2	21.3	21.1	8.1	10.0	23.1	14.6	11.2	12.9	15.1	14.5	15.5	15.2	18.0	14.8	14.4	10.0	18.5	9.0	17.1	21.5	8.7	5.3	7.6	6.9	8.1	5.2	5.8	6.8	6.5	6.9	5.9	6.1	10.5	5.9	6.4	11.1	6.2	8.3	2.7	3.0	8.2	5.2	12.3	5.2	6.2	3.9	8.6	6.3	7.3	12.5	7.4	12.2	3.6	9.8	7.7	102.7	12.3	8.4	5.8	4.9	13.5	18.4	6.9	7.7	6.1	6.1	5.7	2.5	8.1	6.1	3.6	6.3	10.1	9.4	4.0	10.2	5.4	4.8	53.3	6.2	6.0	3.6	14.0	4.0	5.9	10.3	9.0	32.1	5.5	2.5	7.2	10.5	2.5	3.2	5.1	19.9	39.0	6.6	3.8	6.0	36.8	15.7	6.4	2.8	4.1	10.8	9.6	5.5	1.7
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468963-119494708	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 81.2;monocytes: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (2.23e-4)"	6.8	7.2	5.9	7.8	6.1	3.1	7.7	6.0	8.2	7.1	6.9	6.8	4.2	9.0	7.8	5.6	6.0	4.7	5.9	5.9	7.2	5.7	6.6	5.6	10.8	6.6	6.5	5.5	7.9	9.5	4.9	8.2	6.6	5.4	7.2	4.2	4.6	11.6	3.2	10.0	7.8	10.4	6.1	9.0	5.4	2.5	7.2	9.7	5.6	3.4	10.8	8.5	6.3	6.7	10.8	7.1	11.7	13.1	29.5	16.8	8.6	16.7	16.7	12.3	18.4	11.5	6.9	16.5	22.2	21.4	10.6	11.9	15.9	16.8	20.4	14.4	10.6	19.3	11.1	12.9	19.1	21.3	21.7	17.5	9.6	13.3	18.0	15.7	15.5	11.2	10.5	19.7	13.9	10.9	12.5	20.7	12.4	18.6	13.8	12.2	12.2	24.0	11.6	13.9	12.7	20.0	8.1	4.9	13.4	11.7	13.2	17.8	19.7	13.1	8.0	3.8	8.9	27.1	25.2	21.7	11.1	20.6	18.8	2.9	16.4	13.9	16.2	15.7	18.7	13.9	18.2	17.0	20.7	10.1	21.1	20.0	1.2	29.5	10.8	11.5	22.3	15.0	5.9	6.1	6.0	8.2	5.9	7.2	6.6	6.5	6.6	6.1	7.2	6.7	19.1	0.0	6.2	11.4	15.7	16.8	7.3	17.4	16.5	13.6	9.7	8.5	5.2	14.3	10.1	20.2	6.2	10.6	17.1	5.2	0.0	6.9	0.7	5.5	19.3	16.1	9.5	8.4	32.7	5.3	14.7	14.5	9.2	7.0	17.7	11.3	13.6	12.5	8.4	5.0	31.6	11.7	22.4	11.9	81.2	0.2	8.7	16.6	12.4	6.5	151.4	10.3	21.6	23.6	25.8	5.0	8.3	17.0	14.1	8.0	8.5	6.0	6.5	13.0	13.1	16.7	13.4	1.5	1.5	13.9	14.9	6.6	15.5	17.4	13.9	5.9
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 21.0;Spermatogonia: 24.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	0.9	0.9	0.5	5.1	0.3	18.2	3.0	0.5	0.6	2.1	0.0	3.8	2.5	2.5	0.7	3.7	1.0	0.9	0.6	0.2	0.2	0.7	3.1	1.2	5.1	0.2	0.4	1.0	0.8	0.7	0.5	3.0	0.2	1.4	4.5	3.0	1.0	0.7	0.5	3.5	3.6	2.3	0.3	1.5	2.1	4.1	0.2	5.5	0.9	0.9	6.2	1.4	1.9	0.6	37.2	18.6	34.3	16.3	1.7	9.9	18.2	20.4	10.4	31.9	36.7	19.3	27.5	23.6	11.6	11.6	17.5	22.3	35.3	12.8	36.9	27.4	19.6	35.4	20.6	23.9	0.8	41.2	14.6	2.8	0.8	18.5	2.9	4.1	19.0	30.5	30.9	14.3	31.6	32.7	43.6	28.4	20.2	30.9	42.6	35.9	31.7	21.0	11.6	20.6	24.8	14.3	20.5	11.9	6.7	16.5	24.5	15.8	6.7	5.3	38.5	21.4	16.9	10.7	22.7	52.7	9.8	30.1	20.9	0.0	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.0	0.2	0.0	0.9	0.0	0.2	0.7	0.1	0.5	0.3	0.5	0.6	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	2.0	3.2	0.5	4.2	2.4	4.8	2.1	1.9	2.2	0.8	1.5	1.1	1.2	1.5	1.3	0.0	0.0	9.1	1.0	2.2	0.0	1.3	1.2	0.8	2.6	1.5	1.2	21.0	9.5	1.5	10.6	2.7	1.1	1.5	0.0	4.3	5.0	5.5	5.5	0.0	11.9	2.8	0.0	1.9	1.6	0.8	1.5	1.1	1.8	7.5	1.0	2.0	4.1	12.1	11.5	0.8	0.5	3.0	5.7	1.9	1.1	1.2	0.9	3.1	0.0	2.1	7.4	5.3	24.4	6.0	3.7	3.4	1.7	1.8	4.7	1.5
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 334.4;Inhibitory neurons: 348.8;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 499.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA		130000	"Cluster 48: NK-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Cytokinetic bridge"	"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356"	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favorable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	16.5	47.7	79.4	26.1	101.6	16.0	17.7	70.0	113.3	19.8	0.0	55.9	10.8	19.2	38.8	17.8	10.0	26.2	23.8	100.7	107.5	23.8	20.8	15.8	41.8	53.5	44.4	17.8	27.8	23.5	24.7	11.5	65.4	30.6	51.7	71.6	83.7	27.3	4.9	4.1	12.7	28.8	59.9	36.0	34.1	8.1	91.0	63.5	25.2	13.5	36.8	27.6	7.7	110.0	8.6	16.9	26.4	31.8	29.9	26.1	12.3	41.7	31.4	20.8	19.4	0.4	7.5	45.1	28.0	32.8	38.0	5.8	12.6	13.6	22.0	44.1	6.8	99.3	21.3	3.2	29.4	39.8	2.2	15.6	6.0	20.2	11.2	30.2	97.2	16.7	3.2	25.2	34.3	1.6	51.8	21.0	26.1	0.1	11.8	39.6	41.2	27.3	50.5	30.2	8.6	33.4	23.0	8.8	25.6	19.7	8.1	8.2	86.8	28.7	22.4	29.4	31.9	18.6	24.2	45.3	13.7	41.5	36.5	56.3	7.5	16.4	59.3	10.2	47.7	35.2	43.4	52.9	19.4	28.4	65.0	69.5	3.8	73.1	16.2	11.1	44.2	66.8	79.4	101.6	70.0	113.3	100.7	107.5	53.5	44.4	65.4	59.9	91.0	110.0	9.5	0.0	1.5	118.8	56.6	5.1	7.2	3.5	11.4	44.9	11.5	9.1	44.4	21.5	5.2	14.7	35.5	1.9	103.0	115.5	33.2	6.2	2.9	11.4	27.0	13.4	21.7	52.3	334.4	11.9	1.2	17.0	16.3	14.0	58.9	15.2	28.5	17.0	27.1	47.1	348.8	58.1	4.1	62.3	24.4	3.6	14.9	51.6	16.0	95.5	14.6	35.6	96.8	302.6	499.0	20.6	42.2	21.8	53.9	10.0	4.5	25.6	6.3	34.4	13.1	14.1	20.3	13.9	8.0	8.1	2.8	0.7	87.6	11.4	51.1	9.1
PRPF6	"ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, RP60, SNRNP102, TOM, U5-102K"	ENSG00000101161	"Pre-mRNA processing factor 6"	O94906	20	63981132-64033100	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047106	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA047106: AB_10963084"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.16e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (5.39e-3)"	44.0	32.2	33.6	30.8	37.4	33.3	40.1	44.9	37.1	38.5	34.5	39.9	30.0	43.5	27.9	38.9	49.3	27.2	39.0	32.9	34.7	35.3	29.8	32.1	40.9	37.7	35.5	50.6	44.2	37.2	36.7	30.9	37.1	34.5	25.9	36.4	38.3	36.4	64.6	58.3	38.1	29.7	34.6	40.9	37.3	41.0	35.5	44.4	36.2	37.1	40.5	40.5	36.2	46.8	72.8	86.5	62.3	66.3	69.5	48.6	81.5	56.1	62.8	167.9	74.6	233.6	86.2	90.9	133.4	74.5	107.1	110.0	101.2	116.1	88.7	44.0	59.0	76.8	112.7	213.3	76.7	105.3	102.3	55.2	81.4	77.5	89.2	59.9	63.3	83.7	76.2	76.6	56.8	89.2	106.8	131.0	55.4	114.4	106.7	116.0	53.0	87.3	64.4	71.9	61.8	72.4	108.6	110.0	74.1	43.2	108.0	135.5	90.1	96.2	55.1	77.4	104.6	63.7	66.5	94.6	70.3	62.5	76.3	90.8	59.7	73.7	67.0	62.7	93.3	67.1	82.3	72.5	58.6	58.4	95.8	80.9	50.3	130.5	77.8	54.5	79.7	92.3	33.6	37.4	44.9	37.1	32.9	34.7	37.7	35.5	37.1	34.6	35.5	46.8	60.7	60.9	62.6	19.2	69.3	38.4	45.3	50.7	63.2	81.6	54.2	59.8	70.5	34.3	71.6	62.5	37.5	72.5	53.2	43.8	82.2	59.3	49.1	70.3	66.8	55.7	52.7	43.5	12.5	56.7	47.6	51.2	38.7	62.0	91.2	49.0	63.9	55.2	46.3	42.1	14.8	60.6	57.0	44.8	34.1	28.7	58.1	49.9	48.0	5.6	79.7	86.5	57.7	12.5	17.8	65.9	43.9	52.6	67.8	33.5	58.0	65.8	87.7	112.7	59.2	68.2	61.9	120.6	118.9	59.8	46.3	94.5	60.0	32.6	47.7	34.3
PSD4	"EFA6B, TIC"	ENSG00000125637	"Pleckstrin and Sec7 domain containing 4"	Q8NDX1	2	113157325-113209396	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 51.2;Proximal enterocytes: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.8;NB-4: 9.3"	"Low region specificity"	"Detected in single"							"HPA034722, HPA077847"	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA034722: AB_10669730, HPA077847: "	"unprognostic (1.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.56e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.60e-3)"	1.7	13.7	1.4	3.1	1.3	3.7	3.9	0.5	1.2	2.3	0.7	7.0	2.0	0.7	4.0	10.8	1.7	1.3	0.8	1.0	1.0	5.2	21.2	5.8	3.9	1.0	0.8	0.5	11.6	3.0	3.4	0.9	1.1	8.7	1.9	0.5	11.3	1.2	0.6	9.0	17.7	0.4	0.9	23.3	12.4	1.5	1.5	5.9	10.1	0.3	4.0	3.7	4.2	0.9	5.7	1.0	0.3	0.1	0.0	0.0	6.1	0.4	2.2	0.4	0.5	1.5	8.1	9.8	1.2	0.2	1.7	7.4	0.0	2.0	0.1	8.3	0.1	4.1	0.8	2.2	0.1	6.9	6.9	0.1	1.9	0.2	0.5	0.9	0.0	3.8	3.9	4.1	0.0	3.2	7.1	9.3	0.1	1.8	1.1	0.1	0.1	4.3	0.4	1.4	0.5	0.0	0.7	5.1	0.0	0.2	1.6	5.6	0.1	0.3	0.2	0.2	1.6	5.0	4.0	3.0	0.9	3.3	0.1	1.7	0.9	1.7	2.0	0.6	1.7	1.0	1.5	1.8	0.6	1.2	1.7	1.9	3.9	2.4	0.7	1.5	1.1	1.4	1.4	1.3	0.5	1.2	1.0	1.0	1.0	0.8	1.1	0.9	1.5	0.9	0.9	19.2	12.0	7.5	28.6	12.7	10.4	7.6	13.1	0.3	22.5	11.2	1.8	11.5	5.8	33.1	0.0	20.7	41.6	39.1	0.0	21.3	0.3	9.0	1.6	2.1	7.2	13.0	0.9	23.6	11.2	3.0	31.1	20.4	3.8	2.9	2.9	51.2	12.1	3.3	1.7	10.7	4.1	13.8	17.0	0.9	0.9	14.3	1.8	2.8	13.8	10.1	47.4	2.5	0.2	23.1	17.8	0.0	18.3	15.8	50.3	7.1	4.6	0.4	0.0	3.0	1.7	0.2	1.1	17.4	15.8	7.5	28.2	1.7	18.6	11.1
PTGDR	"DP, DP1, PTGDR1"	ENSG00000168229	"Prostaglandin D2 receptor"	Q13258	14	52267698-52276724	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Mast cell degranulation"	"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 7.9;lymphoid tissue: 6.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 50.6;NK-cells: 187.4;T-cells: 31.4"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.0"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 68.0;NK-cell: 90.3"	"Group enriched"	"Detected in many"	33	"NK-cells: 90.3;T-cells: 68.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA049668	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA049668: "	"unprognostic (9.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.60e-8)"	"unprognostic (1.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.89e-2)"	2.0	0.5	0.2	2.1	1.7	1.4	1.2	0.8	0.7	2.1	2.6	5.6	0.7	1.5	1.0	0.4	1.3	1.6	1.9	0.1	0.3	0.5	1.1	1.7	3.2	2.4	0.6	0.8	0.3	0.4	2.1	0.2	0.4	0.8	7.9	0.0	1.1	0.4	0.6	0.6	1.4	0.8	1.5	6.3	1.3	0.2	0.4	0.9	1.1	0.4	1.1	0.9	1.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	68.0	0.0	33.5	0.1	9.0	40.9	0.1	0.0	1.4	22.5	2.3	90.3	0.4	0.2	0.2	12.9	0.2	1.7	0.8	0.7	0.1	0.3	2.4	0.6	0.4	1.5	0.4	0.1	2.9	3.2	0.0	0.0	0.9	0.5	0.0	0.0	0.6	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	50.6	3.2	0.0	0.0	0.0	0.2	0.1	2.0	1.2	2.7	0.2	0.0	0.0	1.5	1.1	0.1	1.3	0.2	2.2	0.5	0.1	0.0	0.2	7.5	0.0	1.9	0.4	0.0	0.0	4.6	1.8	1.0	0.4	0.0	187.4	0.0	0.1	0.0	2.8	0.0	4.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	5.5	0.0	0.0	0.1	0.1	0.0	31.4	2.2	14.6	0.0
PTGER1	EP1	ENSG00000160951	"Prostaglandin E receptor 1"	P34995	19	14472466-14475354	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"kidney: 30.9"	"Cell type enriched"	"Detected in some"	70	"Collecting duct cells: 198.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.4;NB-4: 1.3;PC-3: 3.2;SH-SY5Y: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.50e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.74e-8)"	"unprognostic (1.19e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.88e-2)"	0.9	1.4	0.4	0.5	0.7	0.0	0.4	0.3	2.2	1.2	0.9	0.5	0.3	0.5	0.0	0.8	1.0	0.0	0.1	0.3	1.0	30.9	0.3	2.4	0.0	0.4	0.3	0.1	0.3	0.1	1.4	0.0	0.5	0.7	0.0	0.0	0.3	0.0	0.1	0.1	1.4	0.4	0.1	6.5	3.0	0.2	0.5	0.0	0.5	0.0	0.0	1.1	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.1	0.0	3.2	0.3	0.0	0.1	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.7	0.3	2.2	0.3	1.0	0.4	0.3	0.5	0.1	0.5	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.3	0.9	2.8	0.0	198.6	0.0	0.1	1.3	0.3	0.0	0.1	0.1	1.5	0.4	0.2	0.0	0.0	0.0	0.0	0.2	2.5	1.1	1.4	0.0	0.4	0.4	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.8	0.0	0.8	0.1	0.1	0.0	0.4	2.5	0.3	0.9	0.3	0.0	0.0	0.6	0.8	0.2	0.4
PYCR2	P5CR2	ENSG00000143811	"Pyrroline-5-carboxylate reductase 2"	Q96C36	1	225919877-225924340	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA056873	Approved		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Mitochondria		"HPA056873: AB_2683263"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.07e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	38.0	71.7	53.2	35.8	62.4	47.3	35.8	68.1	54.2	46.4	51.8	39.6	22.3	48.5	26.4	32.3	44.7	22.4	62.3	50.4	61.3	40.2	40.3	38.2	47.2	69.0	61.2	47.9	47.2	42.0	57.0	28.5	66.0	39.6	18.3	34.0	39.6	40.9	66.8	28.3	34.4	25.7	68.6	49.5	38.9	34.4	59.2	43.9	30.0	49.1	33.9	50.3	33.3	72.5	72.6	59.6	35.0	59.1	38.8	40.0	73.2	74.8	46.3	49.7	44.1	77.2	58.3	126.1	156.6	55.0	39.1	81.6	50.5	58.6	28.3	154.6	107.5	120.6	60.2	81.5	59.8	107.9	189.1	38.8	72.3	56.1	64.1	44.1	47.8	103.7	178.4	81.6	50.9	60.5	135.8	120.9	196.0	112.8	80.4	120.2	79.0	263.6	65.2	58.3	44.0	56.7	62.4	48.7	161.0	27.9	62.3	202.0	40.3	38.4	46.5	82.9	104.4	129.9	156.2	127.4	60.7	80.6	109.3	38.4	19.6	39.6	45.5	29.2	47.8	34.4	43.8	42.4	31.3	41.9	74.9	62.4	13.3	67.9	26.3	59.2	44.0	45.1	53.2	62.4	68.1	54.2	50.4	61.3	69.0	61.2	66.0	68.6	59.2	72.5	28.0	19.2	22.8	11.4	31.6	14.8	64.6	53.4	8.0	15.6	24.3	21.2	47.6	20.0	24.8	35.0	14.6	90.6	39.1	12.9	49.0	50.0	8.2	92.8	25.6	26.7	26.5	58.7	4.6	34.0	46.3	23.7	10.2	31.8	38.7	74.9	21.0	16.6	40.0	13.5	5.8	17.8	57.0	20.4	19.8	8.8	38.2	31.5	33.8	8.4	46.4	46.9	46.4	5.5	29.3	29.1	15.8	37.6	23.1	42.1	18.3	35.8	55.4	42.7	26.3	19.8	24.4	40.1	46.2	9.4	12.8	41.7	34.9	44.9	16.1	40.4
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Gastric mucus-secreting cells: 178.4;granulocytes: 246.6;Late spermatids: 209.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.2;NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 63.3;hTCEpi: 46.6;hTERT-HME1: 56.0;U-87 MG: 165.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		6500000	"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	0.3	2.6	7.9	1.1	10.2	1.0	11.9	0.0	11.9	3.0	0.0	4.9	5.1	0.8	0.4	14.0	1.1	3.8	0.1	13.3	5.2	0.3	1.3	7.2	0.5	0.0	0.1	0.2	4.1	2.3	1.0	1.1	0.6	20.5	5.3	1.0	14.0	1.0	0.2	15.6	4.9	0.9	0.1	1.7	44.1	4.5	2.6	1.4	0.3	0.5	5.2	6.2	5.2	3.3	7.8	22.4	0.8	0.0	1.5	19.3	0.0	1.7	13.5	1.8	1.3	0.0	8.6	1.3	0.1	3.9	16.7	14.5	0.2	9.0	0.5	0.0	0.5	63.3	5.0	0.0	2.6	3.4	7.0	15.3	46.6	25.5	56.0	21.1	1.2	0.3	0.0	3.9	16.1	7.9	0.2	7.4	0.2	14.0	14.7	0.0	0.0	0.3	4.1	28.9	0.2	10.3	2.2	13.4	0.0	0.1	8.3	0.3	0.3	18.8	0.6	9.8	2.0	0.4	0.0	0.0	165.2	35.6	0.9	0.6	0.0	0.1	2.2	0.0	0.5	0.0	0.7	1.1	0.0	0.0	0.2	1.0	0.2	2.6	0.0	0.0	0.0	1.6	7.9	10.2	0.0	11.9	13.3	5.2	0.0	0.1	0.6	0.1	2.6	3.3	0.3	48.1	37.6	3.3	0.9	25.6	8.6	18.2	8.0	2.4	59.8	25.3	0.5	8.6	36.9	5.5	2.1	6.5	15.0	5.7	1.9	7.2	259.3	30.9	4.4	1.9	4.2	3.4	101.0	41.0	4.5	2.0	178.4	64.0	246.6	0.4	2.5	0.9	0.6	6.7	75.8	31.3	20.3	0.6	2.7	209.9	2.1	38.1	7.2	2.8	2.1	1.4	29.9	98.5	2.6	34.0	18.6	0.4	3.2	78.9	3.0	0.0	15.8	0.4	6.6	0.3	2.2	7.9	1.4	79.2	49.2	2.9	13.9	0.5	7.9	42.2
RAB38	NY-MEL-1	ENSG00000123892	"RAB38, member RAS oncogene family"	P57729	11	88113251-88175443	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 48.6;skin 1: 44.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.4;Basal respiratory cells: 74.8;Cytotrophoblasts: 94.5;Melanocytes: 131.6;Suprabasal keratinocytes: 98.5;Syncytiotrophoblasts: 54.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 73.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"NK-cell: 18.0"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 18.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 87.7;hTCEpi: 308.0;hTERT-HME1: 271.4;SK-MEL-30: 175.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	HPA071701			Uncertain	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies, Mitochondria"		"HPA071701: "	"unprognostic (2.85e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	2.6	27.8	0.4	1.4	0.4	1.6	8.6	0.3	0.8	11.8	6.3	1.9	2.4	4.7	6.7	48.6	5.6	6.0	1.1	0.7	0.6	4.5	1.8	5.8	1.7	0.5	0.7	3.3	1.6	1.8	2.8	14.7	0.5	2.4	1.3	2.9	7.7	6.4	0.6	44.3	2.3	3.6	0.4	1.6	1.6	2.5	0.8	3.5	7.9	0.4	17.9	8.7	23.5	0.6	10.7	1.4	0.3	0.5	0.4	2.4	0.6	6.5	26.1	10.4	19.0	4.7	4.8	0.5	6.3	6.9	1.2	71.2	5.7	87.7	14.1	1.3	5.1	54.0	6.2	0.0	1.0	0.6	0.6	2.2	308.0	1.4	271.4	13.0	12.3	1.0	0.3	0.9	0.0	0.0	0.7	18.4	8.2	0.7	0.1	0.5	0.1	0.8	20.0	40.6	1.9	1.2	0.3	0.1	175.6	6.2	15.7	4.6	6.7	0.0	4.6	0.0	1.1	1.5	6.5	0.2	1.7	2.2	1.2	0.0	0.8	0.1	1.5	0.6	0.8	0.0	0.4	1.8	1.6	0.0	0.1	0.8	0.6	18.0	1.3	4.4	1.0	0.7	0.4	0.4	0.3	0.8	0.7	0.6	0.5	0.7	0.5	0.4	0.8	0.6	1.0	0.0	6.7	0.7	0.1	46.4	15.9	74.8	21.1	0.1	6.9	9.7	0.2	8.6	25.0	0.0	0.0	94.5	2.7	0.5	3.9	1.7	0.0	2.1	0.9	2.7	0.0	5.5	0.6	1.1	10.5	9.1	3.1	2.3	16.5	5.3	1.1	0.0	17.5	0.0	0.4	0.3	14.2	1.6	21.2	0.1	3.4	3.9	131.6	3.7	6.3	0.6	1.0	2.0	0.1	2.6	2.6	1.2	0.1	9.5	2.1	5.3	7.4	6.4	0.0	0.6	5.3	0.1	5.9	38.1	98.5	54.7	2.7	5.9	2.5	23.3
RAMP1		ENSG00000132329	"Receptor activity modifying protein 1"	O60894	2	237858893-237912106	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 706.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 190.0;Endometrial stromal cells: 546.4;Exocrine glandular cells: 278.2;monocytes: 433.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 152.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	18	"NK-cell: 70.1"	"Lineage enriched"	"Detected in many"	18	"NK-cells: 70.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4;HDLM-2: 146.0;PC-3: 173.8;SH-SY5Y: 201.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057814			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"		"HPA057814: AB_2683536"	"unprognostic (1.13e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (7.61e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.46e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.08e-3)"	18.7	29.2	170.9	21.0	171.2	0.9	7.4	168.7	253.4	362.4	153.7	349.6	57.5	706.0	25.0	9.4	256.6	28.5	287.6	176.0	181.8	26.0	82.7	32.5	6.6	198.8	164.5	45.2	225.0	1.4	15.2	8.6	163.0	142.2	6.4	0.8	10.0	54.6	212.3	11.6	73.5	125.4	171.7	12.3	103.4	5.1	183.5	2.9	6.8	68.8	2.9	171.4	75.1	173.2	29.8	0.0	0.5	0.0	12.4	17.9	1.1	2.1	3.6	1.7	1.5	0.0	47.4	0.3	0.4	0.9	0.1	0.2	7.6	0.1	0.2	146.0	4.0	0.1	0.0	1.2	40.6	0.0	0.2	15.6	22.3	0.1	0.3	0.2	0.0	0.0	0.0	0.3	3.7	2.7	0.1	1.3	0.4	0.1	173.8	0.0	1.5	0.8	0.0	0.0	1.5	201.7	3.5	0.0	0.1	1.8	1.3	0.1	0.0	0.8	0.6	0.4	0.5	0.3	0.3	0.0	0.6	0.1	2.7	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.6	0.1	1.0	0.0	0.5	0.2	0.4	70.1	0.0	0.2	0.0	3.4	170.9	171.2	168.7	253.4	176.0	181.8	198.8	164.5	163.0	171.7	183.5	173.2	1.0	0.0	1.5	64.9	3.1	11.6	13.2	26.9	10.2	2.0	4.4	4.4	190.0	78.6	43.8	11.0	0.0	3.0	44.0	2.1	0.0	62.7	0.2	26.5	546.4	6.2	115.4	4.4	14.2	278.2	5.5	41.7	31.1	11.3	1.3	0.6	30.7	104.0	22.7	1.7	19.2	73.7	10.2	3.1	50.3	0.6	8.4	20.3	64.0	13.1	433.5	6.9	61.8	71.9	11.5	63.5	87.7	11.3	1.9	66.1	96.8	0.2	97.0	2.7	6.6	16.6	78.6	0.3	5.8	2.6	5.8	2.3	7.3	0.5	105.8	28.5
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491648	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 468.3;Late spermatids: 209.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nucleoli rim, Mitotic chromosome"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	32.5	25.4	11.1	32.3	13.6	19.1	31.7	12.5	10.4	33.5	14.8	26.6	23.3	32.2	20.2	25.0	31.8	27.7	25.6	8.7	10.5	39.2	59.5	38.9	49.7	12.3	12.0	37.8	39.0	62.7	17.7	19.3	13.0	42.9	29.3	23.1	34.2	39.9	32.4	26.3	26.1	30.7	11.7	41.0	32.6	48.4	11.4	66.6	40.2	37.7	51.2	30.9	28.9	16.9	25.9	18.1	20.7	20.6	61.2	57.9	9.4	17.8	26.4	23.1	7.9	10.1	30.9	39.0	28.4	32.8	22.3	29.6	17.9	30.1	36.0	12.5	22.4	15.9	14.7	22.0	27.3	23.4	49.0	35.6	34.0	15.3	22.4	43.0	36.3	39.6	12.7	23.2	26.6	7.1	48.6	22.0	7.8	30.8	15.0	33.6	41.8	46.1	25.4	25.3	16.9	14.3	42.2	17.2	19.1	16.8	22.7	30.0	28.3	27.5	14.3	24.1	13.7	35.7	22.9	42.4	34.4	28.2	19.0	53.9	22.5	56.5	53.4	16.2	60.5	22.5	59.7	62.8	21.7	22.0	85.5	75.3	41.8	74.4	28.8	13.1	48.2	76.2	11.1	13.6	12.5	10.4	8.7	10.5	12.3	12.0	13.0	11.7	11.4	16.9	37.9	41.7	101.1	51.2	49.5	23.1	30.1	15.3	40.9	27.8	27.0	15.5	13.5	45.8	32.5	27.6	20.9	6.0	77.0	26.3	17.6	13.4	468.3	38.9	25.8	31.4	19.8	26.5	55.1	10.2	13.0	35.8	24.5	45.9	55.1	27.9	40.7	46.1	11.2	35.3	54.1	30.0	34.6	43.6	23.7	209.1	42.0	35.4	10.6	58.1	44.9	38.3	79.3	63.3	85.7	10.8	19.0	42.9	48.7	31.4	29.2	25.3	38.3	22.5	39.5	36.2	26.1	161.4	61.3	33.7	27.6	4.1	118.9	25.2	21.7	35.6
RGS3	"C2PA, FLJ20370, PDZ-RGS3"	ENSG00000138835	"Regulator of G protein signaling 3"	P49796	9	113444731-113597743	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 111.6;Horizontal cells: 158.2;Proximal tubular cells: 195.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 248.4;HDLM-2: 413.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044234			Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA044234: "	"prognostic unfavorable (9.93e-4)"	"unprognostic (4.04e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (6.62e-4)"	"unprognostic (6.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.90e-1)"	60.5	31.5	32.0	18.1	37.3	9.3	43.7	33.7	29.7	17.9	49.7	30.4	16.9	20.8	11.4	10.8	15.2	42.4	95.0	24.0	31.5	70.9	54.5	64.2	23.9	32.2	44.3	10.3	23.9	12.3	16.6	32.3	32.5	26.3	15.8	10.3	10.8	10.2	48.2	15.2	20.0	18.0	28.2	31.9	27.6	31.2	58.0	7.9	24.5	19.2	11.4	26.5	15.4	34.0	4.5	16.6	40.1	37.0	12.2	18.1	2.9	41.2	248.4	32.9	27.9	40.8	14.7	17.9	29.7	33.6	32.8	10.6	0.6	16.0	19.2	413.2	0.1	1.7	13.0	24.8	24.8	0.4	5.5	32.4	16.6	91.4	13.2	72.6	125.4	1.0	0.3	17.1	60.5	18.7	1.2	1.9	10.6	28.6	13.7	1.3	19.8	2.9	67.7	8.1	31.3	4.2	3.9	31.3	24.7	19.6	21.5	3.8	61.2	109.7	11.8	5.1	79.1	8.6	1.5	2.7	126.2	3.8	51.6	10.2	6.8	3.7	24.7	7.1	16.7	2.4	5.7	20.3	6.6	2.4	2.4	10.8	18.5	42.3	6.0	0.3	3.8	15.6	32.0	37.3	33.7	29.7	24.0	31.5	32.2	44.3	32.5	28.2	58.0	34.0	49.5	16.0	13.9	14.4	5.6	12.0	9.9	7.4	4.6	1.4	9.1	10.7	55.8	72.9	8.4	22.0	6.2	4.6	23.5	28.0	82.2	65.1	38.8	9.9	14.9	111.6	0.0	6.1	2.4	30.4	3.7	29.3	27.0	4.0	47.7	12.8	66.0	35.2	15.6	158.2	3.4	7.4	4.1	14.3	13.8	17.4	4.7	14.6	55.2	21.5	10.3	3.5	50.4	3.5	24.4	31.0	23.4	13.9	4.5	5.0	20.5	195.7	7.5	6.4	6.6	8.4	35.4	9.9	1.8	4.1	11.4	3.0	18.4	55.5	11.5	12.9
RHBDL1	"RHBDL, RRP"	ENSG00000103269	"Rhomboid like 1"	O75783	16	675671-678268	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.6;Excitatory neurons: 30.1;Inhibitory neurons: 27.1;Ionocytes: 18.3;Rod photoreceptor cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.8;MCF7: 9.2;U-266/70: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030359, HPA030360, HPA046593"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711"	"prognostic favorable (8.12e-4)"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.63e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.49e-2)"	0.8	5.0	9.2	0.4	9.7	1.0	1.0	9.1	17.7	2.0	0.0	2.2	2.4	1.0	0.6	1.2	1.6	0.4	2.4	7.9	6.1	4.1	2.0	1.1	0.4	5.5	4.8	2.1	2.6	0.6	8.3	0.3	4.9	2.7	0.3	2.1	2.4	0.9	0.5	2.6	2.5	0.2	3.2	0.9	2.7	4.2	7.4	1.4	0.9	0.0	0.1	1.5	1.5	7.7	1.7	2.1	1.2	1.8	0.9	2.3	6.1	0.7	1.1	0.4	0.1	4.4	1.2	0.6	1.4	0.4	0.2	1.1	0.1	0.3	0.0	1.5	7.7	0.8	9.8	1.8	0.8	1.6	1.1	1.6	2.8	0.3	0.0	0.9	0.1	2.8	1.3	1.2	0.1	9.2	0.4	4.4	1.1	2.3	0.6	7.6	1.1	1.6	0.1	1.5	1.5	2.0	0.9	0.4	2.2	0.7	3.2	4.5	0.5	2.5	2.2	0.8	0.6	10.5	1.5	2.2	0.9	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	9.2	9.7	9.1	17.7	7.9	6.1	5.5	4.8	4.9	3.2	7.4	7.7	0.6	0.0	0.0	15.3	2.8	2.2	3.8	10.3	12.5	17.6	2.5	4.2	0.9	0.0	2.4	0.0	12.5	0.2	0.3	2.7	0.0	0.7	2.7	1.4	1.1	0.3	2.4	0.0	30.1	0.5	0.2	1.1	3.1	1.0	0.0	1.9	0.4	0.7	0.3	15.2	27.1	6.1	18.3	0.9	1.2	1.4	1.5	0.4	0.0	1.9	0.2	2.9	0.0	10.6	4.1	1.4	3.8	2.6	0.9	1.6	17.3	9.9	10.8	31.8	0.0	0.4	1.2	1.5	1.7	1.4	1.8	0.3	0.6	3.0	5.5	2.8
RIBC1	FLJ32783	ENSG00000158423	"RIB43A domain with coiled-coils 1"	Q8N443	X	53422690-53431120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.5;testis: 39.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 249.1;Late spermatids: 609.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 6.1;T-47d: 7.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001150			Approved	"Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA001150: AB_2666211"	"unprognostic (1.08e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.39e-3)"	"unprognostic (9.88e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	0.7	3.9	3.2	0.7	3.1	0.6	1.5	2.9	3.4	2.7	10.2	1.1	0.9	2.4	2.9	0.7	27.5	1.4	1.1	3.1	3.9	3.2	0.7	3.3	0.8	7.5	6.5	2.6	1.9	2.6	6.6	0.3	4.7	1.8	0.5	11.4	2.0	1.6	0.7	1.2	0.8	0.6	5.4	0.9	0.9	39.3	3.4	1.7	3.5	0.5	0.6	0.8	0.9	4.8	1.3	3.5	1.3	0.9	0.4	0.9	0.8	0.4	0.2	0.7	0.7	1.3	2.1	1.3	2.3	0.1	2.3	2.4	0.3	0.7	0.9	0.8	2.3	0.8	6.1	0.6	0.2	0.8	1.3	0.3	0.3	2.0	0.5	1.7	0.6	1.0	0.6	1.5	0.5	0.9	1.5	0.7	1.7	0.6	0.9	1.1	0.9	1.0	2.0	0.7	2.9	0.5	3.4	1.2	0.8	4.1	7.8	0.3	0.2	0.3	1.7	1.0	0.5	1.4	1.1	0.7	1.3	0.3	0.6	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.2	0.5	0.3	0.3	0.1	0.1	0.8	1.2	0.4	0.2	0.5	0.2	3.2	3.1	2.9	3.4	3.1	3.9	7.5	6.5	4.7	5.4	3.4	4.8	0.3	0.0	0.5	1.0	0.2	1.3	2.1	3.7	1.8	2.2	1.7	2.2	1.2	2.8	6.5	0.0	4.2	0.5	0.2	0.3	1.9	1.4	249.1	73.2	1.0	0.8	1.2	0.0	0.2	0.2	0.5	0.9	0.0	1.6	2.5	0.5	0.0	0.7	0.1	1.7	0.3	0.1	10.2	0.6	0.3	609.6	2.5	0.5	1.8	0.0	0.0	5.5	0.0	0.0	0.5	0.5	0.1	1.9	0.0	0.8	0.7	7.2	71.4	11.3	0.0	1.6	1.0	14.2	6.4	0.4	0.9	0.4	0.6	2.1	0.3	0.7
RNF165	"Ark2C, ARKL2, RNF111L2"	ENSG00000141622	"Ring finger protein 165"	Q6ZSG1	18	46326809-46463140	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.6;retina: 18.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 44.0;Cone photoreceptor cells: 100.1;Excitatory neurons: 47.4;Horizontal cells: 80.8;Inhibitory neurons: 34.4;NK-cells: 41.2;Oligodendrocyte precursor cells: 35.7;Rod photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 10.1;HaCaT: 7.3;HeLa: 7.5;RPMI-8226: 6.4;SCLC-21H: 13.9;SH-SY5Y: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041615, HPA047798"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"HPA041615: AB_2677582, HPA047798: AB_2680158"	"unprognostic (6.46e-3)"	"unprognostic (7.25e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-5)"	"unprognostic (3.43e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-5)"	"unprognostic (3.53e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	0.6	0.5	3.1	0.3	3.7	0.3	0.7	7.6	6.4	0.6	0.0	0.4	0.0	0.2	1.9	1.2	1.2	0.3	1.0	4.7	0.2	1.6	5.2	0.3	0.2	0.0	0.3	0.0	0.3	2.4	4.1	0.2	0.0	2.2	0.1	18.2	0.8	1.3	1.5	1.2	0.3	0.1	0.1	2.0	0.2	0.5	1.3	0.9	4.0	0.8	0.4	0.3	0.5	1.9	1.6	0.1	10.1	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	7.3	0.5	1.0	0.0	0.0	1.1	0.1	7.5	0.0	0.0	3.4	0.0	0.0	0.8	0.0	0.0	0.4	0.0	2.3	0.0	0.2	0.0	0.0	2.6	0.9	1.7	0.4	1.3	2.7	0.6	6.4	0.7	2.2	13.9	13.2	2.0	0.0	0.0	0.9	0.3	0.5	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	3.8	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	3.1	3.7	7.6	6.4	4.7	0.2	0.0	0.3	0.0	0.1	1.3	1.9	9.1	3.2	1.7	1.6	0.3	2.7	9.5	12.9	28.5	44.0	2.9	7.2	8.4	1.5	2.8	0.0	100.1	0.2	10.0	0.2	3.9	0.0	3.8	1.5	9.3	5.0	0.0	0.0	47.4	0.0	0.3	2.4	0.0	0.6	0.0	0.0	1.8	8.9	0.1	80.8	34.4	0.0	2.0	1.9	1.3	5.1	2.5	0.4	1.8	1.9	0.3	5.0	41.2	35.7	1.8	0.1	0.0	4.1	0.4	5.0	0.1	0.1	0.6	49.1	0.0	4.5	0.7	0.4	0.9	3.7	2.0	0.3	3.2	3.2	0.0	2.4
RPUSD3	MGC29784	ENSG00000156990	"RNA pseudouridine synthase D3"	Q6P087	3	9837849-9844602	"Predicted intracellular proteins"	"mRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 249.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037551, HPA037552"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA037551: AB_2675538, HPA037552: AB_10672600"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.83e-2)"	18.8	28.8	25.1	13.2	25.4	21.3	19.8	24.3	31.3	20.3	22.0	25.3	17.6	21.5	14.7	32.3	20.0	8.7	37.2	26.5	25.4	24.7	30.7	16.1	17.4	23.8	24.1	17.8	24.5	26.1	20.3	16.7	23.8	19.9	16.5	15.5	19.9	17.4	72.7	27.4	20.1	16.7	21.6	21.0	22.8	54.3	25.3	15.2	16.0	48.2	21.3	24.2	21.0	26.0	30.5	44.8	33.6	21.7	55.1	40.5	249.3	25.9	36.7	41.9	44.3	39.4	30.6	52.4	31.6	29.0	61.7	25.6	75.2	46.3	33.2	40.7	78.9	69.8	39.6	42.5	43.1	43.5	42.3	50.0	63.3	48.9	56.5	34.2	55.9	69.3	52.7	35.4	41.9	72.0	59.6	78.9	36.4	44.4	66.3	41.5	27.5	88.5	46.2	23.0	25.9	21.5	32.6	41.0	69.9	47.9	70.3	46.3	33.6	16.7	30.0	29.8	38.4	52.3	67.4	70.0	35.1	81.3	39.5	35.4	51.0	26.5	44.1	38.2	45.7	50.3	41.4	42.3	46.8	41.9	46.3	41.7	12.3	84.9	26.7	45.0	64.9	41.5	25.1	25.4	24.3	31.3	26.5	25.4	23.8	24.1	23.8	21.6	25.3	26.0	11.8	19.2	9.6	10.1	19.5	8.0	21.4	27.8	13.1	22.8	17.1	21.5	25.4	21.5	20.8	14.7	20.9	44.3	19.8	16.4	46.9	31.1	80.3	6.9	13.7	15.8	13.2	24.6	9.9	31.6	48.6	16.3	15.8	9.7	21.0	20.1	22.1	28.3	39.1	11.8	10.6	17.0	12.2	14.7	7.3	59.5	21.5	15.2	16.0	3.7	27.2	20.6	54.6	8.0	6.3	25.8	20.6	21.4	18.8	19.5	28.1	55.4	12.9	22.2	6.6	13.3	17.2	100.7	20.6	22.3	12.8	17.2	20.5	33.9	28.6	16.2
RUNX2	"AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1"	ENSG00000124813	"RUNX family transcription factor 2"	Q13950	6	45328157-45664349	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 55.8;Early spermatids: 128.3;Inhibitory neurons: 95.2;Microglial cells: 128.4;Plasma cells: 44.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 22.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 39.3;Karpas-707: 62.3;RH-30: 51.8;U-698: 55.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008374, HPA022040, CAB062561, CAB068226, HPA070715"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: "	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (3.97e-9)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (5.52e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (6.66e-5)"	1.7	0.7	1.1	4.3	1.0	9.7	2.8	1.2	1.4	6.7	0.9	3.7	2.0	1.5	0.8	1.4	0.9	3.4	0.7	1.3	1.5	1.5	0.7	2.7	4.5	1.9	1.8	2.2	0.6	0.6	1.6	1.5	1.9	4.8	3.9	0.1	10.7	2.6	0.8	2.4	6.0	1.6	1.6	3.6	3.2	0.5	2.0	4.5	1.8	0.9	5.6	3.6	4.9	1.9	3.6	1.1	0.8	0.0	3.2	8.3	0.0	3.3	7.9	10.9	15.2	0.0	1.9	0.0	3.8	4.7	4.9	4.3	0.0	3.1	19.7	13.7	1.5	0.0	2.4	0.0	16.7	14.2	0.1	22.5	2.5	9.7	10.9	39.3	0.2	5.6	0.0	62.3	19.7	1.0	0.4	24.7	0.7	3.2	0.5	0.1	51.8	0.0	10.7	7.0	0.0	0.0	2.4	0.1	4.1	9.2	3.6	1.2	0.5	11.1	8.8	17.2	12.1	19.6	0.0	55.2	12.5	5.3	5.0	8.6	0.9	4.5	1.5	0.2	12.9	0.2	3.5	4.0	2.4	0.2	0.6	1.8	6.5	22.1	0.1	15.4	3.2	1.0	1.1	1.0	1.2	1.4	1.3	1.5	1.9	1.8	1.9	1.6	2.0	1.9	0.9	0.0	2.7	4.6	5.7	2.8	16.6	5.3	1.2	0.0	2.0	1.4	2.7	0.0	4.9	3.7	0.0	0.0	55.8	0.3	0.0	0.6	128.3	0.7	3.5	0.8	0.0	3.8	17.4	0.2	0.0	7.0	4.1	0.5	2.5	0.1	1.1	0.8	3.7	0.0	95.2	1.0	20.3	6.7	20.8	20.0	1.2	16.3	7.2	128.4	18.6	0.0	7.2	6.6	5.2	0.4	0.1	2.2	44.4	16.5	0.0	3.3	5.1	0.0	6.6	1.5	6.2	0.8	0.5	1.2	1.6	0.1	21.4	0.2	0.2	28.0
RWDD4	"FAM28A, MGC10198, RWDD4A"	ENSG00000182552	"RWD domain containing 4"	Q6NW29	4	183639635-183659203	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036501, HPA036502"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Intermediate filaments"		"HPA036501: AB_2675159, HPA036502: AB_10670800"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (1.01e-6)"	"unprognostic (6.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.65e-2)"	11.9	52.1	9.2	8.9	9.6	14.7	19.1	10.9	12.5	12.3	14.5	12.0	11.0	12.1	14.3	14.5	13.7	12.7	16.2	9.2	11.7	23.7	15.9	9.6	10.7	9.8	10.2	40.4	26.2	11.8	19.0	11.6	9.5	15.2	12.1	6.2	20.6	11.0	44.9	11.2	10.0	10.7	9.5	9.8	13.7	10.0	10.9	15.9	22.2	32.2	12.5	14.0	10.4	10.1	25.6	14.6	22.0	27.2	35.1	36.5	16.7	31.8	25.4	38.9	24.7	9.5	32.8	38.6	7.1	26.6	18.8	11.8	31.1	29.7	40.8	25.5	14.0	27.7	16.4	24.4	24.7	42.5	20.3	24.2	30.0	21.6	24.0	30.2	29.8	29.7	27.0	48.5	42.0	10.8	44.7	36.7	14.7	9.8	19.2	30.7	17.0	24.8	38.5	12.1	21.0	29.6	29.9	34.4	29.0	16.9	17.3	25.8	20.9	16.3	8.0	17.6	24.9	16.2	13.1	13.1	30.6	31.8	23.7	3.2	3.4	6.8	4.4	4.5	4.4	3.8	4.0	4.2	4.4	2.5	3.7	3.9	2.9	6.5	5.5	4.7	5.7	3.5	9.2	9.6	10.9	12.5	9.2	11.7	9.8	10.2	9.5	9.5	10.9	10.1	29.4	22.4	19.5	7.2	25.6	33.6	35.4	32.0	27.3	17.9	39.2	40.8	11.5	37.1	25.3	18.4	6.2	25.9	32.9	19.7	74.3	38.8	10.6	38.4	28.6	27.3	21.7	30.3	10.3	77.5	42.4	33.4	28.1	28.2	35.5	35.9	26.4	35.6	36.1	10.1	9.5	21.6	38.7	30.1	21.9	9.9	74.0	23.8	56.9	6.5	34.7	30.9	32.0	6.6	7.7	55.8	17.1	70.7	32.5	90.3	19.6	116.1	32.0	22.1	19.7	44.5	27.4	47.7	59.7	46.0	35.5	27.1	26.7	70.2	25.4	59.1
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 3084.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 28.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.9;NK-cells: 28.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 811.3;SuSa: 896.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		36000	"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	275.3	137.3	237.4	47.7	247.3	4.4	222.4	241.0	347.5	133.7	214.6	198.9	30.6	111.8	72.1	91.7	129.8	103.9	310.1	233.1	240.8	262.2	66.2	138.0	48.8	252.9	245.5	138.2	75.7	317.4	73.9	70.1	249.4	100.9	59.8	25.8	156.1	64.6	250.6	114.0	116.5	68.9	245.8	111.7	94.4	41.2	251.6	21.2	318.7	220.6	49.6	121.2	122.7	258.6	188.7	153.7	174.5	111.4	150.7	437.5	62.7	254.7	400.0	150.6	172.2	150.4	203.7	4.9	471.6	435.5	22.3	174.7	73.5	158.7	132.7	0.8	68.1	12.0	178.0	129.6	99.8	5.9	39.2	355.3	59.4	135.3	145.0	441.9	346.5	1.3	61.4	0.3	475.2	663.4	0.4	3.4	141.0	161.1	460.2	30.0	180.4	1.4	811.3	141.9	53.4	2.0	544.7	277.2	576.7	896.9	226.4	6.8	495.0	103.3	57.9	139.5	312.0	2.0	5.3	9.3	185.5	3.2	62.1	4.1	2.0	0.2	0.4	0.9	0.9	4.1	0.4	0.3	7.0	2.0	0.6	0.5	0.3	28.3	1.4	11.9	1.4	1.1	237.4	247.3	241.0	347.5	233.1	240.8	252.9	245.5	249.4	245.8	251.6	258.6	331.0	28.9	106.1	29.7	9.3	110.5	177.4	105.0	103.0	2.1	311.2	345.6	141.9	164.5	104.0	465.3	0.0	132.4	15.3	148.7	248.4	323.3	8.4	399.3	449.1	251.9	124.7	17.3	1.2	323.6	202.1	450.0	58.6	573.8	23.5	185.5	372.3	51.8	162.3	0.0	0.5	167.5	61.1	31.7	107.7	36.3	771.7	37.1	238.3	13.1	14.8	308.1	1.0	0.0	8.8	488.4	164.7	314.1	6.3	240.0	128.7	521.7	77.1	6.9	0.0	234.2	132.5	12.8	23.4	80.3	75.7	74.7	20.5	3084.7	100.6	244.3
S100PBP	"FLJ12903, S100PBPR"	ENSG00000116497	"S100P binding protein"	Q96BU1	1	32816767-32858875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.8;Spermatocytes: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027242, HPA027328"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA027242: AB_2672174, HPA027328: AB_2672221"	"unprognostic (4.29e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.44e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (1.61e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.71e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	9.5	10.9	12.1	10.0	19.4	14.2	9.6	13.3	14.1	14.3	13.9	10.8	6.1	12.2	10.1	7.2	12.5	10.0	7.0	10.7	16.1	7.9	8.8	9.2	15.7	14.2	14.1	16.9	6.9	6.5	11.1	10.9	13.7	10.0	7.6	14.0	8.9	8.5	7.0	8.4	11.3	10.9	12.0	15.6	8.2	34.5	15.1	18.7	11.6	8.1	14.9	10.0	10.2	17.6	11.7	15.0	32.2	17.8	15.0	21.0	16.6	22.3	15.7	20.5	22.7	9.5	18.6	36.5	17.2	14.8	19.7	18.3	31.7	13.1	25.2	18.6	10.6	45.7	31.1	12.1	17.6	21.1	18.0	15.2	12.3	19.5	23.9	27.9	21.8	30.8	27.5	27.2	25.0	6.8	32.6	19.0	38.2	7.9	11.7	29.7	34.5	31.3	9.3	7.6	15.0	14.6	22.9	6.6	24.9	49.2	13.8	13.0	11.4	28.3	18.9	24.3	14.7	40.2	39.2	36.5	13.8	22.2	15.9	7.5	3.6	6.5	6.6	2.0	7.9	8.7	5.2	7.1	3.8	5.4	3.6	5.2	4.6	18.7	1.7	11.3	5.5	3.8	12.1	19.4	13.3	14.1	10.7	16.1	14.2	14.1	13.7	12.0	15.1	17.6	18.3	12.8	21.0	32.3	20.0	10.5	10.4	12.5	26.2	21.2	18.0	16.1	6.0	18.6	13.6	20.2	35.5	14.8	32.6	7.7	13.7	11.0	7.8	13.0	20.6	15.4	8.4	23.1	17.9	5.0	17.0	15.5	12.8	13.1	14.5	29.1	21.4	11.5	15.2	18.5	23.9	7.8	8.2	19.3	9.6	6.9	19.0	14.5	5.4	48.7	10.6	13.1	33.0	51.8	78.8	6.6	4.4	17.7	29.2	9.7	12.6	5.9	9.8	25.0	26.3	12.5	16.6	109.9	74.4	17.6	7.1	6.2	22.0	12.3	9.9	6.5
SACM1L	"KIAA0851, SAC1"	ENSG00000211456	"SAC1 like phosphatidylinositide phosphatase"	Q9NTJ5	3	45689056-45745409	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039573, HPA069869"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Golgi apparatus"		"HPA039573: AB_10674983, HPA069869: AB_2686216"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.29e-3)"	"prognostic favorable (5.47e-7)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.33e-2)"	23.5	26.3	13.2	26.2	13.8	21.1	22.0	17.1	16.1	22.1	13.6	24.0	23.3	20.6	23.3	20.2	16.9	19.2	16.3	14.0	18.8	38.1	28.2	28.9	26.8	15.5	14.9	16.2	21.8	35.8	10.9	25.0	14.7	24.3	23.6	20.3	22.9	20.6	8.8	18.4	21.6	21.2	14.6	26.2	25.0	14.2	15.9	32.5	43.5	11.4	25.0	22.9	10.8	16.3	31.0	23.0	38.0	22.0	58.8	39.2	29.6	50.1	43.0	36.9	33.1	30.5	21.8	47.8	24.3	39.8	49.8	22.7	50.4	27.0	48.9	34.3	26.8	50.8	38.2	25.7	37.6	78.0	61.5	26.5	41.1	39.9	29.6	29.9	25.6	43.2	57.9	45.7	60.6	14.0	59.5	41.4	40.1	29.6	40.1	17.2	20.0	48.4	41.2	42.7	15.0	36.1	35.5	36.3	44.7	38.0	31.0	64.1	33.7	36.2	21.1	37.0	44.5	25.3	71.7	32.5	45.1	106.8	36.2	10.3	17.1	27.5	24.6	14.2	27.5	11.0	17.8	26.0	27.2	11.9	17.6	23.5	14.1	65.2	13.0	11.1	16.7	27.6	13.2	13.8	17.1	16.1	14.0	18.8	15.5	14.9	14.7	14.6	15.9	16.3	18.4	28.9	37.3	22.5	22.2	19.6	9.1	14.6	22.2	22.8	15.2	12.3	16.6	14.3	15.7	7.3	31.3	22.9	55.4	16.4	19.6	11.1	1.6	15.9	31.9	17.6	12.0	23.4	44.7	10.0	11.2	19.5	17.3	18.5	17.1	17.2	17.2	15.4	24.5	33.7	42.7	9.4	18.3	23.0	18.7	2.9	16.8	22.6	17.8	30.9	25.5	15.8	46.4	40.7	43.6	12.9	20.7	23.0	33.2	14.6	18.5	22.3	14.1	20.7	6.6	15.8	16.6	12.3	12.0	15.7	17.3	18.3	44.5	19.5	13.6	11.6
SAMD3	"bA73O6.2, FLJ34032"	ENSG00000164483	"Sterile alpha motif domain containing 3"	Q8N6K7	6	130144315-130365425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 157.0;NK-cells: 271.9;Plasma cells: 43.7;T-cells: 84.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	47	"NK-cells: 128.4;T-cells: 113.8"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.8;HDLM-2: 3.4;hTEC/SVTERT24-B: 2.2;hTERT-RPE1: 1.9;NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.1"	"HPA028992, HPA028993"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA028992: AB_10598914, HPA028993: AB_10601891"	"unprognostic (2.91e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.07e-6)"	"unprognostic (7.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.45e-2)"	1.1	2.3	1.4	4.0	2.0	4.2	0.9	0.6	1.6	2.9	0.6	1.2	0.7	4.4	1.9	0.7	1.5	2.3	0.5	2.9	1.2	1.1	1.7	3.3	10.4	0.8	2.0	1.8	1.2	0.1	4.8	0.7	0.9	0.7	2.3	1.4	0.7	0.4	0.8	0.5	1.4	1.7	0.4	9.3	1.6	3.2	1.9	6.3	0.8	0.7	4.2	1.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.3	0.5	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.8	3.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.3	0.0	2.2	0.1	1.9	0.2	0.4	0.1	0.0	0.2	0.0	0.1	0.0	1.7	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.5	113.8	0.4	90.0	2.5	39.8	102.1	0.6	0.3	28.8	68.9	2.3	128.4	0.6	0.6	41.7	41.4	1.4	2.0	0.6	1.6	2.9	1.2	0.8	2.0	0.9	0.4	1.9	0.4	1.1	0.0	2.3	1.3	2.3	0.4	0.0	0.0	0.6	3.0	0.6	0.5	0.8	0.0	0.0	0.0	0.0	0.0	157.0	1.6	0.0	0.2	25.4	1.0	2.1	0.8	3.6	6.6	12.1	0.0	0.0	0.7	0.0	0.5	1.3	14.8	2.9	0.4	0.0	0.0	5.7	0.3	0.0	3.4	1.4	6.7	0.6	1.8	5.4	12.2	2.3	0.0	271.9	1.5	0.6	0.0	1.5	1.9	43.7	0.0	0.1	0.6	0.7	0.4	0.0	0.3	1.4	2.3	1.6	0.2	0.4	0.0	84.3	2.0	0.5	0.1
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345377-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 374.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 180.2;Inhibitory neurons: 283.4;Oligodendrocyte precursor cells: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"naive CD4 T-cell: 113.7"	"Group enriched"	"Detected in all"	4	"NK-cells: 63.4;T-cells: 113.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 455.3;JURKAT: 213.3;MOLT-4: 107.7;REH: 126.5;THP-1: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144, HPA070534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies"	"CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: "	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favorable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	16.1	10.3	13.4	28.8	19.1	42.8	13.2	0.8	32.2	11.4	2.6	29.9	16.0	13.6	24.0	12.2	17.9	17.6	26.0	23.4	0.4	10.8	15.4	15.7	38.1	0.3	6.1	13.8	28.8	32.4	22.5	4.9	0.0	22.5	18.5	29.8	44.0	25.9	89.5	21.4	21.0	11.8	1.4	27.4	18.5	6.7	0.9	374.2	24.5	49.0	27.8	24.6	12.3	11.0	2.1	0.0	12.7	0.0	17.2	16.6	1.4	3.4	12.3	2.9	9.8	0.5	22.9	4.7	0.4	4.1	1.0	0.2	46.4	5.4	5.9	455.3	28.0	0.1	1.1	0.0	2.5	26.7	3.8	7.4	4.0	0.1	0.6	35.1	3.3	213.3	0.6	24.3	2.2	0.4	107.7	33.9	18.5	1.5	1.5	126.5	6.2	4.9	4.8	15.7	5.9	34.5	0.0	3.9	0.3	10.0	98.5	192.7	1.7	12.6	7.9	5.9	3.7	1.3	0.4	10.0	10.3	101.3	5.7	21.1	1.9	4.6	44.2	2.0	78.6	1.6	29.9	23.0	3.5	13.0	113.7	69.5	4.1	63.4	1.1	4.0	6.0	26.6	13.4	19.1	0.8	32.2	23.4	0.4	0.3	6.1	0.0	1.4	0.9	11.0	19.3	25.6	29.6	48.3	44.6	14.3	12.3	10.9	12.0	12.1	33.2	18.0	70.0	22.8	15.0	31.3	87.6	0.5	71.1	11.0	1.9	16.9	8.2	31.6	15.3	17.0	32.4	22.5	180.2	12.5	0.2	16.4	8.6	11.6	23.4	20.6	35.0	20.9	9.3	0.0	283.4	30.8	4.1	41.5	36.4	4.3	8.4	45.5	10.6	41.2	23.0	15.5	56.7	168.9	28.8	10.5	23.6	8.2	20.6	21.7	24.6	9.1	50.9	63.1	6.6	8.3	10.2	3.2	9.3	20.5	22.0	0.3	84.0	16.8	25.7	19.7
SEPTIN11	"FLJ10849, SEPT11"	ENSG00000138758	"Septin 11"	Q9NVA2	4	76949751-77040384	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 90.1;Extravillous trophoblasts: 266.8;Fibroblasts: 40.1;Hofbauer cells: 52.0;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 495.8;fHDF/TERT166: 604.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Approved		Approved	Cytosol		NA	NA		2800000	"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (1.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"prognostic favorable (2.40e-4)"	"unprognostic (5.70e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	84.8	13.0	34.6	27.5	46.5	7.9	39.3	24.3	51.4	40.4	0.0	50.1	21.8	33.8	18.0	22.5	17.4	45.4	30.8	40.5	13.7	52.4	33.9	40.5	24.1	5.2	8.5	20.0	22.3	17.3	11.3	84.1	4.5	21.0	40.4	22.3	11.6	26.1	26.0	13.3	35.3	40.6	0.0	25.6	25.2	7.8	16.6	12.7	21.1	18.3	22.8	39.3	21.5	50.6	87.6	34.9	328.1	293.8	192.8	152.9	94.6	495.8	382.7	110.6	154.5	64.3	62.9	2.0	100.9	604.4	51.9	36.6	109.8	73.8	171.2	114.0	36.7	171.2	44.6	47.1	168.0	93.0	69.7	195.5	34.4	160.2	59.8	87.7	169.0	34.3	72.0	46.6	331.2	50.4	122.8	3.3	111.1	71.4	18.1	142.6	372.8	10.1	62.6	94.0	112.1	83.6	96.2	54.4	77.9	209.9	49.5	37.3	184.4	368.7	109.4	182.8	93.1	28.5	24.3	1.1	140.5	10.0	76.4	12.2	2.4	32.5	8.1	2.2	5.0	3.6	9.2	11.2	7.8	6.7	3.5	9.4	0.6	38.4	7.4	20.8	5.8	6.6	34.6	46.5	24.3	51.4	40.5	13.7	5.2	8.5	4.5	0.0	16.6	50.6	33.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	90.1	24.6	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	266.8	40.1	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	60.5	5.6	0.0	0.0	0.0
SERPINE2	"GDN, nexin, PI7, PN1, PNI"	ENSG00000135919	"Serpin family E member 2"	P07093	2	223975045-224039318	"Plasma proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"placenta: 1091.9"	"Cell type enriched"	"Detected in many"	8	"Granulosa cells: 4466.0"	"Cancer enriched"	"Detected in all"	9	"melanoma: 271.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 12.9;naive CD8 T-cell: 6.8;NK-cell: 23.2"	"Group enriched"	"Detected in many"	15	"NK-cells: 23.2;T-cells: 12.9"	"Cell line enhanced"	"Detected in many"		"BJ: 1492.9;fHDF/TERT166: 6425.1;SK-MEL-30: 2966.9;WM-115: 2183.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000277			Approved	"Golgi apparatus"	"Secreted in female reproductive system"	NA	NA		910000	"Cluster 48: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"		"HPA000277: "	"unprognostic (1.73e-1)"	"unprognostic (7.08e-3)"	"unprognostic (8.49e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.41e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.56e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.48e-5)"	28.0	19.8	120.3	75.7	125.9	6.5	14.3	128.6	158.7	28.1	71.1	22.7	28.2	17.4	5.6	36.2	20.8	46.0	100.0	115.9	145.9	39.3	10.8	14.5	30.9	158.1	152.6	145.6	8.5	3.4	8.7	1091.9	134.4	26.4	21.8	5.4	12.6	7.5	6.6	11.2	27.0	119.6	141.1	30.9	8.9	57.6	146.4	17.0	26.1	10.8	44.0	146.9	27.6	132.0	3.1	83.8	29.4	32.6	1172.5	438.7	4.4	1492.9	851.5	118.1	112.7	4.8	7.0	0.4	32.5	6425.1	188.0	5.0	3.5	102.5	101.0	0.6	26.8	16.6	49.9	22.7	57.7	12.8	1.5	128.3	68.5	342.0	505.6	304.6	9.0	5.4	0.5	1.9	412.1	4.5	2.3	3.9	56.2	31.8	92.3	10.3	25.2	64.5	1100.2	97.5	43.0	7.1	284.4	0.5	2966.9	385.2	1.2	6.4	1056.5	692.5	96.6	214.4	72.7	6.3	13.3	0.8	443.5	11.1	2183.6	0.0	0.0	0.0	0.7	0.0	0.5	0.8	0.6	0.6	0.0	1.2	12.9	6.8	0.5	23.2	0.0	0.2	0.7	2.7	120.3	125.9	128.6	158.7	115.9	145.9	158.1	152.6	134.4	141.1	146.4	132.0	13.5	0.0	1.1	233.1	3.1	23.3	16.0	132.2	351.7	5.3	7.9	8.5	5.3	0.0	4.6	7.3	0.0	106.1	11.3	19.5	11.7	13.0	2.6	5.3	17.7	20.9	24.0	23.1	86.1	33.2	524.3	556.7	5.6	5.9	2.5	4466.0	23.2	0.0	45.5	0.0	11.4	4.7	0.0	0.8	26.9	9.9	401.4	9.7	142.3	23.4	3.5	2.5	2.1	199.6	13.5	22.1	14.9	98.9	5.6	27.2	2.0	146.2	1.7	3.5	13.1	5.2	146.6	4.2	70.9	34.8	14.5	133.9	10.7	18.9	3.1	7.2
SH2D1B	EAT2	ENSG00000198574	"SH2 domain containing 1B"	O14796	1	162395268-162412138	"Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.5;skeletal muscle: 12.1;tongue: 6.6"	"Group enriched"	"Detected in some"	7	"dendritic cells: 47.3;NK-cells: 154.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	8	"NK-cell: 376.5;non-classical monocyte: 149.2"	"Group enriched"	"Detected in many"	38	"monocytes: 149.2;NK-cells: 376.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.4;EFO-21: 2.7;Karpas-707: 4.4;TIME: 1.3"	"Not detected"	"Not detected"							HPA054791	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054791: AB_2682600"	"unprognostic (7.82e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.89e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.15e-3)"	0.5	0.0	0.7	0.7	1.1	4.5	0.2	0.0	1.0	0.1	0.1	0.5	0.8	0.7	0.1	1.4	0.2	0.5	0.1	0.7	0.1	0.4	1.0	2.2	1.2	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.5	0.0	0.3	0.6	12.1	0.0	1.1	0.1	0.1	7.5	0.1	0.3	0.2	0.2	0.1	6.6	1.0	0.2	1.4	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	1.1	6.7	31.0	0.4	0.3	0.1	1.8	6.8	0.1	0.4	1.3	3.0	376.5	149.2	0.5	0.4	67.3	0.7	1.1	0.0	1.0	0.7	0.1	0.1	0.2	0.2	0.1	0.2	1.2	0.1	3.2	0.6	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	1.3	0.0	0.0	0.0	47.3	0.2	0.0	0.0	0.1	1.4	0.3	0.2	0.0	5.3	4.3	0.0	0.0	0.2	0.0	2.1	0.0	0.0	1.8	0.6	0.1	0.0	0.5	0.0	0.0	1.6	0.3	0.5	0.0	2.0	0.0	1.0	1.6	0.0	154.5	0.0	0.7	0.5	0.0	0.0	3.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	13.9	0.0	0.1	0.0
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306368-36329340	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;thyroid gland: 27.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 15.3;Late spermatids: 53.6;Proximal enterocytes: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.4;HaCaT: 21.1;hTERT-RPE1: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042212, HPA042456, HPA066168"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627"	"prognostic favorable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.1	0.7	2.4	2.5	1.1	1.3	10.8	0.2	6.8	4.4	0.0	3.4	14.0	2.2	1.4	6.9	1.2	2.0	2.0	0.8	0.0	8.8	0.8	3.9	2.0	1.1	0.2	3.5	0.5	0.3	1.7	3.1	1.0	6.7	3.7	3.2	13.4	1.4	0.8	17.4	20.9	1.1	0.0	2.2	2.0	6.8	0.8	0.7	27.8	0.3	3.0	1.3	7.2	0.2	11.2	0.3	2.0	2.2	0.5	1.3	14.4	6.1	0.9	2.8	1.3	7.1	4.3	2.2	5.5	1.6	0.3	21.1	1.4	3.3	2.1	0.9	2.1	2.1	4.8	5.3	1.1	1.2	3.2	0.9	3.0	1.9	1.4	21.7	1.0	4.3	0.4	2.6	1.6	7.3	1.4	1.1	1.2	2.6	2.4	2.3	0.3	1.2	3.7	1.8	4.4	2.1	1.1	11.0	3.4	10.3	0.7	0.3	3.2	1.6	1.2	4.3	1.0	3.3	1.0	2.2	3.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	2.4	1.1	0.2	6.8	0.8	0.0	1.1	0.2	1.0	0.0	0.8	0.2	1.1	0.0	2.0	0.3	1.7	3.1	1.7	3.0	1.8	6.9	6.2	4.3	1.4	0.0	1.9	5.5	0.0	2.9	1.9	15.3	1.9	0.6	14.2	2.5	2.0	1.6	0.0	0.0	1.6	0.4	2.2	1.9	4.6	7.7	1.3	2.6	1.1	0.3	7.7	11.8	1.2	2.9	2.0	6.1	7.7	53.6	1.2	5.0	3.6	0.0	2.2	1.2	1.0	0.0	0.2	4.3	5.8	2.6	2.9	2.6	14.9	1.1	2.3	1.2	0.0	0.7	2.1	2.6	1.2	2.4	3.1	5.7	1.3	3.2	1.6	1.3
SHQ1	"FLJ10539, Shq1p"	ENSG00000144736	"SHQ1, H/ACA ribonucleoprotein assembly factor"	Q6PI26	3	72749277-72861914	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 113.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042792	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA042792: AB_10959736"	"unprognostic (1.10e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.83e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.05e-1)"	"unprognostic (4.54e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.30e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	5.9	7.0	7.3	8.1	10.1	9.2	8.1	7.1	7.6	6.7	6.1	8.8	6.7	7.1	11.4	6.4	10.7	5.6	10.1	5.1	6.6	7.4	8.0	6.2	8.9	7.1	7.0	7.6	7.0	8.5	4.6	5.3	7.4	5.7	8.7	5.5	5.7	6.0	9.1	7.5	6.1	8.0	5.2	7.0	6.4	10.0	8.0	15.3	8.2	8.6	10.0	8.4	5.1	10.4	13.5	18.1	12.0	20.3	15.7	19.2	12.1	21.8	15.8	22.4	24.6	14.5	10.7	22.4	10.2	15.2	18.2	10.9	24.9	20.5	27.5	20.1	19.6	23.3	14.1	17.3	15.9	39.7	18.8	19.2	15.4	33.1	13.6	10.4	21.2	35.8	19.0	13.5	18.5	20.2	113.4	14.1	33.9	41.5	22.7	27.1	18.8	17.3	19.7	17.6	7.6	30.4	20.3	14.3	10.6	16.0	14.7	14.9	15.1	18.0	17.5	30.1	19.5	24.9	53.8	32.7	16.1	32.0	18.3	0.9	11.9	4.3	14.2	13.5	19.1	13.7	15.8	15.4	12.3	13.3	17.7	15.4	0.5	24.2	12.3	17.6	14.4	14.5	7.3	10.1	7.1	7.6	5.1	6.6	7.1	7.0	7.4	5.2	8.0	10.4	5.9	12.8	6.9	8.8	8.3	13.3	4.3	6.9	5.7	7.5	7.2	5.3	9.5	4.3	6.5	5.5	0.0	6.1	9.9	4.3	7.9	8.6	6.9	11.5	9.6	9.1	4.2	10.3	12.1	6.1	7.9	7.1	5.6	8.0	15.2	6.6	11.4	7.6	6.9	3.3	13.5	6.8	4.1	6.6	6.2	1.9	5.9	5.7	5.4	20.6	4.1	3.2	2.1	16.1	33.9	6.5	4.3	5.7	6.1	5.1	4.7	5.7	16.2	5.4	0.0	8.0	5.9	9.1	19.5	10.8	10.2	5.7	7.6	14.8	9.3	3.9
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646196	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4"	"Group enriched"	"Detected in some"	7	"HEL: 91.2;JURKAT: 51.8"	"Not detected"	"Not detected"							"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	1.3	0.6	0.4	5.7	0.6	12.5	0.8	1.6	0.7	0.8	0.3	1.7	2.7	1.0	0.5	0.7	0.9	2.4	0.7	0.4	0.2	0.5	1.5	4.1	10.4	0.7	0.4	0.4	0.4	0.1	0.4	0.6	0.8	0.7	1.7	0.5	1.4	0.5	0.6	0.7	3.1	0.5	0.3	8.0	2.6	0.5	0.6	18.3	0.7	0.2	9.0	2.2	0.6	1.1	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	91.2	0.6	3.4	0.0	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	51.8	0.1	0.2	0.0	0.2	10.9	7.6	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	7.6	0.1	3.0	0.4	3.8	28.8	0.7	24.1	0.4	23.8	27.1	0.4	0.3	21.8	30.5	4.8	39.2	0.1	48.5	33.4	26.5	0.4	0.6	1.6	0.7	0.4	0.2	0.7	0.4	0.8	0.3	0.6	1.1	0.6	0.0	3.9	0.0	1.6	0.4	0.1	0.0	0.0	0.3	0.5	0.3	0.3	0.0	0.7	0.0	0.0	0.1	97.0	0.6	0.0	0.2	1.1	0.4	0.4	0.4	0.0	8.2	2.2	0.0	0.2	0.5	4.1	0.6	1.3	0.0	0.7	0.1	0.2	0.0	1.7	0.0	0.0	1.6	0.4	0.0	0.3	21.8	0.0	1.9	1.2	0.4	44.3	1.5	1.4	0.3	0.1	0.0	25.8	0.1	0.0	0.1	0.0	0.9	0.0	0.3	0.4	0.0	0.2	0.2	0.1	0.1	59.2	0.0	0.2	0.3
SLC17A9	"C20orf59, FLJ23412, VNUT"	ENSG00000101194	"Solute carrier family 17 member 9"	Q9BYT1	20	62952707-62969585	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Exocytosis, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 18.2;Gastric mucus-secreting cells: 29.0;Hepatocytes: 48.8;Hofbauer cells: 18.0;Intestinal goblet cells: 19.7;Plasma cells: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 35.7;CACO-2: 32.9;Hep G2: 69.5;NB-4: 39.0;RPMI-8226: 36.1;U-937: 43.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA047470			Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA047470: AB_2680060"	"unprognostic (2.65e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-3)"	"unprognostic (5.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (2.78e-15)"	"unprognostic (6.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	1.3	1.0	0.3	5.8	0.5	11.4	1.3	0.7	0.7	1.9	0.7	3.7	5.5	1.5	0.2	0.8	1.9	1.3	1.3	0.6	0.8	0.9	43.0	3.5	5.2	1.2	0.9	1.7	1.4	0.0	2.2	1.7	1.3	1.3	3.1	0.0	4.0	0.6	1.0	0.7	4.2	1.4	0.9	11.1	9.5	0.4	1.2	0.7	1.2	0.1	4.2	2.7	1.7	2.0	0.0	0.0	0.0	0.2	0.3	3.1	0.1	35.7	10.0	11.4	18.0	32.9	0.0	25.9	0.0	28.3	0.0	0.0	5.0	0.0	2.8	0.0	0.0	11.5	0.9	69.5	7.7	20.9	0.0	2.5	0.0	13.6	0.0	0.0	7.6	0.1	0.1	14.6	0.0	0.0	0.9	39.0	0.0	12.9	0.2	26.9	0.0	36.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	19.4	2.6	0.0	0.0	1.2	0.0	5.0	0.3	14.2	0.0	43.8	0.0	0.0	0.9	0.0	0.7	1.7	0.5	2.2	0.0	0.4	2.6	1.7	0.0	0.3	0.0	4.9	0.3	0.0	0.1	0.7	0.3	0.5	0.7	0.7	0.6	0.8	1.2	0.9	1.3	0.9	1.2	2.0	1.1	0.0	1.1	0.0	18.2	0.9	0.2	0.3	0.0	0.4	1.0	1.0	1.3	12.8	1.0	0.0	0.0	0.3	5.5	6.4	0.0	0.3	0.7	2.6	7.3	1.4	3.0	1.7	0.7	0.4	0.9	4.0	29.0	2.5	5.1	2.4	1.4	48.8	18.0	0.0	0.4	19.7	0.0	5.1	12.4	0.6	1.2	7.2	5.4	2.8	1.3	0.1	4.1	1.0	0.1	1.7	3.1	0.7	38.6	0.6	0.2	0.4	0.8	0.1	0.0	1.6	4.2	0.4	1.0	0.0	1.1	0.8	3.6	3.8	9.3	0.6
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 171.1"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 778.8;Alveolar cells type 2: 305.6;Extravillous trophoblasts: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 158.9;HL-60: 120.9;Karpas-707: 171.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038832, HPA038833"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA038832: AB_2676226, HPA038833: AB_10670910"	"prognostic favorable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	45.5	3.5	9.6	28.9	10.7	36.5	18.1	10.2	12.1	84.7	9.9	37.8	6.7	11.0	5.7	3.0	11.9	7.8	30.4	8.3	10.5	18.3	40.0	171.1	13.3	14.6	10.7	14.0	54.5	42.0	8.0	13.0	14.4	8.4	43.0	6.4	89.3	6.6	1.1	9.4	7.3	9.1	14.2	6.7	7.8	2.6	13.5	14.4	12.3	2.0	12.3	20.8	6.8	11.6	20.2	19.5	4.4	0.1	15.8	35.4	10.1	2.2	158.9	5.8	9.3	0.9	72.5	19.3	21.0	0.6	20.0	1.4	13.5	4.4	3.4	34.1	39.5	51.0	37.5	0.3	6.3	120.9	16.8	19.1	5.0	3.1	9.1	15.4	2.1	47.1	51.6	171.2	30.7	13.4	43.7	55.9	13.0	26.8	19.0	11.0	0.2	63.8	33.3	7.4	5.6	14.0	55.0	1.0	5.3	3.8	13.4	44.4	11.3	19.3	7.3	39.1	31.6	76.3	34.1	90.4	31.0	77.4	18.2	0.0	1.8	1.4	6.3	1.1	10.9	1.8	11.7	10.0	3.3	3.9	8.6	5.9	0.1	13.7	0.4	1.2	5.0	4.2	9.6	10.7	10.2	12.1	8.3	10.5	14.6	10.7	14.4	14.2	13.5	11.6	16.1	778.8	305.6	15.7	14.5	11.7	9.2	35.9	5.2	2.6	42.8	13.1	21.3	4.3	23.9	5.5	4.2	19.2	14.9	20.3	11.7	1.8	0.7	17.7	5.2	19.8	24.0	46.7	6.6	32.7	217.5	17.4	4.1	40.9	3.8	32.4	5.7	26.1	42.9	3.3	1.5	74.1	6.1	29.8	79.0	0.7	1.2	28.9	28.4	60.9	10.8	5.2	9.2	5.0	1.7	11.8	26.2	1.2	56.0	9.6	2.1	17.7	2.9	1.6	6.6	2.6	8.8	2.3	6.0	2.1	7.0	60.6	23.6	31.0	64.3	6.8
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 57.6;retina: 72.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 733.9;Rod photoreceptor cells: 704.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	8.6	5.1	3.2	9.0	5.2	4.0	18.7	3.4	16.9	10.5	1.6	16.2	57.6	6.4	8.2	8.6	6.0	13.7	7.8	19.3	2.5	12.7	3.9	8.3	11.2	0.5	3.2	6.8	3.4	1.7	3.4	5.8	0.6	7.9	7.4	72.9	5.8	8.7	5.0	4.6	17.4	6.6	1.8	7.0	6.0	7.1	4.4	5.8	4.9	27.2	10.3	12.1	8.8	2.6	13.0	23.8	21.0	9.8	9.6	17.2	15.0	43.3	20.0	16.3	12.6	6.5	6.6	29.4	3.6	16.8	15.7	5.5	20.2	21.1	25.7	25.1	6.6	13.5	15.4	7.1	16.5	30.9	11.3	13.7	9.0	24.8	78.9	34.2	27.1	19.0	9.1	10.1	33.8	4.7	31.1	7.2	13.8	1.6	23.4	21.0	16.7	5.9	38.1	9.2	5.3	13.1	19.7	14.4	6.9	17.9	32.9	11.8	19.0	38.2	10.6	26.7	33.7	3.8	4.3	16.6	33.3	21.4	17.8	0.0	0.2	0.0	1.0	0.2	0.7	0.4	1.3	1.4	0.5	0.5	0.5	0.9	0.0	1.0	0.3	0.7	1.2	0.3	3.2	5.2	3.4	16.9	19.3	2.5	0.5	3.2	0.6	1.8	4.4	2.6	30.0	0.0	11.2	10.7	37.5	29.3	39.5	23.4	11.4	130.2	72.4	30.4	23.1	21.5	22.8	62.5	733.9	5.8	51.8	5.5	9.8	15.5	10.2	73.6	40.7	53.6	38.2	7.2	46.2	7.1	29.3	52.2	15.8	124.1	23.5	24.6	17.5	6.2	17.0	6.7	88.7	58.5	36.7	48.4	61.6	7.6	9.0	46.5	35.6	185.5	26.7	45.7	20.6	60.8	20.9	19.1	23.4	9.8	27.8	93.1	142.5	10.2	9.6	704.2	39.5	56.4	43.7	40.0	21.7	21.7	30.7	8.1	56.1	19.0	26.7	35.2
SLIT3	"MEGF5, SLIL2, Slit-3, SLIT1, slit2"	ENSG00000184347	"Slit guidance ligand 3"	O75094	5	168661733-169301139	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 202.3;Fibroblasts: 112.7;Sertoli cells: 85.5;Smooth muscle cells: 99.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 12.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 310.3;fHDF/TERT166: 116.0;RT4: 101.1;SH-SY5Y: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051630	Approved		Supported	"Cell Junctions"	"Secreted in other tissues"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Cell Junctions"		"HPA051630: AB_2681557"	"unprognostic (2.86e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (5.90e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.53e-1)"	61.9	20.7	10.0	11.9	10.6	0.1	32.7	11.9	7.5	36.4	0.3	20.0	5.4	23.9	8.8	21.4	22.2	43.5	39.7	12.3	4.3	16.7	1.5	38.1	6.2	12.9	0.7	17.0	7.8	44.9	4.4	21.7	11.6	10.3	9.7	3.1	16.8	15.4	4.4	25.8	10.4	27.1	0.3	14.3	10.1	2.7	6.9	20.0	23.3	6.5	4.2	55.5	24.3	2.2	0.0	11.0	0.1	0.0	310.3	5.7	0.0	18.1	3.1	4.0	8.4	0.1	0.0	0.0	4.2	116.0	13.1	0.0	2.9	1.2	0.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.8	4.2	0.5	3.9	44.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	101.1	1.1	73.3	0.0	0.0	0.0	12.5	0.0	0.0	0.0	3.0	1.9	25.5	0.1	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	10.0	10.6	11.9	7.5	12.3	4.3	12.9	0.7	11.6	0.3	6.9	2.2	11.7	0.0	2.3	4.2	0.5	26.6	1.8	5.5	3.4	8.6	1.1	3.8	25.9	0.0	0.4	0.0	0.0	2.3	0.5	0.0	0.0	0.2	11.9	1.3	35.7	5.4	0.0	0.0	202.3	0.0	0.5	112.7	4.6	3.6	1.3	0.5	1.8	0.0	1.2	0.0	20.2	0.0	0.0	0.0	32.5	8.2	0.9	1.1	35.6	14.0	0.0	13.7	0.0	8.0	2.9	0.0	0.0	0.4	0.8	1.1	0.1	1.9	0.2	0.9	85.5	1.8	99.3	1.2	2.2	1.1	17.6	1.1	1.8	0.3	0.0	0.8
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 406.1;Excitatory neurons: 725.6;Inhibitory neurons: 788.3;Microglial cells: 277.3;Oligodendrocyte precursor cells: 372.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 402.2;K-562: 162.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458"	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	7.9	12.1	9.5	5.0	9.6	9.7	11.1	16.4	9.6	9.1	5.8	7.5	5.0	7.1	22.1	6.4	10.3	8.2	6.7	10.4	10.2	9.4	6.0	9.8	7.7	7.0	10.3	8.2	7.8	9.5	9.2	5.3	9.8	6.8	8.8	7.0	6.6	5.4	11.6	8.0	6.0	6.7	4.4	5.7	7.3	8.7	11.6	10.8	16.0	9.8	7.7	10.1	5.9	6.8	20.8	12.6	17.8	15.4	19.9	27.1	17.3	28.7	21.4	33.4	74.4	16.2	23.7	33.5	22.6	27.0	20.8	13.2	16.3	32.1	111.3	17.7	16.4	20.0	17.9	19.5	37.3	20.1	402.2	73.5	7.6	44.3	28.5	25.3	23.1	23.5	162.0	11.5	33.0	7.0	38.8	38.8	15.9	29.1	19.5	35.5	21.3	48.9	24.5	29.3	41.9	19.8	13.5	2.0	26.4	19.3	16.5	33.8	17.6	15.9	11.0	11.4	34.8	57.0	16.7	17.3	30.5	27.3	18.8	13.1	4.6	11.5	12.9	4.1	13.7	14.2	13.7	16.4	8.0	15.8	15.1	16.1	3.2	27.5	4.6	5.0	16.2	12.1	9.5	9.6	16.4	9.6	10.4	10.2	7.0	10.3	9.8	4.4	11.6	6.8	14.2	6.4	30.7	406.1	16.2	12.2	14.7	26.5	13.1	7.7	8.7	9.3	9.1	4.3	18.9	12.9	22.9	8.1	15.8	5.1	15.6	22.3	54.8	24.9	14.3	12.7	25.1	6.3	725.6	31.1	42.6	15.9	9.2	13.6	110.9	25.7	12.5	4.9	12.3	10.1	788.3	7.9	26.4	4.1	10.2	110.9	11.1	6.0	12.4	277.3	3.7	7.6	16.5	372.4	136.5	24.0	3.7	17.3	19.9	4.8	4.0	19.3	36.9	13.2	0.0	12.1	20.7	19.6	27.5	12.0	11.5	7.3	18.3	46.3	8.8	10.0
SPAG1	"CILD28, CT140, FLJ32920, HSD-3.8, SP75, TPIS"	ENSG00000104450	"Sperm associated antigen 1"	Q07617	8	100157906-100259278	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Fertilization	Hydrolase	"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 96.0;Endometrial ciliated cells: 190.6;Respiratory ciliated cells: 198.6;Spermatocytes: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023748, HPA053682"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA023748: AB_2671304, HPA053682: AB_2682229"	"unprognostic (9.95e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (9.11e-3)"	"unprognostic (8.83e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.62e-4)"	1.8	1.3	3.0	3.6	3.2	10.1	3.0	4.2	3.0	5.4	14.0	12.9	2.9	2.4	1.5	7.8	10.0	3.7	1.5	3.0	4.6	3.2	4.7	5.0	2.7	7.2	9.0	1.0	2.5	9.0	5.7	1.8	6.2	3.1	18.3	1.9	4.6	3.5	0.4	7.9	2.7	1.8	6.0	2.0	6.3	19.4	4.8	2.1	3.4	0.6	4.4	5.3	3.0	5.4	31.3	8.3	0.5	1.8	1.8	1.5	4.6	5.7	3.4	6.8	7.1	8.3	13.5	1.2	20.0	1.8	10.1	16.1	5.9	11.1	6.3	18.1	6.1	5.2	9.0	3.1	2.4	1.4	4.5	1.3	5.8	8.4	6.6	5.3	5.8	5.7	0.2	16.1	1.0	11.2	3.1	1.4	0.5	15.6	9.1	0.5	1.3	4.7	26.1	14.8	4.8	3.5	7.8	6.4	7.0	2.2	9.2	5.9	5.3	6.8	9.8	3.6	14.9	10.9	8.9	0.9	6.5	5.0	3.4	0.0	0.1	0.6	0.1	0.0	0.0	0.8	0.1	0.1	0.1	0.3	0.0	0.1	0.7	1.0	0.2	0.2	0.0	0.0	3.0	3.2	4.2	3.0	3.0	4.6	7.2	9.0	6.2	6.0	4.8	5.4	7.7	48.1	22.8	18.9	7.7	5.6	9.6	18.1	2.2	2.0	13.3	7.7	5.6	22.8	37.2	18.4	0.0	1.3	19.0	32.9	5.9	19.7	96.0	190.6	7.1	6.9	22.1	0.4	30.1	8.6	8.7	5.0	22.4	39.5	10.1	7.3	4.2	8.0	2.8	8.4	21.6	14.9	6.1	2.2	5.3	32.3	5.0	3.9	1.8	6.5	4.5	11.5	5.2	4.5	4.1	14.9	17.7	3.8	15.9	10.3	2.4	10.0	198.6	2.3	0.0	4.8	6.4	91.9	4.7	2.9	5.4	2.3	12.0	1.3	20.1	23.3
SPIN4	"FLJ44984, TDRD28"	ENSG00000186767	"Spindlin family member 4"	Q56A73	X	63347228-63351332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA044559	Uncertain		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Nucleoli	"HPA044559: AB_10794171"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.22e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.44e-3)"	"unprognostic (8.62e-2)"	"unprognostic (3.65e-3)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (1.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.09e-2)"	1.8	1.7	1.4	2.7	1.3	10.2	3.3	0.9	1.7	2.4	1.7	3.6	2.2	3.4	2.3	5.9	2.7	2.1	1.3	1.3	3.1	1.5	1.3	3.1	3.5	1.6	2.0	2.9	1.7	1.7	2.3	4.4	1.6	3.3	4.1	2.0	7.2	1.7	0.5	2.0	2.2	3.5	1.2	2.8	2.2	0.7	2.5	3.1	2.5	0.5	5.6	2.1	2.7	1.8	31.7	8.0	18.2	14.9	3.9	5.5	13.1	15.6	6.5	8.9	10.6	5.4	30.7	0.0	6.7	7.3	10.2	10.3	23.7	11.2	16.2	13.7	7.5	40.5	10.3	4.9	1.7	35.5	30.3	2.6	3.9	14.9	8.0	4.3	9.9	7.0	12.5	38.2	20.4	10.7	11.9	19.0	18.8	5.2	11.5	16.4	39.2	8.7	6.5	8.3	0.1	10.0	27.9	8.1	3.0	37.4	17.4	16.9	4.3	17.9	19.9	29.8	9.8	8.4	10.4	20.5	9.5	28.8	10.7	0.7	0.8	1.6	0.5	0.9	0.2	0.4	0.3	0.3	0.6	0.4	0.1	0.4	0.0	2.6	0.8	0.0	0.2	0.4	1.4	1.3	0.9	1.7	1.3	3.1	1.6	2.0	1.6	1.2	2.5	1.8	3.0	0.0	2.0	2.3	2.9	3.3	1.4	3.5	6.2	5.7	6.0	4.3	1.5	1.5	5.8	3.7	2.1	6.1	3.9	3.6	1.9	0.6	0.0	3.4	3.2	5.1	6.7	11.1	2.4	1.4	6.8	3.4	2.0	2.1	9.5	3.5	8.6	1.3	2.6	1.7	3.3	6.7	4.1	1.0	2.1	0.4	3.1	2.2	5.4	1.9	1.1	1.3	5.2	3.0	4.5	1.3	6.3	3.4	0.7	2.3	0.6	1.3	5.7	2.8	0.0	2.5	2.6	0.1	0.5	9.8	6.3	3.3	3.1	4.3	5.7	5.7
SPINDOC	"C11orf84, SPIN-DOC"	ENSG00000168005	"Spindlin interactor and repressor of chromatin binding"	Q9BUA3	11	63813456-63827716	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 7.2;Breast glandular cells: 6.7;Breast myoepithelial cells: 8.6;Cytotrophoblasts: 13.3;dendritic cells: 9.4;Endometrial stromal cells: 8.0;Granulosa cells: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040128, HPA050313"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA040128: AB_10673027, HPA050313: AB_2681083"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	11.9	10.4	25.8	12.1	26.3	6.2	8.9	27.9	38.1	16.3	20.7	19.2	5.4	19.1	5.1	10.1	15.3	9.3	15.8	26.0	31.5	13.8	5.2	16.4	15.0	25.4	26.4	16.6	8.0	3.3	17.3	26.4	27.9	18.2	3.6	9.8	9.0	10.4	8.0	6.0	11.3	8.2	22.9	13.9	11.4	38.8	31.4	12.3	13.4	7.2	9.8	18.0	12.3	25.8	34.9	45.7	65.7	57.6	12.5	12.3	24.7	26.6	22.7	47.4	32.9	48.7	23.4	58.1	60.6	15.5	60.8	44.9	60.3	13.7	17.1	55.6	26.4	64.2	46.4	42.0	20.1	36.4	53.6	14.2	14.1	37.2	13.6	24.9	28.5	54.8	36.1	27.6	20.2	48.0	75.7	98.2	112.9	10.0	42.1	100.3	45.5	19.7	16.5	20.2	50.0	63.2	40.6	25.6	55.3	39.7	35.3	43.0	32.2	52.9	60.8	64.0	47.3	40.1	61.9	58.2	27.3	31.8	38.1	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	25.8	26.3	27.9	38.1	26.0	31.5	25.4	26.4	27.9	22.9	31.4	25.8	7.2	3.2	1.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	6.7	8.6	0.0	0.0	0.6	0.0	0.0	13.3	9.4	0.0	0.0	2.2	0.0	5.6	8.0	3.1	0.0	0.0	0.0	1.8	3.0	2.7	0.0	6.5	0.0	9.6	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.4	0.0	0.0	0.7	0.7	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	3.8	2.8	4.0	0.0	0.0
SPINK2	HUSI-II	ENSG00000128040	"Serine peptidase inhibitor Kazal type 2"	P20155	4	56809860-56821742	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"epididymis: 5310.4"	"Group enriched"	"Detected in many"	10	"Early spermatids: 1217.2;Late spermatids: 1399.4;Spermatocytes: 1989.6"	"Group enriched"	"Detected in some"	5	"lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"NK-cell: 146.4"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 146.4"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 90.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB020824, HPA026813"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB020824: , HPA026813: AB_1857446"	"unprognostic (5.56e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.60e-1)"		"prognostic favorable (2.82e-4)"	"unprognostic (9.83e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.87e-2)"	0.5	0.1	0.1	1.1	0.2	13.5	1.3	0.1	0.6	1.3	1.8	2.8	1.9	0.3	5310.4	0.2	0.3	0.1	7.4	0.2	0.2	0.3	0.2	0.2	4.7	0.3	0.3	0.4	0.1	0.0	4.2	0.0	0.2	3.5	2.1	0.0	2.0	240.7	1.8	0.5	3.1	0.3	0.2	1.7	3.0	346.1	0.3	3.9	0.6	2.3	4.8	0.5	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.7	2.9	18.0	0.5	0.0	0.0	0.0	0.0	4.5	0.0	6.0	0.3	3.0	0.0	0.0	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	90.5	0.4	0.0	0.0	0.0	0.0	4.4	0.0	1.1	0.5	0.1	0.6	9.1	5.1	5.4	1.4	10.5	11.1	21.6	0.9	146.4	0.0	0.8	0.3	5.4	0.1	0.2	0.1	0.6	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.1	0.2	0.0	0.0	0.0	7.2	2.0	14.2	1.8	1.8	0.0	0.2	0.6	3.4	0.0	0.2	0.0	0.0	0.0	2.5	1.4	0.0	0.0	1217.2	0.2	0.1	1.6	1.8	32.4	0.3	0.0	0.3	0.8	0.5	0.2	1.3	0.3	0.0	0.0	0.1	0.0	0.2	10.4	0.0	0.0	3.6	1399.4	37.9	2.5	12.4	0.0	1.6	1.5	1.0	0.0	0.1	0.0	13.1	24.5	35.2	9.5	0.4	0.3	0.3	0.0	13.1	0.4	1.9	1989.6	149.9	0.1	0.3	0.0	16.8	0.0	2.6	2.6
SPRY2	hSPRY2	ENSG00000136158	"Sprouty RTK signaling antagonist 2"	O43597	13	80335976-80341126	"Disease related genes, Plasma proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 267.9;SK-MEL-30: 156.9;WM-115: 136.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037205, HPA042198"	Approved		Supported	"Actin filaments,Microtubules"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments, Microtubules"		"CAB037205: AB_261923, HPA042198: AB_2677896"	"unprognostic (9.37e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.80e-2)"	"unprognostic (8.99e-2)"	"unprognostic (3.95e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.86e-2)"	69.6	24.1	37.4	11.8	38.0	29.5	66.2	57.6	42.9	31.0	27.7	40.4	17.6	29.3	15.3	20.0	46.7	30.1	50.9	38.5	36.0	21.1	27.8	31.5	8.9	50.2	40.4	16.9	27.4	10.2	17.3	13.9	40.2	26.2	27.3	34.2	34.8	18.9	39.1	26.5	25.4	23.5	42.0	30.8	25.9	4.1	39.7	11.3	27.1	41.4	4.9	27.0	30.8	43.4	1.8	7.6	84.2	267.9	108.4	70.6	5.8	69.3	31.1	15.3	18.2	34.9	10.3	0.0	11.6	28.5	10.6	6.7	4.8	13.9	17.0	0.1	15.3	12.0	4.5	8.9	24.9	63.4	4.8	31.8	14.6	26.1	63.3	95.6	29.9	13.0	4.4	0.3	35.0	1.5	8.6	28.8	33.7	23.6	19.6	25.6	112.0	0.2	28.8	11.7	1.0	46.7	5.7	3.1	156.9	32.9	6.3	56.0	44.3	14.3	5.6	30.3	13.6	0.1	0.1	0.0	97.6	23.9	136.9	0.0	0.0	2.1	0.3	0.0	0.1	0.4	0.0	0.8	0.9	0.0	0.0	0.1	0.0	4.1	0.0	0.1	0.0	0.1	37.4	38.0	57.6	42.9	38.5	36.0	50.2	40.4	40.2	42.0	39.7	43.4	48.5	25.6	29.3	59.4	2.9	43.5	38.0	12.5	53.5	5.9	12.4	21.3	20.5	18.6	6.3	1.8	6.2	8.7	12.1	33.4	5.9	11.3	0.3	25.2	17.6	22.3	12.0	8.4	22.1	8.0	2.9	65.9	11.2	41.7	16.4	7.2	32.5	17.0	10.9	8.4	15.3	36.1	4.1	27.3	10.7	1.5	29.5	12.2	14.2	15.9	0.8	68.5	3.1	39.7	17.6	18.0	33.7	5.7	1.7	23.1	7.2	8.3	4.8	23.3	26.3	57.7	67.6	0.1	1.5	16.2	29.1	9.6	11.1	8.5	27.6	11.9
SPTLC3	"C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L"	ENSG00000172296	"Serine palmitoyltransferase long chain base subunit 3"	Q9NUV7	20	13008972-13169103	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 28.4;Early spermatids: 27.9;Glandular and luminal cells: 47.4;Microglial cells: 35.6;Syncytiotrophoblasts: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 33.3;RPTEC TERT1: 43.7;U-2197: 30.4;U-87 MG: 57.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA044247, HPA048079"	Enhanced		Approved	Microtubules		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	Microtubules		"HPA044247: AB_2678872, HPA048079: AB_2680252"	"unprognostic (6.81e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (5.08e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-1)"	4.6	4.3	1.4	1.4	1.4	0.6	8.3	1.2	1.3	7.4	8.5	6.1	15.7	4.7	16.8	5.9	6.7	10.9	6.4	1.5	2.7	18.2	20.0	7.8	1.3	2.4	2.1	7.1	5.6	11.0	2.7	20.9	2.4	5.9	7.4	2.8	6.7	3.6	0.4	25.6	16.2	3.9	1.8	2.9	4.5	6.4	3.8	5.0	24.4	2.0	1.7	5.7	5.1	2.5	1.5	2.4	1.8	0.0	14.1	20.2	11.4	0.0	3.2	2.1	8.2	18.6	9.3	0.0	1.2	0.6	18.2	25.0	0.0	7.0	3.0	0.0	0.1	0.0	5.6	26.4	1.3	0.0	0.2	11.5	21.4	8.4	2.8	7.7	1.4	4.4	0.0	33.3	23.7	0.5	0.1	0.0	0.1	2.2	2.9	2.3	4.2	15.1	43.7	18.2	0.0	0.3	0.2	2.3	0.1	3.1	18.6	0.5	3.3	9.2	3.1	30.4	2.2	0.2	0.0	0.0	57.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.4	1.4	1.2	1.3	1.5	2.7	2.4	2.1	2.4	1.8	3.8	2.5	3.6	6.4	22.3	5.2	0.1	2.4	5.3	2.3	4.6	0.1	5.4	5.0	17.9	4.3	4.9	9.2	0.0	28.4	1.0	3.4	7.9	3.0	27.9	18.7	5.2	4.6	0.0	2.1	0.5	4.4	13.0	5.4	4.6	47.4	1.3	5.6	1.8	20.7	2.8	0.0	0.9	5.7	6.1	2.6	0.4	11.6	3.7	2.4	0.0	35.6	0.0	12.3	3.1	0.0	0.1	3.2	6.7	2.6	0.1	2.3	10.9	18.6	3.5	0.4	0.0	6.1	0.8	1.2	0.1	4.9	2.3	46.1	1.2	2.9	7.3	2.6
SPTSSB	"ADMP, C3orf57, ssSPTb"	ENSG00000196542	"Serine palmitoyltransferase small subunit B"	Q8NFR3	3	161344792-161372880	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 45.5;stomach 1: 61.4;urinary bladder: 49.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 28.5;Exocrine glandular cells: 46.0;Gastric mucus-secreting cells: 37.2;Melanocytes: 46.2;Prostatic glandular cells: 74.6;Suprabasal keratinocytes: 36.4;Urothelial cells: 65.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 24.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	13	"NK-cell: 353.6"	"Lineage enriched"	"Detected in many"	13	"NK-cells: 353.6"	"Group enriched"	"Detected in some"	10	"MCF7: 1167.1;RT4: 304.2"									HPA047712			Uncertain	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear speckles"		"HPA047712: AB_2680127"	"unprognostic (2.09e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.37e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.08e-2)"	"unprognostic (5.37e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.51e-3)"	1.9	0.1	3.7	0.6	1.9	0.3	8.3	5.2	7.9	4.8	3.0	0.8	0.3	1.0	0.1	8.7	0.4	1.3	0.4	2.2	1.3	1.2	0.5	0.1	1.2	2.8	5.6	0.2	0.8	0.1	0.4	0.0	4.8	14.7	0.7	2.5	11.4	0.1	0.1	45.5	0.3	0.2	0.2	1.3	61.4	0.0	6.7	0.4	0.3	1.5	2.0	49.5	11.1	3.7	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.9	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.4	0.0	0.0	0.1	0.1	2.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1167.1	0.0	0.0	4.3	71.5	13.4	0.0	0.0	0.5	0.0	304.2	1.9	11.9	0.0	40.6	0.0	0.1	64.7	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.1	0.2	26.2	0.1	0.9	2.5	0.0	0.1	0.3	0.4	0.9	353.6	0.0	0.2	0.0	2.5	3.7	1.9	5.2	7.9	2.2	1.3	2.8	5.6	4.8	0.2	6.7	3.7	0.2	0.0	0.0	4.2	0.1	3.8	16.6	19.6	1.8	1.4	16.6	8.4	0.4	1.5	22.5	3.7	0.0	0.0	3.6	0.1	0.0	1.3	0.0	0.5	0.2	0.8	0.0	0.0	28.5	46.0	0.0	0.7	37.2	1.2	0.0	4.3	0.0	0.0	0.2	0.0	14.2	2.5	6.1	0.0	0.8	0.0	0.0	0.4	46.2	1.0	0.1	0.6	7.2	5.0	1.5	27.6	0.0	0.0	0.4	74.6	0.0	0.0	4.1	1.4	0.0	0.1	2.2	0.0	0.0	6.8	36.4	0.1	3.2	0.0	0.0	65.6
ST6GALNAC6	"SIAT7F, ST6GALNACVI"	ENSG00000160408	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6"	Q969X2	9	127885321-127905408	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 258.8;Intestinal goblet cells: 100.6;Paneth cells: 178.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"NK-cells: 23.7;T-cells: 25.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 157.1"					"Low region specificity"	"Detected in all"			HPA018890	Approved				"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA018890: AB_1857531"	"unprognostic (2.27e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.31e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.67e-2)"	95.8	37.4	155.5	21.4	156.0	17.7	68.7	129.5	177.8	48.7	120.2	75.5	9.5	48.6	50.0	35.0	67.2	28.4	61.3	165.6	130.9	50.1	63.5	66.7	27.5	133.4	137.2	83.0	52.8	32.4	26.0	22.0	128.3	40.2	126.4	16.0	28.3	41.5	46.0	37.4	35.2	38.0	128.3	64.1	43.9	17.6	140.6	14.9	32.5	40.2	23.1	56.6	42.6	134.6	12.0	9.2	18.9	36.9	157.1	91.9	7.4	29.7	69.6	43.7	35.9	16.3	10.0	13.8	13.4	68.1	28.4	21.9	25.6	23.7	19.0	50.9	14.0	13.4	19.0	16.7	48.1	3.3	18.9	94.9	27.5	34.0	15.1	61.6	40.9	11.9	12.2	14.6	54.9	9.9	8.4	19.3	9.1	12.3	17.5	24.6	27.0	14.3	32.2	2.4	13.1	21.3	21.4	8.8	7.6	12.3	9.3	29.0	26.7	27.6	16.3	30.5	15.8	18.4	9.8	21.5	24.5	4.1	8.7	3.3	1.2	0.1	25.3	1.9	18.5	5.3	16.5	18.8	1.8	3.9	10.0	13.7	0.6	23.7	5.0	2.1	25.6	12.4	155.5	156.0	129.5	177.8	165.6	130.9	133.4	137.2	128.3	128.3	140.6	134.6	1.3	3.2	4.3	13.1	10.5	23.2	17.2	15.7	9.1	22.0	0.9	0.6	8.7	8.6	9.5	0.0	6.2	4.3	11.7	258.8	0.0	0.3	2.5	0.8	1.7	20.6	38.5	26.1	11.5	0.4	7.7	26.6	3.6	1.4	7.0	0.2	46.8	28.5	11.6	25.2	10.7	100.6	18.3	10.0	35.6	9.4	66.5	4.1	24.9	8.4	3.2	58.7	46.4	5.5	3.8	0.3	178.3	60.9	8.9	20.5	0.3	0.0	16.1	8.5	85.5	41.2	31.9	1.4	4.8	10.3	26.9	3.6	17.7	0.5	84.7	18.6
STAC	STAC1	ENSG00000144681	"SH3 and cysteine rich domain"	Q99469	3	36380503-36548007	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 13.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 5.9;Early spermatids: 5.2;granulocytes: 6.3;Granulosa cells: 12.5;Late spermatids: 5.3;Muller glia cells: 21.6;Smooth muscle cells: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.5;NK-cell: 1.3;T-reg: 1.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.5;NK-cells: 1.3;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 46.8;HaCaT: 34.1;SH-SY5Y: 49.1;U-251 MG: 30.3;U-87 MG: 48.1"	"Low region specificity"	"Detected in many"							HPA035143	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA035143: AB_10603892"	"unprognostic (5.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-6)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.73e-4)"	"unprognostic (8.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.94e-3)"	2.8	5.1	1.4	0.6	1.9	0.4	1.9	3.6	3.9	7.0	5.0	3.6	0.1	1.4	0.3	2.1	3.2	2.7	0.7	0.8	4.3	2.5	0.9	11.1	0.4	2.3	2.5	2.5	0.1	10.1	1.1	0.3	6.9	13.8	0.7	5.8	1.3	4.4	1.6	1.2	0.4	3.4	1.9	0.6	0.9	1.9	2.1	0.7	0.5	5.3	0.2	3.7	2.2	0.5	7.7	3.3	1.6	0.0	6.5	2.1	0.1	19.9	0.4	4.0	4.6	0.0	0.0	0.0	7.8	46.8	13.0	34.1	2.4	8.2	4.1	0.0	7.2	1.1	10.0	0.2	0.0	20.3	0.4	2.4	0.2	0.1	0.7	27.6	0.0	1.8	0.0	0.4	0.5	0.0	4.1	0.2	13.8	0.0	3.0	0.0	0.0	0.0	10.8	0.0	6.2	49.1	7.9	5.2	0.1	13.6	0.0	2.0	8.5	0.5	19.1	0.6	30.3	0.0	0.0	0.0	48.1	7.9	8.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.5	0.0	1.4	1.9	3.6	3.9	0.8	4.3	2.3	2.5	6.9	1.9	2.1	0.5	0.9	0.0	0.5	0.3	0.0	0.0	0.0	0.5	0.0	0.7	2.3	0.8	0.9	0.0	1.3	0.0	0.0	0.0	0.1	0.0	5.9	0.2	5.2	0.9	0.5	0.4	0.0	2.1	0.6	0.0	0.1	1.5	0.0	2.1	6.3	12.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.2	5.3	0.0	4.8	0.0	0.0	0.0	21.6	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.4	5.0	1.8	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0
STARD6		ENSG00000174448	"StAR related lipid transfer domain containing 6"	P59095	18	54324358-54357964	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 26.6"	"Group enriched"	"Detected in some"	53	"Early spermatids: 189.8;Late spermatids: 271.2;Spermatocytes: 103.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.0;Karpas-707: 2.7;U-266/70: 3.2;U-266/84: 1.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (7.81e-2)"	"unprognostic (1.50e-1)"		"unprognostic (5.56e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.25e-1)"		"unprognostic (8.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.98e-3)"	"unprognostic (6.98e-5)"	"unprognostic (1.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.16e-3)"	0.1	0.3	0.3	0.0	0.5	0.1	0.1	0.5	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	26.6	0.6	0.3	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.3	0.2	0.1	0.0	0.4	0.1	0.0	0.7	0.1	2.0	0.3	0.1	0.0	0.0	0.2	0.7	0.3	0.5	0.1	0.2	0.1	0.2	0.3	0.7	0.1	2.7	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.7	0.3	0.7	0.7	0.4	0.0	0.1	0.2	0.0	0.2	0.7	0.2	0.5	0.3	0.2	3.2	1.6	0.3	0.9	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.5	0.5	0.6	0.4	1.1	0.4	0.3	0.5	0.1	0.6	0.7	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	189.8	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.9	0.0	0.0	0.0	0.4	271.2	2.5	0.2	0.0	0.0	0.0	1.3	0.0	2.0	1.6	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	103.9	3.5	0.0	0.0	0.3	0.2	0.0	0.0	0.1
STING1	"ERIS, FLJ38577, MITA, MPYS, NET23, STING, TMEM173"	ENSG00000184584	"Stimulator of interferon response cGAMP interactor 1"	Q86WV6	5	139475533-139482935	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 25.3;Cardiomyocytes: 27.7;dendritic cells: 17.0;Hofbauer cells: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 64.4;EFO-21: 83.8;HDLM-2: 200.5;THP-1: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038116, HPA038534"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA038116: AB_2675841, HPA038534: AB_2676067"	"unprognostic (1.45e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.59e-8)"	"unprognostic (9.18e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.34e-1)"	38.9	9.3	4.6	18.4	5.0	16.9	26.2	4.4	5.4	32.6	12.8	16.6	6.7	25.0	6.8	21.5	36.2	11.9	35.7	4.3	4.9	17.3	5.5	48.1	15.0	5.5	4.9	21.9	5.4	3.3	11.8	12.9	5.1	20.7	11.6	0.3	24.5	15.5	7.5	15.5	19.0	18.7	5.3	37.8	11.6	3.1	6.0	12.4	20.2	8.5	27.1	21.7	28.4	4.8	2.9	0.7	0.2	0.0	4.0	12.0	0.2	15.3	64.4	7.6	24.4	0.0	18.8	0.0	83.8	49.0	1.9	10.8	0.4	22.9	4.8	200.5	3.3	13.5	6.6	0.8	7.5	4.1	0.8	16.2	1.2	4.6	5.7	12.8	27.8	1.4	3.9	58.3	33.6	0.0	2.2	24.1	0.1	0.8	4.7	0.7	6.1	18.0	9.4	7.0	5.8	0.0	6.5	5.3	16.0	0.6	0.7	73.3	17.2	1.9	1.3	6.8	5.6	0.0	20.0	0.1	0.3	56.2	11.3	16.6	60.9	0.1	56.9	40.0	29.3	0.6	57.4	47.8	55.6	0.3	40.3	35.0	5.0	90.6	17.5	19.2	65.3	60.6	4.6	5.0	4.4	5.4	4.3	4.9	5.5	4.9	5.1	5.3	6.0	4.8	25.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.8	17.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.6	8.4	0.0	0.0	0.0	0.0	0.0	0.0	67.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.8	5.8	0.0	0.0	0.0
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43650713	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 644.6;T-cells: 273.7;Urothelial cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018138, HPA037979"	Uncertain		Supported	"Nuclear speckles,Plasma membrane"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Plasma membrane"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	6.7	8.1	3.9	7.9	4.2	4.8	5.2	6.9	4.9	4.0	4.0	6.4	3.2	3.5	1.2	7.2	3.9	5.3	10.8	4.0	4.1	6.3	4.6	9.4	14.4	3.4	4.4	6.2	9.1	0.8	4.2	3.2	3.6	4.3	2.4	5.5	5.8	2.1	9.9	4.6	11.5	3.3	3.6	12.6	9.5	9.0	4.3	9.0	3.8	2.5	13.5	5.6	5.0	3.1	5.8	8.2	9.0	5.3	7.8	8.3	1.9	12.3	15.1	6.6	5.9	7.5	3.1	7.9	20.2	15.3	17.8	8.5	3.6	17.4	10.4	16.9	7.0	9.3	8.2	8.4	4.9	21.1	5.6	6.4	26.4	8.2	8.6	36.4	12.6	11.0	16.7	15.1	9.6	3.6	18.2	8.0	17.3	4.1	18.3	8.4	6.9	14.2	15.6	6.7	6.9	11.2	8.1	8.5	6.1	13.6	6.5	10.8	16.9	20.7	8.3	14.3	17.2	13.3	11.2	13.5	18.4	14.0	31.7	0.5	0.0	2.7	2.0	0.0	1.5	2.4	2.0	3.2	0.1	2.2	3.0	3.0	1.6	4.9	0.1	0.4	1.3	0.9	3.9	4.2	6.9	4.9	4.0	4.1	3.4	4.4	3.6	3.6	4.3	3.1	44.2	121.8	33.1	29.0	237.8	181.9	644.6	64.5	99.6	2.9	17.7	37.8	28.7	7.2	69.8	20.2	10.4	54.8	222.3	54.4	33.2	153.0	47.0	129.1	17.4	35.2	7.2	54.1	9.5	95.4	23.3	39.1	78.0	88.3	38.8	17.7	17.9	9.6	16.9	0.0	5.6	34.3	38.7	20.3	65.9	14.7	5.9	60.9	35.6	34.7	42.1	7.9	221.4	39.2	3.7	89.4	73.0	2.6	81.2	192.6	23.8	13.2	42.4	26.3	6.6	39.4	51.3	75.8	36.1	42.3	136.1	66.8	273.7	27.0	18.0	326.1
STK36	"FU, KIAA1278"	ENSG00000163482	"Serine/threonine kinase 36"	Q9NRP7	2	218672069-218702716	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Respiratory ciliated cells: 38.2;Spermatocytes: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027409, HPA027453, HPA030058"	Approved		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225"	"unprognostic (8.11e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.83e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-3)"	5.6	9.9	1.5	5.4	1.7	2.5	6.6	1.0	3.2	14.1	15.4	9.0	4.4	11.4	13.4	5.1	14.3	10.5	3.5	2.3	1.0	7.3	4.5	7.3	4.5	1.2	2.6	13.4	10.7	9.4	14.8	4.3	0.8	9.6	6.5	11.6	7.3	8.2	3.7	5.0	6.4	8.0	0.3	5.1	8.8	32.0	1.3	3.2	11.8	2.3	4.0	8.2	7.6	1.0	3.7	8.2	17.6	15.0	18.7	14.5	10.9	9.8	7.8	12.2	11.4	10.7	6.0	4.8	13.3	10.3	8.2	7.2	12.2	10.3	10.7	2.8	10.2	4.7	27.1	15.0	9.1	6.7	7.6	15.7	7.5	12.0	8.4	32.3	9.3	6.2	11.1	6.0	10.3	8.5	4.0	8.5	10.7	4.6	5.2	7.3	7.6	5.1	14.9	18.2	14.2	12.3	7.6	12.2	5.0	18.2	12.4	5.3	8.9	16.8	6.1	6.5	6.8	7.5	6.3	2.5	10.4	3.1	7.1	0.0	0.4	0.7	0.3	0.2	0.1	0.4	0.2	0.2	0.3	0.1	0.2	0.3	0.0	0.5	0.3	0.3	0.2	0.4	1.5	1.7	1.0	3.2	2.3	1.0	1.2	2.6	0.8	0.3	1.3	1.0	2.1	9.6	6.3	18.3	1.6	1.1	0.9	3.6	2.8	7.4	7.4	5.5	4.0	5.7	3.7	3.7	37.5	1.8	2.9	2.9	0.0	3.7	16.9	17.5	9.0	3.3	2.4	0.8	22.0	2.5	1.5	4.5	10.7	6.3	1.3	12.2	3.3	5.9	2.7	1.7	18.0	4.4	6.1	2.5	1.2	6.0	5.9	2.0	0.0	2.8	2.5	4.9	1.0	8.5	6.2	2.2	5.0	4.9	0.6	1.6	2.5	4.4	38.2	9.1	6.6	3.1	4.0	28.0	8.9	3.7	1.0	0.8	1.5	11.0	4.9	0.9
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618923-10674318	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.1;stomach 1: 17.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Excitatory neurons: 20.6;Gastric mucus-secreting cells: 15.3;Paneth cells: 12.6;Proximal enterocytes: 10.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.2"	"Immune cell enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.7;HDLM-2: 17.5;HMC-1: 18.3;HUVEC TERT2: 25.5;TIME: 23.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	Nucleoplasm	"HPA040468: AB_2676998, HPA048569: AB_2680446"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.4	0.3	1.2	1.8	3.0	1.1	3.9	0.0	5.2	1.9	0.0	15.9	2.4	0.5	1.2	7.3	2.2	3.5	0.1	3.6	0.0	0.6	0.3	1.3	1.4	0.0	0.0	0.3	0.3	0.0	2.4	0.7	0.0	11.6	17.1	0.9	6.7	0.9	0.1	2.8	11.2	0.6	0.0	0.9	17.5	0.2	0.0	0.2	0.4	0.0	2.5	5.1	3.3	0.3	4.8	0.2	0.0	0.6	0.0	0.0	1.3	7.3	0.7	3.5	3.4	2.6	28.7	0.3	4.7	1.8	4.5	1.4	1.6	8.0	7.4	17.5	0.4	1.0	2.4	0.2	0.0	2.2	18.3	0.4	0.4	5.1	0.3	0.5	25.5	0.2	0.3	0.3	8.1	3.1	0.2	1.3	4.2	11.8	2.0	0.1	2.0	0.3	2.5	14.6	0.9	0.1	4.5	4.9	0.0	6.7	3.5	0.6	23.8	1.0	3.8	0.5	0.8	0.0	1.0	0.2	3.5	0.2	5.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.1	12.5	0.0	0.0	0.0	0.3	1.2	3.0	0.0	5.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	2.2	0.0	0.0	0.3	0.8	3.1	1.2	0.6	3.3	2.0	0.7	1.5	3.3	0.0	0.0	0.1	1.8	19.6	0.0	0.5	0.2	7.3	0.5	0.4	4.2	0.8	20.6	0.2	0.6	0.2	15.3	4.5	1.3	6.3	0.0	0.0	0.0	0.0	1.6	8.9	2.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	6.2	0.0	0.5	5.9	12.6	0.0	0.9	4.7	10.6	0.0	8.8	0.4	0.0	1.2	0.2	0.2	0.8	3.1	1.0	0.3	1.9	0.0	6.9	5.5
SUV39H2	"FLJ23414, KMT1B"	ENSG00000152455	"Suppressor of variegation 3-9 homolog 2"	Q9H5I1	10	14878820-14904315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 39.3"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 421.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045901, HPA057554"	Enhanced		Uncertain	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA045901: AB_10960702, HPA057554: AB_2683466"	"prognostic unfavorable (5.55e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.39e-1)"	2.1	1.5	1.4	2.4	1.8	4.7	3.8	8.3	3.5	1.6	1.4	2.9	2.0	2.0	1.5	3.1	2.1	1.7	1.0	1.5	1.2	2.4	3.1	1.3	2.5	1.2	1.4	2.5	1.8	1.9	1.3	3.8	1.2	2.7	3.4	3.4	1.7	2.3	1.4	1.9	2.6	2.3	1.2	1.5	1.8	39.3	1.3	6.1	1.4	1.2	3.1	3.1	1.4	3.1	28.6	20.8	40.8	24.1	7.5	10.7	16.9	14.8	8.1	24.1	34.6	29.5	15.2	22.4	13.4	5.8	22.6	21.3	27.7	16.4	31.6	22.9	15.1	29.4	14.0	21.5	4.3	14.8	16.2	4.1	5.3	24.2	5.4	6.4	19.0	37.4	41.9	15.2	20.3	19.3	31.3	4.4	28.8	26.6	5.9	38.4	28.1	20.7	10.9	11.0	13.8	16.8	23.9	16.6	11.1	23.8	24.6	11.0	11.6	21.4	31.7	22.9	23.1	9.5	36.1	47.9	12.1	14.8	13.5	0.2	0.3	0.2	1.5	1.1	1.9	0.4	1.1	1.7	1.1	0.3	1.8	1.8	0.3	3.0	0.4	1.8	2.0	0.5	1.4	1.8	8.3	3.5	1.5	1.2	1.2	1.4	1.2	1.2	1.3	3.1	2.0	0.0	1.5	4.2	2.6	8.3	10.2	6.7	9.1	7.5	4.0	3.7	2.9	2.8	7.5	1.8	10.4	13.9	1.7	1.1	5.9	4.4	421.0	3.4	5.1	4.3	3.5	16.2	8.0	2.2	25.6	5.1	4.1	4.0	2.5	7.8	1.8	3.0	5.0	11.8	7.9	3.1	6.1	1.6	2.8	104.4	4.7	1.8	1.8	2.8	0.7	4.2	3.1	4.5	4.5	2.1	1.7	2.6	7.1	14.5	1.0	7.4	3.5	10.2	6.6	5.8	6.6	47.5	46.6	8.3	8.8	8.9	3.4	8.7	4.5	10.9
SYNRG	"AP1GBP1, MGC104959, SYNG"	ENSG00000275066	"Synergin gamma"	Q9UMZ2	17	37514807-37609472	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023554, HPA023555"	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA023554: AB_1844892, HPA023555: AB_2058337"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.68e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.91e-2)"	"prognostic favorable (3.96e-4)"	8.3	9.1	4.5	12.9	6.6	6.7	7.7	5.6	7.0	8.4	7.1	8.7	6.8	7.6	10.8	9.6	7.5	8.1	5.7	4.1	7.4	9.9	8.5	8.8	21.4	6.7	7.5	8.3	8.8	11.9	11.7	7.7	7.4	8.0	9.5	9.2	9.1	6.7	7.1	8.5	12.1	6.9	6.2	16.6	10.4	13.0	6.8	24.2	9.8	6.0	19.3	8.5	8.4	7.5	7.9	13.1	18.0	12.0	12.0	11.5	7.6	12.3	12.4	13.2	15.1	12.5	11.8	15.5	11.4	11.3	13.5	8.0	15.8	6.5	19.7	14.0	9.1	8.9	8.2	6.0	14.0	14.0	19.2	13.1	14.9	15.5	8.8	12.4	18.3	26.3	18.0	13.3	14.3	6.4	29.4	7.3	7.9	7.3	4.8	19.1	15.3	10.5	12.3	15.4	14.2	13.4	11.5	3.7	10.8	20.5	10.5	11.0	17.4	9.6	12.3	8.0	11.5	14.9	18.5	24.4	10.9	7.1	10.7	12.4	4.0	8.8	12.5	2.9	16.4	10.9	10.9	12.5	3.4	10.9	10.7	10.6	8.3	17.5	3.2	13.2	11.8	4.4	4.5	6.6	5.6	7.0	4.1	7.4	6.7	7.5	7.4	6.2	6.8	7.5	26.9	54.5	38.7	37.5	64.8	8.5	14.6	17.2	19.9	49.8	22.6	21.2	26.3	20.0	25.1	33.1	54.2	18.5	77.0	24.1	17.6	24.7	43.7	26.4	29.7	28.1	42.6	17.9	36.5	21.8	10.6	20.4	26.0	31.8	25.9	23.5	22.9	23.2	21.8	37.0	42.5	22.4	18.3	40.9	24.7	50.1	22.7	27.2	16.0	40.3	30.4	31.2	108.1	55.3	71.3	26.4	19.6	24.0	67.6	17.5	23.5	29.7	23.4	49.5	13.1	29.3	20.2	65.8	23.9	19.0	9.2	26.5	81.8	21.7	17.1	20.8
TBCEL	"LRRC35, MGC10233"	ENSG00000154114	"Tubulin folding cofactor E like"	Q5QJ74	11	121024072-121090775	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 104.0;Oligodendrocytes: 39.4;Plasma cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA038593, HPA038594"	Approved		Uncertain	Cytosol		NA	NA		22000	"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA038593: AB_10669647, HPA038594: AB_2676103"	"unprognostic (9.06e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.02e-1)"	7.4	7.6	10.7	5.9	14.2	5.6	9.0	14.4	11.5	7.2	15.0	7.4	5.4	8.5	9.6	5.7	6.2	7.7	9.8	8.5	11.0	8.3	15.1	9.6	7.5	10.5	10.5	9.2	6.3	16.5	7.9	10.8	9.8	9.0	5.9	8.3	7.2	12.3	6.1	5.1	5.8	9.6	10.2	8.4	6.0	14.8	14.2	7.2	10.3	8.2	7.4	6.6	4.7	13.6	6.2	5.8	9.8	8.5	17.5	16.5	7.5	11.5	14.2	8.7	12.7	6.0	9.7	7.6	17.3	14.3	8.4	1.6	10.8	3.8	11.4	9.1	8.0	13.2	4.5	6.0	21.6	9.4	8.8	18.2	12.8	8.4	9.1	8.8	14.4	4.3	3.9	14.3	12.3	4.2	3.9	7.8	5.8	0.2	5.6	3.3	14.3	3.5	11.7	3.8	5.2	12.0	11.3	11.7	7.9	8.3	11.3	7.9	18.9	19.2	4.2	7.8	6.4	5.5	4.3	4.0	2.7	0.1	7.3	0.0	0.2	0.1	0.3	0.3	0.4	0.1	0.4	0.4	0.2	0.2	0.4	0.3	0.1	0.6	0.2	0.4	0.2	0.2	10.7	14.2	14.4	11.5	8.5	11.0	10.5	10.5	9.8	10.2	14.2	13.6	9.4	6.4	11.3	15.7	7.8	2.9	1.8	2.0	2.8	9.0	4.4	2.9	10.3	7.2	1.7	7.3	14.6	1.7	3.4	2.0	1.9	4.7	11.3	9.3	8.2	8.0	3.6	104.0	34.1	2.6	1.9	7.0	1.5	3.7	1.3	6.7	13.2	20.7	3.1	8.4	32.9	2.5	4.1	6.7	2.8	5.8	9.3	4.3	10.6	20.6	10.1	5.5	6.2	36.2	39.4	3.3	1.0	9.8	42.7	2.7	2.0	4.3	8.4	9.2	0.0	14.8	6.0	14.9	6.0	3.7	1.7	1.4	3.7	6.8	2.3	1.2
TFAP2E	AP2E	ENSG00000116819	"Transcription factor AP-2 epsilon"	Q6VUC0	1	35573314-35595328	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 9.8;Excitatory neurons: 9.0;Inhibitory neurons: 9.8;Oligodendrocytes: 11.3;Rod photoreceptor cells: 5.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 4.6;SK-MEL-30: 1.7;U-937: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (7.06e-4)"	"unprognostic (1.96e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.27e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.67e-15)"	"unprognostic (2.03e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.40e-2)"	1.0	0.6	3.0	0.9	2.8	1.5	1.0	9.2	4.0	3.5	0.2	1.1	0.1	1.3	0.3	1.2	2.5	0.2	0.9	2.6	2.2	1.1	0.3	1.3	0.9	2.8	2.3	2.5	0.6	0.0	3.2	0.2	3.0	1.7	0.1	4.4	1.0	0.1	0.4	5.2	1.2	0.0	2.4	1.9	1.0	2.2	2.4	0.3	0.5	0.0	0.3	0.8	3.1	5.1	0.2	0.2	0.2	0.1	0.1	0.1	0.8	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.2	0.5	0.4	0.3	0.0	0.0	0.6	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	4.6	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.1	1.7	0.1	0.4	1.4	0.1	0.1	0.7	0.4	0.1	0.8	0.4	0.0	0.1	3.6	0.5	0.5	0.8	0.5	0.9	0.3	0.3	0.4	0.5	0.8	0.4	0.4	0.2	0.8	0.0	0.9	0.4	0.3	0.8	0.5	3.0	2.8	9.2	4.0	2.6	2.2	2.8	2.3	3.0	2.4	2.4	5.1	0.2	0.0	1.3	4.9	0.2	3.7	0.1	0.3	0.0	9.8	0.5	0.5	0.4	0.0	0.8	0.0	2.1	0.4	0.9	0.1	0.0	0.2	0.5	0.3	0.4	0.3	0.0	0.0	9.0	0.0	0.0	0.4	2.6	0.5	0.0	0.1	0.4	0.2	1.0	0.0	9.8	0.0	0.0	1.0	0.0	1.0	2.1	0.6	1.8	1.9	0.5	0.3	3.1	3.5	11.3	0.2	0.3	0.7	0.3	0.1	0.1	0.0	0.2	5.6	0.0	0.2	0.4	2.4	0.4	0.0	4.4	0.1	0.9	0.1	0.4	0.2
THAP12	"DAP4, P52rIPK, PRKRIR, THAP0"	ENSG00000137492	"THAP domain containing 12"	O43422	11	76349956-76381132	"Plasma proteins, Predicted membrane proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 42.4;dendritic cells: 31.6;Endometrial stromal cells: 34.7;Theca cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 241.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008758, HPA077077"	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA008758: AB_1855714, HPA077077: "	"unprognostic (2.79e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.47e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-2)"	25.7	21.9	13.8	20.1	14.2	33.4	29.7	13.6	16.3	21.4	13.2	24.1	19.9	24.2	21.1	11.2	19.0	16.7	17.2	14.4	13.8	19.6	19.5	21.8	33.0	13.1	14.2	20.3	41.6	14.2	9.5	26.2	13.1	17.1	25.7	37.2	15.6	19.0	31.7	14.5	20.0	22.0	13.9	26.0	21.5	18.1	14.2	30.6	22.1	32.9	28.7	20.4	15.0	13.6	37.7	29.3	54.6	31.1	36.4	51.5	33.4	38.0	38.9	46.4	40.8	58.9	38.9	100.8	57.1	36.2	40.7	36.5	67.4	44.6	73.9	78.3	21.5	72.2	20.2	27.4	40.2	92.3	34.9	37.1	57.8	41.3	76.9	28.1	40.7	70.5	85.3	55.3	42.0	40.4	81.4	51.9	22.7	98.5	31.8	60.3	124.7	105.0	27.1	38.8	53.1	35.6	36.7	40.1	20.5	36.5	40.6	35.8	36.7	55.4	91.7	114.2	33.9	49.9	56.6	241.7	13.3	50.8	30.6	0.7	1.5	1.7	4.5	1.6	5.2	3.3	4.7	5.0	2.1	3.6	3.4	4.4	0.5	5.6	1.5	0.9	4.7	1.7	13.8	14.2	13.6	16.3	14.4	13.8	13.1	14.2	13.1	13.9	14.2	13.6	42.4	25.6	25.3	0.0	13.6	0.0	0.0	0.0	0.0	0.0	29.6	24.0	0.0	0.0	6.2	11.0	0.0	14.2	31.6	0.0	13.7	10.9	0.0	13.6	34.7	9.8	0.0	0.0	0.0	26.4	21.5	11.3	0.0	19.3	7.6	24.5	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	8.3	0.0	0.0	0.0	0.0	14.1	0.0	0.0	7.6	0.0	0.0	16.3	5.8	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	16.3	13.4	34.4	0.0	0.0
TMEM200A	"KIAA1913, TTMC"	ENSG00000164484	"Transmembrane protein 200A"	Q86VY9	6	130366017-130443067	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 39.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.5;Distal enterocytes: 23.3;Endometrial stromal cells: 18.6;Enteroendocrine cells: 24.6;Granulosa cells: 49.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 4.0"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 40.8;hTEC/SVTERT24-B: 67.1;hTERT-RPE1: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014396	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA014396: AB_2204904"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.19e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.27e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-3)"	5.7	17.1	1.7	3.9	2.5	0.1	5.9	0.1	2.2	11.1	0.0	11.1	7.3	39.3	5.3	1.2	12.9	6.4	0.6	4.5	2.7	13.6	0.4	6.8	3.8	0.9	4.6	15.6	1.5	0.8	5.3	3.3	1.5	2.7	22.3	11.2	1.6	1.4	0.6	2.0	8.3	18.7	0.8	1.0	6.3	2.7	3.8	4.7	5.6	0.4	3.4	5.6	3.5	0.8	0.1	0.1	0.2	0.0	11.7	14.6	0.1	10.6	13.0	11.1	19.6	16.6	0.0	0.0	0.0	22.3	2.5	2.5	1.0	0.0	40.8	15.5	0.0	0.0	0.0	0.8	5.3	0.3	0.0	16.7	0.0	67.1	13.3	33.5	0.4	0.3	0.0	1.5	5.2	0.0	0.0	0.1	8.4	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	13.4	12.5	4.0	1.1	1.9	8.2	0.0	0.0	7.4	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.8	0.4	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.1	1.7	2.5	0.1	2.2	4.5	2.7	0.9	4.6	1.5	0.8	3.8	0.8	0.5	0.0	0.5	1.3	0.2	2.0	0.1	0.1	1.2	26.5	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.5	0.4	23.3	0.0	0.0	2.0	5.2	18.6	0.8	24.6	2.7	7.1	0.0	1.7	3.6	2.0	0.7	0.0	49.9	0.0	0.0	0.2	13.5	4.3	1.6	0.0	0.0	0.9	1.8	5.9	0.3	1.8	1.9	0.0	0.5	0.0	1.0	0.3	0.1	6.0	10.5	3.3	0.0	4.6	9.9	0.0	2.1	0.0	0.8	8.4	3.3	2.6	0.1	1.4	0.5	5.8	11.3	4.0	0.1
TMEM213		ENSG00000214128	"Transmembrane protein 213"	A2RRL7	7	138797952-138838101	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 76.0;salivary gland: 52.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 53.3;Distal tubular cells: 144.8;Melanocytes: 26.6"	"Cancer enriched"	"Detected in some"	22	"renal cancer: 21.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 2.1;neutrophil: 1.1;NK-cell: 2.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.1;NK-cells: 2.0"	"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA054059	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA054059: AB_2682361"	"unprognostic (2.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.84e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (5.54e-7)"	"unprognostic (4.33e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	0.1	0.1	0.5	0.2	0.5	1.1	4.7	0.6	0.7	2.8	0.4	0.1	1.3	0.2	0.6	0.3	0.1	0.2	0.0	0.6	0.1	76.0	0.1	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.1	0.1	0.4	0.4	0.1	0.3	52.3	1.2	0.1	5.3	0.3	0.1	0.0	0.2	0.4	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.1	2.1	0.2	0.2	0.3	0.2	0.4	0.2	0.1	0.2	0.1	0.3	0.2	0.1	1.1	2.0	0.2	0.2	0.1	0.1	0.5	0.5	0.6	0.7	0.6	0.1	0.2	0.1	0.4	0.0	0.5	1.0	0.1	3.2	9.9	0.0	0.1	0.0	0.9	3.0	0.0	0.4	14.1	7.9	0.4	0.0	4.4	53.3	0.0	0.0	0.2	0.0	144.8	0.0	0.0	0.9	0.4	0.5	0.0	0.0	0.6	0.2	0.1	0.2	0.0	1.3	1.3	0.1	0.0	0.0	0.1	1.7	0.4	0.0	2.0	0.0	0.8	0.0	0.0	0.1	26.6	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.9	3.5	1.3	0.0	0.5	0.2	0.0	0.2	0.0	0.4	0.0	0.6	0.0	0.2	0.6
TMEM25	FLJ14399	ENSG00000149582	"Transmembrane protein 25"	Q86YD3	11	118531041-118547280	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 35.9;SK-BR-3: 33.7;T-47d: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA012163, HPA051562"	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		6900000	"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus, Vesicles"		"HPA012163: AB_1858112, HPA051562: AB_2681535"	"unprognostic (1.53e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.19e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.15e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.01e-2)"	6.9	25.3	35.0	3.8	36.0	2.2	14.6	33.9	44.3	14.9	32.2	16.0	46.0	15.3	25.7	11.1	13.7	8.9	8.9	37.5	36.7	18.6	23.1	9.9	4.8	32.1	30.3	23.4	17.6	23.3	29.5	6.0	32.0	15.7	3.7	22.3	21.0	18.3	18.5	8.7	35.2	10.8	31.5	5.3	13.3	6.5	35.1	5.1	15.9	9.9	5.3	14.4	11.6	35.1	3.4	0.7	5.8	9.5	6.0	0.9	5.6	5.2	9.9	4.9	9.8	27.1	18.8	0.3	20.1	5.3	10.9	14.8	0.0	18.3	4.4	11.9	11.1	0.5	5.4	6.0	16.0	0.3	0.5	7.3	10.9	5.3	0.9	35.9	7.2	13.7	2.6	11.7	4.9	4.1	6.0	0.5	4.9	0.1	12.8	8.1	4.2	12.3	25.3	0.3	17.0	11.5	5.1	33.7	0.1	8.7	43.8	0.6	2.5	2.1	10.6	0.4	1.6	11.7	8.3	3.1	0.4	0.2	0.2	0.7	0.2	0.2	5.1	0.2	7.1	4.0	7.3	2.9	0.5	2.6	10.0	5.4	0.4	7.4	0.2	3.4	6.0	3.5	35.0	36.0	33.9	44.3	37.5	36.7	32.1	30.3	32.0	31.5	35.1	35.1	5.1	6.4	3.9	11.1	6.2	5.7	10.7	14.7	13.1	27.7	27.7	30.6	6.1	14.3	9.3	16.5	29.2	37.1	4.8	0.9	11.7	16.6	2.8	4.1	5.0	6.4	11.4	5.2	20.1	6.4	16.9	8.7	2.6	5.5	8.9	18.0	3.6	9.6	2.9	11.8	22.0	7.8	10.2	0.0	1.9	5.5	23.3	1.1	7.2	2.8	3.4	28.8	5.2	8.5	6.5	5.0	5.5	23.3	5.5	5.5	149.1	25.6	7.4	41.1	0.0	12.1	7.5	3.9	5.2	4.0	3.7	16.3	4.7	15.3	15.0	5.7
TMSB15A	"TMSL8, TMSNB"	ENSG00000158164	"Thymosin beta 15A"	P0CG34	X	102513682-102516739	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.0;prostate: 15.8"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 12.8;Granulosa cells: 25.9;Prostatic glandular cells: 13.8;Smooth muscle cells: 13.5;Spermatogonia: 19.8"	"Group enriched"	"Detected in many"	4	"glioma: 20.1;prostate cancer: 56.4;testis cancer: 14.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 571.5;HAP1: 110.2;MOLT-4: 113.4;NTERA-2: 148.0;RH-30: 259.9;SH-SY5Y: 148.1"					"Low region specificity"	"Detected in all"									NA	NA		130000	"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (5.33e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.96e-4)"	"unprognostic (2.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.07e-1)"	1.0	1.0	1.1	1.1	1.2	1.0	5.1	1.7	2.1	5.1	1.4	0.9	0.4	5.0	0.7	0.3	1.9	1.2	1.9	1.2	1.1	2.4	0.1	7.1	4.0	1.3	1.0	4.7	0.9	0.8	0.8	0.5	1.3	15.8	1.1	1.4	3.9	1.2	0.3	0.5	0.6	2.3	1.1	0.4	0.5	4.8	1.2	13.0	5.9	0.3	2.8	0.7	2.3	1.1	0.1	0.0	571.5	107.7	2.4	0.3	0.2	12.4	0.7	1.7	4.8	0.0	0.7	0.0	1.3	2.1	28.5	0.0	110.2	0.7	1.2	0.0	5.6	10.3	1.7	0.3	0.3	0.2	10.1	1.4	0.0	1.1	0.0	14.3	6.7	5.5	1.0	0.0	41.2	0.1	113.4	0.2	148.0	0.0	1.4	0.2	259.9	0.0	11.7	0.2	98.1	148.1	14.0	0.9	0.3	22.0	1.4	3.2	2.4	0.3	62.6	1.4	10.5	11.8	2.1	0.0	6.7	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	1.1	1.2	1.7	2.1	1.2	1.1	1.3	1.0	1.3	1.1	1.2	1.1	1.4	0.0	0.0	0.0	0.0	0.8	0.9	0.1	1.8	0.3	7.3	12.8	0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.0	0.5	0.3	0.5	5.6	1.2	0.0	0.8	0.0	0.0	0.5	4.6	0.0	1.2	0.0	25.9	2.5	0.0	0.5	0.0	0.0	0.6	0.0	0.6	0.5	0.1	0.3	0.1	1.8	0.0	0.0	0.7	1.0	0.5	0.0	0.0	0.1	2.6	0.3	13.8	0.1	0.4	0.0	0.1	6.6	1.2	13.5	3.4	19.8	1.8	0.0	0.3	0.7	0.9	0.9	1.0
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391288	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.5;salivary gland: 25.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.6;Intestinal goblet cells: 24.0;Paneth cells: 42.3;Proximal enterocytes: 25.5;Undifferentiated cells: 42.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 5.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 5.3"	"Cell line enriched"	"Detected in many"	6	"HDLM-2: 125.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		110000	"Cluster 48: NK-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	1.8	1.1	0.8	5.7	1.6	0.4	4.1	0.1	1.9	1.4	0.3	17.1	30.5	0.9	0.3	2.8	0.9	7.6	0.6	2.0	1.1	0.4	0.6	1.0	1.2	0.7	1.1	0.4	1.7	0.9	6.8	3.2	0.2	1.3	17.6	0.2	25.4	2.7	0.3	2.7	18.6	1.7	0.7	0.8	5.5	0.9	1.2	1.0	1.2	0.1	1.9	1.6	1.6	2.1	3.2	2.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.6	0.4	0.6	0.0	3.5	0.4	1.4	2.2	8.3	0.9	0.2	125.9	5.4	0.0	1.3	1.7	0.0	0.5	1.3	0.2	0.4	0.8	3.1	4.2	3.1	0.3	0.0	0.0	0.0	1.1	0.0	0.1	5.9	7.0	19.3	0.4	0.0	0.6	1.5	1.5	20.4	0.7	0.6	3.0	0.1	0.8	1.3	0.4	2.0	0.0	0.1	0.1	0.0	1.2	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.3	0.6	0.0	0.8	1.6	0.1	1.9	2.0	1.1	0.7	1.1	0.2	0.7	1.2	2.1	0.4	0.0	2.2	0.0	0.4	1.3	3.8	1.1	0.6	0.6	4.5	3.3	1.3	8.6	2.3	0.0	0.0	0.1	3.3	35.6	0.0	8.3	0.3	3.2	0.5	5.3	10.8	0.0	4.0	7.5	0.6	0.7	11.7	6.2	0.0	2.0	7.1	0.3	15.5	3.3	0.2	24.0	0.0	17.0	2.4	0.4	0.6	7.7	1.8	8.4	19.7	0.0	3.1	0.5	0.4	14.7	42.3	0.0	0.5	2.8	25.5	0.0	3.8	0.2	0.0	0.5	0.4	0.8	1.9	1.7	2.3	0.1	0.7	0.0	42.2	4.4
TNFRSF18	"AITR, CD357, GITR"	ENSG00000186891	"TNF receptor superfamily member 18"	Q9Y5U5	1	1203508-1206592	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 189.0;dendritic cells: 72.2;Langerhans cells: 86.4;Melanocytes: 49.8;Plasma cells: 55.3;Suprabasal keratinocytes: 150.6;T-cells: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cell: 184.5;T-reg: 71.8"	"Group enriched"	"Detected in many"	11	"NK-cells: 184.5;T-cells: 71.8"	"Group enriched"	"Detected in some"	12	"RPMI-8226: 225.6;SCLC-21H: 152.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA008025	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA008025: AB_1849696"	"unprognostic (1.20e-3)"	"unprognostic (4.61e-2)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (2.73e-4)"	"prognostic favorable (4.12e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.40e-11)"	"unprognostic (1.02e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.08e-1)"	1.9	0.6	1.1	7.3	1.3	2.9	2.4	2.5	3.1	11.1	0.7	6.0	7.2	1.4	0.0	6.3	1.4	0.9	0.5	1.0	0.6	2.8	0.9	4.6	5.5	1.3	0.6	0.3	0.3	9.4	4.9	0.3	1.3	2.8	1.5	0.0	5.6	0.6	0.8	38.5	7.1	0.3	0.6	9.0	5.2	0.9	0.9	1.9	1.4	0.0	3.8	2.0	3.3	1.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	1.7	0.1	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.3	1.2	0.1	0.5	16.1	0.1	0.1	225.6	0.3	0.0	152.8	0.2	0.0	0.6	0.0	0.0	8.2	0.1	0.0	0.0	0.3	0.2	0.0	0.9	0.3	0.2	0.6	0.1	0.0	0.2	0.2	0.0	6.8	0.1	12.6	4.6	28.9	4.4	0.1	11.5	0.9	1.5	0.8	184.5	0.1	0.3	71.8	6.7	1.1	1.3	2.5	3.1	1.0	0.6	1.3	0.6	1.3	0.6	0.9	1.2	11.2	0.0	1.3	0.3	23.5	189.0	12.5	15.5	16.5	0.0	5.0	3.0	2.9	0.0	3.2	0.0	0.0	0.0	72.2	0.3	0.0	0.8	0.0	1.2	1.2	4.1	3.5	0.0	2.0	0.6	1.3	4.7	1.1	2.9	45.7	0.0	0.7	0.0	0.8	0.0	0.3	0.2	20.3	0.3	86.4	0.0	0.0	5.4	49.8	0.0	12.7	0.0	21.6	0.5	0.3	0.4	0.0	0.0	55.3	10.1	0.1	0.1	0.8	0.0	0.0	6.2	2.2	0.0	0.0	0.3	150.6	0.0	75.7	0.0	0.8	7.0
TONSL	"IKBR, NFKBIL2"	ENSG00000160949	"Tonsoku like, DNA repair protein"	Q96HA7	8	144428775-144444440	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024679, HPA046494"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nuclear bodies"	"HPA024679: AB_1854441, HPA046494: AB_2679673"	"unprognostic (6.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.04e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.11e-3)"	"unprognostic (7.96e-2)"	1.0	2.1	0.4	2.5	0.4	8.5	1.3	0.4	1.3	1.7	0.0	3.4	3.5	1.6	0.2	3.9	1.4	0.6	1.4	0.3	0.3	1.4	1.7	1.3	2.3	1.3	0.6	1.7	1.5	0.4	0.9	1.5	1.1	1.6	0.8	0.1	1.5	0.8	0.5	3.3	4.4	0.6	0.1	3.9	2.2	3.8	0.8	2.3	2.4	0.1	1.4	2.3	2.1	0.3	21.2	18.6	13.7	21.7	1.0	1.7	33.0	17.6	3.4	10.4	8.1	15.0	17.9	19.6	17.5	2.7	4.9	14.2	13.4	10.7	2.3	20.2	26.6	46.5	26.1	15.9	0.6	14.3	28.1	1.7	1.5	10.9	2.1	2.6	5.0	26.5	53.0	14.3	4.2	43.4	35.5	24.5	19.4	20.4	26.7	42.6	8.9	20.3	5.9	22.6	22.9	13.0	18.4	12.3	7.8	5.2	17.6	13.2	5.9	12.7	52.3	14.5	21.7	5.0	9.9	12.0	12.3	30.2	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.4	0.4	1.3	0.3	0.3	1.3	0.6	1.1	0.1	0.8	0.3	2.5	6.4	22.4	1.6	2.9	8.9	5.2	1.0	1.2	3.1	3.5	2.9	2.3	8.6	3.7	1.8	2.1	4.1	1.3	20.2	0.0	0.9	0.4	4.3	2.7	4.3	2.4	7.2	2.4	1.0	5.3	3.8	11.7	6.1	2.5	8.5	2.9	11.4	4.5	1.7	1.0	14.6	0.0	0.9	16.7	0.7	0.3	3.0	14.2	1.9	1.2	1.1	1.0	0.5	0.8	1.2	7.1	1.2	4.0	3.9	76.5	7.7	4.1	3.0	6.6	6.4	2.8	4.6	7.8	3.4	11.2	1.2	3.1	3.3	15.9	3.9
TPD52L1	"D53, hD53, TPD53"	ENSG00000111907	"TPD52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.3;salivary gland: 298.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 390.1;Squamous epithelial cells: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 269.1;hTCEpi: 234.3;MCF7: 365.5;RPTEC TERT1: 271.4;SK-BR-3: 189.4;T-47d: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favorable (3.97e-4)"	"prognostic unfavorable (5.34e-4)"	44.7	258.3	83.9	10.1	96.2	0.8	67.0	72.6	97.4	35.8	103.4	36.2	9.7	15.2	68.8	152.4	34.6	27.3	71.4	78.4	81.3	40.6	58.4	10.9	6.6	81.4	76.8	20.7	47.1	67.3	24.8	8.9	78.8	41.0	13.0	1.9	298.3	79.1	111.9	47.9	10.6	12.3	68.5	2.0	43.1	5.1	81.5	3.4	60.7	126.2	12.3	59.6	60.8	76.6	37.7	42.0	0.5	269.1	2.4	0.6	63.3	6.2	5.9	0.0	0.7	67.3	46.9	0.1	136.2	31.2	9.1	83.8	8.4	58.2	0.2	0.8	58.0	0.8	58.0	0.5	5.7	0.2	0.1	7.4	234.3	0.1	30.7	82.5	0.0	0.0	30.5	0.6	4.7	365.5	0.0	0.7	4.4	36.8	22.7	0.4	0.1	0.0	271.4	9.8	9.1	0.2	70.5	189.4	4.6	9.6	162.3	0.8	0.2	1.8	5.9	0.5	2.0	0.1	0.1	0.2	1.0	0.3	0.7	1.8	0.5	0.3	0.3	0.2	0.3	0.3	0.6	0.2	0.2	0.4	0.7	0.5	2.7	2.6	0.1	0.4	0.2	0.4	83.9	96.2	72.6	97.4	78.4	81.3	81.4	76.8	78.8	68.5	81.5	76.6	141.6	0.0	28.3	390.1	2.2	19.6	44.6	70.2	128.1	3.8	164.4	154.9	45.8	25.8	51.7	125.0	4.2	32.7	3.2	3.9	176.1	30.7	6.9	71.7	21.1	87.2	16.2	0.0	16.4	110.8	140.2	18.8	13.7	184.5	2.5	29.5	15.4	59.9	10.9	0.0	48.2	11.3	83.4	2.1	5.2	4.9	17.4	3.4	131.6	28.1	0.6	3.9	1.0	11.6	2.9	35.3	2.3	36.5	2.6	37.1	10.9	45.4	15.7	1.3	0.0	177.1	10.1	5.7	9.2	272.2	37.2	14.4	3.5	53.8	17.8	19.2
TRAPPC2	"hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L"	ENSG00000196459	"Trafficking protein particle complex 2"	P0DI81	X	13712244-13734635	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004665, HPA063308"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"CAB004665: AB_425678, HPA063308: AB_2684982"	"unprognostic (1.97e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (2.13e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.35e-4)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.89e-5)"	6.0	5.7	12.5	6.7	13.4	7.6	6.8	13.1	14.2	10.0	10.7	10.9	6.0	11.0	6.3	8.4	9.4	5.5	5.3	13.3	13.9	7.4	8.2	7.5	12.7	12.1	11.2	11.2	9.2	5.2	7.7	5.3	12.5	8.3	6.4	10.2	7.3	5.1	4.4	7.4	9.6	8.8	10.2	10.3	9.7	3.2	14.9	9.0	7.8	2.7	11.8	8.9	9.9	11.8	9.1	6.2	10.5	26.1	8.0	5.9	3.7	8.5	7.8	6.7	6.9	5.8	11.0	14.8	13.2	6.9	8.8	11.0	13.8	12.4	8.6	15.3	20.4	11.3	16.0	5.2	6.4	15.9	20.8	8.0	7.0	14.7	17.1	13.4	6.3	11.1	15.0	26.3	7.3	16.0	16.0	21.7	10.6	7.2	11.4	15.3	14.3	14.6	10.8	5.5	10.6	13.6	14.5	12.1	11.0	16.3	13.5	10.6	7.9	6.7	6.2	11.4	5.5	13.3	13.8	19.6	6.0	10.5	6.4	19.3	6.0	11.0	18.1	8.4	18.2	13.2	14.3	17.8	5.5	12.8	11.8	16.6	11.7	22.9	6.9	13.0	18.7	11.1	12.5	13.4	13.1	14.2	13.3	13.9	12.1	11.2	12.5	10.2	14.9	11.8	8.9	9.6	6.5	7.8	22.0	15.2	10.0	14.8	9.6	16.5	16.5	13.6	11.0	15.7	14.6	9.2	12.5	14.1	49.8	14.6	21.5	10.0	17.7	17.3	11.0	9.3	12.1	12.4	20.7	13.4	19.9	11.5	14.8	21.2	9.5	16.9	16.8	12.2	11.6	20.2	20.2	14.0	8.2	12.9	14.4	6.1	12.8	13.6	8.8	10.3	12.0	8.8	44.3	31.7	17.3	15.7	18.6	11.3	17.6	9.8	15.4	23.8	8.5	14.5	6.6	8.6	18.5	4.3	4.0	11.3	17.6	17.9	28.8	16.6	13.2	12.5
TRDJ2		ENSG00000211827	"T cell receptor delta joining 2"		14	22456689-22456742	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 37.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	89	"gdT-cell: 953.4;NK-cell: 2991.2"	"Group enriched"	"Detected in all"	279	"NK-cells: 2991.2;T-cells: 953.4"	"Cell line enriched"	"Detected in some"	17	"NB-4: 104.6"															NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 24: NB-4 - Immune response"																						3.0	0.0	0.5	3.7	0.3	4.8	0.8	0.2	0.9	0.0	0.0	3.3	0.0	4.8	0.0	0.0	1.6	0.0	0.0	0.8	0.4	1.2	0.0	7.6	6.4	0.7	0.2	1.7	0.0	0.0	0.0	1.8	0.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	26.2	1.4	0.7	0.8	37.0	0.0	0.0	2.9	0.5	0.0	1.9	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	6.3	0.4	0.0	953.4	2.0	3.3	0.8	22.0	14.7	3.9	1.7	17.6	14.4	7.0	2991.2	2.2	1.4	19.2	206.2	0.5	0.3	0.2	0.9	0.8	0.4	0.7	0.2	0.4	0.0	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRDJ4		ENSG00000211826	"T cell receptor delta joining 4"		14	22455249-22455296	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 5.9;lymphoid tissue: 13.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	10	"ovarian cancer: 2.9"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	45	"gdT-cell: 123.0;NK-cell: 281.9"	"Group enriched"	"Detected in many"	362	"NK-cells: 281.9;T-cells: 123.0"	"Cell line enriched"	"Detected in some"	16	"NB-4: 38.7"															NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"																						0.9	0.0	0.2	0.0	0.3	0.9	1.7	0.5	2.3	0.0	2.5	1.4	5.9	2.4	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.0	0.0	1.2	1.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.1	0.4	13.2	1.3	0.1	0.7	4.4	0.0	0.0	2.0	0.0	0.0	0.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	123.0	0.0	0.3	0.2	1.9	0.6	0.3	0.0	1.5	4.5	0.0	281.9	0.5	0.0	3.0	13.1	0.2	0.3	0.5	2.3	0.3	0.2	0.4	0.2	0.6	0.4	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRGJP1	"JP1, TCRGJP1"	ENSG00000211692	"T cell receptor gamma joining P1"		7	38276259-38276318	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	10	"bone marrow: 271.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"NK-cell: 1153.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 1153.0"	"Group enriched"	"Detected in some"	5	"HL-60: 282.5;U-937: 715.8"															NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"																					3.1	0.0	9.8	7.3	11.1	271.5	4.2	9.8	24.0	4.1	7.2	1.1	5.3	0.3	0.0	0.6	2.1	1.3	0.6	9.1	9.4	0.7	1.7	10.2	8.8	12.1	10.8	0.0	0.0	0.0	0.0	3.9	12.3	1.8	4.3	0.0	0.0	0.0	3.9	0.0	2.0	1.2	9.3	27.9	1.1	0.7	11.3	13.6	0.0	0.0	4.5	1.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	0.0	282.5	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	49.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	715.8	0.0	13.4	0.4	4.4	241.1	0.9	169.1	0.2	16.2	80.9	0.0	0.7	9.3	44.1	4.2	1153.0	0.1	2.8	0.0	58.9	9.8	11.1	9.8	24.0	9.1	9.4	12.1	10.8	12.3	9.3	11.3	10.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282429-27307439	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"heart muscle: 213.2;skeletal muscle: 580.7;tongue: 177.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 81.7;Ductal cells: 35.5;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 46.5;Skeletal myocytes: 17.9;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.1"	"Immune cell enriched"	"Detected in single"	17	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	17	"NK-cells: 3.6"	"Group enriched"	"Detected in some"	8	"HAP1: 7.3;NTERA-2: 15.6"	"Region enhanced"	"Detected in some"		"amygdala: 3.1"					HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	0.4	9.3	1.5	0.0	0.9	0.0	0.3	0.9	5.1	0.9	0.1	0.3	4.3	0.8	24.5	5.0	0.8	0.2	213.2	2.3	0.0	1.7	0.1	0.2	0.2	0.6	0.3	0.5	0.5	0.0	0.1	0.0	0.3	3.4	0.0	0.0	9.5	0.1	580.7	0.9	2.1	0.0	0.3	0.9	0.1	22.3	0.1	0.1	0.5	177.3	0.0	0.1	0.5	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.2	0.0	1.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	15.6	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	1.5	0.9	0.9	5.1	2.3	0.0	0.6	0.3	0.3	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.4	81.7	10.0	0.1	3.7	0.0	0.0	0.3	2.3	0.0	35.5	1.5	0.1	0.0	0.8	0.0	2.7	11.3	42.5	0.0	2.2	0.0	0.2	4.5	0.0	0.4	0.0	0.1	0.0	0.8	1.8	0.0	0.0	0.0	4.7	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.3	46.5	1.9	0.7	0.0	0.2	2.4	3.1	0.2	0.0	0.0	17.9	16.8	6.8	2.4	0.0	0.0	0.0	0.3	0.2	6.4	0.3
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529060-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"choroid plexus: 801.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 905.0;Excitatory neurons: 390.3;Inhibitory neurons: 186.9;Muller glia cells: 184.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HAP1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA072650, HPA074393"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.7	0.6	22.0	0.1	30.4	0.2	0.1	40.5	9.6	1.0	801.0	0.2	0.8	1.1	1.3	0.1	0.4	0.4	0.8	39.3	27.8	16.5	0.2	0.1	0.1	36.7	46.8	3.6	0.5	0.0	2.9	0.1	20.8	0.5	0.1	23.0	0.1	2.5	0.3	0.1	0.0	0.2	25.2	0.3	0.6	5.1	41.6	0.2	0.9	0.1	0.0	0.1	0.4	15.4	0.0	0.0	0.9	0.0	1.1	2.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	17.2	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.2	0.0	0.0	1.0	4.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.9	0.0	1.1	0.0	0.2	0.0	0.3	0.2	0.0	0.0	3.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	22.0	30.4	40.5	9.6	39.3	27.8	36.7	46.8	20.8	25.2	41.6	15.4	0.3	3.2	3.0	905.0	0.5	0.4	0.9	0.0	0.6	16.4	0.3	0.5	5.3	5.7	2.5	16.5	66.7	0.1	0.2	0.1	5.9	0.1	4.8	1.4	1.0	1.3	15.4	0.0	390.3	0.2	0.1	3.0	0.0	3.2	0.0	1.4	0.7	0.3	0.2	1.7	186.9	0.1	0.0	0.9	1.4	2.3	5.6	0.8	0.0	56.2	0.2	184.5	1.0	105.6	8.3	0.1	0.1	9.1	0.0	0.5	0.1	33.3	0.8	10.1	0.0	3.5	1.3	1.3	0.6	0.0	0.9	0.3	0.9	0.6	0.0	0.3
TSEN15	C1orf19	ENSG00000198860	"TRNA splicing endonuclease subunit 15"	Q8WW01	1	184051651-184123978	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029237	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA029237: AB_10671361"	"unprognostic (4.54e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.72e-3)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.82e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.82e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.66e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-1)"	16.4	17.9	21.4	14.8	23.0	19.8	17.8	22.2	27.9	17.1	15.4	20.6	11.6	17.4	28.1	15.1	14.7	12.3	21.9	21.1	22.6	14.7	15.3	16.6	19.1	23.1	20.4	11.6	17.3	15.9	11.8	17.5	22.5	17.2	13.6	21.7	15.2	15.2	36.2	14.1	11.5	17.8	19.9	14.7	15.3	14.6	22.3	28.1	21.0	22.8	18.7	16.4	12.3	29.7	83.3	28.2	39.2	41.6	30.1	31.7	96.6	40.1	77.9	64.1	61.7	30.0	35.8	54.3	40.2	50.4	41.0	38.8	44.2	38.7	69.6	78.1	23.4	28.2	19.7	34.7	60.1	103.4	32.3	21.1	67.2	29.7	60.9	25.4	38.1	95.5	55.9	144.0	59.7	43.4	97.8	46.5	72.6	107.6	30.7	60.3	65.0	113.0	37.6	26.6	35.2	52.3	54.0	39.0	102.7	41.2	51.1	57.8	20.0	39.5	83.9	26.5	61.9	190.4	141.7	87.1	36.7	52.5	86.1	33.5	16.7	24.7	33.7	27.5	30.2	24.8	32.3	35.3	35.9	18.1	24.4	33.7	3.1	54.3	25.4	31.8	39.8	35.0	21.4	23.0	22.2	27.9	21.1	22.6	23.1	20.4	22.5	19.9	22.3	29.7	15.5	48.1	8.1	22.2	26.1	11.1	12.4	17.3	16.5	8.7	18.4	13.7	32.0	10.0	17.1	12.9	4.2	42.5	31.4	3.4	54.8	33.0	1.6	6.7	13.1	15.9	6.7	22.7	30.9	41.8	48.9	20.0	14.3	11.7	32.3	18.0	18.2	34.0	31.7	3.3	32.7	8.4	10.2	13.1	29.1	2.5	21.8	16.6	33.8	13.1	21.6	19.8	64.9	42.7	91.7	35.9	4.5	19.5	45.7	13.3	5.4	71.4	6.9	12.5	13.1	11.3	24.9	46.0	44.6	23.1	13.2	22.6	34.8	19.1	9.8	10.5
TSHB		ENSG00000134200	"Thyroid stimulating hormone subunit beta"	P01222	1	115029826-115034302	"Human disease related genes, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2634	"pituitary gland: 1757.6"	"Cell type enhanced"	"Detected in single"		"Late spermatids: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.7"	"Not detected"	"Not detected"			"CAB022202, HPA042681"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 25: Spermatids - Spermatogenesis"			"CAB022202: , HPA042681: AB_2732500"											"unprognostic (2.14e-4)"	"unprognostic (1.37e-1)"		"unprognostic (1.73e-1)"				0.1	0.6	0.3	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.4	0.2	0.0	0.4	0.3	0.0	0.3	0.0	1757.6	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.4	0.3	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TTC39B	"C9orf52, FLJ33868"	ENSG00000155158	"Tetratricopeptide repeat domain 39B"	Q5VTQ0	9	15163622-15307360	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 64.4;Paneth cells: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 2.0;gdT-cell: 2.9;MAIT T-cell: 3.9;memory CD4 T-cell: 4.0;memory CD8 T-cell: 4.6;naive CD4 T-cell: 4.7;naive CD8 T-cell: 2.9;NK-cell: 6.3;T-reg: 3.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.0;NK-cells: 6.3;T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HEL: 40.9;RT4: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063162			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA063162: AB_2684952"	"unprognostic (1.64e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (9.64e-6)"	"unprognostic (5.99e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.89e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (3.31e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.48e-1)"	1.9	2.6	2.9	4.0	2.5	1.5	4.8	10.8	7.0	4.3	1.8	6.7	5.7	3.5	1.9	8.8	3.3	6.9	1.3	1.5	4.6	9.0	5.4	4.6	6.1	7.0	2.9	2.9	3.9	1.9	3.9	1.2	7.2	2.3	5.6	2.9	3.0	1.9	1.8	9.6	5.6	4.2	2.5	3.8	5.5	5.7	4.7	3.4	2.6	1.3	6.0	3.6	4.7	2.9	3.9	0.8	1.2	5.6	5.3	9.9	1.2	5.0	9.1	3.9	9.3	0.8	1.6	0.0	0.6	6.3	4.6	3.4	0.9	6.2	3.3	4.5	0.8	40.9	1.7	7.3	8.8	0.0	0.8	9.7	4.7	8.1	9.0	2.8	5.6	3.3	0.1	9.1	10.0	1.3	2.2	0.2	1.6	12.3	1.2	0.4	3.0	1.9	8.3	23.0	2.9	0.5	1.2	2.9	0.9	1.8	12.7	2.5	4.2	2.2	1.8	3.1	1.4	0.1	0.1	0.0	2.1	0.5	1.1	2.0	0.7	0.9	2.9	0.5	3.9	0.2	4.0	4.6	0.4	0.6	4.7	2.9	0.4	6.3	0.7	0.1	3.8	2.5	2.9	2.5	10.8	7.0	1.5	4.6	7.0	2.9	7.2	2.5	4.7	2.9	7.5	12.8	19.8	10.4	7.0	17.3	7.8	19.1	10.8	25.5	9.0	4.4	4.1	10.0	15.8	7.3	0.0	3.2	18.0	40.6	17.6	6.6	43.2	11.8	10.1	7.4	12.7	0.4	44.0	21.8	1.1	10.0	22.4	7.7	29.1	3.6	7.5	11.6	4.1	13.5	64.4	16.1	24.4	3.1	9.2	33.2	7.2	16.7	7.2	12.2	2.9	14.9	11.3	24.6	2.3	10.5	65.0	12.8	5.5	11.5	30.3	35.5	25.3	4.3	0.0	9.4	12.4	4.7	3.0	8.6	21.5	4.1	22.3	6.8	17.3	14.4
TTLL11	"bA244O19.1, C9orf20"	ENSG00000175764	"Tubulin tyrosine ligase like 11"	Q8NHH1	9	121821928-122093606	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 24.3"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 201.7;Inhibitory neurons: 157.5;Oligodendrocytes: 412.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021828	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021828: AB_2670841"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.56e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.61e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.53e-2)"	3.8	5.5	7.7	2.7	11.4	1.3	3.6	7.7	18.0	4.2	0.0	10.3	2.6	5.2	3.0	7.0	4.9	3.4	5.1	3.3	7.6	2.8	5.4	3.8	2.4	9.2	8.8	4.3	4.9	4.3	2.9	4.4	9.1	4.4	4.0	6.0	4.7	5.2	24.3	4.2	3.2	9.3	8.4	3.2	4.2	12.1	8.1	2.7	3.5	8.7	2.6	5.7	4.2	19.0	2.4	1.2	3.9	5.3	5.4	6.5	1.6	4.5	5.5	7.7	4.4	3.6	1.4	5.4	1.4	9.3	2.5	5.8	6.8	5.4	4.7	3.7	5.6	2.6	5.2	3.7	6.2	4.7	2.9	4.7	7.6	3.1	4.9	2.9	2.8	4.6	8.1	5.3	2.7	3.8	3.3	3.8	2.1	8.2	8.3	3.4	6.8	8.4	4.0	1.9	8.2	3.4	2.7	5.0	3.6	2.1	4.0	4.0	3.2	3.6	0.7	6.5	6.1	5.8	7.9	2.3	3.3	5.2	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	7.7	11.4	7.7	18.0	3.3	7.6	9.2	8.8	9.1	8.4	8.1	19.0	2.1	0.0	1.5	18.3	1.6	2.5	0.9	0.8	6.2	3.0	2.2	2.4	1.4	1.5	0.4	1.8	10.4	1.7	1.2	1.1	1.9	1.9	22.3	2.8	2.7	1.5	1.2	3.4	201.7	1.8	0.7	2.2	1.1	1.3	1.3	1.0	0.7	1.8	1.6	6.7	157.5	1.6	0.0	0.9	1.2	23.1	3.7	0.9	3.6	22.5	0.9	2.4	2.1	58.8	412.6	1.9	0.1	3.0	2.2	0.8	0.5	2.0	1.8	2.6	0.0	5.5	2.6	13.3	2.5	4.2	4.1	1.0	1.8	2.7	1.0	0.9
TUBA8	TUBAL2	ENSG00000183785	"Tubulin alpha 8"	Q9NY65	22	18110100-18146683	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 128.9;skeletal muscle: 332.2;tongue: 154.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.4;Excitatory neurons: 8.1;Inhibitory neurons: 5.6;Late spermatids: 22.9;Sertoli cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basophil: 2.8;eosinophil: 2.7;neutrophil: 5.0;NK-cell: 10.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 5.0;NK-cells: 10.4"	"Group enriched"	"Detected in many"	5	"NB-4: 30.2;SCLC-21H: 10.9;TIME: 36.3"	"Group enriched"	"Detected in all"	4	"cerebellum: 54.7;olfactory bulb: 53.9"	"Low region specificity"	"Detected in all"			"HPA043684, CAB046031, HPA063394"	Approved		Supported	Microtubules		NA	NA		80000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Microtubules		"CAB046031: AB_11124541, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (1.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.90e-5)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.61e-4)"	7.3	1.9	9.0	1.0	11.8	4.7	7.2	24.3	16.3	2.5	0.8	2.0	0.8	2.7	6.3	4.3	4.8	1.0	128.9	15.0	2.8	2.3	4.3	2.4	3.5	0.6	9.0	2.3	4.4	2.7	14.5	0.6	0.8	2.5	0.5	2.8	4.4	0.6	332.2	4.4	2.6	0.7	1.5	4.2	4.7	52.3	11.5	0.8	6.5	154.7	1.0	2.0	2.2	12.5	0.6	1.1	1.2	1.4	1.8	0.5	0.4	0.6	0.3	1.4	0.8	0.9	1.1	0.9	2.2	0.7	0.4	0.6	2.2	0.4	0.3	0.8	1.6	2.2	1.7	0.9	1.0	1.0	1.0	0.7	0.8	0.8	0.6	0.5	2.0	0.9	0.6	0.9	0.6	3.4	1.0	30.2	1.0	0.5	0.5	0.9	0.5	0.2	0.7	1.1	10.9	1.1	0.6	1.9	1.0	0.5	0.6	4.8	36.3	0.9	1.0	1.0	0.4	2.2	1.3	0.7	0.9	1.4	0.6	2.8	0.7	2.7	0.5	0.6	0.7	0.4	0.4	0.3	0.4	0.6	0.7	0.4	5.0	10.4	0.4	1.0	0.8	17.1	9.0	11.8	24.3	16.3	15.0	2.8	0.6	9.0	0.8	1.5	11.5	12.5	0.2	0.0	1.7	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	4.7	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.3	16.4	0.2	0.1	0.4	0.0	0.0	8.1	1.1	0.0	0.3	0.0	0.2	2.5	0.1	0.7	0.0	0.1	3.3	5.6	0.0	0.0	0.3	0.0	22.9	0.3	0.1	0.0	0.0	0.2	0.1	1.0	3.5	1.7	0.6	0.1	0.4	0.0	0.0	0.4	0.1	0.0	0.2	6.6	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0
TXK	"BTKL, PSCTK5, PTK4, RLK, TKL"	ENSG00000074966	"TXK tyrosine kinase"	P42681	4	48066393-48134250	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 12.4;lymphoid tissue: 15.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 84.1;NK-cells: 288.4;T-cells: 52.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 152.3"	"Group enriched"	"Detected in many"	19	"NK-cells: 152.3;T-cells: 54.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.1;HMC-1: 14.0;U-266/70: 6.8;U-266/84: 9.2;WM-115: 32.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062482			Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA062482: AB_2684778"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.04e-2)"	0.9	1.0	0.1	7.8	0.0	5.6	0.9	0.0	0.4	0.8	0.3	1.5	1.8	1.0	12.4	1.5	2.0	2.2	0.6	0.0	0.5	1.1	2.1	2.8	15.8	1.2	0.2	0.2	0.8	0.4	0.7	1.9	1.5	0.5	1.4	2.0	1.4	0.5	0.6	2.2	5.6	0.4	0.2	10.6	1.1	1.1	0.8	5.7	1.2	0.0	10.8	2.2	0.9	0.2	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.1	6.1	0.0	1.8	0.0	0.2	0.3	0.0	0.1	0.6	0.3	0.1	3.1	0.0	0.0	0.0	0.4	14.0	0.0	0.0	0.1	0.0	0.9	0.2	0.6	0.2	0.1	0.8	0.0	0.0	2.8	0.0	0.8	1.0	0.4	0.0	0.0	1.7	1.6	0.0	0.3	0.0	0.0	1.6	0.1	0.0	0.2	0.5	0.0	0.0	0.4	0.1	6.8	9.2	0.6	0.0	0.5	32.0	5.4	0.1	1.0	42.0	0.2	54.8	0.2	21.1	20.2	0.2	0.1	53.2	37.0	2.4	152.3	0.3	0.6	17.6	36.3	0.1	0.0	0.0	0.4	0.0	0.5	1.2	0.2	1.5	0.2	0.8	0.2	0.7	0.0	1.8	0.3	3.2	0.4	0.6	0.0	0.6	0.5	0.8	0.4	1.1	1.5	0.0	0.0	4.2	0.4	84.1	0.2	1.9	1.5	10.1	2.0	0.4	0.9	0.0	10.7	21.5	0.0	0.1	0.6	0.0	5.5	1.3	0.1	3.6	1.5	1.6	0.0	3.3	0.2	0.0	6.9	0.4	2.8	0.3	1.9	1.8	3.7	1.6	1.4	288.4	0.5	0.5	0.1	0.1	0.0	8.9	0.6	0.4	0.5	0.0	0.4	0.0	1.2	0.1	1.0	0.8	0.8	1.1	0.5	52.3	0.1	0.4	0.8
UBXN10	"FLJ25429, UBXD3"	ENSG00000162543	"UBX domain protein 10"	Q96LJ8	1	20186096-20196050	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 49.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 117.5;Endometrial ciliated cells: 72.6;Late spermatids: 146.8;Respiratory ciliated cells: 117.8;Spermatocytes: 48.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.9;HMC-1: 7.1;K-562: 8.5;SCLC-21H: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028555, HPA028564"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA028555: AB_10600417, HPA028564: AB_10601897"	"unprognostic (3.00e-3)"	"unprognostic (3.30e-2)"	"unprognostic (4.31e-2)"	"prognostic favorable (2.02e-4)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.60e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	0.6	1.3	2.5	0.5	2.8	2.0	2.9	2.1	2.9	7.1	15.3	9.7	0.8	6.2	4.7	4.1	49.7	2.0	3.5	3.3	3.3	2.1	5.9	5.3	0.3	5.2	5.6	0.4	1.5	4.8	3.0	1.0	4.5	2.4	4.8	2.2	0.9	2.7	0.2	0.5	2.0	3.4	4.8	0.1	2.3	14.1	3.7	0.3	5.4	0.2	0.5	2.6	0.3	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	1.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	8.5	0.0	0.0	0.0	0.3	0.3	0.8	0.2	0.0	0.0	0.0	0.0	0.6	0.4	5.6	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.0	2.7	0.4	0.7	0.9	0.8	0.1	0.5	0.8	0.4	4.1	0.0	0.0	0.4	0.5	2.5	2.8	2.1	2.9	3.3	3.3	5.2	5.6	4.5	4.8	3.7	4.3	0.1	0.0	6.1	0.7	0.2	0.1	0.0	5.5	0.0	0.5	1.2	1.5	5.3	1.5	13.0	3.7	0.0	0.1	0.4	5.1	5.9	3.7	117.5	72.6	2.0	0.8	1.2	2.1	1.8	1.7	0.6	2.0	0.0	7.4	13.9	0.4	1.1	4.2	0.9	0.0	1.6	10.6	10.2	1.2	0.0	146.8	2.8	0.8	0.0	0.0	0.6	1.9	0.0	0.0	0.1	1.4	1.4	1.2	0.0	0.1	0.6	2.9	117.8	3.1	0.0	0.4	4.1	48.9	2.2	0.0	0.0	0.3	1.2	0.0	3.2	0.3
UPF1	"HUPF1, KIAA0221, NORF1, pNORF1, RENT1, smg-2"	ENSG00000005007	"UPF1 RNA helicase and ATPase"	Q92900	19	18831959-18868230	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Nonsense-mediated mRNA decay"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019587, HPA020857"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		19000	"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019587: AB_1856174, HPA020857: AB_1856175"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (2.94e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.71e-3)"	"prognostic favorable (2.97e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.01e-2)"	22.7	21.2	11.6	22.2	13.2	26.1	21.2	13.9	14.3	23.4	8.9	23.2	21.6	24.4	8.1	24.1	20.6	17.7	17.5	11.8	11.6	16.3	17.3	21.6	25.8	15.8	12.7	22.5	42.2	35.1	18.6	22.3	11.4	21.1	10.7	10.1	36.7	22.3	31.3	29.3	21.7	13.8	13.3	24.8	23.8	30.9	12.6	27.0	23.0	19.6	16.5	23.5	23.1	15.3	61.2	39.8	27.4	32.8	41.5	27.1	89.7	50.6	31.1	48.0	37.4	76.9	54.0	54.5	65.4	32.0	25.5	60.0	38.7	55.2	18.2	29.2	76.5	59.9	37.2	49.8	35.7	67.2	34.7	30.3	39.3	37.4	40.3	27.5	30.8	46.6	76.6	51.4	25.8	66.5	78.5	42.2	45.7	42.2	96.0	62.1	44.2	51.4	21.1	54.3	57.8	44.6	46.4	52.2	27.3	21.8	31.4	42.7	43.9	42.6	29.6	52.8	57.3	33.0	27.4	83.7	30.3	64.0	48.0	0.0	0.6	1.1	0.2	0.3	0.2	0.1	0.3	0.0	0.4	0.3	0.2	0.1	1.7	1.0	0.8	0.2	0.2	0.3	11.6	13.2	13.9	14.3	11.8	11.6	15.8	12.7	11.4	13.3	12.6	15.3	24.2	22.4	13.6	10.1	14.8	15.7	13.3	10.0	10.2	30.8	24.7	24.5	14.5	12.8	11.0	27.6	14.6	16.4	18.7	32.5	0.0	11.1	13.5	46.5	27.8	19.4	21.6	8.8	9.9	9.8	13.7	15.8	29.0	65.9	0.0	24.4	13.9	24.1	14.4	37.0	9.5	27.4	10.2	19.1	12.2	7.9	14.6	19.5	12.4	10.3	11.8	19.5	13.4	9.0	11.4	16.6	16.6	19.2	18.9	22.2	17.5	10.5	29.0	18.5	13.1	15.6	15.0	26.8	18.4	20.1	18.6	20.5	16.5	20.5	22.8	27.2
UST	2OST	ENSG00000111962	"Uronyl 2-sulfotransferase"	Q9Y2C2	6	148747030-149076990	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 339.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032022	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA032022: AB_10603326"	"unprognostic (3.43e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.22e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.25e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.02e-2)"	6.0	12.2	6.3	3.0	7.4	0.2	6.2	10.0	7.9	7.6	7.5	9.2	1.7	6.8	5.6	4.6	9.2	6.0	4.3	5.8	16.0	3.6	1.3	5.2	3.9	28.2	17.2	11.6	13.1	4.6	1.9	4.6	14.1	6.3	2.7	6.8	3.2	4.8	1.7	6.7	5.7	8.8	13.5	6.5	5.0	6.7	22.7	6.5	27.5	5.8	3.7	8.8	7.7	15.6	0.1	3.2	18.2	14.0	21.5	17.8	0.1	7.9	20.5	3.8	9.8	0.0	1.2	6.7	1.7	12.3	9.5	5.7	13.0	6.6	7.6	9.1	9.9	0.2	10.0	0.1	7.9	0.3	2.8	9.2	14.6	9.8	18.1	7.6	0.2	11.1	0.0	0.0	3.0	8.3	0.1	0.0	10.7	32.4	4.2	3.3	2.5	7.7	0.1	14.8	9.4	0.0	26.4	6.3	5.0	13.0	4.7	0.3	0.4	10.9	1.3	2.5	7.4	0.0	0.0	0.0	12.1	5.4	6.3	0.0	0.0	0.0	0.6	0.2	0.4	0.3	0.4	0.5	0.4	0.5	0.0	0.2	0.0	2.5	0.3	0.4	0.1	0.1	6.3	7.4	10.0	7.9	5.8	16.0	28.2	17.2	14.1	13.5	22.7	15.6	0.9	3.2	3.2	70.2	4.5	9.4	5.4	2.6	3.4	0.1	1.7	1.5	1.7	0.0	2.7	1.8	0.0	2.0	8.9	0.2	0.0	0.1	1.1	0.3	8.7	0.6	0.0	0.0	36.3	2.0	0.3	16.3	7.1	0.4	0.0	12.3	1.4	0.3	1.7	0.0	39.7	1.8	10.2	1.0	20.9	3.4	18.3	2.8	5.4	80.6	1.0	14.6	5.2	339.8	3.2	1.1	0.3	11.3	0.4	5.9	0.0	0.6	2.3	0.8	0.0	6.8	3.5	2.9	5.7	1.9	11.6	1.4	2.0	10.2	0.5	6.8
VANGL1	STB2	ENSG00000173218	"VANGL planar cell polarity protein 1"	Q8TAA9	1	115641970-115698224	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.3;NK-cells: 6.2;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025235, CAB076375"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB076375: AB_2665604, HPA025235: AB_1858718"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (9.94e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.18e-3)"	"unprognostic (5.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-3)"	"unprognostic (9.06e-3)"	4.9	3.9	2.1	3.8	1.2	2.5	3.2	0.8	1.1	9.1	3.0	6.8	3.8	5.5	4.9	10.4	12.0	3.8	5.4	1.3	1.3	5.3	3.0	4.1	2.1	1.2	3.0	4.4	5.0	5.2	0.5	3.6	1.7	4.4	6.4	1.6	6.4	4.5	0.9	6.8	3.9	7.3	1.2	2.2	5.5	5.0	6.5	7.3	7.6	2.4	2.5	6.4	4.4	1.0	49.6	20.7	6.6	8.9	24.1	21.5	13.1	18.8	13.5	24.1	19.1	12.0	24.1	0.0	31.5	21.9	22.7	60.9	11.2	33.3	15.8	57.9	13.7	27.4	18.4	9.8	8.8	8.2	11.4	11.4	23.1	17.2	18.2	12.8	24.1	45.9	16.8	14.8	24.5	65.7	41.0	3.4	16.7	28.8	19.5	0.1	19.1	14.3	11.0	32.8	5.9	8.0	33.9	22.2	15.4	12.4	11.3	8.8	26.2	16.5	25.7	36.3	34.6	2.1	2.3	0.2	22.3	14.3	41.1	0.0	0.5	0.0	1.9	0.3	0.5	0.2	1.2	1.9	2.3	0.0	0.4	2.0	0.0	6.2	0.5	2.0	3.0	1.0	2.1	1.2	0.8	1.1	1.3	1.3	1.2	3.0	1.7	1.2	6.5	1.0	9.2	3.2	3.2	5.5	0.5	7.4	7.4	16.8	11.4	5.2	4.6	4.6	7.9	2.8	9.6	9.2	39.6	5.0	3.4	11.2	0.0	15.7	6.1	25.1	7.7	10.5	6.7	13.2	0.9	13.8	7.3	10.1	8.2	17.0	0.0	5.1	28.9	2.5	4.3	0.0	0.7	8.6	10.2	1.9	1.4	3.0	5.9	2.9	0.0	4.7	11.1	4.7	9.2	2.0	0.1	20.8	6.1	8.2	1.8	8.3	2.6	5.6	12.8	0.9	6.6	4.3	8.5	5.5	7.0	20.0	6.5	0.4	3.1	3.2	10.3	6.5
WDR37	KIAA0982	ENSG00000047056	"WD repeat domain 37"	Q9Y2I8	10	1049538-1132384	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 184.8;Late spermatids: 92.9;NK-cells: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037376, HPA037565"	Enhanced		Approved	"Intermediate filaments"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Intermediate filaments"		"HPA037376: AB_10672789, HPA037565: AB_10696937"	"unprognostic (1.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.51e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.75e-5)"	"unprognostic (2.59e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.62e-2)"	"prognostic favorable (1.46e-6)"	"unprognostic (3.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (5.98e-2)"	8.4	16.5	10.4	9.3	10.5	22.2	7.8	0.4	18.7	8.1	2.0	8.9	7.3	7.9	8.9	9.1	7.8	6.1	17.6	13.1	2.5	8.7	10.3	10.3	12.5	1.5	1.9	9.7	10.1	9.8	14.6	6.3	2.9	8.1	6.7	14.9	7.6	5.1	18.3	11.5	11.2	6.6	0.0	21.0	10.3	21.2	3.1	10.3	9.5	15.7	9.8	7.0	7.9	9.7	12.4	9.0	11.6	9.4	10.9	15.8	8.2	15.5	8.4	9.5	9.4	11.3	10.4	6.1	9.2	20.3	2.0	11.2	6.1	18.1	8.1	7.4	10.0	14.8	9.6	7.7	7.7	8.8	16.0	19.8	13.6	13.6	4.8	11.3	21.0	12.1	9.1	7.3	15.2	10.9	9.8	6.9	6.4	9.6	4.8	14.9	6.5	10.5	13.2	13.8	5.2	10.1	7.2	13.3	11.9	8.8	12.8	17.9	27.7	7.5	2.5	24.8	12.5	13.4	13.3	8.2	17.4	9.9	5.4	6.0	4.8	3.5	10.0	6.2	8.7	5.5	5.6	7.4	5.2	4.4	6.3	7.3	3.8	11.2	7.1	4.8	5.3	5.2	10.4	10.5	0.4	18.7	13.1	2.5	1.5	1.9	2.9	0.0	3.1	9.7	10.5	3.2	8.1	33.6	14.5	13.4	13.0	7.5	10.2	16.3	8.4	7.2	23.3	5.7	7.9	11.0	12.5	6.2	27.4	8.6	0.0	4.8	184.8	5.7	8.6	13.6	10.7	6.5	65.3	6.1	4.2	9.0	13.3	11.1	12.0	7.3	30.7	7.0	9.0	8.4	59.7	8.1	8.2	18.8	13.7	92.9	12.5	14.8	16.0	43.1	23.7	5.3	86.5	36.7	47.3	9.5	8.3	18.0	9.6	13.6	7.2	4.8	4.9	14.7	6.6	13.0	8.5	11.6	14.3	11.9	12.4	11.4	19.1	10.1	5.9	19.7
WDSUB1	"FLJ36175, UBOX6, WDSAM1"	ENSG00000196151	"WD repeat, sterile alpha motif and U-box domain containing 1"	Q8N9V3	2	159235798-159286703	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036840, HPA058172"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036840: AB_10670926, HPA058172: AB_2683628"	"unprognostic (1.37e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (2.56e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.76e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.87e-2)"	6.7	10.9	9.1	4.6	10.2	10.6	12.0	10.7	12.0	7.8	11.7	6.7	4.9	8.2	17.5	7.5	9.8	5.9	10.1	8.9	9.3	23.5	6.9	9.0	7.9	9.7	9.3	13.5	10.6	13.9	9.1	9.7	9.8	9.1	7.6	11.1	10.4	6.8	6.7	6.9	5.8	6.6	8.9	8.6	7.4	6.7	9.4	7.0	17.3	6.5	5.8	6.2	6.3	11.7	8.4	6.3	5.4	9.0	10.1	11.4	19.1	6.7	13.0	11.4	20.4	13.7	13.6	11.7	6.9	9.9	20.3	5.2	15.9	5.9	16.1	4.5	13.4	12.1	6.8	14.0	12.2	10.2	15.6	6.7	21.5	14.4	12.0	22.2	9.8	14.9	16.0	8.5	11.1	8.8	7.3	18.5	7.5	14.3	13.6	11.3	8.3	6.2	13.6	12.2	10.3	6.8	7.0	8.6	15.9	26.0	6.7	17.3	4.1	8.2	6.2	11.8	6.5	4.2	7.7	10.7	14.4	12.6	5.3	3.9	11.1	3.5	14.3	8.6	10.9	11.8	5.6	9.1	12.2	9.9	6.7	8.0	0.8	20.8	7.9	11.6	3.3	7.8	9.1	10.2	10.7	12.0	8.9	9.3	9.7	9.3	9.8	8.9	9.4	11.7	8.2	12.8	6.8	28.4	10.7	5.4	8.7	13.0	11.4	6.9	9.3	8.0	11.3	10.0	11.3	20.2	2.1	25.4	11.2	5.1	35.2	9.5	4.5	13.7	6.9	7.0	5.4	6.7	42.4	3.6	9.2	9.9	10.2	16.1	12.0	13.2	6.4	2.0	17.3	5.0	52.0	4.5	12.2	14.8	4.8	2.9	12.8	10.2	5.4	29.0	9.2	6.6	14.4	31.7	34.6	4.0	7.0	11.3	3.8	6.8	6.9	23.7	15.0	9.7	0.0	12.0	7.8	10.1	22.5	11.1	6.3	23.0	9.1	12.7	7.1	7.3
XCL1	"ATAC, LPTN, LTN, SCM-1, SCM-1a, SCYC1"	ENSG00000143184	"X-C motif chemokine ligand 1"	P47992	1	168576605-168582069	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 185.3;T-cells: 213.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	14	"NK-cell: 88.5"	"Lineage enriched"	"Detected in many"	14	"NK-cells: 88.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.8;Hep G2: 4.1;SCLC-21H: 3.3;SuSa: 6.1;U-266/70: 5.0;U-266/84: 1.9"	"Not detected"	"Not detected"							HPA057725	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA057725: AB_2683511"	"unprognostic (5.38e-3)"	"unprognostic (5.72e-2)"	"unprognostic (8.23e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.34e-10)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.15e-2)"	0.5	0.1	0.1	1.0	0.1	3.5	1.0	0.0	0.2	1.0	0.0	0.7	1.0	2.2	0.8	0.2	0.6	1.1	0.5	0.1	0.2	0.5	2.6	1.8	2.3	0.1	0.1	0.2	0.5	0.0	0.1	2.2	0.2	0.4	1.0	0.0	1.5	0.3	0.1	0.1	1.5	0.3	0.1	4.6	1.2	0.2	0.6	4.1	0.3	0.0	1.6	0.9	0.4	0.1	0.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.3	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.0	1.9	0.0	0.0	0.0	0.0	3.2	0.0	0.0	6.2	0.0	0.2	0.0	1.0	5.9	0.0	0.0	0.3	4.0	0.3	88.5	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.6	0.1	2.3	3.2	5.5	0.0	1.5	4.0	0.5	0.0	2.2	0.0	1.3	1.5	2.0	1.5	0.0	0.0	0.0	1.4	185.3	0.7	0.0	0.0	1.3	2.0	1.9	1.9	0.0	8.4	0.0	0.2	1.2	1.9	8.2	2.9	2.5	0.0	1.4	0.9	0.4	0.0	0.1	0.8	0.0	1.9	10.6	0.0	0.0	3.1	39.2	0.0	0.1	0.0	42.2	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.1	0.0	0.0	0.0	0.3	1.7	0.2	0.2	1.8	4.3	0.8	213.4	0.0	0.4	0.1
XCL2	"SCM-1b, SCYC2"	ENSG00000143185	"X-C motif chemokine ligand 2"	Q9UBD3	1	168540768-168543997	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 13.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 513.6;NK-cells: 277.1;T-cells: 240.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"NK-cell: 423.5"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 423.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;RT4: 1.1;SuSa: 1.1"									HPA057725	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA057725: AB_2683511"	"unprognostic (9.88e-3)"	"unprognostic (7.89e-3)"	"unprognostic (4.77e-2)"	"unprognostic (9.32e-3)"	"unprognostic (8.21e-2)"	"unprognostic (6.79e-4)"	"unprognostic (9.33e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (6.26e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (8.36e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.06e-1)"	1.1	0.8	0.3	3.2	0.3	14.1	0.9	0.3	0.5	1.0	0.4	1.9	3.2	3.6	0.9	0.6	1.8	1.9	0.7	0.3	0.4	0.4	5.6	3.3	5.6	0.5	0.3	0.4	0.6	0.3	0.2	1.4	0.4	0.5	1.5	0.0	1.9	1.0	0.3	0.1	2.0	1.4	0.4	13.4	2.9	0.3	0.6	3.8	0.6	0.5	3.6	2.0	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.4	0.1	0.4	47.2	0.2	2.7	0.3	3.6	50.1	0.3	0.1	2.1	37.1	1.9	423.5	0.3	0.1	0.0	17.1	0.3	0.3	0.3	0.5	0.3	0.4	0.5	0.3	0.4	0.4	0.6	0.4	2.9	0.0	1.1	0.0	3.3	2.4	0.0	0.0	1.8	0.0	1.6	1.4	0.8	0.0	0.0	0.0	0.0	0.1	513.6	0.3	0.0	0.1	0.0	2.4	2.0	1.0	0.0	19.2	0.0	0.0	0.0	1.1	8.2	2.2	1.3	0.0	1.4	0.6	0.4	0.0	0.0	0.7	0.0	5.0	4.0	0.0	0.0	3.7	33.8	0.0	0.8	0.0	277.1	0.0	0.0	0.0	1.1	0.0	13.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.9	1.1	0.0	240.6	0.0	0.1	0.1
YARS1	"tyrRS, YARS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase 1"	P54577	1	32775237-32817380	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 17.5;Cytotrophoblasts: 41.8;Extravillous trophoblasts: 48.1;Hofbauer cells: 41.0;Syncytiotrophoblasts: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		No	No		1400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavorable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (6.57e-4)"	24.9	40.3	39.9	35.0	51.2	19.9	21.3	38.1	60.4	20.5	30.1	27.5	26.0	16.9	25.0	34.4	21.6	15.3	22.4	42.1	46.6	20.6	47.7	27.8	38.2	37.5	38.4	15.1	85.6	34.1	14.8	26.2	42.3	18.8	32.4	38.0	29.6	29.0	31.9	26.0	21.6	35.4	38.5	22.0	40.8	31.2	44.2	34.6	42.3	36.6	50.0	34.6	14.0	49.6	157.1	92.1	86.1	194.5	111.2	117.7	91.7	151.0	136.7	133.2	165.0	116.6	103.0	287.5	63.1	173.2	112.7	90.8	269.0	204.4	198.9	122.6	113.9	254.2	117.2	114.2	383.4	202.9	147.3	129.0	252.3	212.7	544.2	98.3	140.9	245.8	291.8	268.7	117.8	107.8	233.0	159.3	149.1	185.3	134.5	198.3	75.2	234.9	109.8	76.5	149.5	94.2	89.0	102.7	300.8	99.2	95.2	247.5	103.6	73.6	135.7	152.1	135.7	242.8	265.2	255.7	184.8	297.7	203.6	56.1	33.3	17.8	59.0	35.2	58.4	23.8	35.4	55.1	45.8	20.3	25.2	39.0	6.9	98.1	35.0	26.9	40.9	51.5	39.9	51.2	38.1	60.4	42.1	46.6	37.5	38.4	42.3	38.5	44.2	49.6	7.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	41.8	11.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	48.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	37.6	1.4	0.0	0.0	0.0
YPEL1		ENSG00000100027	"Yippee like 1"	O60688	22	21697536-21735794	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 29.9;testis: 77.9"	"Group enriched"	"Detected in many"	9	"Early spermatids: 706.3;Late spermatids: 1354.3;Spermatocytes: 394.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 18.8;JURKAT: 38.0;MOLT-4: 20.4;REH: 22.1;SCLC-21H: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030501, HPA045621"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA030501: AB_10602683, HPA045621: "	"unprognostic (1.36e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (3.82e-3)"	"unprognostic (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.68e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.16e-3)"	3.3	2.3	13.2	2.9	29.9	6.4	3.3	8.9	16.6	2.0	8.1	3.3	2.4	4.1	1.6	2.0	2.7	3.1	7.2	17.4	13.3	2.4	2.5	5.5	5.8	4.8	6.2	7.6	3.9	3.3	2.6	1.3	5.6	2.7	1.8	3.7	2.7	1.2	15.7	1.7	2.5	2.4	4.6	8.4	3.4	77.9	14.4	14.6	2.7	6.4	4.5	2.1	1.3	9.4	2.1	0.4	18.8	11.6	1.4	0.6	1.0	0.7	0.2	1.3	1.8	0.0	1.0	3.1	2.4	0.3	1.7	0.2	1.1	0.3	1.1	9.6	3.3	0.2	0.3	0.9	1.1	2.1	2.4	1.3	0.3	0.5	0.2	3.3	3.2	38.0	1.2	10.1	1.8	0.5	20.4	5.0	1.1	0.3	2.9	22.1	4.7	1.2	0.4	0.1	19.2	13.6	2.3	2.2	1.5	3.7	1.1	2.7	1.8	0.3	5.0	0.4	0.7	13.9	7.2	10.7	1.1	2.2	3.1	0.2	0.1	0.1	1.9	0.4	1.5	0.3	0.3	1.8	0.2	0.6	0.1	0.9	0.8	2.4	0.1	1.7	0.8	0.5	13.2	29.9	8.9	16.6	17.4	13.3	4.8	6.2	5.6	4.6	14.4	9.4	6.3	3.2	4.8	13.7	9.1	1.8	2.9	0.5	0.6	6.8	6.4	3.8	4.8	7.2	2.1	3.7	6.2	0.6	62.1	0.6	0.0	7.1	706.3	6.1	3.1	6.4	13.1	10.3	16.7	3.5	0.4	3.6	2.6	3.6	0.0	23.0	10.4	6.7	1.6	6.7	11.6	1.8	0.0	3.2	3.7	1354.3	11.5	4.9	0.0	8.4	2.9	4.7	90.6	9.0	7.6	3.9	0.3	10.9	12.5	3.4	0.2	4.2	2.3	7.5	13.1	8.4	4.3	394.7	12.0	0.5	1.8	1.4	20.6	1.7	2.6	2.4
ZKSCAN7	"FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39"	ENSG00000196345	"Zinc finger with KRAB and SCAN domains 7"	Q9P0L1	3	44555193-44594173	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Late spermatids: 17.1;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;NTERA-2: 3.1;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048312, HPA049906, HPA071850"	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear speckles"	"HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458"	"unprognostic (3.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.17e-3)"	1.5	2.7	0.8	1.0	0.8	0.3	1.6	1.8	1.0	2.8	1.2	1.9	0.4	2.8	2.3	0.8	2.5	0.9	2.1	0.7	0.8	2.7	2.2	1.3	1.3	0.7	0.7	4.2	3.0	0.8	4.2	0.7	0.6	2.4	0.7	3.0	1.6	1.3	1.0	0.6	1.7	1.4	0.4	2.0	1.7	4.1	0.7	2.2	2.6	0.6	1.2	2.4	1.5	0.9	0.0	0.0	2.6	4.0	0.8	0.3	0.0	1.3	1.1	1.4	1.5	0.0	0.0	0.0	0.4	0.9	0.4	0.0	0.0	0.8	1.7	0.0	0.0	0.1	0.9	1.1	2.4	0.0	0.0	1.8	0.9	0.7	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.2	0.0	0.7	0.3	1.9	4.8	0.0	0.1	0.0	2.9	0.0	1.9	0.4	0.8	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.2	0.3	0.8	0.1	0.2	0.3	0.5	0.6	0.2	0.7	0.3	0.7	0.4	0.6	0.3	0.6	0.5	0.3	0.8	0.8	1.8	1.0	0.7	0.8	0.7	0.7	0.6	0.4	0.7	0.9	0.3	0.0	0.5	5.2	1.4	0.1	0.4	0.9	0.6	6.6	0.9	1.1	4.8	0.0	0.4	1.8	0.0	0.0	3.3	0.2	0.0	2.1	15.4	0.6	1.8	0.9	3.0	1.3	4.3	0.5	0.1	2.1	0.0	0.4	0.0	3.1	0.4	1.4	1.1	3.3	4.7	0.3	0.0	0.3	0.4	17.1	0.9	0.7	0.0	1.0	1.4	3.8	6.2	10.6	6.4	0.9	0.0	2.6	0.4	0.5	0.4	1.3	0.3	4.2	0.0	1.0	1.1	10.8	3.6	0.5	0.4	0.1	1.0	2.9	0.6	0.2
ZMAT4	FLJ13842	ENSG00000165061	"Zinc finger matrin-type 4"	Q9H898	8	40530590-40897833	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.5;retina: 4.4;thyroid gland: 16.3"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 220.9;Inhibitory neurons: 507.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	86	"NK-cell: 8.6"	"Lineage enriched"	"Detected in single"	86	"NK-cells: 8.6"	"Group enriched"	"Detected in some"	5	"AF22: 22.5;U-2197: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069813, HPA071585"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA069813: AB_2686206, HPA071585: AB_2686423"	"unprognostic (1.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.07e-1)"		"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.46e-4)"	"unprognostic (5.44e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.79e-3)"	0.0	0.7	3.2	0.1	7.5	0.0	0.1	1.6	15.0	1.4	0.0	0.7	0.0	0.3	0.1	0.0	0.1	0.1	0.4	6.2	2.7	0.3	0.0	0.0	0.1	15.5	4.5	0.4	0.1	0.0	1.8	0.1	15.4	0.6	0.2	4.4	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.3	0.1	1.4	11.1	0.3	16.3	0.0	0.1	0.0	0.0	4.1	0.0	1.3	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.7	3.6	0.0	0.0	0.0	0.6	14.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	3.2	7.5	1.6	15.0	6.2	2.7	15.5	4.5	15.4	0.3	11.1	4.1	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	8.5	0.1	0.0	0.9	2.8	0.0	0.0	6.2	0.0	1.0	0.0	1.9	0.0	19.7	0.0	0.1	0.0	1.8	0.0	220.9	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	507.5	0.0	0.0	0.0	0.0	55.2	2.8	0.0	0.0	7.5	0.0	1.3	42.2	13.0	4.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.3	0.6	0.1	0.1
ZNF133	"pHZ-13, pHZ-66, ZNF150"	ENSG00000125846	"Zinc finger protein 133"	P52736	20	18288283-18316996	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 37.1;Inhibitory neurons: 42.0;Oligodendrocyte precursor cells: 32.6;Oligodendrocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA001493	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA001493: AB_1080666"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-1)"	"unprognostic (8.27e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.46e-6)"	"unprognostic (6.01e-3)"	"unprognostic (8.60e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (2.20e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.52e-1)"	12.3	13.1	16.8	4.6	17.1	4.3	14.5	19.0	19.0	17.1	20.5	15.7	5.2	13.3	16.5	14.8	14.1	7.7	11.1	16.9	17.7	18.1	13.0	10.9	5.7	16.1	16.4	17.6	16.0	11.4	21.2	8.7	16.7	18.7	6.8	10.5	12.9	8.8	14.0	16.7	10.3	10.5	15.5	15.5	12.9	10.2	16.9	7.1	17.4	9.8	5.9	14.1	15.1	17.8	10.0	10.8	8.3	12.0	19.9	13.7	17.6	9.2	13.5	11.5	16.6	8.7	11.5	2.6	5.4	10.9	13.2	21.4	8.1	24.1	10.8	2.9	5.6	6.8	9.9	19.4	14.9	5.8	1.0	13.4	16.3	9.6	28.0	15.6	11.2	11.0	8.1	2.8	10.0	10.0	7.2	9.5	6.9	11.9	10.6	6.2	11.4	6.4	11.3	6.8	11.7	11.9	7.1	18.9	13.3	11.5	7.4	15.7	8.0	12.1	5.8	8.6	9.2	9.1	9.8	0.9	3.7	3.9	7.0	1.5	3.1	2.4	5.9	2.2	3.9	3.2	5.0	4.0	3.9	3.4	3.8	4.6	1.0	8.7	3.5	2.1	4.0	2.7	16.8	17.1	19.0	19.0	16.9	17.7	16.1	16.4	16.7	15.5	16.9	17.8	3.7	6.4	9.2	18.6	2.5	2.2	2.7	7.3	3.4	7.5	4.6	7.4	7.9	5.7	5.7	1.8	4.2	5.0	0.8	2.2	3.9	4.5	14.7	5.1	7.7	4.7	1.2	3.2	37.1	2.3	3.2	5.3	5.1	4.5	7.0	7.1	5.3	4.2	4.7	3.3	42.0	4.6	2.0	3.8	0.9	25.0	7.8	2.2	0.0	21.5	1.4	3.1	4.1	32.6	31.8	3.7	1.5	4.5	2.3	3.3	2.5	3.4	5.0	5.0	0.0	4.4	3.6	6.1	2.6	3.0	3.1	2.3	1.9	3.7	3.3	3.0
ZNF205	"Zfp13, ZNF210"	ENSG00000122386	"Zinc finger protein 205"	O95201	16	3112560-3120517	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001791	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA001791: AB_1080688"	"unprognostic (8.46e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.71e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.17e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.19e-3)"	10.0	10.4	7.0	4.0	6.7	1.9	10.1	18.0	9.9	12.2	4.6	11.4	8.0	13.0	2.0	10.7	11.1	6.2	12.7	6.7	6.1	12.0	14.0	9.2	3.0	7.0	6.8	14.4	16.3	6.8	10.7	5.5	6.7	14.0	3.2	4.0	10.6	5.3	20.4	14.3	7.7	4.5	4.8	7.6	11.9	3.8	6.8	1.6	11.5	6.8	1.6	9.9	10.7	7.7	11.0	14.3	12.2	19.6	4.7	6.2	16.5	9.0	9.3	11.5	14.1	7.6	10.2	0.4	11.4	5.6	7.4	16.5	10.8	9.3	5.5	2.9	22.1	4.5	21.2	9.0	10.6	0.5	2.5	7.0	14.4	11.1	7.5	11.9	13.4	0.2	9.9	8.1	5.8	18.6	0.2	0.5	12.8	7.2	11.3	0.7	15.1	9.9	6.8	6.3	17.1	14.9	9.3	19.9	13.1	6.3	13.9	3.9	7.8	11.5	13.2	11.3	13.0	0.2	8.6	0.5	5.0	0.6	9.8	0.0	0.1	0.4	0.5	0.1	0.4	0.1	0.1	0.4	0.1	0.1	0.4	0.5	0.0	0.8	0.0	0.0	0.3	0.1	7.0	6.7	18.0	9.9	6.7	6.1	7.0	6.8	6.7	4.8	6.8	7.7	12.7	0.0	0.0	4.6	1.4	5.7	3.8	4.3	8.0	7.8	8.4	9.8	1.5	14.3	2.3	5.5	4.2	9.7	0.3	12.7	5.9	13.1	0.8	7.5	7.8	9.9	10.3	0.8	3.2	13.7	13.8	7.5	10.2	7.3	4.5	20.1	12.1	8.6	8.9	6.7	4.3	14.6	2.0	4.4	4.2	1.5	17.1	3.7	5.4	3.7	4.2	9.6	0.0	3.5	6.7	14.0	7.7	19.5	0.1	3.8	19.5	15.3	1.9	8.4	26.3	9.1	9.8	1.7	2.1	7.5	5.5	4.8	0.4	15.0	13.0	2.1
ZNF221		ENSG00000159905	"Zinc finger protein 221"	Q9UK13	19	43951223-43967709	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA059435	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"HPA059435: AB_2684016"	"unprognostic (2.06e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	0.9	1.2	1.3	0.6	1.5	0.6	1.2	4.8	1.5	1.0	1.0	0.7	0.5	1.1	0.8	0.8	1.3	0.6	1.2	1.1	1.5	1.1	1.1	1.0	0.7	1.1	1.3	1.9	0.7	2.3	0.9	1.3	1.7	1.5	0.8	3.0	0.7	1.1	0.4	1.2	0.8	1.3	0.8	1.0	0.8	1.1	1.5	1.2	1.8	0.7	0.7	1.0	0.7	3.5	1.4	1.2	3.6	2.8	1.2	2.4	1.0	1.5	2.3	1.3	2.0	1.6	0.5	0.0	0.8	1.5	0.9	0.6	1.4	1.0	2.3	0.0	2.9	3.8	5.1	0.6	1.2	0.4	1.6	3.5	0.9	2.2	0.8	2.7	2.4	0.0	0.2	0.0	1.7	0.1	0.0	0.6	3.3	0.5	1.2	0.1	4.0	0.4	0.8	4.6	2.9	2.5	3.0	0.2	0.3	2.1	1.0	3.5	4.1	1.6	3.6	0.8	1.2	1.9	2.6	0.0	0.5	1.5	1.9	0.3	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.3	0.2	0.2	0.1	0.3	0.6	0.1	0.3	0.1	0.1	1.3	1.5	4.8	1.5	1.1	1.5	1.1	1.3	1.7	0.8	1.5	3.5	1.4	0.0	2.0	1.0	0.2	0.0	0.1	1.1	0.6	2.8	0.5	0.3	0.7	0.0	0.4	0.0	2.1	0.3	0.2	0.1	0.0	0.4	0.3	0.8	1.8	0.8	0.0	1.3	2.7	0.4	0.2	1.4	1.5	0.8	1.3	1.3	0.7	0.1	0.3	0.0	2.1	0.0	0.0	0.0	0.3	0.5	1.2	0.2	1.8	0.0	0.0	1.3	1.0	2.5	2.6	0.5	0.0	0.4	0.4	0.1	0.0	0.4	0.3	2.3	0.0	0.9	1.1	0.9	0.7	0.7	0.1	0.3	0.4	1.3	0.1	0.4
ZNF365	"KIAA0844, UAN"	ENSG00000138311	"Zinc finger protein 365"	Q70YC5	10	62374192-62480288	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;esophagus: 10.2"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 112.7;Oligodendrocyte precursor cells: 113.6;Oligodendrocytes: 195.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 22.7;hippocampal formation: 8.3;thalamus: 8.0;white matter: 16.6"	"Group enriched"	"Detected in many"	9	"gdT-cell: 2.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.7;naive CD8 T-cell: 2.7;NK-cell: 6.4;T-reg: 5.9"	"Group enriched"	"Detected in many"	62	"NK-cells: 6.4;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 22.3;PC-3: 13.9;U-251 MG: 18.6;U-87 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052446	Supported		Approved	Vesicles,Centrosome		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Centrosome"		"HPA052446: AB_2681836"	"unprognostic (7.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-6)"	"unprognostic (2.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.89e-2)"	0.1	1.3	1.0	0.1	2.8	0.0	0.3	1.5	22.7	0.9	0.0	0.0	0.1	0.1	0.2	10.2	0.1	0.3	1.0	8.3	0.0	0.1	0.0	0.7	0.0	0.0	3.2	0.0	0.4	5.6	1.6	0.1	0.0	1.8	0.1	5.1	1.1	2.0	0.0	0.8	0.1	0.1	0.0	0.3	0.0	0.5	8.0	0.5	0.6	0.1	1.4	0.8	1.1	16.6	6.3	0.6	0.1	0.0	0.1	0.0	0.0	5.5	5.8	2.6	2.1	0.0	1.0	0.0	0.2	3.1	8.4	22.3	0.0	0.4	3.5	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.9	6.6	0.9	0.0	0.0	0.0	5.5	2.1	0.7	0.0	0.9	0.0	13.9	0.0	0.2	0.0	0.3	2.8	0.1	1.2	1.1	0.2	0.6	0.0	0.0	0.0	0.0	1.1	6.1	0.0	18.6	0.0	0.0	0.0	12.9	0.0	1.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.1	2.7	0.0	0.0	0.4	2.7	0.0	6.4	0.0	0.0	5.9	0.8	1.0	2.8	1.5	22.7	8.3	0.0	0.0	3.2	0.0	0.0	8.0	16.6	0.0	0.0	0.0	15.3	0.2	0.5	3.7	0.6	0.0	13.5	0.3	0.3	2.6	1.5	0.1	3.7	2.1	0.0	2.8	0.0	0.0	0.2	0.5	0.3	0.2	0.2	0.0	0.0	112.7	0.0	0.0	0.9	0.0	0.6	0.0	0.1	0.0	0.0	0.1	18.5	23.4	0.0	0.0	0.3	1.1	0.3	0.0	0.4	0.0	6.5	0.0	2.7	0.0	113.6	195.5	0.9	0.0	0.0	1.9	1.2	0.0	0.7	0.1	5.3	0.0	0.8	0.8	0.1	0.7	0.0	0.4	0.0	3.9	0.2	0.0	6.0
ZNF468		ENSG00000204604	"Zinc finger protein 468"	Q5VIY5	19	52838010-52857649	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 44.4"															NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"				"prognostic unfavorable (6.87e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (3.94e-7)"	"unprognostic (1.04e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.59e-2)"	2.9	4.2	2.4	4.2	2.0	7.3	6.3	3.9	2.4	4.5	2.6	6.7	3.5	3.4	6.4	3.9	5.9	4.3	2.2	1.8	1.9	6.3	2.2	4.1	6.0	2.2	1.8	3.0	5.8	6.8	1.8	9.4	2.3	7.3	7.3	3.2	4.0	4.7	1.5	4.3	5.3	3.1	1.6	4.6	7.1	3.3	2.0	6.5	12.2	3.2	6.4	4.6	3.8	2.7	9.7	0.5	4.3	10.7	5.8	5.4	26.9	6.3	9.0	8.6	13.2	8.3	6.9	14.0	6.1	7.2	9.7	6.1	8.1	6.6	12.0	0.0	10.6	10.5	4.8	5.5	20.4	0.2	12.2	8.0	10.3	11.6	12.4	4.8	6.6	9.0	9.4	0.1	7.6	3.0	11.5	8.4	5.4	9.7	8.8	7.3	12.2	7.8	11.5	44.4	5.6	6.1	13.1	9.3	3.1	12.2	11.0	9.9	4.7	2.4	6.5	4.3	9.6	4.6	13.3	14.0	0.2	1.5	11.5	7.5	5.7	11.2	10.1	9.0	10.5	6.9	6.7	8.2	6.1	8.2	8.1	7.3	5.3	16.5	8.0	3.9	8.9	8.4	2.4	2.0	3.9	2.4	1.8	1.9	2.2	1.8	2.3	1.6	2.0	2.7	3.9	3.2	4.8	1.3	5.9	3.3	5.3	4.6	7.4	0.8	6.3	4.3	3.9	8.6	6.5	9.2	0.0	9.0	7.1	8.2	17.6	6.8	3.1	8.9	5.8	4.0	8.5	7.4	2.1	9.7	12.8	4.1	6.6	18.4	17.2	5.5	5.0	3.5	6.4	0.0	2.0	11.3	6.1	9.4	4.9	1.3	0.9	4.5	1.8	3.7	5.4	0.6	5.2	1.0	3.3	9.7	6.7	2.6	3.9	12.1	4.7	6.1	2.9	0.2	0.0	1.9	3.2	0.5	3.4	7.3	5.4	24.1	6.5	2.8	8.5	14.0
ZNF48	"DKFZp762K013, FLJ31751, MGC43952, ZNF553"	ENSG00000180035	"Zinc finger protein 48"	Q96MX3	16	30378106-30400108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"REH: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023806	Uncertain		Approved	Mitochondria		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA023806: AB_1859335"	"unprognostic (5.35e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (5.36e-2)"	"prognostic favorable (7.50e-5)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	2.9	5.1	7.1	3.4	7.3	2.0	3.2	7.9	8.2	4.5	3.9	8.0	3.7	7.2	2.5	2.8	5.7	2.5	4.4	7.5	6.6	4.2	4.2	3.5	4.5	5.7	6.0	3.2	5.6	6.4	5.1	2.0	5.8	4.6	2.4	3.8	4.2	4.4	5.3	4.2	4.1	4.5	5.3	4.2	4.9	2.4	6.7	8.1	3.5	3.7	3.0	5.5	2.8	7.1	7.7	13.4	32.0	25.2	4.3	3.0	9.8	5.7	9.7	12.1	11.2	6.7	10.0	16.2	10.7	5.3	3.4	6.6	15.7	8.9	6.8	12.0	20.2	7.2	6.9	10.2	5.9	9.6	9.1	2.6	11.0	10.0	6.6	11.4	10.9	14.3	12.6	7.2	5.3	28.1	20.8	11.9	26.4	6.0	5.4	47.7	7.4	20.0	7.4	6.6	25.1	31.6	2.5	16.7	2.5	8.4	11.2	8.9	5.1	7.0	8.1	6.3	6.5	8.6	10.9	14.8	4.0	5.8	1.7	0.0	0.0	0.4	0.9	0.0	0.6	0.3	0.4	0.5	0.1	0.3	0.5	0.6	0.0	0.9	0.0	0.4	0.5	0.1	7.1	7.3	7.9	8.2	7.5	6.6	5.7	6.0	5.8	5.3	6.7	7.1	4.0	3.2	2.2	4.6	6.1	3.1	2.5	1.7	4.0	11.7	4.8	5.1	5.4	14.3	3.9	3.7	8.4	3.7	6.7	4.8	1.9	10.4	0.2	3.7	2.8	5.4	9.6	5.2	4.9	7.4	2.2	2.8	1.5	3.7	17.2	7.5	4.2	3.1	2.7	16.8	5.5	4.0	2.0	1.6	2.6	0.3	2.8	1.7	1.8	2.8	6.9	6.6	3.1	1.0	4.0	7.2	5.4	6.8	2.0	4.3	3.5	4.1	1.0	7.3	0.0	3.0	5.5	3.5	3.3	1.8	5.3	0.3	5.0	3.7	6.1	1.7
ZNF502	"FLJ12515, FLJ14855"	ENSG00000196653	"Zinc finger protein 502"	Q8TBZ5	3	44712643-44723831	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 16.2;Spermatogonia: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA024761, HPA029557"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA024761: AB_10599830, HPA029557: AB_10601448"	"unprognostic (1.80e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.35e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.49e-2)"	"prognostic favorable (4.51e-5)"	"unprognostic (1.88e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.06e-4)"	3.0	3.1	1.5	0.9	1.8	0.8	3.5	2.7	1.7	4.2	1.2	3.9	0.8	4.6	1.3	2.6	4.1	0.9	2.8	1.6	1.8	4.2	2.1	1.9	1.2	1.6	1.7	5.3	4.0	1.3	4.2	1.8	1.5	4.9	1.5	5.2	3.2	2.2	3.2	3.6	2.6	1.9	1.5	3.4	3.1	5.0	1.8	1.4	3.8	2.3	1.1	3.9	3.4	1.5	0.0	0.7	1.9	0.0	2.1	3.0	0.0	1.6	0.4	1.9	1.1	0.1	0.9	0.0	0.5	1.5	2.0	1.0	0.0	2.4	1.6	0.0	0.9	0.0	0.0	0.0	2.3	0.0	0.9	2.4	0.9	2.2	0.0	0.5	1.4	0.0	0.0	0.0	1.9	0.0	0.0	0.5	3.1	0.5	0.0	0.0	1.2	0.0	2.2	2.4	2.0	2.5	0.9	1.6	0.0	2.2	0.0	0.0	1.8	0.0	1.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.2	0.4	0.6	0.3	1.0	0.8	1.0	0.8	0.5	1.2	1.5	1.2	0.0	1.2	0.3	0.3	0.2	0.3	1.5	1.8	2.7	1.7	1.6	1.8	1.6	1.7	1.5	1.5	1.8	1.5	4.0	6.4	5.1	3.3	3.9	1.7	3.3	3.2	4.0	12.0	2.4	3.6	4.5	2.8	4.4	3.7	14.6	2.5	3.3	1.4	0.0	3.2	3.1	1.0	3.4	5.4	4.9	1.7	3.0	3.0	1.3	3.2	1.5	1.5	2.5	5.6	4.2	1.6	1.1	10.1	5.9	1.6	4.1	0.8	0.7	2.9	4.7	1.0	0.0	3.7	2.1	11.5	2.1	3.0	2.6	2.7	1.1	6.8	0.5	3.4	2.0	1.6	3.1	16.2	0.0	4.6	2.8	14.1	17.8	2.6	2.6	1.5	1.9	4.3	3.0	1.9
ZNF550	MGC41917	ENSG00000251369	"Zinc finger protein 550"	Q7Z398	19	57535257-57559863	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA003251	Uncertain		Approved	Vesicles,Microtubules		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	Microtubules	"HPA003251: AB_1080736"	"unprognostic (3.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.52e-1)"	2.8	3.7	1.8	5.1	2.0	5.2	6.0	5.8	2.7	5.5	3.2	2.8	2.2	4.6	3.9	3.1	4.6	3.1	5.6	1.7	2.9	2.9	3.0	3.4	6.7	1.5	1.8	9.1	2.4	7.8	2.5	6.5	2.3	6.0	2.9	7.3	4.2	4.4	2.2	4.0	3.6	3.3	1.1	7.7	3.5	2.8	1.7	7.4	4.8	3.3	5.4	3.6	1.3	2.9	4.3	3.0	8.4	8.0	2.8	6.9	0.0	5.7	4.8	5.0	2.1	3.7	3.9	1.2	3.9	4.2	4.0	3.6	4.4	5.0	6.3	0.1	23.2	11.5	10.9	4.9	4.1	10.1	4.3	5.8	3.0	3.9	11.2	6.9	4.2	10.6	1.8	0.1	5.4	1.0	15.5	4.4	9.2	1.3	5.8	12.3	8.7	12.1	2.7	7.6	7.8	11.0	7.2	4.8	3.5	5.9	5.5	6.6	4.8	6.9	4.2	2.6	5.6	24.0	24.0	10.0	2.8	5.8	6.1	0.4	1.4	2.0	3.6	1.9	4.5	1.8	4.5	2.5	2.0	2.6	5.8	3.4	0.4	5.2	0.6	0.7	4.5	2.3	1.8	2.0	5.8	2.7	1.7	2.9	1.5	1.8	2.3	1.1	1.7	2.9	4.5	0.0	1.1	4.2	8.9	5.1	3.9	2.6	5.7	4.5	4.7	3.6	7.2	2.8	3.4	0.0	6.2	4.2	4.9	0.5	1.9	2.8	1.0	3.4	4.7	5.8	3.6	5.0	4.8	1.2	4.4	3.9	0.5	2.9	5.1	8.3	5.0	3.2	2.3	11.8	5.3	2.8	4.1	1.9	2.2	0.6	4.7	1.4	3.6	2.8	2.5	3.0	12.3	4.0	3.7	2.2	0.8	0.7	3.4	6.7	1.2	0.9	6.5	5.1	0.0	3.3	4.4	3.2	5.0	4.4	6.8	5.2	6.2	4.4	2.7	4.3
ZNF558	FLJ30932	ENSG00000167785	"Zinc finger protein 558"	Q96NG5	19	8806170-8832314	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003151	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"			"HPA003151: AB_1859344"	"unprognostic (2.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.89e-3)"	"prognostic unfavorable (1.23e-6)"	"unprognostic (2.28e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (9.30e-5)"	9.3	10.1	7.8	6.5	8.0	4.6	9.5	8.6	9.3	15.0	8.3	11.2	6.0	13.6	9.4	7.9	14.7	5.4	6.6	7.6	8.1	11.4	11.0	8.3	7.3	8.3	8.2	15.1	11.5	10.3	8.5	5.5	8.1	11.5	8.0	14.5	8.3	8.7	6.9	10.1	9.2	10.3	8.0	9.7	9.5	6.2	8.3	7.9	12.2	6.6	8.0	9.9	10.7	8.6	8.1	2.8	12.8	17.6	11.8	13.2	10.9	5.6	8.5	8.2	12.8	4.1	4.9	4.0	14.5	6.4	10.0	7.2	10.9	0.8	11.5	9.6	0.5	0.3	5.0	2.1	9.4	5.9	9.3	12.7	18.5	5.2	0.0	20.0	0.0	12.3	8.6	15.4	10.8	3.3	5.4	31.4	8.0	3.0	4.0	2.8	10.1	3.5	15.2	8.9	2.7	12.7	6.5	3.7	11.5	15.0	7.9	8.5	0.1	10.4	5.9	16.5	6.7	7.0	6.4	8.8	2.4	5.8	3.5	0.4	0.6	0.3	1.0	0.6	0.8	0.3	0.7	1.1	0.7	1.0	1.2	1.5	0.7	2.0	0.5	1.0	0.5	0.5	7.8	8.0	8.6	9.3	7.6	8.1	8.3	8.2	8.1	8.0	8.3	8.6	3.8	9.6	5.6	8.1	3.2	3.6	2.9	3.1	9.1	4.8	5.5	5.5	3.6	2.8	5.5	3.7	8.4	4.0	3.9	3.6	1.9	4.5	9.6	4.5	9.3	4.0	1.2	4.0	4.0	3.3	3.7	4.6	11.2	5.0	3.8	5.1	2.9	5.3	2.9	8.4	3.3	3.3	0.0	4.7	1.3	5.2	2.1	2.9	0.0	3.7	2.4	5.9	5.2	5.5	7.9	4.2	2.7	2.6	1.8	3.3	2.8	1.9	3.6	8.6	0.0	5.2	4.8	4.1	3.9	5.4	2.7	1.5	3.9	2.8	3.9	1.5
ZNF572	FLJ38002	ENSG00000180938	"Zinc finger protein 572"	Q7Z3I7	8	124973295-124979389	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.9;Inhibitory neurons: 2.5;Microglial cells: 2.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.7;Spermatogonia: 2.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 4.1"					"Low region specificity"	"Detected in all"			HPA066838	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"		"HPA066838: AB_2685734"	"unprognostic (8.65e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.37e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.17e-2)"	0.6	0.3	0.9	1.0	1.3	0.1	1.8	1.0	1.2	1.1	0.7	1.0	0.9	1.4	2.2	0.5	1.5	0.7	0.9	0.8	1.0	1.7	0.9	0.7	1.9	1.4	1.1	2.3	1.0	0.6	0.4	1.5	1.1	1.4	1.3	1.9	1.3	1.5	0.2	0.8	0.9	0.8	1.1	1.5	1.4	3.6	1.1	1.9	1.8	0.2	1.9	1.1	0.8	1.6	1.0	0.5	1.1	0.0	1.5	1.7	0.0	0.3	0.1	1.3	0.7	1.4	0.7	2.5	1.6	0.4	0.2	1.9	0.6	0.0	1.1	0.0	0.5	0.0	0.7	1.7	1.2	0.0	1.2	1.3	1.6	1.3	0.0	0.3	0.8	0.0	1.5	0.0	1.7	4.1	0.0	0.0	0.0	2.4	0.0	1.6	2.8	0.3	0.7	0.7	2.5	2.4	1.5	2.4	2.6	2.1	1.0	1.6	0.5	1.5	1.7	0.4	0.0	0.0	1.4	1.1	0.3	0.0	0.1	0.0	0.1	0.3	0.2	0.3	0.4	0.6	0.2	0.1	0.1	0.6	0.8	0.5	0.0	0.7	0.2	0.0	0.0	0.1	0.9	1.3	1.0	1.2	0.8	1.0	1.4	1.1	1.1	1.1	1.1	1.6	0.2	0.0	0.0	3.9	0.8	0.1	0.2	0.0	0.0	1.0	0.3	0.4	0.6	0.0	0.6	0.0	0.0	0.9	0.2	0.2	1.9	0.3	0.5	0.9	0.5	0.4	0.0	0.4	1.3	0.2	0.3	0.4	0.0	0.3	0.0	1.6	0.4	0.3	0.4	0.0	2.5	0.1	0.0	0.3	0.0	0.4	0.0	0.2	0.0	2.8	0.6	2.3	1.0	2.5	2.7	0.0	0.1	1.2	0.0	0.1	0.1	1.0	0.9	0.6	0.0	0.1	0.2	2.4	2.8	0.3	0.0	0.3	0.3	0.5	0.6	0.1
ZNF578	FLJ31384	ENSG00000258405	"Zinc finger protein 578"	Q96N58	19	52453553-52516882	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 6.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 6.7;NK-cells: 8.2;Oligodendrocyte precursor cells: 10.1;Rod photoreceptor cells: 8.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 5.5;U-266/84: 9.4"															NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"				"unprognostic (6.57e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.96e-3)"	"unprognostic (5.42e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.14e-2)"	"unprognostic (9.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.42e-1)"	0.7	0.6	2.1	0.7	3.1	0.8	0.8	5.1	2.7	0.9	1.4	0.5	0.4	1.1	1.8	0.4	1.3	0.6	1.2	2.0	3.0	0.9	0.3	0.7	0.7	2.5	2.2	1.7	0.7	1.0	0.3	1.3	2.4	1.4	0.7	3.1	0.7	1.2	0.9	1.2	0.4	0.9	1.6	1.2	0.6	6.3	2.6	1.0	1.7	0.6	0.7	0.5	0.2	3.2	0.5	0.3	2.1	2.7	1.2	0.7	1.2	1.3	0.7	0.5	0.9	0.9	0.7	0.9	0.5	2.0	2.5	0.7	1.1	0.6	0.6	0.2	1.5	0.8	1.6	0.5	1.1	0.2	2.7	1.9	0.3	0.9	0.8	1.0	0.9	0.8	0.6	0.6	2.6	0.8	0.9	1.2	4.1	0.6	0.7	0.8	0.8	0.3	1.8	2.7	0.6	1.5	0.6	0.6	0.2	5.5	2.0	0.6	1.3	0.6	0.7	0.8	0.7	0.5	9.4	0.8	0.1	0.2	1.7	1.4	0.3	0.4	0.9	0.3	0.7	0.5	0.6	0.5	0.1	0.8	0.7	0.8	0.5	1.1	0.3	0.5	0.3	0.3	2.1	3.1	5.1	2.7	2.0	3.0	2.5	2.2	2.4	1.6	2.6	3.2	3.9	0.0	0.0	4.9	1.3	0.9	1.7	0.2	0.0	4.4	0.5	0.5	4.1	0.0	0.2	0.0	4.2	0.7	4.0	0.0	0.0	0.2	5.9	0.9	1.4	1.6	0.0	0.8	3.9	0.2	0.8	1.4	0.0	2.1	1.3	3.9	0.7	0.0	0.2	6.7	5.8	0.1	0.0	0.3	0.6	6.1	0.6	0.4	0.0	0.0	0.4	1.8	8.2	10.1	6.2	0.0	0.0	0.0	0.4	1.0	0.2	0.8	0.1	8.2	0.0	0.7	1.8	0.2	2.3	0.1	0.4	0.8	1.8	2.6	0.1	1.7
ZNF600	"DKFZp686F06123, KR-ZNF1"	ENSG00000189190	"Zinc finger protein 600"	Q6ZNG1	19	52749942-52786807	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 9.1"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.5"	"Group enriched"	"Detected in all"	5	"NK-cells: 45.5;T-cells: 18.9"	"Cell line enhanced"	"Detected in many"		"RT4: 24.6"															NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (6.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.54e-2)"	"unprognostic (5.19e-6)"	"unprognostic (1.34e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.61e-3)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.11e-5)"	4.1	3.2	1.4	3.5	1.5	5.5	4.4	9.1	1.9	5.3	2.0	5.7	5.6	3.9	2.6	6.1	4.4	3.0	2.3	1.3	1.4	3.7	4.1	4.9	6.3	1.5	1.6	3.8	5.3	2.5	2.6	3.7	2.2	6.4	5.7	0.7	4.2	3.6	1.2	6.0	8.4	3.1	1.5	9.2	6.0	1.8	1.8	3.4	4.2	1.6	6.3	5.2	6.5	1.9	6.1	0.0	0.1	2.6	3.6	3.4	14.5	4.6	3.8	3.1	7.7	4.8	5.5	6.9	2.0	3.2	6.0	7.1	0.0	4.2	5.3	1.4	2.9	3.9	3.5	3.9	4.3	0.0	9.1	4.7	6.7	3.3	5.4	2.5	1.6	0.1	5.6	0.0	3.4	2.3	0.0	3.6	1.4	5.8	6.6	0.0	0.0	5.4	5.6	24.6	2.6	3.2	6.3	5.0	0.8	9.5	3.1	5.5	4.4	0.8	1.8	0.7	4.5	3.3	5.5	8.3	0.0	0.0	3.4	3.6	2.2	2.9	18.9	1.7	11.2	6.8	6.4	9.9	4.0	6.4	6.2	10.9	0.5	45.5	4.1	0.9	4.0	6.0	1.4	1.5	9.1	1.9	1.3	1.4	1.5	1.6	2.2	1.5	1.8	1.9	4.8	25.6	9.6	1.3	13.3	20.3	18.3	4.9	15.9	0.8	4.9	4.4	3.4	5.7	5.9	5.5	0.0	9.2	25.8	8.9	0.0	6.7	7.4	10.8	4.1	7.1	4.2	5.7	1.6	9.7	9.7	5.0	16.8	23.9	31.7	6.0	3.3	2.2	3.2	0.0	1.3	6.5	2.0	1.9	6.0	1.4	2.8	4.3	1.8	4.7	4.0	1.5	51.5	1.0	4.7	11.6	8.2	1.9	17.0	14.0	12.9	2.9	13.2	1.7	0.0	2.6	4.0	0.5	2.6	13.1	24.3	14.6	19.1	3.3	9.9	27.9
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	13.0	16.5	35.1	4.7	36.3	7.5	16.3	36.3	48.5	26.6	34.1	20.1	5.1	17.1	8.2	23.2	25.3	4.9	18.0	35.0	34.7	27.0	21.7	12.5	6.2	36.5	35.5	27.6	28.2	7.4	29.1	4.2	37.7	34.9	3.6	8.5	17.8	5.3	17.7	18.7	16.6	3.8	34.1	23.5	19.7	38.9	35.7	7.0	24.7	4.7	4.4	21.3	20.8	36.8	7.1	6.4	6.1	14.7	4.7	2.5	26.4	6.1	1.9	6.2	4.0	8.2	9.8	8.8	11.7	2.3	2.5	9.5	9.1	8.8	3.9	12.6	5.7	9.9	17.8	2.2	3.5	11.4	8.3	3.2	10.2	6.8	17.5	5.8	5.9	11.1	21.1	6.2	2.9	3.8	5.9	23.7	12.2	17.1	13.1	19.3	3.6	16.9	11.9	4.5	11.7	8.8	6.3	10.1	12.2	2.3	13.1	18.5	4.5	2.7	5.0	2.7	8.0	17.0	11.3	5.8	6.2	14.9	4.7	0.0	1.5	1.4	3.6	1.1	3.3	3.0	2.9	4.0	3.1	2.3	4.1	3.0	3.3	8.1	1.0	2.5	3.5	2.0	35.1	36.3	36.3	48.5	35.0	34.7	36.5	35.5	37.7	34.1	35.7	36.8	7.8	9.6	8.6	27.1	10.7	9.6	12.5	19.0	11.4	15.3	16.8	18.7	5.4	7.2	10.8	11.0	22.9	12.8	10.3	10.0	5.9	7.6	14.3	6.1	7.0	6.7	8.3	22.7	20.6	4.0	10.4	8.1	15.8	6.8	5.7	15.9	2.9	6.2	6.5	11.8	19.7	12.3	12.2	6.0	5.5	7.8	10.2	5.4	16.0	10.3	6.1	8.3	9.2	8.5	23.5	5.7	5.2	7.2	6.6	17.3	11.6	4.1	10.8	13.6	0.0	8.4	8.0	52.7	15.4	11.0	8.0	6.2	11.3	9.5	14.3	10.0
ZNF696	FLJ14129	ENSG00000185730	"Zinc finger protein 696"	Q9H7X3	8	143289676-143299952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA057855, HPA072473"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA057855: AB_2683545, HPA072473: AB_2686524"	"unprognostic (3.23e-2)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (3.52e-5)"	"unprognostic (2.58e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.76e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (6.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.09e-3)"	4.0	3.3	3.9	3.3	3.7	3.5	3.2	5.9	6.1	3.4	0.0	3.3	6.0	4.5	2.5	2.6	3.4	2.1	2.8	4.2	2.5	3.3	4.6	2.8	3.8	5.6	3.0	4.7	5.0	4.3	3.2	2.7	5.0	3.1	1.9	3.6	5.7	2.3	3.9	6.6	3.7	2.3	0.9	4.0	3.3	3.5	3.4	2.1	3.7	2.4	3.0	3.7	2.8	4.9	8.2	7.4	7.8	8.8	3.2	2.5	14.9	6.3	2.4	4.4	2.7	4.3	6.3	0.7	8.2	2.5	2.5	5.8	8.5	3.8	4.5	9.1	17.9	10.8	8.8	6.7	3.4	4.5	13.5	2.4	6.1	3.0	6.8	3.3	2.2	6.4	22.2	5.3	3.1	17.3	4.6	8.8	10.2	9.7	17.1	9.8	4.4	8.1	3.0	6.3	11.6	16.1	9.3	6.7	8.2	5.3	10.3	8.1	4.5	6.2	13.4	5.5	10.9	9.7	7.3	10.0	4.2	9.2	7.5	1.2	2.0	1.7	2.9	1.1	3.0	2.4	2.1	3.1	2.1	3.2	3.9	3.5	1.2	3.5	2.0	3.8	0.7	1.9	3.9	3.7	5.9	6.1	4.2	2.5	5.6	3.0	5.0	0.9	3.4	4.9	2.2	0.0	0.0	3.6	3.0	2.9	2.3	0.6	0.0	5.3	1.5	1.3	2.8	2.8	0.3	3.7	6.2	1.7	1.8	2.1	3.9	2.4	1.2	0.8	2.3	2.5	0.0	1.3	3.4	2.0	1.8	1.9	2.0	1.0	0.0	2.9	2.2	2.2	1.2	3.3	3.9	1.0	2.0	0.9	0.7	2.4	4.1	0.7	1.8	1.0	0.9	1.8	6.2	4.5	3.1	1.5	0.3	1.2	2.3	1.7	2.7	1.9	0.3	4.5	6.6	1.7	2.2	3.0	5.7	1.1	2.0	0.4	2.5	2.7	2.0	0.6
ZNF71	"Cos26, EZFIT"	ENSG00000197951	"Zinc finger protein 71"	Q9NQZ8	19	56595300-56626481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.6"									HPA018124	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoli	Nucleoplasm	"HPA018124: AB_1848339"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.03e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.97e-3)"	3.3	2.1	3.1	2.0	2.9	1.1	3.1	2.4	4.8	3.3	0.0	3.9	1.3	4.3	1.3	2.5	3.1	1.9	3.9	4.9	2.0	2.4	0.9	2.4	3.0	1.9	2.5	3.6	2.5	2.4	2.9	2.1	1.7	3.1	1.1	3.3	2.5	2.7	3.5	2.8	2.2	2.5	1.0	2.7	2.5	3.2	2.0	3.2	2.3	2.7	1.5	3.5	2.7	2.3	3.1	7.9	9.1	8.7	3.1	3.3	5.7	3.2	3.9	3.6	4.0	1.5	1.4	3.3	3.2	3.5	3.3	1.1	2.0	3.5	2.1	0.0	20.6	5.4	0.9	3.0	3.7	6.4	4.3	4.7	3.4	3.1	2.6	4.0	4.6	7.2	2.3	0.0	3.4	0.0	12.5	2.3	9.0	0.0	7.9	4.8	6.9	3.0	2.1	5.8	9.0	10.5	2.9	4.5	4.4	3.7	3.4	6.3	5.3	10.5	5.1	2.6	6.4	2.2	3.0	5.0	3.0	3.8	3.1	2.9	1.7	3.5	4.3	1.4	4.5	3.2	3.3	3.6	2.8	3.5	3.4	3.6	0.6	6.1	2.6	2.3	3.7	2.6	3.1	2.9	2.4	4.8	4.9	2.0	1.9	2.5	1.7	1.0	2.0	2.3	8.9	3.2	1.7	3.9	4.5	2.9	2.8	3.8	2.8	9.3	4.8	4.3	3.9	4.3	2.0	7.3	4.2	4.9	5.5	0.6	3.9	10.1	2.7	2.5	3.5	9.8	2.4	2.5	7.4	4.9	6.8	4.6	1.5	2.1	0.0	7.8	3.6	1.0	5.7	11.8	6.6	2.1	4.1	2.4	5.2	3.6	6.2	3.5	3.6	1.9	4.2	3.4	12.3	5.0	4.8	6.3	1.9	5.7	1.4	2.4	1.0	5.8	0.9	8.1	0.0	5.1	6.3	7.4	10.7	2.3	4.3	1.5	5.5	5.5	2.3	1.4
ZNF74	"Cos52, Zfp520, ZNF520"	ENSG00000185252	"Zinc finger protein 74"	Q16587	22	20394115-20408461	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 47.9"									HPA003354	Approved		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Actin filaments"	"HPA003354: AB_1080747"	"unprognostic (1.40e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.44e-3)"	1.7	2.4	5.0	1.2	5.1	0.6	2.1	4.4	5.2	4.5	3.9	4.3	1.3	4.7	1.9	3.2	3.1	0.8	2.3	5.1	5.2	2.8	2.4	1.9	1.5	4.8	4.8	4.4	4.2	2.7	5.4	1.5	4.8	3.6	1.4	1.7	2.9	3.0	4.7	2.9	2.2	2.4	4.4	2.6	3.1	1.3	5.2	2.5	2.5	2.4	1.1	3.9	3.0	5.2	4.3	4.1	10.4	15.8	2.9	2.8	8.2	4.0	2.9	4.8	4.5	5.7	2.0	0.1	5.6	3.2	1.6	5.2	7.8	5.1	2.7	2.8	17.8	4.9	2.0	8.1	4.8	10.7	5.1	3.1	8.6	3.7	4.2	3.6	4.8	9.3	47.9	0.1	3.4	7.1	10.2	6.6	11.6	8.9	7.2	14.0	6.1	1.6	3.1	4.6	22.8	14.1	4.4	7.9	9.3	5.2	3.6	5.1	3.4	4.6	9.5	5.8	3.0	5.2	6.2	0.1	1.1	6.1	4.0	0.0	1.2	0.9	2.0	1.0	1.6	1.1	1.5	2.4	1.9	1.0	1.8	1.7	0.0	3.8	0.7	1.3	1.4	1.9	5.0	5.1	4.4	5.2	5.1	5.2	4.8	4.8	4.8	4.4	5.2	5.2	1.4	3.2	2.0	3.6	2.1	1.5	1.9	1.6	2.8	5.1	3.6	3.0	3.1	2.8	2.5	0.0	2.1	3.1	3.8	0.9	3.9	3.8	0.5	2.3	3.7	1.7	4.2	2.1	8.5	2.4	4.6	3.5	3.1	2.0	0.0	5.6	2.5	1.7	2.2	3.3	8.8	2.3	2.0	0.6	0.3	0.3	7.2	1.0	0.0	2.8	1.6	2.6	3.1	6.0	6.6	2.5	1.0	4.9	0.9	4.0	1.5	1.7	0.6	2.1	6.6	2.7	3.2	4.3	3.0	1.8	1.0	1.1	2.7	4.4	2.8	1.1
ZNF805		ENSG00000204524	"Zinc finger protein 805"	Q5CZA5	19	57240632-57262728	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA046330, HPA058895"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA046330: , HPA058895: AB_2683846"	"unprognostic (2.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.68e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.64e-1)"	1.5	1.9	2.6	1.5	3.0	6.7	2.0	2.6	2.5	1.6	3.3	1.3	1.0	1.7	1.6	1.1	1.4	1.2	1.5	2.1	2.7	1.3	1.9	1.6	1.5	3.1	3.1	2.1	1.3	2.2	1.3	1.8	2.7	1.3	1.6	2.7	1.4	1.5	1.8	2.0	1.1	1.8	2.5	2.1	1.5	2.2	3.2	1.6	1.7	2.1	2.0	1.3	1.1	3.7	1.3	1.8	2.1	3.0	3.9	2.7	2.6	1.2	2.6	2.1	4.2	1.9	1.1	2.5	0.9	2.9	1.4	0.8	2.1	2.3	3.5	1.3	5.3	2.6	1.8	2.2	3.0	2.5	2.3	3.1	2.6	2.7	4.7	1.9	1.9	2.7	0.9	3.5	1.7	0.9	2.9	1.3	1.6	1.2	2.1	1.3	3.9	2.1	1.6	3.9	1.7	1.9	3.2	1.9	2.1	2.5	1.2	2.5	2.2	3.3	2.1	1.3	1.6	3.2	2.4	2.4	2.0	1.3	1.6	1.0	0.8	2.4	1.6	0.4	1.8	1.5	1.3	2.0	0.8	0.7	1.3	1.4	0.9	2.8	0.6	0.8	1.6	0.9	2.6	3.0	2.6	2.5	2.1	2.7	3.1	3.1	2.7	2.5	3.2	3.7	4.1	3.2	0.5	7.2	2.3	1.7	2.2	1.3	2.8	6.3	2.1	2.2	2.0	0.0	0.7	1.8	8.4	1.1	3.5	0.7	1.9	1.6	5.3	2.8	4.2	2.3	1.2	3.2	7.4	1.1	1.6	2.9	2.0	2.7	4.5	2.6	2.9	0.6	0.9	3.3	7.1	1.1	0.0	0.8	0.4	0.8	1.2	1.9	0.0	10.3	0.0	2.5	2.1	7.5	9.7	1.4	0.2	0.7	3.9	2.1	0.9	0.8	1.6	5.4	0.0	4.4	3.7	7.8	2.8	1.8	1.1	2.3	2.7	5.1	0.7	2.4
ZNF843	MGC46336	ENSG00000176723	"Zinc finger protein 843"	Q8N446	16	31432593-31443160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 4.6;Cardiomyocytes: 5.3;Prostatic glandular cells: 3.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;EFO-21: 1.8;HMC-1: 1.6"									"HPA030911, HPA030912, HPA077945"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nuclear speckles"	"HPA030911: AB_2673656, HPA030912: AB_10670434, HPA077945: "	"unprognostic (9.27e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.43e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.86e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.93e-3)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-5)"	"unprognostic (1.17e-1)"	0.6	0.5	1.5	0.3	1.2	0.3	0.6	2.5	1.3	1.0	0.0	0.4	0.2	1.0	0.7	0.4	1.1	0.7	1.7	1.6	1.9	0.6	0.4	0.3	0.3	1.1	1.4	3.0	2.1	0.9	1.5	0.4	0.9	0.6	0.1	1.1	1.5	0.8	2.2	0.9	0.3	0.5	1.1	0.4	0.4	0.5	1.8	0.2	1.0	0.8	0.2	0.5	0.6	0.9	0.1	0.3	0.2	1.2	2.3	0.6	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.0	1.8	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.6	0.2	1.6	1.2	0.3	0.0	0.1	0.8	0.0	0.2	0.2	0.2	0.6	0.8	0.1	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.8	0.0	0.2	0.1	0.1	0.0	0.1	0.4	1.0	0.2	0.2	0.7	0.1	0.4	0.2	0.2	0.7	0.1	0.2	0.1	0.4	0.7	1.7	0.1	0.2	0.1	1.0	1.5	1.2	2.5	1.3	1.6	1.9	1.1	1.4	0.9	1.1	1.8	0.9	0.5	0.0	0.5	2.9	0.3	0.8	4.6	0.1	0.0	2.2	0.9	1.3	5.3	0.0	0.7	0.0	2.1	0.3	0.1	0.3	0.0	0.3	0.2	0.4	2.0	1.0	1.2	0.0	1.4	0.2	0.1	1.4	0.0	0.4	1.3	1.4	1.8	0.3	0.6	0.0	1.7	0.0	0.0	0.3	2.1	0.0	1.5	0.9	0.0	0.0	0.1	1.4	2.1	1.0	1.3	0.1	0.1	1.5	0.1	3.6	0.0	0.4	0.0	1.9	0.0	2.8	1.3	0.4	0.7	0.1	1.4	0.3	1.2	0.8	0.1	1.9
ZNRF3	"BK747E2.3, FLJ22057, KIAA1133, RNF203"	ENSG00000183579	"Zinc and ring finger 3"	Q9ULT6	22	28883572-29057488	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Astrocytes: 504.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036702, HPA036703"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Golgi apparatus"		"HPA036702: , HPA036703: AB_10672227"	"unprognostic (1.07e-1)"	"unprognostic (2.13e-3)"	"unprognostic (7.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (9.55e-5)"	"unprognostic (6.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.55e-2)"	2.8	7.1	11.3	1.3	11.2	0.3	2.6	8.1	13.8	4.4	1.0	3.9	3.0	5.1	13.4	3.4	4.8	2.1	2.6	12.1	5.5	8.2	6.6	4.3	0.5	13.2	9.2	5.9	3.3	8.7	2.7	5.0	4.2	7.2	3.4	1.1	7.5	7.7	3.8	5.3	2.7	4.6	5.1	1.2	4.4	5.0	13.6	1.3	4.1	1.9	0.6	3.2	3.3	6.2	5.8	13.7	12.5	3.5	2.3	2.6	23.7	3.5	1.7	2.7	2.6	20.8	3.2	0.1	5.4	1.8	4.9	9.8	8.7	5.5	3.3	7.8	8.9	2.3	2.5	46.1	2.0	6.9	2.3	2.7	5.0	4.3	4.3	2.3	2.4	4.1	5.0	3.2	3.9	5.6	0.2	3.5	4.6	7.3	5.4	6.9	8.2	5.3	11.6	8.5	20.6	7.6	6.2	6.1	3.5	3.8	4.1	3.1	2.3	10.3	8.8	8.2	5.8	4.3	6.3	8.1	4.4	3.9	5.5	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	11.3	11.2	8.1	13.8	12.1	5.5	13.2	9.2	4.2	5.1	13.6	6.2	4.2	12.8	23.6	504.1	0.3	12.6	5.2	4.9	15.9	3.7	5.7	9.5	7.5	8.6	5.3	12.9	0.0	28.1	0.5	2.1	1.9	5.0	12.7	8.0	8.0	5.8	8.4	4.0	62.9	2.5	2.5	5.8	5.6	15.5	0.0	5.4	2.2	17.6	3.5	1.7	37.4	9.4	0.0	1.0	3.1	15.0	10.8	0.8	0.0	82.4	0.0	6.0	0.0	54.8	34.4	3.7	2.1	12.8	0.6	9.6	2.4	11.6	4.9	3.9	0.0	16.0	6.6	4.6	3.2	7.8	7.5	7.7	0.7	14.5	12.9	2.8
ZSCAN9	"PRD51, ZNF193"	ENSG00000137185	"Zinc finger and SCAN domain containing 9"	O15535	6	28224886-28233487	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA054512, HPA059951"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA054512: AB_2682511, HPA059951: AB_2684176"	"unprognostic (1.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.69e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.14e-3)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.74e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.16e-5)"	9.7	11.2	11.3	8.9	12.6	10.7	13.9	15.0	13.8	14.5	14.4	13.4	9.2	14.2	13.4	7.9	11.4	9.4	11.8	11.1	12.6	15.2	9.3	10.1	8.6	12.4	12.5	14.3	12.1	11.5	14.2	11.2	12.9	14.6	14.8	17.4	11.6	11.8	9.1	6.4	12.9	11.7	12.2	16.3	11.8	20.9	12.6	4.4	13.2	7.9	10.3	12.0	10.3	13.4	11.2	7.7	25.7	30.9	9.8	10.6	8.9	13.5	11.3	12.9	14.4	7.1	5.5	0.1	19.9	8.5	12.5	7.7	12.3	12.5	14.6	7.5	10.6	17.1	16.8	13.1	12.4	20.4	13.1	9.1	19.1	10.9	16.6	19.5	16.9	0.0	25.8	9.3	19.2	6.5	0.1	33.4	9.5	5.0	8.6	10.5	17.9	11.7	16.3	15.4	22.3	30.0	11.8	8.8	16.3	19.1	10.9	13.8	13.9	26.2	18.0	6.3	23.2	20.8	22.5	4.5	5.4	24.6	15.4	4.3	3.5	5.1	3.5	1.8	2.9	4.7	1.2	2.7	5.0	4.0	0.4	0.7	1.3	11.7	0.9	2.6	0.9	2.2	11.3	12.6	15.0	13.8	11.1	12.6	12.4	12.5	12.9	12.2	12.6	13.4	6.1	9.6	3.6	5.9	4.4	0.9	5.3	8.0	0.6	7.3	5.5	4.3	5.1	12.8	10.2	3.7	0.0	5.1	5.3	3.8	1.9	8.5	21.5	2.5	4.9	6.5	5.4	4.0	4.5	6.4	3.1	5.3	2.0	3.6	5.7	7.3	5.7	2.4	5.4	6.7	4.7	6.9	4.1	5.3	4.6	5.1	3.7	5.0	3.6	10.3	3.1	4.8	4.1	8.0	10.0	6.1	6.1	4.9	3.6	3.5	4.9	3.8	4.8	6.6	6.6	5.0	5.3	23.7	15.8	3.1	1.1	12.0	2.3	5.8	6.7	2.5
ZXDA	ZNF896	ENSG00000198205	"Zinc finger X-linked duplicated A"	P98168	X	57905430-57910458	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA043789	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA043789: AB_2678673"	"unprognostic (1.53e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.85e-3)"	"unprognostic (6.50e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.27e-2)"	2.2	2.0	1.7	1.7	2.6	2.9	2.5	4.4	2.0	2.5	0.1	1.7	1.4	2.8	2.1	1.4	3.1	1.9	2.1	1.6	1.8	2.1	1.8	1.9	2.9	2.3	2.0	4.5	2.4	2.7	1.1	1.0	2.3	2.8	1.5	1.8	1.7	2.4	3.1	1.6	1.4	2.1	1.9	3.2	2.5	0.9	2.1	2.2	3.0	3.0	2.5	1.7	1.2	3.9	1.8	1.6	0.5	2.0	2.1	2.9	1.2	1.1	2.0	1.3	1.5	0.3	1.3	4.2	2.5	2.7	1.5	1.7	1.9	2.2	1.3	3.0	3.0	0.5	1.4	0.0	3.1	0.0	0.2	2.4	4.6	2.0	4.3	2.5	2.5	2.4	0.6	0.1	3.0	1.5	1.9	1.0	2.1	0.3	1.3	2.0	1.5	1.1	1.4	1.6	0.2	1.7	2.3	1.6	1.8	2.6	2.1	1.5	1.7	2.2	4.7	0.6	1.1	0.0	0.0	2.2	1.6	1.8	1.4	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.2	0.0	1.7	2.6	4.4	2.0	1.6	1.8	2.3	2.0	2.3	1.9	2.1	3.9	4.1	0.0	0.5	1.0	5.6	9.3	4.2	1.5	8.0	2.8	1.6	1.4	2.3	2.8	1.4	1.8	4.2	0.9	1.7	0.6	0.0	1.6	0.0	1.5	1.6	3.3	1.2	0.0	2.6	0.8	0.7	2.8	3.6	1.9	1.3	1.5	0.7	0.7	1.1	3.3	3.7	1.4	2.0	1.9	2.9	0.0	2.5	1.3	3.6	3.7	0.7	1.9	0.0	2.5	5.8	0.9	0.8	1.2	4.7	2.2	0.5	1.6	1.2	2.4	0.0	2.9	2.4	0.0	0.4	1.4	6.5	0.8	3.2	1.4	1.1	2.8